Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
36 "Diabetic nephropathies"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Review
Complications
Article image
Non-Albuminuric Diabetic Kidney Disease: Pathophysiology and Clinical Implications
Eun Roh, Nan Hee Kim
Diabetes Metab J. 2026;50(6):1058-1069.   Published online November 1, 2026
DOI: https://doi.org/10.4093/dmj.2026.1009
  • 587 View
  • 36 Download
AbstractAbstract PDF
Diabetic kidney disease traditionally progresses from glomerular hyperfiltration to albuminuria and kidney function loss. However, many individuals with type 2 diabetes mellitus develop reduced kidney function without increased urinary albumin excretion. This non-albuminuric phenotype accounts for approximately 20%–40% of diabetic kidney disease and 39%–55% of cases with reduced kidney function and is increasingly prevalent. Its emergence may reflect changes in disease biology and clinical management, including renin-angiotensin system blockade, improved cardiovascular risk factor control, and population aging. Histological, imaging, and biomarker studies suggest less prominent classic glomerular injury and greater contributions from intrarenal vascular disease, tubulointerstitial injury, and previous acute kidney injury. Kidney outcomes are generally more favorable than in albuminuric diabetic kidney disease, but associations with mortality remain inconsistent and may be influenced by coexisting cardiovascular disease. Treatment evidence is limited because most landmark kidney outcome trials preferentially enrolled patients with albuminuria, leaving uncertainty about optimal management. This review summarizes evidence on the epidemiology, pathophysiology, clinical characteristics, prognosis, and treatment of non-albuminuric diabetic kidney disease, highlighting its heterogeneity and clinical implications.
Original Articles
Complications
Article image
Differential Associations of Social Determinants of Health with Diabetic Kidney Disease and Treatment Targets in Korean Adults with Diabetes
Yeoree Yang, Kyungdo Han, Young-Sang Lyu, Yun Kyung Cho, Kyeong Hye Park, Sang Mo Hong, Committee of Planning, Korean Diabetes Association
Received May 13, 2026  Accepted July 26, 2026  Published online September 30, 2026  
DOI: https://doi.org/10.4093/dmj.2026.0534    [Epub ahead of print]
  • 984 View
  • 25 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Social determinants of health (SDOH) are linked to adverse diabetes outcomes internationally, but it remains unclear whether these associations are uniform or concentrated across major treatment targets in Korea’s universal-coverage setting.
Methods
We analyzed two Korea National Health and Nutrition Examination Survey cohorts (2021–2024, n=3,129; 2011–2014, n=2,602). A 4-item SDOH composite was derived from 14 candidate items; because the cohort×SDOH interaction was nonsignificant (P=0.36), the cohorts were pooled (n=5,731). Outcomes included diabetic kidney disease (DKD)-related laboratory abnormalities, defined using Kidney Disease: Improving Global Outcomes (KDIGO)-consistent single-measurement thresholds, severe hyperglycemia (glycosylated hemoglobin [HbA1c] ≥8%), uncontrolled blood pressure (≥140/85 mm Hg), and elevated low-density lipoprotein cholesterol (LDL-C; ≥100 mg/dL). Associations were analyzed using survey-weighted logistic regression adjusted for age, sex, body mass index, and cohort.
Results
The composite showed a dose-response association with DKD-related laboratory abnormalities (15.9% [score 0] to 34.2% [score ≥3]; odds ratio [OR] per +1 item, 1.23; 95% confidence interval [CI], 1.14 to 1.33; P<0.001). It was associated with severe hyperglycemia (OR, 1.13; 95% CI, 1.03 to 1.23), but not uncontrolled blood pressure (OR, 0.95; 95% CI, 0.88 to 1.02) or elevated LDL-C (OR, 1.00; 95% CI, 0.94 to 1.08). The HbA1c association was threshold-dependent, emerging only at severe-hyperglycemia levels. This pattern persisted among actively treated patients. Sequential adjustment for HbA1c ≥8% and blood pressure attenuated the SDOH–DKD association by less than 1%.
Conclusion
Cumulative social disadvantage was associated with DKD-related laboratory abnormalities and severe hyperglycemia, but not failure to meet blood pressure or lipid targets. These exploratory findings may inform future SDOH assessment in Korean diabetes care. Longitudinal registry-linked studies are needed to confirm chronicity and temporality.
Metabolic Risk/Epidemiology
Article image
Glucose-Independent Metabolic Signatures of SGLT2 Inhibition in Diabetic Kidney Disease: Integrated Insights from Mendelian Randomization and Transcriptomics
Yang Zhou, Jie Peng, Xuchang Zhou, Yucheng Wang, Guolin Hong, Xinguo Zhuang
Received December 16, 2025  Accepted March 18, 2026  Published online August 7, 2026  
DOI: https://doi.org/10.4093/dmj.2025.1273    [Epub ahead of print]
  • 2,255 View
  • 44 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Diabetic kidney disease (DKD) remains a major cause of terminal renal failure, with residual risk remaining unacceptably high despite standard glucose control. Although the sodium-glucose co-transporter 2 (SGLT2) inhibitors have proven reno-protective properties extending beyond that explained by glucose lowering alone, unique glucose-independent molecular mechanisms are still incompletely defined. Unveiling these non-glycemic metabolic pathways is of paramount importance for new therapeutic targets and optimized clinical management.
Methods
A systematic multi-omics triangulation framework integrating Mendelian randomization (MR) with tissue-specific transcriptomics was conducted. Two-sample MR and multivariable Mendelian randomization (MVMR) adjusted for fasting blood glucose were leveraged as a screening tool to detect glucose-independent serum metabolites in humans using large-scale genome-wide association study data. These findings were validated with transcriptomic signatures from both diabetic and non-diabetic mouse kidney models to identify conserved core genes and convergent metabolic pathways.
Results
Genetically proxied SGLT2 inhibition associated with a reduced risk of DKD, with an odds ratio of 0.58, and improved renal function markers. MVMR highlighted 259 glucose-independent metabolites, covering systemic alterations in lipid and amino acid metabolism. A cross-model transcriptomic comparison revealed seven key genes functionally enriched in fatty acid oxidation and ketone body utilization. This convergence supports the concept of a fasting-like metabolic switch and coordinated downregulation of fibrosis-related extracellular matrix pathways irrespective of diabetic status.
Conclusion
This study delineates a systemic-renal metabolic axis whereby SGLT2 inhibition drives renoprotection via metabolic reprogramming and anti-fibrotic mechanisms distinct from blood glucose lowering. These findings provide genetic evidence for specific non-glycemic targets and represent a novel mechanistic insight for precision therapeutic intervention in kidney disease.
Complications
Article image
Cardiorespiratory Fitness and Risk of Microvascular Complications in Patients with Type 2 Diabetes Mellitus
Anning Xu, Haofeng Zhou, Chaofan Wang, Qian He, Ping Wu, Wenjing Wu, Hongjiang Wu, Alice P.S. Kong, Huanyi Cao, Haixia Guan, Yunjiu Cheng
Received November 5, 2025  Accepted February 10, 2026  Published online May 18, 2026  
DOI: https://doi.org/10.4093/dmj.2025.1109    [Epub ahead of print]
  • 3,265 View
  • 65 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study investigated the association between cardiorespiratory fitness (CRF) and the risk of incident microvascular complications in patients with type 2 diabetes mellitus (T2DM), as well as the effects of genetic risk and potential mediation by circulating biomarkers.
Methods
This prospective analysis included 3,102 adults with T2DM from the UK Biobank. CRF was estimated as maximal oxygen uptake using a submaximal cycle test and categorized as low, moderate, or high. Cox proportional hazards models estimated hazard ratios (HRs) for incident diabetic nephropathy, retinopathy, and neuropathy. Interactions with a polygenic risk score and mediating roles of biomarkers were evaluated.
Results
Over a median follow-up of 12.47-years, 331 nephropathy, 268 retinopathy, and 88 neuropathy cases were recorded. Compared to low CRF, moderate and high CRF were associated with a 22% (HR, 0.78; 95% confidence interval [CI], 0.61 to 0.99) and 45% (HR, 0.55; 95% CI, 0.36 to 0.85) lower risk of nephropathy, respectively. Each 1-metabolic equivalent of task increment in CRF was linked to 11% lower nephropathy risk. No significant associations were found for retinopathy or neuropathy. Genetic predisposition did not modify the association between CRF and diabetic nephropathy. Triglycerides and white blood cell count accounted for 7.46% and 12.88% of the association, respectively.
Conclusion
Higher CRF is independently associated with a lower risk of diabetic nephropathy in T2DM, and genetic risk does not alter this relationship. The association is partially mediated by triglycerides and white blood cell count. Assessing CRF may improve risk stratification and prevention of diabetic kidney disease.
Review
Others
Article image
Neutrophil-Linked Inflammatory Mechanisms and Biomarkers in Diabetic Microvascular Complications
Junseo Kim, Daeun Jung, Da Hyun Kang, Hyeongseok Kim, Junyoung O. Park, Jun Young Heo, Seong Eun Lee, Hyun Jin Kim, Ju Hee Lee, Yea Eun Kang, Bon Jeong Ku
Diabetes Metab J. 2026;50(3):450-471.   Published online April 27, 2026
DOI: https://doi.org/10.4093/dmj.2025.1034
  • 6,188 View
  • 151 Download
AbstractAbstract PDFPubReader   ePub   
Diabetic microvascular complications, including nephropathy, retinopathy, and neuropathy, are major causes of morbidity in diabetes. Increasing evidence highlights neutrophils as key contributors to the chronic inflammatory processes underlying these complications. In the diabetic environment, neutrophils exhibit impaired recruitment, defective phagocytosis, dysregulated degranulation, and excessive production of reactive oxygen species and neutrophil extracellular traps (NETs). These dysfunctions not only reduce pathogen clearance but also exacerbate tissue injury through persistent low-grade inflammation. Furthermore, neutrophils interact with other immune cells, such as macrophages, dendritic cells, T cells, and B cells, perpetuating immune imbalance and tissue damage. Various neutrophil-derived cytokines and granular proteins also influence vascular permeability and endothelial dysfunction. In recent years, neutrophil-related biomarkers—such as absolute neutrophil count, neutrophil-to-lymphocyte ratio, platelet-to-neutrophil ratio, and systemic immune-inflammation index—have gained attention as accessible and cost-effective tools for predicting and monitoring diabetic microvascular complications. This review summarizes the multifaceted roles of neutrophils in the pathogenesis of diabetic microvascular disease and highlights emerging clinical applications of neutrophil-based inflammatory biomarkers. A better understanding of neutrophil-driven mechanisms may open new avenues for early diagnosis, therapeutic intervention, and personalized care in diabetic patients.
Original Articles
Basic and Translational Research
Article image
Characterizing the Immune Cell Infiltration in Renal Interstitium and Therapeutic Targets of Drugs in Diabetic Nephropathy by Multiomics Study
Chongbin Liu, Zurong Zhang, Yiyun Xi, Ming Yang, Huafeng Liu, Lin Sun
Diabetes Metab J. 2026;50(5):887-902.   Published online January 30, 2026
DOI: https://doi.org/10.4093/dmj.2025.0016
  • 4,926 View
  • 155 Download
  • 1 Web of Science
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Immune cell infiltration in the renal interstitium contributes to the progression of diabetic nephropathy (DN), yet the precise mechanisms remain incompletely unclear.
Methods
Public multi-omics datasets were integrated for comprehensive bioinformatic analyses. Interactions between infiltrating immune cells and damaged tubular epithelial cells (TECs) were analyzed with the CellChat, and key regulators were identified by machine learning. DN was modeled in C57BL/6 mice by high-fat diet/streptozotocin. Human kidney 2 (HK-2) cells were exposed to high glucose plus palmitic acid (HGPA). Gene function was validated by Western blotting, real-time quantitative polymerase chain reaction, immunohistochemistry and surface plasmon resonance (SPR).
Results
Renal interstitium from DN patients displayed markedly increased infiltration of M1 macrophages, regulatory T-cells, natural killer cells and other immune subsets, all correlating with indices of renal injury. CellChat analysis indicated that damaged TECs communicated with infiltrating immune cells primarily through chemokine networks centered on C-X-C motif chemokine ligand (CXCL), C-X3-C motif chemokine ligand (CX3CL), and C-C motif chemokine ligand 2 (CCL2). Retinoic acid-induced 2 (RAI2) was upregulated in DN kidneys and showed significant associations with immune infiltration and renal injury via these chemokine pathways. Consistently, RAI2 expression was elevated in kidneys of DN mice and in HGPA-treated HK-2 cells. SPR demonstrated direct, high-affinity binding of resveratrol to human RAI2 protein. Knockdown of RAI2 or treatment with resveratrol attenuated HGPA-induced apoptosis and suppressed CCL2, CXCL, and CX3CL expression levels.
Conclusion
RAI2 is a pivotal mediator of tubule injury and immune cell infiltration in DN, and resveratrol via direct binding to RAI2 and suppressed its function.
Complications
Article image
Optimizing Early Detection of Diabetic Kidney Disease through Synergistic Biomarkers and Serum Metabolites in Humans
Xianke Zhou, Yuan Gui, Jia-Jun Liu, Shijia Liu, Dongning Liang, Yuanyuan Wang, Henry Wells Shaffer, Samantha Mae Mallari, Cameron Jones, Priya Gupta, Dier Li, Ke Zhang, Ying Yu, Jianling Tao, Yanlin Wang, Silvia Liu, Dong Zhou, Haiyan Fu
Diabetes Metab J. 2026;50(4):752-769.   Published online January 29, 2026
DOI: https://doi.org/10.4093/dmj.2025.0193
  • 6,031 View
  • 184 Download
  • 3 Web of Science
  • 3 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Diabetic kidney disease (DKD) often progresses to end-stage renal disease more rapidly than nondiabetic kidney disease because of persistent hyperglycemia and early activation of multiple pathogenic pathways. Early detection of DKD is crucial for identifying subtle kidney damage before clinical symptoms appear.
Methods
This study combined human serum proteomics with public single-cell RNA sequencing and spatial transcriptomics data from diabetic kidneys to identify key biomarkers for DKD diagnosis. These biomarkers were validated in multiple organs of db/db mice at early and advanced stages. In a discovery cohort, sera from 173 healthy adults and 444 patients with type 2 diabetes mellitus (T2DM), with or without kidney disease, were analyzed using metabolomics and enzyme-linked immunosorbent assay (ELISA). Multiple machine learning algorithms were developed to integrate synergistic biomarkers and serum metabolites for early DKD detection, with results validated in 435 participants from four independent clinical cohorts.
Results
Metalloproteinase-7 (MMP-7) and tenascin C (TNC) were elevated in human diabetic kidneys at the single-cell and spatial levels. Proteomics indicated upregulation of serum amyloid A1 (SAA1) and TNC in the serum of patients with DKD. In db/db mice, all three biomarkers increased in multiple organs by 18 weeks of age. In sera from patients with DKD, MMP-7 and TNC levels were consistently elevated across cohorts. The new algorithms combining MMP-7, SAA1, and TNC enhanced early-stage DKD detection, with approximately 13% improvements in accuracy when serum metabolites were included to distinguish progression from early to advanced DKD stages.
Conclusion
Integrating synergistic biomarkers with serum metabolomics enhances the early detection of DKD, potentially improving outcomes by slowing disease progression in patients with T2DM.

Citations

Citations to this article as recorded by  
  • Recent advances in point-of-care colorimetric biosensors for detecting small molecule metabolites
    Zhiqiang Zhu, Zhun Gu, Xinxing Cao, Shanshan Zhang, Shao Su
    Chemical Communications.2026; 62(48): 12000.     CrossRef
  • Pathology-Anchored Biomarker Research Progress for the Early Diagnosis of Diabetic Kidney Disease: From Pathological Association to Early Validation
    Qiu Li, Mei Yang, Yingyu Luo, Nannan Zhang
    Biomedicines.2026; 14(7): 1643.     CrossRef
  • A hypoxia-derived seven-gene signature reflects immune remodeling in diabetic kidney disease: integrated transcriptomic analysis and experimental validation
    Yue Ji, Jiakun Zhang, Xi Guo, Yunming Xiao, Tieshan Wang, Yifei Zhang, Zhixun Guo, Yuqi Wu, Liangzhen You, Wei Jing Liu
    Diabetes Research and Clinical Practice.2026; 241: 113568.     CrossRef
Basic and Translational Research
Article image
Interactions between Tau Phosphorylation and Endoplasmic Reticulum Stress in Diabetic Nephropathy
Eun Soo Lee, Jeong Suk Kang, Seong-Woo Lee, Su Ho Jo, Ji-Hye Lee, Eun Young Lee, Choon Hee Chung
Diabetes Metab J. 2026;50(5):938-951.   Published online November 11, 2025
DOI: https://doi.org/10.4093/dmj.2024.0618
  • 5,119 View
  • 114 Download
  • 1 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Tau is a microtubule-associated protein whose abnormal phosphorylation disrupts the cytoskeleton and induces cell death. While its role is well known in neurodegenerative diseases, its function in kidney pathology, particularly diabetic nephropathy (DN), is not well understood.
Methods
DN was induced in NADPH oxidase 5 (NOX5) pod+ mice through a high-fat diet (HFD; 60% kcal fat) for 3, 6, and 12 weeks. Kidney tissues and cultured mesangial cells were analyzed for tau phosphorylation at specific residues (Ser202 and Thr205), fibrosis markers (e.g., α-smooth muscle actin), and endoplasmic reticulum (ER) stress. Tau phosphorylation was modulated using thousand and one amino acid kinase inhibitor and ER stress inhibitors. Immunohistochemistry was also performed on human renal biopsy samples from DN patients.
Results
pTau Ser202 and Thr205 expression levels were elevated by 6 weeks of the HFD and remained persistently upregulated at 12 weeks. Human biopsy analysis further revealed elevated pTau Ser202 and Thr205 expression in the patients with DN, which correlated with proteinuria. In NOX5 pod+ mice, early metabolic changes developed by HFD led to tau phosphorylation and kidney damage. Transforming growth factor β-induced fibrosis or thapsigargin-induced ER stress increased tau phosphorylation, while inhibiting tau phosphorylation or ER stress alleviated mesangial cell damage.
Conclusion
Our findings demonstrate that site-specific tau phosphorylation is associated with renal injury in DN and may serve as a potential marker of disease severity. The interplay between tau phosphorylation and ER stress appears to contribute to disease progression. Targeting tau phosphorylation and its upstream stress pathways may offer new therapeutic strategies for DN.

Citations

Citations to this article as recorded by  
  • Targeting the PD-L1-induced PDK4/GLS metabolic axis overcomes anti-PD-1 resistance in non-small cell lung cancer
    Wenxin Lian, Hui Yang, Yuqi Zhang, Chenchen Liu, Chunyao Fang, Mengyue Xu, Yixing Yang, Yan Wang, Runqiu Jiang, Jing Xu, Wen Gao
    Journal for ImmunoTherapy of Cancer.2026; 14(9): e015037.     CrossRef
  • Tau beyond the Brain: Endoplasmic Reticulum Stress and Tau Phosphorylation as Emerging Drivers of Diabetic Nephropathy
    Na-Yeong Kim, Chang-Myung Oh
    Diabetes & Metabolism Journal.2026; 50(5): 884.     CrossRef
Basic and Translational Research
Article image
STING Promotes Renal Fibrosis in Diabetic Kidney Disease via ID1-Dependent Epithelial-Mesenchymal Transition
Hongya Wang, Xiaobing Mao, Yuqing Huang, Xiaozhen Tan, Yuling Yang, Mengting Huang, Zongzhe Jiang, Yang Long, Xia Fang, Yong Xu
Diabetes Metab J. 2026;50(4):724-738.   Published online October 28, 2025
DOI: https://doi.org/10.4093/dmj.2024.0645
  • 24,442 View
  • 163 Download
  • 4 Web of Science
  • 4 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Tubulointerstitial fibrosis (TIF) due to epithelial-mesenchymal transition (EMT) is an inseparable feature of diabetic renal fibrosis. Although stimulator of interferon genes (STING) has been shown to play a potential role in regulating EMT, whether and how it modulates EMT in diabetic kidney disease (DKD) mice remain unclear. Here, we investigated the role and underlying mechanisms of STING-mediated EMT in TIF in DKD.
Methods
STING expression was detected in human renal biopsy tissues and serum samples from patients with DKD. Mouse models with genetic STING deletion or pharmacological by a STING inhibitor (C176) were established to further investigate the functions of STING in vivo. The in vitro roles of STING were analyzed in human renal tubular epithelial (HK2) cells with STING overexpression or knockdown. RNA sequencing was used to explore the underlying mechanisms.
Results
STING was upregulated in the kidneys and serum of patients with DKD and was negatively correlated with kidney function. STING deletion or pharmacological inhibition with C176 ameliorated pathological lesions, renal dysfunction and fibrosis in mouse models of DKD. STING deficiency alleviated renal fibrosis in DKD mice by inhibiting EMT. Mechanistically, RNA sequencing identified, inhibitor of differentiation 1 (ID1) as a downstream molecule of STING. Inhibition of ID1 in the setting of STING overexpression suppressed EMT and renal fibrosis.
Conclusion
Our study provides evidence that STING deficiency relieves renal fibrosis by inhibiting ID1-mediated EMT and that inhibition of STING and ID1 has therapeutic potential for patients with DKD.

Citations

Citations to this article as recorded by  
  • The Role and Therapeutic Potential of the STING Signaling Pathway in the Pathogenesis of Diabetic Nephropathy
    Xin-Yuan Zhang, Yan Hu, Ming-Tan Tang
    Pharmaceuticals.2026; 19(6): 927.     CrossRef
  • S100A1 Promotes MDM2‐Mediated KLF15 Ubiquitination to Regulate ID1‐Driven Tubular Injury in Diabetic Kidney Disease
    Zhitao Zeng, Jiazhen Shang, Shouyu Chai, Xia Zhang, Xincong Lv, Xiaotian Han, Yifan Xu, Baoze Ma, Zhimei Lv, Rong Wang
    The FASEB Journal.2026;[Epub]     CrossRef
  • Free Mitochondrial DNA and Mitophagy Dysfunction in Diabetic Kidney Disease: A Central Mitochondrial–Inflammatory Axis Driving Progressive Renal Injury
    Aasthika Das, Eric Lalu, Vikky Awasthi, Cyrine Ben Dhaou, Hebaalaha Hussein, Glenn Gerhard, Karim Bahmed, Iris Lee, Vishwajeet Puri, Rihab Bouchareb
    Cells.2026; 15(19): 1746.     CrossRef
  • Intrinsic Inflammatory Signaling in Life and Death of Podocytes
    Danila E. Bobkov, Sofya A. Konopleva, Dmitry A. Osin, Oleg N. Demidov, Veronika S. Mihailovskaya
    International Journal of Molecular Sciences.2026; 27(21): 9923.     CrossRef
Review
Pharmacotherapy
Article image
SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application
Jae Hyun Bae
Diabetes Metab J. 2025;49(3):386-402.   Published online May 1, 2025
DOI: https://doi.org/10.4093/dmj.2025.0220
  • 46,241 View
  • 1,912 Download
  • 63 Web of Science
  • 70 Crossref
AbstractAbstract PDFPubReader   ePub   
Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease and significantly increases cardiovascular risk and mortality. Despite conventional therapies, including renin-angiotensin-aldosterone system inhibitors, substantial residual risk remains. The emergence of sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists has reshaped DKD management. Beyond glycemic control, these agents provide distinct and complementary cardiorenal benefits through mechanisms such as hemodynamic modulation, anti-inflammatory effects, and metabolic adaptations. Landmark trials, including CREDENCE, DAPA-CKD, EMPA-KIDNEY, and FLOW, have demonstrated their efficacy in preserving kidney function and reducing adverse outcomes. SGLT2 inhibitors appear more effective in mitigating glomerular hyperfiltration and lowering heart failure risk, whereas GLP-1 receptor agonists are particularly beneficial in reducing albuminuria and atherosclerotic cardiovascular events. Although indirect comparisons suggest that SGLT2 inhibitors may offer greater protection against kidney function decline, direct head-to-head trials are lacking. Combination therapy holds promise, however further studies are needed to define optimal treatment strategies. This review synthesizes current evidence, evaluates comparative effectiveness, and outlines future directions in DKD management, emphasizing precision medicine approaches to enhance clinical outcomes. The integration of these therapies represents a paradigm shift in diabetes care, expanding treatment options for people with diabetes mellitus at risk of kidney failure.

Citations

Citations to this article as recorded by  
  • Trends in nephrology: kidney metabolism as a therapeutic target
    Jessica S Kleer, Markus M Rinschen
    Nephrology Dialysis Transplantation.2026; 41(2): 193.     CrossRef
  • Renoprotective effect of dulaglutide in L-NAME-induced hypertensive nephropathy in rats: insight into the roles of PPAR-gamma and VEGF
    Nermeen Bastawy, Aliaa E. M. K. El-Mosallamy, Rabab Ahmed Rasheed, A. S. Sadek, R. T. Khattab, Esraa Ali, Randa A. Zaghloul, Wael B. A. Ghaly, Amy F. Boushra
    Hypertension Research.2026; 49(3): 816.     CrossRef
  • Sodium‐glucose cotransporter 2 inhibitor ameliorates thiazolidinedione‐induced fluid retention through vascular leakage reduction in white adipose tissue
    Ji Yoon Kim, Hye‐Min Jang, Hye‐Jin Lee, Ah Hyeon Lee, Dong‐Hoon Kim, Sin Gon Kim, Nam Hoon Kim
    Diabetes, Obesity and Metabolism.2026; 28(3): 1764.     CrossRef
  • Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex
    Changyuan Yang, Petra Denig, Lynne Chepulis, Ryan G. Paul, Jung‐Im Shin, Ron T. Gansevoort, Priya Vart
    Diabetes, Obesity and Metabolism.2026; 28(3): 2265.     CrossRef
  • GLP-1 Receptor Agonists and Blood Pressure: A State-of-the-Art Review of Mechanisms, Evidence, and Clinical Implications
    Areesha Moiz, Tetiana Zolotarova, Kristian B Filion, Mark J Eisenberg
    American Journal of Hypertension.2026; 39(5): 611.     CrossRef
  • Diabetic kidney disease: integrating multi-omics insights, artificial intelligence, and novel therapeutics for precision medicine
    Tao Li, Kaili Chen, Yiting Sun, Linqi Zhang
    Frontiers in Genetics.2026;[Epub]     CrossRef
  • Nobiletin Ameliorated the Development of Diabetic Kidney Disease via Modulating Ferroptosis and Epithelial–Mesenchymal Transition Involving Gut–Kidney Axis
    Tingting Zhao, Chuyun Zhao, Qian Xiang, Xi Zhang, Kin-Fong Hong, Peiyu Liu, Zhongyan Sun, Yadi Liu, Ruiting Huang, Yiran Li, Hio-Fai Cheong, Yuwei Wu, Yingqiu Mo, Yiduo Xu, Yingxi Zhao, Qiruo Huang, Ying Xie, Youhua Xu
    The American Journal of Chinese Medicine.2026; 54(01): 303.     CrossRef
  • Bridging Innovation and Practice in Type 2 Diabetes Mellitus: Novel Antidiabetic Therapies and the Expanding Role of Community Pharmacists
    Marios Spanakis, Agapi Fournaraki, Frantzeska Nimee, Christos Kontogiorgis, Emmanouil K. Symvoulakis
    Pharmaceuticals.2026; 19(2): 271.     CrossRef
  • Diabetic kidney disease in northwest Ethiopia: Prevalence and determinants among adults with type 2 diabetes
    Workagegnehu Hailu, Tadesse Asmamaw Dejene, Markeshaw Tiruneh, Meseret Derbew Molla, Eshetie Melese Birru, Shitaye Alemu, Tadesse Awoke, Francesca D'Addio
    PLOS One.2026; 21(2): e0343210.     CrossRef
  • The Role of Non-Coding RNAs in the Pathogenesis and Progression of Diabetic Kidney Disease
    Yinfeng Guo, Yonghao Feng, Henglan Wu, Huanqing Gao
    International Journal of Molecular Sciences.2026; 27(5): 2352.     CrossRef
  • Association between cardiovascular-kidney-metabolic syndrome stages and risk of all-cause mortality in U.S. adults: a cross-sectional survey based on NHANES
    Yuanze Du, Wenxue Sun, Jiaqi Zhang, Jinfeng Wang, Kai Deng, Xiaowei Qiao, Jie Zhang, Xiaofang Zhang, Yueyuan Li, Xinyu Zhang, Xin Yang, Fangyu Cheng, Zongshuai Wang, Chunping Wang
    BMC Cardiovascular Disorders.2026;[Epub]     CrossRef
  • Integrated discovery of SBLR876: a potent RAGE inhibitor mitigating AGE–RAGE–NF-κB-mediated cytotoxicity and inflammation in diabetic kidney disease
    Mesfer Mohammad AL Shahrani, Mohammad Abohassan, Ayed A. Dera, Sivakumar Vijayaraghavalu, Prasanna Rajagopalan
    Biochemical and Biophysical Research Communications.2026; 811: 153540.     CrossRef
  • Glucagon-like peptide-1 receptor agonist and lupus nephritis in systemic lupus erythematosus with type 2 diabetes
    Muhammad Hanif, Jai S. Nagarajan, Ryan Murphy, Shiva P. Sah, Shuang Ye, Andras Perl, Cynthia C. Taub
    The American Journal of Medicine.2026; 139(6): 769.     CrossRef
  • Impact of a structured nurse-delivered multi component SGLT2 inhibitor initiation and optimization pathway on kidney function and clinical outcomes in type 2 diabetes and chronic kidney disease: a real-world retrospective study
    Liang Huang, Muhui Yi
    BMC Nephrology.2026;[Epub]     CrossRef
  • Інгібітори натрій-глюкозного котранспортера 2-го типу в контексті кардіоренально-метаболічної коморбідності. Частина 2: метаболомічні аспекти нефропротекції
    Vira V. Zlatkina, Andriy O. Nesen, Nadiia V. Demikhova
    Ukrainian Journal of Nephrology and Dialysis.2026; (1(89)): 94.     CrossRef
  • Kidney angiopoietin-like protein 4 regulates fibrotic responses in diabetic kidney disease
    Swayam Prakash Srivastava, Ajan Vishnu Arora, Mariam Hamed, Adesh Urval, Aashika Dupati, Shangyang Xia, Shota Yoshida, Ken Inoki
    Frontiers in Pharmacology.2026;[Epub]     CrossRef
  • Prediction model for rapid estimated glomerular filtration rate decline in type 2 diabetes mellitus
    Peng Huang, Xue-Qiong Qin, Qing Huang, Si-Dan Wang, Yuan-Yuan Wu, Xiu-Rong Huang, Xu Lin
    World Journal of Diabetes.2026;[Epub]     CrossRef
  • Integrated analysis of the circRNA–miRNA–mRNA regulatory network underlying the therapeutic effects of Jinkui Shenqi Wan, a traditional Chinese medicine formula, in diabetic kidney disease: A network pharmacology and bioinformatics study
    Yao Xu, Qingying Tan, Tianxiao Hu, Yanxia Ren, Jiaqi Yao, Xiujing Wang, Peiwu Jiang
    Medicine.2026; 105(16): e48377.     CrossRef
  • Fatty Kidney: The Interplay of Lipids and Diabetic Kidney Disease
    Zhiyue Zou, Pan Gao, Qian Yuan, Zhiwen Wang, Pengli Luo, Chun Zhang
    Biomedicines.2026; 14(4): 944.     CrossRef
  • Efficacy and safety of anagliptin added to metformin and empagliflozin 25 mg in patients with type 2 diabetes: a 24-week randomized, double-blind, placebo-controlled phase 3 trial with 28-week open-label extension
    Jun Sung Moon, Kyung-Ah Han, Jae Myung Yu, Jong Chul Won, Jun Goo Kang, Soojin Park, Cheol-Young Park
    Diabetes Research and Clinical Practice.2026; 236: 113272.     CrossRef
  • Inflammation mediates the association of heavy metal exposures with kidney function: Evidence from a longitudinal study
    Jingtao Wu, Amujilite, Guohuan Yin, Ziyu Dong, Jing Xu, Qun Xu
    Ecotoxicology and Environmental Safety.2026; 316: 120174.     CrossRef
  • From Single-target to System Remodeling:Combination Therapeutic Strategies for Metabolic Diseases
    Zhifu Xie, Jingya Li
    Bulletin of National Natural Science Foundation of China.2026; 40(2): 301.     CrossRef
  • Should Incretin Agonist-Based Drugs be Considered for First Line Antihypertensive Therapy?
    Dominik Kylies, Leonie Dreher, Ulrich O. Wenzel
    Current Hypertension Reports.2026;[Epub]     CrossRef
  • Comparative effectiveness of SGLT-2 inhibitors and GLP-1 receptor agonists on the risk of incident dementia after acute kidney injury: a target-trial emulation
    Ying-Ru Chen, Zheng-Hong Jiang, Jui-Yi Chen, Vin-Cent Wu
    GeroScience.2026;[Epub]     CrossRef
  • Protective effects of SGLT2 inhibitors and GLP-1 receptor agonists on infection-related implant failure following ankle fracture ORIF: A global big data analysis
    Mao Yi Yang, Li Wei Hung
    Journal of Orthopaedic Surgery.2026;[Epub]     CrossRef
  • Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi Consensus
    Yehuda Handelsman, Alice Y. Y. Cheng, Gian Paolo Fadini, Pam Kushner, Fabrice Bonnet, Paola Fioretto, Takashi Kadowaki, Naresh Kanumilli, Xavier Cos, Thomas Frese, Linong Ji, Peter Rossing
    Advances in Therapy.2026; 43(9): 3886.     CrossRef
  • Inotodiol ameliorates oxidative stress and apoptosis by regulating PI3K/Akt/GSK-3β signaling pathways in diabetic nephropathy
    Lingling Tian, SiJie Zhang, Ziyang Ye, Jianbo Qing, Feng Wu, Qian Wang, Rongshan Li, Yafeng Li, Qi Duan
    Renal Failure.2026;[Epub]     CrossRef
  • Personalizing Cardio-Kidney-Metabolic Therapy
    Qandeel H. Soomro, David M. Charytan
    Journal of the American Society of Nephrology.2026; 37(8): 1619.     CrossRef
  • Molecular Pathways of Cardiometabolic Residual Risk in Type 2 Diabetes: Insulin Resistance, Metaflammation, and Liver–Kidney–Vascular Crosstalk
    Antonio Maria Labate, Elena Cimino, Laura Giacomelli, Stefano Ettori, Oladayo Adigun Oladeji, Barbara Agosti
    International Journal of Molecular Sciences.2026; 27(14): 6170.     CrossRef
  • Revisiting Insulin Resistance in the Pathophysiology of Type 2 Diabetes Mellitus: A Multi-Organ Perspective
    Soo Lim, Seung-Hwan Lee, Robert H. Eckel
    Diabetes & Metabolism Journal.2026; 50(4): 641.     CrossRef
  • Molecular and cellular mechanisms of GLP-1 receptor agonists and their emerging clinical applications
    Mateusz Kurowski, Katarzyna Rekiel, Aleksandra Marcinkowska, Oskar Ratajczyk, Piotr Urbanowicz, Stanisław Iwankiewicz, Wojciech Grzelczak, Zuzanna Kaz mierczak
    Medical Journal of Cell Biology.2026; 14(2): 40.     CrossRef
  • Ozone-induced renal homeostasis disruption in diabetic mice: The role of Th17/Treg imbalance and drug intervention
    Ruru Meng, Jingge Cao, Shurui Wang, Donglei Wang, Shanshan Feng, Ruohui Chen, Caixia Guo, Min Zhang, Yanbo Li
    Journal of Hazardous Materials.2026; 515: 143029.     CrossRef
  • Renal Replacement Therapy in Cardiovascular-Kidney-Metabolic Syndrome: Challenges for Dialytic Therapies and Kidney Transplantation
    Mahtab Mashayekhi, Jasjot Bhullar, Zohreh Gholizadeh Ghozloujeh, Sayna Norouzi, Khalil Pathan, Amir Abdipour
    Cardiorenal Medicine.2026; 16(1): 357.     CrossRef
  • From FLOW to translational positioning in chronic kidney disease: mechanistic complementarity of SGLT2 inhibitors and GLP-1 receptor agonists
    Xue Tian, Xiaoying Ma, Enxue Song, Xilian Li, Wenlan Fu, Haiwei He, Zhiyuan Gao, Biao Gao
    Translational Research.2026; 296: 86.     CrossRef
  • From Risk Determinants to Clinical Action
    Tazeen H. Jafar, Anqi Zhu, Oluwabunmi Ogungbe
    Clinical Journal of the American Society of Nephrology.2026;[Epub]     CrossRef
  • Cardiometabolic Syndrome Part 2: Pharmacological Management, Public Health Strategies, and Future Direction
    Soo Lim, You-Cheol Hwang, Jang Won Son, Seung-Hwan Lee, Chang Hee Jung, Hyun-Jin Kim, Hyunjung Lim, Seong-Mi Park, Jang-Young Kim, Jong Chan Youn, Sung Kee Ryu, Sihoon Lee, Min-Jeong Shin, Sae Young Jae, Hun-Jun Park, Sang Min Park, Børge G Nordestgaard,
    CardioMetabolic Syndrome Journal.2026; 6(2): 193.     CrossRef
  • Real-World Prescribing Patterns and Clinical Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Empagliflozin-Sitagliptin-Metformin Fixed-Dose Combination Therapy
    Balaji T Naik, Shrimant Y, Debasish Patro, Suryakant Pankaj, Manoj Gaur, George Paulose, Rohan Kate, Dilip Gude, Ashish Patel, Sumit Sarkar, Aadil B Wasil, Utsa Basu, Ankit Chhabra, N Thyagarajan, Gurunath Chavan, Pradip Mate
    Cureus.2026;[Epub]     CrossRef
  • Lifestyle Medicine as Co-Therapy During Incretin-Based Anti-Obesity Pharmacotherapy: Integrating Physical Activity, Nutrition, and Behavioral Strategies for Long-Term Success
    Marta Mallardo, Antonietta Messina, Vincenzo Monda, Marco La Marra, Antonietta Monda, Salvatore Allocca, Maria Casillo, Girolamo Di Maio, Pasquale Perrone, Aurora Daniele, Marcellino Monda, Giovanni Messina, Fiorenzo Moscatelli, Rita Polito
    Nutrients.2026; 18(17): 2748.     CrossRef
  • Unveiling the molecular toxicity of plasticizers derived from microplastics (DMP and DEP) in diabetic kidney disease: integrative insights from network toxicology and multi-omics analysis
    Kaifeng Xie, Jiasheng Huang, Shiyun Ling, Xinyu Shi, Hesheng Li, Renfa Huang, Hanli Lin
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • Short-Term Comparative Effects Of Semaglutide, Either Alone Or In Conjunction With Canagliflozin, On Early Diabetic Kidney Disease
    Wang Long
    Pakistan Journal of Pharmaceutical Sciences.2026;[Epub]     CrossRef
  • Efficacy and Safety of Enavogliflozin as Add-on in Adults with Type 2 Diabetes Mellitus Inadequately Controlled with Insulin or Insulin with Other Antidiabetic Drugs
    Jun Hwa Hong, Kyung Wan Min, Chang Beom Lee, Parinya Chamnan, Thanitha Sirirak, Kiran Sony, Sarinya Sattanon, Hae Jin Kim, Sang-Yong Kim, Younghee Kim, Jung A Heo, Jae Min Cho, Jae Jin Nah, Mi Hee Park, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2026; 50(5): 952.     CrossRef
  • Beyond Fat Loss: Addressing the Sarcopenia Challenge of Incretin-Based Therapies
    Ji Yoon Kim, Nam Hoon Kim
    Diabetes & Metabolism Journal.2026; 50(5): 844.     CrossRef
  • Hypothalamic Inflammaging: A Central Driver of Type 2 Diabetes Mellitus and Metabolic Disease in Aging
    Sang Hee Lyoo, Ki Hun Kim, Ki Woo Kim
    Diabetes & Metabolism Journal.2026; 50(5): 863.     CrossRef
  • Associations Between Antidiabetic Pharmacotherapy and Hearing Thresholds in Adult Hearing‐Impaired Patients With Type 2 Diabetes
    Francesco Martines, Pietro Salvago, Francesca Vaccaro, Davide Vaccaro, Ginevra Malta, Fabiana Plescia, Stella Cascioferro, Gianluca Lavanco, Fulvio Plescia
    Pharmacology Research & Perspectives.2026;[Epub]     CrossRef
  • A hypoxia-derived seven-gene signature reflects immune remodeling in diabetic kidney disease: integrated transcriptomic analysis and experimental validation
    Yue Ji, Jiakun Zhang, Xi Guo, Yunming Xiao, Tieshan Wang, Yifei Zhang, Zhixun Guo, Yuqi Wu, Liangzhen You, Wei Jing Liu
    Diabetes Research and Clinical Practice.2026; 241: 113568.     CrossRef
  • Dysregulation of the miR-4286 in diabetic kidney disease and its role in inflammatory response
    Jiayong Zhang, Qilin Tang, Mengmeng Pu, Lin Yan, Yijun Chen, Bin Wang
    Diabetology & Metabolic Syndrome.2026;[Epub]     CrossRef
  • Beyond waste: arginine metabolism and ammonium detoxification in cardiovascular–renal–metabolic disease
    Lauren Peysakhova, Maria Chrysopoulou, Markus M. Rinschen
    Trends in Endocrinology & Metabolism.2026;[Epub]     CrossRef
  • Metabolic reprogramming and metabolic homeostasis in podocyte injury: novel mechanistic insights and natural product therapies
    Zhongjie Qu, Wenqing Ba, Meijing Tang, Wenze Jiang, Mengting Zhu, Keda Lu
    Frontiers in Cell and Developmental Biology.2026;[Epub]     CrossRef
  • Endoplasmic reticulum stress and organelle crosstalk: Core mechanisms and therapeutic targets in diabetic kidney disease
    Yanhong Gao, Huijun Wu, Henglan Wu, Yinfeng Guo, Huanqing Gao
    Metabolism Open.2026; 32: 100510.     CrossRef
  • Cardiorenal and survival outcomes of GLP-1 receptor agonist and SGLT-2 inhibitor therapy in diabetic kidney disease: two stage-stratified real-world comparisons
    Mona Mohammed Alshahrani, Ahmed Y. Azzam, Mahmoud M. Morsy, Haider Ali Omer, Saif Aboud M. Alqahtani, Amal Fahmy Dawood, Muhammed Amir Essibayi, Mohamed D. Morsy
    Scientific Reports.2026;[Epub]     CrossRef
  • Germacrone inhibits podocyte pyroptosis in diabetic kidney disease by modulating ABCA1 expression
    Binqi Wang, Bo Lin, Jiang Chen, Li Zhao, Yali Ye, Danna Zheng
    Journal of Molecular Histology.2026;[Epub]     CrossRef
  • Finerenone and SGLT2 Inhibitors in Cardiorenal Disease: A Phenotype-Based Approach to Nephroprotection
    Chiara Serpico, Ettore Luisi, Mariarosaria Morello, Achille Solimene, Matteo Granata, Benito Acampora, Gisella Titolo, Josephine Bernazeaut, Saverio d’Elia, Francesco S. Loffredo, Paolo Golino, Francesco Natale, Giovanni Cimmino
    Journal of Personalized Medicine.2026; 16(11): 557.     CrossRef
  • Changes in CBC-derived inflammatory indices following dapagliflozin initiation in patients with type 2 diabetes mellitus
    Hamood AlSudais, Abdulrahman Alshalani, Turky AlSulaiman, Fawziah AlShehri, Bandar Alqarni, Abdulaziz M. Almuqrin, Rehab B. Albakr, Jehad A. Aldali, Badi A. Alotaibi
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Changes in Metabolic and Blood Pressure Outcomes With Semaglutide Across Chronic Kidney Disease Stages: A Post Hoc Analysis of the FLOW Trial
    Allon N. Friedman, Jan Basile, Robert Busch, David M. Charytan, Kenneth W. Mahaffey, Sherif Mehanna, Søren Rasmussen, Peter Rossing, Caroline Swift, Katherine R. Tuttle, Richard Pratley
    Diabetes, Obesity and Metabolism.2026;[Epub]     CrossRef
  • Gut microbiota-associated metabolites and microbial products in diabetic kidney disease: linking intestinal dysbiosis, inflammation, and renal fibrosis
    Xiaoxiao Yu, Haina Liang, Zhenzhen Lin, Zhouxiang Shao
    Frontiers in Medicine.2026;[Epub]     CrossRef
  • Special Issue “Molecular Therapeutics for Diabetes and Related Complications”
    Kota V. Ramana
    International Journal of Molecular Sciences.2025; 26(12): 5585.     CrossRef
  • Targeting ion channel networks in diabetic kidney disease: from molecular crosstalk to precision therapeutics and clinical innovation
    Wenfeng Wang, Bi Ke, Chen Wang, Xiaojing Xiong, Xiuyuan Feng, Hua Yan
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular–Kidney–Metabolic Syndrome
    Aryan Gajjar, Arvind Kumar Raju, Amani Gajjar, Mythili Menon, Syed Asfand Yar Shah, Sourbha Dani, Andrew Weinberg
    Biomedicines.2025; 13(8): 1924.     CrossRef
  • Comparative analysis on renal and cardiovascular outcomes of antidiabetic treatment in chronic kidney disease patients—A systematic review and network meta‐analysis
    Peter Bramlage, Anjaly Vijayan, Treesa P. Varghese, Deepthy Melepurakkal Sadanandan, Stefanie Lanzinger, Carmen Ferrero Rodriguez
    Diabetes, Obesity and Metabolism.2025; 27(11): 6254.     CrossRef
  • Type 2 Diabetes and the Multifaceted Gut-X Axes
    Hezixian Guo, Liyi Pan, Qiuyi Wu, Linhao Wang, Zongjian Huang, Jie Wang, Li Wang, Xiang Fang, Sashuang Dong, Yanhua Zhu, Zhenlin Liao
    Nutrients.2025; 17(16): 2708.     CrossRef
  • Nutriomics and artificial intelligence nutrition obesity cohort (NAINOC): a design paper for a prospective cohort for nutrition and obesity research
    Minyoung Lee, Sungha Park, Soo-Hyun Park, Ho-Young Park, Yu Ra Lee, Min-Sun Kim, Miso Nam, Jangho Lee, Hyein Seo, Yong-ho Lee, Chan Joo Lee, Jae-Ho Park, Hye Hyun Yoo, Hyun-Jin Kim, Kyong-Oh Shin, Yoshikazu Uchida, Kyungho Park
    Clinical Hypertension.2025;[Epub]     CrossRef
  • Microvascular Outcomes of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Type 2 Diabetes: A Systematic Review of Retinopathy and Nephropathy Evidence
    Atia Arif, Sanu Lama, Bhavna Singla, Shivam Singla, Sunita Kumawat, Anusha Tharwani, Muhammad Usman, Hamna Khalid, Venkata Madusudana Rao Kanukollu, Osatohanmwen Ekomwereren, Shabir Khan
    Cureus.2025;[Epub]     CrossRef
  • Integrating UHPLC-QE-MS and Bioinformatics with Experimental Validation Reveals MAPK/FOS-Mediated Podocyte Apoptosis as the Key Mechanism of Alpiniae oxyphyllae and Saposhnikovia divaricata in Treating Diabetic Kidney Disease
    Xian Wang, Lin Zhang, Rongxin Tang, Wenlong Zhang, Yiqiang Xie, Kai Li
    Pharmaceuticals.2025; 18(10): 1449.     CrossRef
  • GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity
    Mark E. Cooper, Daniël H. van Raalte
    Journal of Clinical Investigation.2025;[Epub]     CrossRef
  • Short-Term Laboratory Outcomes of SGLT2 Inhibitor Use in Type 2 Diabetic Patients: A Retrospective Analysis
    Hamood AlSudais, Turky AlSulaiman, Badi A. Alotaibi, Abdulrahman Alshalani, Abdulaziz M. Almuqrin, Rehab B. Albakr, Jehad A. Aldali
    Journal of Clinical Medicine.2025; 14(22): 7985.     CrossRef
  • Chronic cardiorenal syndrome: cardio-renal protective effect of SGLT2i
    Yixin Zhu, Chenxi Lv, Hanqi Yang, Qian Lu, XuChen Wang, Yueqi Zhang, Maojuan Guo, Bo Yang
    Renal Failure.2025;[Epub]     CrossRef
  • FGF4-FGFR1 signaling promotes podocyte survival and glomerular function to ameliorate diabetic kidney disease in male mice
    Jie Zhou, Shuxin Wang, Jiaxin Lou, Beibin Pan, Min Zhao, Qian Li, Jing Zhou, Yali Du, Shuodan Ding, Meiling Yu, Jingjing Zhou, Xinwei Chen, Lingwei Jin, Xinyi Wang, Yepeng Hu, Zhe Wang, Xiaokun Li, Chao Zheng, Jian Sun, Zhifeng Huang
    Nature Communications.2025;[Epub]     CrossRef
  • Food‐Herb Dual‐Function in Astragali Radix‐Poria‐Rheum: Network Pharmacology and Database Mining for Diabetic Kidney Disease Mechanisms Exploration
    Meizi Wang, Weizhong Li, Qiong Cheng, Jiayu Sun, Cheng Cheng, Nana Wang, Ping Zhou, Min Zha, Yufeng Yang
    Food Science & Nutrition.2025;[Epub]     CrossRef
  • Інгібітори натрій-глюкозного котранспортера 2-го типу в контексті кардіоренально-метаболічної коморбідності. Частина 1: основи патофізіології та ключові клінічні дослідження
    Vira V. Zlatkina, Andriy O. Nesen, Nadiia V. Demikhova
    Ukrainian Journal of Nephrology and Dialysis.2025; (4(88)): 88.     CrossRef
  • Long-term efficacy of dapagliflozin combined with Bifidobacterium triple viable tablets on metabolic syndrome and gut microbiota in overweight/obese patients with type 2 diabetes
    Kunyi Li, Zhi Li, Lifeng Liu
    Endocrine Connections.2025;[Epub]     CrossRef
Original Articles
Basic and Translational Research
Article image
Inflammatory Milieu by Crosstalk between Glomerulus and Proximal Tubular Cells in Type 2 Diabetes Mellitus Kidney Disease
Peong Gang Park, Juhyeon Hwang, Yongjun Kim, Minki Hong, Donghwan Yun, Haein Yoon, Chaelin Kang, Sohyun Bae, Soo Heon Kwak, Yong Chul Kim, Kyung Chul Moon, Dong-Sup Lee, Yon Su Kim, Hee Gyung Kang, Hyun Je Kim, Seung Seok Han
Diabetes Metab J. 2025;49(5):1024-1039.   Published online March 31, 2025
DOI: https://doi.org/10.4093/dmj.2024.0535
  • 9,155 View
  • 297 Download
  • 6 Web of Science
  • 7 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Due to the limited availability of therapeutic agents for type 2 diabetic kidney disease (T2DKD), there is a need for further knowledge derived from experimental models and innovative techniques. In addressing this issue, single-cell RNA sequencing (scRNA-seq) has been exclusively applied to a genetically modified diabetic kidney disease model, but not to an induced model representing T2DKD. Herein, we analyzed scRNA-seq and other experiments from an induced T2DKD model and validated the results in human-derived biospecimens.
Methods
The model was induced by combining a high-fat diet with streptozotocin to simulate induced T2DKD. scRNA-seq, histological, and flow cytometric analyses were conducted, and the results were compared with control mice. The findings were then applied to human T2DKD kidneys.
Results
Biochemical and histological analyses unveiled early-stage T2DKD features, such as hyperfiltration, increased proteinuria, glomerulomegaly, and interstitial fibrosis. scRNA-seq identified that proximal tubules secreted a variety of chemokines, potentially in response to crosstalk with glomeruli. Notably, C-X-C motif chemokine 12 (CXCL12) emerged as a key player in potentially promoting T-cell recruitment. Flow cytometry substantiated T-cell infiltration into the kidney of the T2DKD model. This finding was further corroborated in human biopsied kidney tissues, showing a correlation between elevated CXCL12 levels and T2DKD progression.
Conclusion
The induced T2DKD model highlights the pivotal role of CXCL12-mediated T-cell infiltration, stemming from the crosstalk between proximal tubules and glomeruli. This data serves as a foundation for future studies, promising a therapeutic target for T2DKD.

Citations

Citations to this article as recorded by  
  • Inflammation and Diabetic Kidney Disease
    Rong Mei Zhang, Maria Luiza Caramori
    International Journal of Molecular Sciences.2026; 27(2): 1097.     CrossRef
  • Research progress in single‑cell omics technologies for kidney disease (Review)
    Jia Xu, Ziwei Chen, Shengyao Li, Xiaoya Wang, Ming Chen
    International Journal of Molecular Medicine.2026; 57(5): 1.     CrossRef
  • SFRP2 aggravates diabetic kidney disease by repressing the renal protective CH25H/25-hydroxycholesterol axis in mesangial cells
    Dan Lv, Ziyue Lin, Jiakun Yang, Wuchao Li, Keqian Wu, Rui Peng, Handeng Liu, He Zha, Xiong Zhong Ruan, Xiaohui Liao, Yan Sun, Zheng Zhang
    Journal of Advanced Research.2026;[Epub]     CrossRef
  • Qiling Hushen Formula Ameliorates Type 2 Diabetic Kidney Disease via Gut‐Kidney Axis Restoration and TLR4/NF‐κB/NLRP3 Suppression
    Yuxin Wang, Pei Sheng, Xue Wang, Min Lin, Wentao Cai, Shiyao Wei, Yuyun Du, Ming Yan, Lei Wang, Xiaofei An, Haoqiang Zhang
    Journal of Diabetes Research.2026;[Epub]     CrossRef
  • Efficacy and safety of jinlida granule in the treatment of diabetic kidney disease: a systematic review and meta-analysis of randomized controlled trials
    Qi Yong, Yunxi Xu, Peiying Zhang, Hua Bai, Chao Xu, Hejiang Ye
    Frontiers in Pharmacology.2026;[Epub]     CrossRef
  • Glomerulo–Tubular Crosstalk in Diabetic Kidney Disease: From Pathophysiology to Novel Therapeutics
    Il Young Kim
    Electrolytes & Blood Pressure.2026; 24(2): 106.     CrossRef
  • Aging Mediates Inflammatory Transformation of Kidney-Resident Macrophages via Thrombospondin-1 Signaling
    Chaelin Kang, Donghwan Yun, Boyoun Jang, Yongjun Kim, Minki Hong, Juhyeon Hwang, Haein Yoon, Jeongmin Oh, Hyun Mu Shin, Kyung Chul Moon, Dong-Sup Lee, Yon Su Kim, Hyun Je Kim, Seung Seok Han
    Immune Network.2025;[Epub]     CrossRef
Complications
Article image
Does 10-Year Atherosclerotic Cardiovascular Disease Risk Predict Incident Diabetic Nephropathy and Retinopathy in Patients with Type 2 Diabetes Mellitus? Results from Two Prospective Cohort Studies in Southern China
Jiaheng Chen, Yu Ting Li, Zimin Niu, Zhanpeng He, Yao Jie Xie, Jose Hernandez, Wenyong Huang, Harry H.X. Wang, on Behalf of the Guangzhou Diabetic Eye Study Group
Diabetes Metab J. 2025;49(2):298-310.   Published online February 4, 2025
DOI: https://doi.org/10.4093/dmj.2024.0239
  • 10,230 View
  • 209 Download
  • 2 Web of Science
  • 3 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Diabetic macrovascular and microvascular complications often coexist and may share similar risk factors and pathological pathways. We aimed to investigate whether 10-year atherosclerotic cardiovascular disease (ASCVD) risk, which is commonly assessed in diabetes management, can predict incident diabetic nephropathy (DN) and retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM).
Methods
This prospective cohort study enrolled 2,891 patients with clinically diagnosed T2DM who were free of ASCVD, nephropathy, or retinopathy at baseline in the Guangzhou (2017–2022) and Shaoguan (2019–2021) Diabetic Eye Study in southern China. The 10-year ASCVD risk was calculated by the Prediction for ASCVD Risk in China (China-PAR) equations. Multivariable- adjusted Cox proportional hazard models were developed to estimate hazard ratios (HRs) with 95% confidence intervals (CIs). The area under the receiver operating characteristic curve (AUC) was used to evaluate predictive capability.
Results
During follow-up, a total of 171 cases of DN and 532 cases of DR were documented. Each 1% increment in 10-year ASCVD risk was associated with increased risk of DN (pooled HR, 1.122; 95% CI, 1.094 to 1.150) but not DR (pooled HR, 0.996; 95% CI, 0.979 to 1.013). The model demonstrated acceptable performance in predicting new-onset DN (pooled AUC, 0.670; 95% CI, 0.628 to 0.715). These results were consistent across cohorts and subgroups, with the association appearing to be more pronounced in women.
Conclusion
Ten-year ASCVD risk predicts incident DN but not DR in our study population with T2DM. Regular monitoring of ASCVD risk in routine diabetes practice may add to the ability to enhance population-based prevention for both macrovascular and microvascular diseases, particularly among women.

Citations

Citations to this article as recorded by  
  • Oral microbiome alterations in individuals with type 1 diabetes: a systematic review
    Aspasia Pachiou, Mariana Damanaki, Pune Nina Paqué, Christos Rahiotis, Eftychia Pappa
    Clinical Oral Investigations.2026;[Epub]     CrossRef
  • Prior Cardiovascular Disease and Incident Diabetic Retinopathy in Newly Diagnosed Type 2 Diabetes Mellitus
    Jung Soo Yoon, Jiyeong Kim, Lei Liu, Dongjin Nam, Sunjin Hwang
    Journal of Clinical Medicine.2026; 15(21): 8544.     CrossRef
  • Investigation of the Potential Association Between Atherosclerotic Cardiovascular Disease Risk Score and Diabetic Retinopathy in Patients with Type 2 Diabetes: A Cross-Sectional Study
    Chrysa Agapitou, Theodoros N. Sergentanis, Effie G. Papageorgiou, Panagiotis Theodossiadis, Ignatios Ikonomidis, Vaia Lambadiari, Irini Chatziralli
    Biomedicines.2025; 13(3): 633.     CrossRef
Basic and Translational Research
Article image
Revealing VCAN as a Potential Common Diagnostic Biomarker of Renal Tubules and Glomerulus in Diabetic Kidney Disease Based on Machine Learning, Single-Cell Transcriptome Analysis and Mendelian Randomization
Li Jiang, Jie Jian, Xulin Sai, Xiai Wu
Diabetes Metab J. 2025;49(3):407-420.   Published online January 24, 2025
DOI: https://doi.org/10.4093/dmj.2024.0233
  • 12,045 View
  • 420 Download
  • 4 Web of Science
  • 5 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Diabetic kidney disease (DKD) is recognized as a significant complication of diabetes mellitus and categorized into glomerular DKDs and tubular DKDs, each governed by distinct pathological mechanisms and biomarkers.
Methods
Through the identification of common features observed in glomerular and tubular lesions in DKD, numerous differentially expressed gene were identified by the machine learning, single-cell transcriptome and mendelian randomization.
Results
The diagnostic markers versican (VCAN) was identified, offering supplementary options for clinical diagnosis. VCAN significantly highly expressed in glomerular parietal epithelial cell and proximal convoluted tubular cell. It was mainly involved in the up-regulation of immune genes and infiltration of immune cells like mast cell. Mendelian randomization analysis confirmed that serum VCAN protein levels were a risky factor for DKD, while there was no reverse association. It exhibited the good diagnostic potential for estimated glomerular filtration rate and proteinuria in DKD.
Conclusion
VCAN showed the prospects into DKD pathology and clinical indicator.

Citations

Citations to this article as recorded by  
  • Transient versican expression is required for β1-integrin accumulation during podocyte layer morphogenesis in amphibian developing kidney
    Isabelle Buisson, Jean-François Riou, Muriel Umbhauer, Ronan Le Bouffant, Valérie Bello
    Cells & Development.2026; 185: 204062.     CrossRef
  • m6A Modified VCAN Promotes Glomerular Endothelial Cells Injury and Diabetic Nephropathy by SHH Pathway
    Jie Jiang, Jicheng Zhang, Chao Wang, Feng Wang
    Applied Biochemistry and Biotechnology.2026; 198(5): 3461.     CrossRef
  • Pathology-Anchored Biomarker Research Progress for the Early Diagnosis of Diabetic Kidney Disease: From Pathological Association to Early Validation
    Qiu Li, Mei Yang, Yingyu Luo, Nannan Zhang
    Biomedicines.2026; 14(7): 1643.     CrossRef
  • Kidney-compartment genomic prioritization across diabetic and population kidney traits: an exploratory Mendelian randomization and colocalization study
    Ran Chen, Xiaohui Bi
    Frontiers in Genetics.2026;[Epub]     CrossRef
  • Multi-omics and machine learning identify FN1 and ALDH2 as diagnostic biomarkers and therapeutic targets in early and late diabetic kidney disease
    Jingwei Lin, Yingying Zheng, Diman Mai, Fuxiang Fang, Zhuokun Wei, Mengyu Liu, Trung Hieu Pham, Ming Li, Jiawen Zhao
    Renal Failure.2025;[Epub]     CrossRef
Complications
Article image
Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
Inha Jung, Seungyoon Nam, Da Young Lee, So Young Park, Ji Hee Yu, Ji A Seo, Dae Ho Lee, Nan Hee Kim
Diabetes Metab J. 2024;48(6):1126-1134.   Published online July 1, 2024
DOI: https://doi.org/10.4093/dmj.2023.0377
  • 10,070 View
  • 175 Download
  • 14 Web of Science
  • 13 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Although the prevalence of diabetic kidney disease (DKD) is increasing, reliable biomarkers for its early detection are scarce. This study aimed to evaluate the association of adenosine and succinate levels and their related pathways, including hyaluronic acid (HA) synthesis, with DKD.
Methods
We examined 235 participants and categorized them into three groups: healthy controls; those with diabetes but without DKD; and those with DKD, which was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2. We compared the concentrations of urinary adenosine, succinate, and HA and the serum levels of cluster of differentiation 39 (CD39) and CD73, which are involved in adenosine generation, among the groups with DKD or albuminuria. In addition, we performed multiple logistic regression analysis to evaluate the independent association of DKD or albuminuria with the metabolites after adjusting for risk factors. We also showed the association of these metabolites with eGFR measured several years before enrollment. This study was registered with the Clinical Research Information Service (https://cris.nih.go.kr; Registration number: KCT0003573).
Results
Urinary succinate and serum CD39 levels were higher in the DKD group than in the control and non-DKD groups. Correlation analysis consistently linked urinary succinate and serum CD39 concentrations with eGFR, albuminuria, and ΔeGFR, which was calculated retrospectively. However, among the various metabolites studied, only urinary succinate was identified as an independent indicator of DKD and albuminuria.
Conclusion
Among several potential metabolites, only urinary succinate was independently associated with DKD. These findings hold promise for clinical application in the management of DKD.

Citations

Citations to this article as recorded by  
  • Diabetic kidney disease: integrating multi-omics insights, artificial intelligence, and novel therapeutics for precision medicine
    Tao Li, Kaili Chen, Yiting Sun, Linqi Zhang
    Frontiers in Genetics.2026;[Epub]     CrossRef
  • Spatial metabolomics: A new tool for unravelling the metabolic disorders and heterogeneity in diabetic kidney disease (Review)
    Hanfei Li, Yuxi Li, Bo Zhang, Wenhao Cheng, Guowei Ma, Jin Rong, Shiru Duan, Di Feng, Tingting Zhao
    International Journal of Molecular Medicine.2026; 57(4): 1.     CrossRef
  • Next-Generation Redox Mediators: Itaconate, Nitro-Fatty Acids, Reactive Sulfur Species and Succinate as Emerging Switches in Predictive Redox Medicine
    Luca Gammeri, Alessandro Allegra, Fabio Stagno, Sebastiano Gangemi
    Antioxidants.2026; 15(4): 427.     CrossRef
  • Metabolic Reprogramming and Immunometabolic Dysregulation in Diabetic Kidney Disease: From Pathogenesis to Precision Multi-target Therapies
    Ziyue Zhang, Yilun Qu, Xiaochen Wang, Yuwei Ji, Jin Yao, Weizhu Deng, Guannan Sun, Hua Xu, Xiangmei Chen, Quan Hong
    Research.2026;[Epub]     CrossRef
  • AI-assisted metabolomic profiling identifies candidate metabolites associated with diabetic kidney disease staging in a Korean cohort
    Inha Jung, Sungjin Park, Moongi Ji, So Young Park, Da Young Lee, Ji Hee Yu, Ji A. Seo, Man-Jeong Paik, Hyeong Kyu Park, Soon Hyo Kwon, Dae Ho Lee, Nan Hee Kim
    iScience.2026; 29(10): 117506.     CrossRef
  • Urinary succinate is associated with kidney injury in type 2 diabetes mellitus: a cross-sectional analysis
    Ting Cai, Yihan Jiao, Xinyu Chen, Xinyue Kong, Caimei Chen, Hanzhi Chen, Yue Zhang, Jia Hua, Xiaobin Liu, Bin Cai, Xiaowei Zhu, Liang Wang
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Trifolirhizin: A Phytochemical with Multiple Pharmacological Properties
    Varun Jaiswal, Hae-Jeung Lee
    Molecules.2025; 30(2): 383.     CrossRef
  • The role of redox signaling in mitochondria and endoplasmic reticulum regulation in kidney diseases
    Omar Emiliano Aparicio-Trejo, Estefani Yaquelin Hernández-Cruz, Laura María Reyes-Fermín, Zeltzin Alejandra Ceja-Galicia, José Pedraza-Chaverri
    Archives of Toxicology.2025; 99(5): 1865.     CrossRef
  • Chronic succinate exposure does not cause liver injury
    Joseph Balnis, Emily L. Jackson, Lisa A. Drake, Catherine E. Vincent, Hwajeong Lee, Harold A. Singer, Ariel Jaitovich
    American Journal of Physiology-Endocrinology and Metabolism.2025; 329(1): E39.     CrossRef
  • Succinate Facilitates CD4+ T Cell Infiltration and CCL1 Production to Promote Myofibroblast Activation and Renal Fibrosis in UUO Mice
    Yuandong Tao, Wei Zhang, Dehong Liu, Hualin Cao, Xiaoyu Yi, Xiangling Deng, Pin Li, Xiaoli Shen, Huixia Zhou
    Journal of Inflammation Research.2025; Volume 18: 7827.     CrossRef
  • From inflammation to healing: the crucial role of GPR91 activation and SDH inhibition in chronic diabetic wound recovery
    Hengdeng Liu, Shixin Zhao, Hanwen Wang, Xuefeng He, Suyue Gao, Minmin Su, Miao Zhen, Shuying Chen, Lei Chen, Julin Xie
    Stem Cell Research & Therapy.2025;[Epub]     CrossRef
  • Network pharmacology and untargeted metabolomics reveal the mechanisms of Bushen Kaixuan Tongluo formula in diabetic kidney disease
    You Wang, Baosheng Zhao, Zhuqing Yang, Lingling Qin, Haiyan Wang, Cuiyan Lv, Tonghua Liu, Guangrui Huang
    Journal of Chromatography B.2025; 1265: 124752.     CrossRef
  • Oxidative Stress, Metabolic Impairment and Neuroinflammation are Associated With Target Organ Damage in SHRSP
    S Hojná, L Mráziková, A Shánělová, H Pelantová, A Montezano, R Touyz, L Maletínská, J Kuneš
    Physiological Research.2025; : 779.     CrossRef
Complications
Article image
Construction of Risk Prediction Model of Type 2 Diabetic Kidney Disease Based on Deep Learning
Chuan Yun, Fangli Tang, Zhenxiu Gao, Wenjun Wang, Fang Bai, Joshua D. Miller, Huanhuan Liu, Yaujiunn Lee, Qingqing Lou
Diabetes Metab J. 2024;48(4):771-779.   Published online April 30, 2024
DOI: https://doi.org/10.4093/dmj.2023.0033
  • 13,453 View
  • 382 Download
  • 11 Web of Science
  • 10 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
This study aimed to develop a diabetic kidney disease (DKD) prediction model using long short term memory (LSTM) neural network and evaluate its performance using accuracy, precision, recall, and area under the curve (AUC) of the receiver operating characteristic (ROC) curve.
Methods
The study identified DKD risk factors through literature review and physician focus group, and collected 7 years of data from 6,040 type 2 diabetes mellitus patients based on the risk factors. Pytorch was used to build the LSTM neural network, with 70% of the data used for training and the other 30% for testing. Three models were established to examine the impact of glycosylated hemoglobin (HbA1c), systolic blood pressure (SBP), and pulse pressure (PP) variabilities on the model’s performance.
Results
The developed model achieved an accuracy of 83% and an AUC of 0.83. When the risk factor of HbA1c variability, SBP variability, or PP variability was removed one by one, the accuracy of each model was significantly lower than that of the optimal model, with an accuracy of 78% (P<0.001), 79% (P<0.001), and 81% (P<0.001), respectively. The AUC of ROC was also significantly lower for each model, with values of 0.72 (P<0.001), 0.75 (P<0.001), and 0.77 (P<0.05).
Conclusion
The developed DKD risk predictive model using LSTM neural networks demonstrated high accuracy and AUC value. When HbA1c, SBP, and PP variabilities were added to the model as featured characteristics, the model’s performance was greatly improved.

Citations

Citations to this article as recorded by  
  • Multi-feature integrated machine learning prediction model for early nephropathy in elderly living with type 2 diabetes mellitus
    Tingting Fang, Yuanyuan Yang, Feng Zhuo, Xinran Xie, Jialun Song, Linghua Kong
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • DiffLSTM-MTE: A Hybrid LSTM-Diffusion Framework for Virtual iEEG Reconstruction From MEG
    Xiangyu Xue, Liankun Ren, Hongyu Zhou, Anqi Dai, Di Wang, Huaqiang Zhang
    IEEE Access.2026; 14: 27444.     CrossRef
  • Machine learning and deep learning in predicting the risk of diabetic kidney disease: A systematic review and meta-analysis
    Qing Chen, Hua-Wei Peng, Chen-Xiao Fu, Kai-Kai Meng, Jun-Bei Zhang
    World Journal of Diabetes.2026;[Epub]     CrossRef
  • Development and validation of an early risk prediction model based on inflammatory and metabolically derived markers for early diagnosis of diabetic kidney disease
    Xu Liu, Wanting Zhao, Yu Fu, Yan Yu, Min Chen, Yimin Yao, Ying Yu
    Scientific Reports.2026;[Epub]     CrossRef
  • Artificial intelligence for diabetes complications: Detection, prediction, and clinical management
    Shujie Yu, Zhouyu Guan, Shiyu Wang, Hongfeng Mao, Bin Sheng, Weiping Jia, Huating Li
    EngMedicine.2026; 3(2): 100133.     CrossRef
  • A systematic review on machine learning based predictive modeling for diabetic kidney disease (DKD)
    Subhashree Palaur, Manoj Ranjan Mishra, Nikunj Kishore Rout, Rekha Sahu, Satya Ranjan Dash, Rajani Kanta Mahapatra
    International Journal of Diabetes in Developing Countries.2026;[Epub]     CrossRef
  • Artificial Intelligence in Medicine: Basic Knowledge, Applications, Ethics and Perspectives
    Marco Cascella, Maria Teresa Avella, Marcello Di Pumpo, Enrico Sebastiani, Martino Bussa, Alessio Tagliaferri, Barbara Brunetti, Pierluigi Meloni, Elisa Bianchini, Paolo Graziani, Federico Faustini, Guido D'Onofrio, David Manetta, Cristina Angela Catania,
    Journal of Evaluation in Clinical Practice.2026;[Epub]     CrossRef
  • ROC, Doğrudan Uzlaşma ve Angoff Yöntemleriyle Belirlenen Kesme Puanlarının Karşılaştırılması
    Merve Kılıç, Hakan Atılgan, Sungur Gürel
    Boğaziçi Üniversitesi Eğitim Dergisi.2026;[Epub]     CrossRef
  • Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: A population‐based study
    Yifei Wang, Ting Lin, Jiale Lu, Wenfang He, Hongbo Chen, Tiancai Wen, Juan Jin, Qiang He
    Diabetes, Obesity and Metabolism.2025; 27(4): 1902.     CrossRef
  • Artificial Intelligence for Diabetes Complication Prediction: A Systematic Review of Current Applications and Future Directions
    Francesca Pescol, Pietro Bosoni, Stefania Ghilotti, Pasquale De Cata, Lucia Sacchi, Riccardo Bellazzi
    Journal of Diabetes Science and Technology.2025;[Epub]     CrossRef
Metabolic Risk/Epidemiology
Article image
2023 Diabetic Kidney Disease Fact Sheet in Korea
Nam Hoon Kim, Mi-Hae Seo, Jin Hyung Jung, Kyung Do Han, Mi Kyung Kim, Nan Hee Kim, on Behalf of Diabetic Kidney Disease Research Group of the Korean Diabetes Association
Diabetes Metab J. 2024;48(3):463-472.   Published online March 19, 2024
DOI: https://doi.org/10.4093/dmj.2023.0310
  • 19,687 View
  • 716 Download
  • 27 Web of Science
  • 34 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
To investigate the prevalence, incidence, comorbidities, and management status of diabetic kidney disease (DKD) and diabetes-related end-stage kidney disease (ESKD) in South Korea.
Methods
We used the Korea National Health and Nutrition Examination Survey data (2019 to 2021, n=2,665) for the evaluation of prevalence, comorbidities, control rate of glycemia and comorbidities in DKD, and the Korean Health Insurance Service-customized database (2008 to 2019, n=3,950,857) for the evaluation of trends in the incidence and prevalence rate of diabetes-related ESKD, renin-angiotensin system (RAS) blockers and sodium glucose cotransporter 2 (SGLT2) inhibitors use for DKD, and the risk of atherosclerotic cardiovascular disease (ASCVD) and mortality according to DKD stages. DKD was defined as albuminuria or low estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 in patients with diabetes mellitus.
Results
The prevalence of DKD was 25.4% (albuminuria, 22.0%; low eGFR, 6.73%) in patients with diabetes mellitus aged ≥30 years. Patients with DKD had a higher rate of comorbidities, including hypertension, dyslipidemia, and central obesity; however, their control rates were lower than those without DKD. Prescription rate of SGLT2 inhibitors with reduced eGFR increased steadily, reaching 5.94% in 2019. Approximately 70% of DKD patients were treated with RAS blockers. The prevalence rate of diabetesrelated ESKD has been steadily increasing, with a higher rate in older adults. ASCVD and mortality were significantly associated with an in increase in DKD stage.
Conclusion
DKD is prevalent among Korean patients with diabetes and is an independent risk factor for cardiovascular morbidity and mortality, which requiring intensive management of diabetes and comorbidities. The prevalence of diabetes-related ESKD has been increasing, especially in the older adults, during past decade.

Citations

Citations to this article as recorded by  
  • Glycemia Risk Index is Associated With Risk of Albuminuria Among Individuals With Type 1 Diabetes
    Ji Yoon Kim, Jee Hee Yoo, Nam Hoon Kim, Jae Hyeon Kim
    Journal of Diabetes Science and Technology.2026; 20(3): 775.     CrossRef
  • THE STATE OF CARBOHYDRATE METABOLISM AND RENAL FUNCTION IN PATIENTS WITH ACUTE CORONARY SYNDROME. LITERATURE REVIEW
    S.U. Kazaryan, R.B. Bazarbekova, A.K. Dosanova, R.A. Kasymalieva, Zh.A. Nurlykaimova, K.S. Absatarova, M.M. Yakubova
    Наука и здравоохранение.2026; (6(27)): 172.     CrossRef
  • Nationwide Big Data Studies of Endocrine Diseases Using the Korean National Health Information Database: Research Trends and Standardization of Operational Definitions
    Sun Wook Cho, Jung Hee Kim, Kyoung Jin Kim, Beom-Jun Kim, Mee Kyoung Kim, Eun Jung Rhee
    Endocrinology and Metabolism.2026; 41(1): 86.     CrossRef
  • Continuous glucose monitoring and risks of acute and chronic diabetes-related complications and mortality in adults with type 1 diabetes: a nationwide cohort study
    Ji Yoon Kim, Seohyun Kim, Jae Hyeon Kim
    Diabetologia.2026; 69(7): 1858.     CrossRef
  • Xaliproden improves diabetic kidney disease through JNK-mediated renal tubular protection
    Hsin-Jou Lee, Chih-Hung Chiang, Szu-Chi Kuo, Chen-Wei Chu, Su-Chu Lin, Ting-Ting Chang
    Biochemical Pharmacology.2026; 249: 117923.     CrossRef
  • Cardiorenal outcomes of empagliflozin versus dapagliflozin in primary prevention among patients with type 2 diabetes: A nationwide cohort study
    Sangwoo Park, Jooyi Jung, Joonho Jeong, Mi Hee Jang, Yong-Giun Kim, Soe Hee Ann, Shin-Jae Kim, Seungbong Han, Gyung-Min Park
    Diabetes Research and Clinical Practice.2026; 236: 113239.     CrossRef
  • Diabetes-dependent association between metabolic score for visceral fat and chronic kidney disease: findings from a longitudinal cohort study
    Yu-Jin Kwon, Youhyun Song, Ji-Won Lee, Seok-Jae Heo, Jung Eun Lee
    Diabetes Research and Clinical Practice.2026; 236: 113284.     CrossRef
  • Patient-reported unmet healthcare needs among people with diabetic kidney disease in primary care in Peninsular Malaysia: a sequential mixed-methods study
    Soong Yiing Yap, Shamsul Azhar Shah, Subashini Ambigapathy
    BMJ Open.2026; 16(6): e105861.     CrossRef
  • Integrating Blood Pressure Control With Multi-Class Kidney Protective Agents in Diabetic Kidney Disease
    Hyoungnae Kim
    Electrolytes & Blood Pressure.2026; 24(2): 95.     CrossRef
  • Elevated remnant cholesterol levels and variability with incident mental disorders in adults with type 1 diabetes: a nationwide cohort study
    Seohyun Kim, Sang Ho Park, So Hyun Cho, Rosa Oh, Ji Yoon Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Gyuri Kim, Jae Hyeon Kim
    Journal of Psychosomatic Research.2026; 211: 112984.     CrossRef
  • Differential Associations of Social Determinants of Health with Diabetic Kidney Disease and Treatment Targets in Korean Adults with Diabetes
    Yeoree Yang, Kyungdo Han, Young-Sang Lyu, Yun Kyung Cho, Kyeong Hye Park, Sang Mo Hong
    Diabetes & Metabolism Journal.2026;[Epub]     CrossRef
  • Navigating the kidney disease care cascade in type 2 diabetes: insights from the national diabetes registry
    Soong Yiing Yap, Shamsul Azhar Shah, Ruslinda Mustafar, Noraryana Hassan
    BMC Public Health.2026;[Epub]     CrossRef
  • Renin-angiotensin system blockade in diabetic kidney disease: an old pillar that still stands at the core of therapy
    Dong Hoon Kang, Tae-Hyun Yoo
    Kidney Research and Clinical Practice.2026; 45(6): 867.     CrossRef
  • Rationale and design of a nationwide prospective cohort study in type 2 diabetic kidney disease: the Korean Diabetic Kidney Disease (K-DKD) Cohort
    Jin Joo Cha, Dae Ryong Cha, Yaeni Kim, Cheol Whee Park, Hyung Duk Kim, Ju-Young Moon, Kyubok Jin, Sang Heon Song, Jung-Hwan Lee, Samel Park, Eun Young Lee, Tae-Hyun Yoo, Won Kim, So Young Lee, Jwa-Kyung Kim, Seung Seok Han, Mi-Yeon Yu, Sang Youb Han
    Kidney Research and Clinical Practice.2026; 45(6): 1045.     CrossRef
  • Big Data Research for Diabetes-Related Diseases Using the Korean National Health Information Database
    Kyung-Soo Kim, Bongseong Kim, Kyungdo Han
    Diabetes & Metabolism Journal.2025; 49(1): 13.     CrossRef
  • Effect of Glomerular Hyperfiltration on Incident Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
    Seung Min Chung, Inha Jung, Da Young Lee, So Young Park, Ji Hee Yu, Jun Sung Moon, Ji A. Seo, Kyung-Do Han, Nan Hee Kim
    Clinical Journal of the American Society of Nephrology.2025; 20(3): 410.     CrossRef
  • Impact of Muscle Quality on Muscle Strength and Physical Performance Beyond Muscle Mass or Diabetes Status
    Jung A Kim, Chol Shin, Inha Jung, So Young Park, Da Young Lee, Ji Hee Yu, Hyunjoo Cho, Seung Ku Lee, Kyoung Jin Kim, Eyun Song, Kyeong Jin Kim, Nam Hoon Kim, Hye Jin Yoo, Sin Gon Kim, Kyung Mook Choi, Nan Hee Kim, Ji A Seo
    Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub]     CrossRef
  • A Machine Learning-Based Prediction Model for Diabetic Kidney Disease in Korean Patients with Type 2 Diabetes Mellitus
    Kyung Ae Lee, Jong Seung Kim, Yu Ji Kim, In Sun Goak, Heung Yong Jin, Seungyong Park, Hyejin Kang, Tae Sun Park
    Journal of Clinical Medicine.2025; 14(6): 2065.     CrossRef
  • Optimal Management of Diabetic Kidney Disease
    Jae-Han Jeon
    The Journal of Korean Diabetes.2025; 26(1): 1.     CrossRef
  • Association Between Healthy Dietary Patterns and Chronic Kidney Disease in Patients with Diabetes: Findings from Korean National Health and Nutrition Examination Survey 2019–2021
    Minsang Kim, Jung Koh, Jeong Cho, Semin Cho, Soojin Lee, Hyuk Huh, Seong Kim, Sehyun Jung, Eunjeong Kang, Sehoon Park, Jin Paek, Woo Park, Kyubok Jin, Seungyeup Han, Kwon Joo, Kyungdo Han, Dong Kim, Yaerim Kim
    Nutrients.2025; 17(9): 1600.     CrossRef
  • SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application
    Jae Hyun Bae
    Diabetes & Metabolism Journal.2025; 49(3): 386.     CrossRef
  • The Triglyceride-Glucose Index and Risk of End-Stage Renal Disease across Different Durations of Type 2 Diabetes Mellitus: A Longitudinal Cohort Study
    Mi-sook Kim, Kyu-Na Lee, Jeongmin Lee, Jeongeun Kwak, Seung-Hwan Lee, Hyuk-Sang Kwon, Jing Hughes, Kyung-Do Han, Eun Young Lee
    Endocrinology and Metabolism.2025; 40(5): 718.     CrossRef
  • Risk of End-Stage Kidney Disease in Individuals with Diabetes Living Alone: A Large-Scale Population-Based Study
    Kyunghun Sung, Jae-Seung Yun, Bongseong Kim, Hun-Sung Kim, Jae-Hyoung Cho, Yong-Moon Mark Park, Kyungdo Han, Seung-Hwan Lee
    Diabetes & Metabolism Journal.2025; 49(4): 862.     CrossRef
  • Physical activity intensity and amount are inversely correlated with the risk of tuberculosis in patients with diabetes
    Chiwook Chung, Kyu Na Lee, Kyungdo Han, Junhee Park, Dong Wook Shin, Sei Won Lee
    Scientific Reports.2025;[Epub]     CrossRef
  • 2024 Cardio-cerebrovascular disease fact sheet in Korea
    Kyungdo Han, Jin-Hyung Jung, Sang-Suk Choi, Seung-Hyun Ko
    Cardiovascular Prevention and Pharmacotherapy.2025; 7(3): 85.     CrossRef
  • Metabolomics and nutrient intake reveal metabolite–nutrient interactions in metabolic syndrome: insights from the Korean Genome and Epidemiology Study
    Minyeong Kim, Suyeon Lee, Junguk Hur, Dayeon Shin
    Nutrition Journal.2025;[Epub]     CrossRef
  • Dysregulation of miR‐21‐5p in diabetic nephropathy and its role in inflammatory response
    Yujiang Zhang, Qin Deng, Jianping Yi
    Journal of Diabetes Investigation.2025; 16(11): 2033.     CrossRef
  • Current Status of Continuous Glucose Monitoring Use in South Korean Type 1 Diabetes Mellitus Population–Pronounced Age-Related Disparities: Nationwide Cohort Study
    Ji Yoon Kim, Seohyun Kim, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2025; 49(5): 1040.     CrossRef
  • Burden of End-Stage Kidney Disease by Type 2 Diabetes Mellitus Status in South Korea: A Nationwide Epidemiologic Study (Diabetes Metab J 2025;49:498-506)
    Ji Eun Jun
    Diabetes & Metabolism Journal.2025; 49(5): 1137.     CrossRef
  • Remnant Cholesterol as an Independent Cardiovascular Risk Factor in Young Adults
    Han Na Jung, Ji Hye Heo, Myung Jin Kim, Kyung-Do Han, Jun Goo Kang, Seong Jin Lee
    JACC.2025; 86(21): 2047.     CrossRef
  • Impact of Type 2 Diabetes Mellitus on Age at Death in the Hemodialysis Population: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
    Ji Hong You, Kang Ju Son, Kyoung Sook Park, Byung-Wan Lee, Sun Ok Song
    Diabetology.2025; 6(12): 145.     CrossRef
  • Endothelial NOX5 Obliterates the Reno-Protective Effect of Nox4 Deletion by Promoting Renal Fibrosis via Activation of EMT and ROS-Sensitive Pathways in Diabetes
    Karin A. M. Jandeleit-Dahm, Haritha R. Kankanamalage, Aozhi Dai, Jaroslawna Meister, Sara Lopez-Trevino, Mark E. Cooper, Rhian M. Touyz, Christopher R. J. Kennedy, Jay C. Jha
    Antioxidants.2024; 13(4): 396.     CrossRef
  • Management Strategies for Potassium Levels During Non-steroidal Mineralocorticoid Receptor Antagonist Therapy: A Comprehensive Review
    Hyung Eun Son
    Electrolytes & Blood Pressure.2024; 22(2): 29.     CrossRef
  • A New Era in Diabetic Kidney Disease Treatment: The Four Pillars and Strategies to Build Beyond
    Sangyub Han, Sejoong Kim
    Electrolytes & Blood Pressure.2024; 22(2): 21.     CrossRef
Cardiovascular Risk/Epidemiology
Article image
Two-Year Changes in Diabetic Kidney Disease Phenotype and the Risk of Heart Failure: A Nationwide Population-Based Study in Korea
Seung Eun Lee, Juhwan Yoo, Han Seok Choi, Kyungdo Han, Kyoung-Ah Kim
Diabetes Metab J. 2023;47(4):523-534.   Published online April 25, 2023
DOI: https://doi.org/10.4093/dmj.2022.0096
  • 8,250 View
  • 148 Download
  • 3 Web of Science
  • 3 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Diabetic kidney disease (DKD) is a risk factor for hospitalization for heart failure (HHF). DKD could be classified into four phenotypes by estimated glomerular filtration rate (eGFR, normal vs. low) and proteinuria (PU, negative vs. positive). Also, the phenotype often changes dynamically. This study examined HHF risk according to the DKD phenotype changes across 2-year assessments.
Methods
The study included 1,343,116 patients with type 2 diabetes mellitus (T2DM) from the Korean National Health Insurance Service database after excluding a very high-risk phenotype (eGFR <30 mL/min/1.73 m2) at baseline, who underwent two cycles of medical checkups between 2009 and 2014. From the baseline and 2-year eGFR and PU results, participants were divided into 10 DKD phenotypic change categories.
Results
During an average of 6.5 years of follow-up, 7,874 subjects developed HHF. The cumulative incidence of HHF from index date was highest in the eGFRlowPU– phenotype, followed by eGFRnorPU+ and eGFRnorPU–. Changes in DKD phenotype differently affect HHF risk. When the persistent eGFRnorPU– category was the reference, hazard ratios for HHF were 3.10 (95% confidence interval [CI], 2.73 to 3.52) in persistent eGFRnorPU+ and 1.86 (95% CI, 1.73 to 1.99) in persistent eGFRlowPU–. Among altered phenotypes, the category converted to eGFRlowPU+ showed the highest risk. In the normal eGFR category at the second examination, those who converted from PU– to PU+ showed a higher risk of HHF than those who converted from PU+ to PU–.
Conclusion
Changes in DKD phenotype, particularly with the presence of PU, are more likely to reflect the risk of HHF, compared with DKD phenotype based on a single time point in patients with T2DM.

Citations

Citations to this article as recorded by  
  • Rationale and design of a nationwide prospective cohort study in type 2 diabetic kidney disease: the Korean Diabetic Kidney Disease (K-DKD) Cohort
    Jin Joo Cha, Dae Ryong Cha, Yaeni Kim, Cheol Whee Park, Hyung Duk Kim, Ju-Young Moon, Kyubok Jin, Sang Heon Song, Jung-Hwan Lee, Samel Park, Eun Young Lee, Tae-Hyun Yoo, Won Kim, So Young Lee, Jwa-Kyung Kim, Seung Seok Han, Mi-Yeon Yu, Sang Youb Han
    Kidney Research and Clinical Practice.2026; 45(6): 1045.     CrossRef
  • Different Associations between Lipid Levels and Risk for Heart Failure according to Diabetes Progression
    Seung-Hwan Lee, Kyu Na Lee, Jong-Chan Youn, Hun Sung Kim, Kyungdo Han, Mee Kyoung Kim
    Diabetes & Metabolism Journal.2025; 49(1): 105.     CrossRef
  • Persistent proteinuria is associated with the occurrence of cardiovascular disease: a nationwide population-based cohort study
    Ho Geol Woo, Moo-Seok Park, Tae-Jin Song
    Scientific Reports.2024;[Epub]     CrossRef
Review
Complications
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
Chan-Young Jung, Tae-Hyun Yoo
Diabetes Metab J. 2022;46(2):181-197.   Published online March 24, 2022
DOI: https://doi.org/10.4093/dmj.2021.0329
  • 47,890 View
  • 1,651 Download
  • 243 Web of Science
  • 258 Crossref
AbstractAbstract PDFPubReader   ePub   
Although diabetic kidney disease (DKD) remains the leading cause of end-stage kidney disease eventually requiring chronic kidney replacement therapy, the prevalence of DKD has failed to decline over the past 30 years. In order to reduce disease prevalence, extensive research has been ongoing to improve prediction of DKD onset and progression. Although the most commonly used markers of DKD are albuminuria and estimated glomerular filtration rate, their limitations have encouraged researchers to search for novel biomarkers that could improve risk stratification. Considering that DKD is a complex disease process that involves several pathophysiologic mechanisms such as hyperglycemia induced inflammation, oxidative stress, tubular damage, eventually leading to kidney damage and fibrosis, many novel biomarkers that capture one specific mechanism of the disease have been developed. Moreover, the increasing use of high-throughput omic approaches to analyze biological samples that include proteomics, metabolomics, and transcriptomics has emerged as a strong tool in biomarker discovery. This review will first describe recent advances in the understanding of the pathophysiology of DKD, and second, describe the current clinical biomarkers for DKD, as well as the current status of multiple potential novel biomarkers with respect to protein biomarkers, proteomics, metabolomics, and transcriptomics.

Citations

Citations to this article as recorded by  
  • Integrative network pharmacology and machine learning identify coagulation–inflammation hub targets of Jinkui Shenqi Pill in diabetic kidney disease: molecular docking and molecular dynamics/MM/GBSA analysis of quercetin binding to PAR1 and tissue factor
    Yao Xu, Qingying Tan, Tianxiao Hu, Yanxia Ren, Jiaqi Yao, Xiujing Wang, Yingchun Pan, Peiwu Jiang
    Journal of Molecular Structure.2027; 1381: 147628.     CrossRef
  • Diabetic kidney disease: exploring mechanistic depths and the future of pharmacological intervention
    Pratik Shankar Rakshe, Anil Bhanudas Gaikwad
    Naunyn-Schmiedeberg's Archives of Pharmacology.2026; 399(2): 1625.     CrossRef
  • Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors
    Pedro Carrera-Bastos, Marcel H. A. Muskiet, Fernando Mata-Ordoñez, Leo Pruimboom, Alejandro Lucia, Raul M. Luque, Frits A. J. Muskiet
    Reviews in Endocrine and Metabolic Disorders.2026; 27(1): 69.     CrossRef
  • Andrographolide alleviates type 2 diabetic nephropathy through suppressing PI3K/AKT1/RRM2-triggered oxeiptosis
    Mingzheng Han, Jingchun Wang, Shuaihao Guo, Heyun Zhu, Lijiao Zhao, Ziqi Wu, Yijin Wu, Jianying Guo, Jianzhao Liao, Zhaoxin Tang
    Journal of Advanced Research.2026; 85: 1051.     CrossRef
  • β-sitosterol potential against chronic hyperglycemia induced diabetic nephropathy: A dual approach using computational and in-vivo studies
    Sachin Sharma, Manjusha Choudhary, Jeevan K, Onkar Sharma, Hari Kishan, Ashwani Mittal
    Journal of Ethnopharmacology.2026; 357: 120934.     CrossRef
  • Diabetic peripheral neuropathy as measured using a point‐of‐care sural nerve conduction device is associated with a faster decline in renal function in patients with type 2 diabetes
    Tatsuya Fukuda, Akiko Fujii, Taro Akihisa, Naoya Otsubo, Tetsuya Yamada, Chisato Maki
    Journal of Diabetes Investigation.2026; 17(2): 291.     CrossRef
  • Duration-dependent alterations of lipid profiles and microvascular complications in GCK-MODY
    Yadi Huang, Yuxin Fan, Yang Liu, Xuan Liu, Wei Li, Ying Yang, Ziyue Zhang, Shifeng Ma, Shuhui Ji, Shanshan Chen, Hua Shu, Wenli Feng, Kunling Wang, Qing He, Wenjun Qi, Ming Liu, Xin Li, Yu Fan
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2026; 1872(3): 168137.     CrossRef
  • Extracellular vesicles in diabetic kidney disease: Emerging mechanisms, therapeutic implications, and biomarker prospects
    Yang Yu, Yunjie Shan, Anjie Ding, Hui Qian
    Biochemical Pharmacology.2026; 244: 117605.     CrossRef
  • S-methylmethionine ameliorates renal injury in diabetic mice by modulating macrophage inflammaging via ERK/NF-κb signaling pathway
    Hao Dong, Linjie Shen, Pawuziya Abulizi, Yuezhang Sun, Lulingxiao Nie, Aimin Cui, Qian Fu, Ning Ji, Yuwen Luo, Chienshan Chen, Aimin Xu, Wai Keung Leung, Qi Wang
    International Immunopharmacology.2026; 170: 116038.     CrossRef
  • A non-invasive urinary diagnostic signature for diabetic kidney disease revealed by machine learning and single-cell analysis
    Yonggang Chen, Jintai Luo, Yingying Zheng, Xiaomei Jiang, Zixiang Yang, Xiaobing Liu, Yusuf Oloruntoyin Ayipo
    PLOS One.2026; 21(1): e0340096.     CrossRef
  • Emerging technologies for early risk stratification and precision management of diabetic kidney disease: a multimodal framework integrating digital phenotypes and clinical biomarkers
    Lingdong Meng, Zhen Li, Ling Xu, Fang Wei, Hongyan Ji, Lankun Zhang, Anning Zhu, Zhijia Zhou
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Glycerol-selective biosensor and microbial biofuel cell based on recombinant yeast and glycerol dehydrogenase nanocomposite
    Nataliya Stasyuk, Andriy Zakalskiy, Daria Larowska-Zarych, Oksana Zakalska, Susanna Kushnir, Iryna Slyvka, Olha Demkiv, Sylwester Gawinkowski, Marcin Holdynski, Wojciech Nogala, Mykhailo Gonchar
    Microchemical Journal.2026; 221: 116853.     CrossRef
  • C‐X‐C Motif Chemokine Ligand 3 as a Potential Biomarker for Diagnosis and Prognosis of Diabetic Kidney Disease
    Sensen Su, Xin Chen, Li Zhang, Hui Yu, Han Qin, Lin Li, Zhanchuan Ma, Yinyu Yu, Zhonggao Xu, Huanfa Yi
    The FASEB Journal.2026;[Epub]     CrossRef
  • The triglyceride-high-density lipoprotein-glucose-body index: a superior novel biomarker for diabetic kidney disease in type 2 diabetes
    Jian Yang, Bingsong Xie, Zhiling Deng, Zhifu Zhang, Hairong Zhou
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Diabetic kidney disease, biomarkers, and finerenone
    Ashish Verma, Ashish Upadhyay
    Diabetes, Obesity and Metabolism.2026; 28(4): 2582.     CrossRef
  • Functional Molecular Plasma Biomarkers of Inflammation and Repair in Kidney Disease Progression in Gum Arabica Modality of CKD
    Sameeha AlShelleh, Maysa Suyagh, Hussein Alhawari, Nailya Bulatova, Violet Kasabri, Ayman Wahbeh, Izzat Alawwa, Ashraf Oweis, Haneen Mustafa
    International Journal of Molecular Sciences.2026; 27(2): 973.     CrossRef
  • Integrated Transcriptomic Analysis Identifies TAP1 as a Key Regulator of PANoptosis in Diabetic Kidney Disease Tubular Injury
    Qingsong Chen, Hongxuan He, Gang Wang, Lili Huang, Jiakun Yang, Yan Sun, Zheng Zhang, Xiaohui Liao
    Inflammation.2026;[Epub]     CrossRef
  • Network Pharmacology Prediction and Molecular Docking Validation of Active Components of Atractylodes macrocephala in Intervening Diabetic Nephropathy
    新宇 刘
    Journal of Clinical Personalized Medicine.2026; 05(01): 414.     CrossRef
  • Integrated network pharmacology and bioinformatics analysis reveals MME as key target of Notoginsenoside R1 in diabetic nephropathy
    Xinyu Gan, Mingzhu Liang, Halinuer Shadekejiang, Huan Hong, Jinyu Lu, Xu Li, Xueqin Zhang, Chen Lu
    BMC Complementary Medicine and Therapies.2026;[Epub]     CrossRef
  • Characterization of gut microbiota in patients with diabetic kidney disease
    Shoujuan Yu, Huimin Niu, Yan Zhang, Ling Yu, Qi Zhang, Xingchen Liu, Yue Sang, Ran Wang, Min Zhang
    Frontiers in Cellular and Infection Microbiology.2026;[Epub]     CrossRef
  • Connecting glycation and lipotoxicity to mitochondrial dysfunction in diabetic kidney disease: A ‘tubulocentric’ perspective
    Mayura Apte, Girish Kumthekar, Rashmi Santosh Tupe
    Biochemical and Biophysical Research Communications.2026; 809: 153479.     CrossRef
  • Changes of retinal microvascular parameters in patients with type 2 diabetes mellitus with or without diabetic kidney disease
    Ruirui Ma, Chunwen Zheng, Yuling Niu, Duanrong Cao, Yijun Hu, Ling Jin
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Prevalence and associated factors of diabetic kidney disease among rural patients with type 2 diabetes mellitus in Guangxi, China: a cross-sectional study
    Yelan Huang, Jingfeng Chen, Chaoqun Bai, Xiaoxue Lei, Yanping Zhang, Guifen Fu
    Frontiers in Clinical Diabetes and Healthcare.2026;[Epub]     CrossRef
  • Traditional Chinese medicine in the treatment of diabetic kidney disease: the mechanisms of signaling pathways regulations
    Wencan Li, Chaoqi Lei, Qinxuan Wu, Keqian Chen, Zheng Liu, Qichang Xing, Xiang Liu, Jiani Zhang
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Lactylation: a metabolic-epigenetic bridge in diabetic kidney disease and a therapeutic target for TCM
    Wen Zhang, Xiangdong Zhu, Yan Zhang, Jiahao Yang, Xiaobo Sun, Jianfeng Wang, Bin Zhang
    Chinese Medicine.2026;[Epub]     CrossRef
  • Deubiquitinase USP10 regulates angiotensin II-induced renal fibrosis by modulating the expression of TLR4
    Rong Wang, Yanjun Shen, Jiaqi Shi, Huaxing Huang, Sujuan Feng, Xingxing Fang, Xiameng Gu, Yang Yu
    Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis.2026; 832: 111932.     CrossRef
  • Assessing the association of FIB-4 index with diabetic kidney disease in patients with diabetes mellitus: a cross-sectional and retrospective study utilizing NHANES and clinical data
    Ronglu Yang, Yongjun Liu, Jinhu Li
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Diabetes-related renal complications: Insights on the impact of diabetic kidney disease on mortality
    Guido Gembillo, Maria Federica Ricca, Domenico Santoro
    World Journal of Nephrology.2026;[Epub]     CrossRef
  • Exosomes in diabetic kidney disease: pathogenesis, biomarker discovery, and emerging therapeutics—a comprehensive systematic review
    Lin Ding, Zuolin Li, Yan Xia, Shan Liu, Mingxia Zhang, Lunzhi Liu
    Renal Failure.2026;[Epub]     CrossRef
  • Phytochemical characterization and antidiabetic efficacy of elephant foot yam (Amorphophallus paeoniifolius) extract in a high-fat diet and low-dose streptozotocin-induced diabetic rat model
    Gopika Biju, Nagaraja Ingaladal, Sruthi P. K., Achuthan C. Ragavamenon, Ravi S. Lankalapalli, M. V. Reshma
    Journal of Food Measurement and Characterization.2026; 20(5): 7496.     CrossRef
  • Prediction of Diagnostic Markers and Potential Therapeutic Small-Molecule Drugs for Diabetic Nephropathy
    一玮 夏
    Hans Journal of Biomedicine.2026; 16(02): 323.     CrossRef
  • The diagnostic value of immune-inflammatory markers for diabetic kidney disease in type 2 diabetic patients: a meta-analysis
    Yan Wang, Xiaohua Liu, Zhenwen Xiao
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Palmitoylation in Renal Physiology and Pathology
    Jingru Ma, Zhen Zhang, Jiaqi Guo, Hu Cai, Jian Yao, Dahai Yang, Huiyuan Zhu, Haijing Liu, Changhe Wang, Hongbo Xu
    Biomolecules.2026; 16(3): 473.     CrossRef
  • High inflammatory burden may link non-albuminuric diabetic kidney disease to carotid atherosclerosis
    Maurizio Di Marco, Sabrina Scilletta, Nicoletta Miano, Nicola Marrano, Annalisa Natalicchio, Angelo Cignarelli, Valentina Annamaria Genchi, Francesco Giorgino, Giosiana Bosco, Francesco Di Giacomo Barbagallo, Roberto Scicali, Francesco Galeano, Andrea Tum
    Cardiovascular Diabetology.2026;[Epub]     CrossRef
  • Paeoniflorin‐6′‐O‐Benzenesulfonate Mediates Dendritic Cell Differentiation to Alleviate Diabetic Kidney Disease
    Wei Liang, Dongchun Zhu, Lei Xiao, Xiaoqian Wu, Hongwei Zhang, Li Cao, Mengxue Hu, Chun Wang, Feng Xiao, Wei Wei, Tingting Liu
    Clinical and Experimental Pharmacology and Physiology.2026;[Epub]     CrossRef
  • Risk Stratification of Chronic Kidney Disease in Adults Using Noninvasive Fibrosis Tests Based on the American Diabetes Association Algorithm
    Chan‐Young Jung, Hye Won Lee, Jung Il Lee, Han Ah Lee, Seung Up Kim
    Diabetes, Obesity and Metabolism.2026; 28(6): 5240.     CrossRef
  • Succinylation modification in diabetes and diabetic complications: Mechanisms and functions (Review)
    Yeteng Xiong, Fei Luo, Bingnan Li, Qinfeng Yang
    Molecular Medicine Reports.2026; 33(5): 1.     CrossRef
  • Serum biomarkers in diabetic kidney disease: A comprehensive narrative review
    Guido Gembillo, Luca Soraci, Giuseppe Spadaro, Rossella Messina, Felicia Cuzzola, Michela Calderone, Maria Federica Ricca, Simona Di Piazza, Flavia Sudano, Maria Elsa Gambuzza, Maria Princiotto, Lorenzo Lo Cicero, Domenico Santoro
    World Journal of Diabetes.2026;[Epub]     CrossRef
  • Correlation of CRP/HDL-C ratio with diabetic kidney disease in type 2 diabetes mellitus patients: evidence from the NHANES 2015–2020
    Tingting Wu, Tianwei Gu, Qian Wang, Yuanqin Li, Xuetao Chen, Shanmei Shen, Yangyang Xia
    Journal of Laboratory Medicine.2026; 50(3): 153.     CrossRef
  • Clinical Utility of Urinary Cystatin C in Early Screening and Staging of Diabetic Kidney Disease in Type 2 Diabetes
    Shanshan Ji, Fanghao Shang, Bingbing Chen, Wentao Tang, Hua Fang, Jinbao Huang, Yizhong Hu, Suraiya Saleem
    International Journal of Endocrinology.2026;[Epub]     CrossRef
  • Superior In Vivo Efficacy of Fermented Over Aqueous Astragalus membranaceus in Diabetic Nephropathy: A Systematic Pharmacological Evaluation and Mechanistic Study
    Rui Wu, Guangzhe Yao, Huizhen Zhao, Shufeng Zhang, Chao Li, Guangyuan Li, Guoming Wang
    Biomedical Chromatography.2026;[Epub]     CrossRef
  • Glycolytic lactylation modulates cell death decisions in diabetic kidney disease: Metabolic‑epigenetic interplay between ferroptosis and autophagy in fibrotic remodeling (Review)
    Taimin Zhang, Xizhe Zhang, Yaru Xie, Yue Liu, Siyu Xia, Xiaodie Yin, Tian Li, Libin Liao
    International Journal of Molecular Medicine.2026; 57(6): 1.     CrossRef
  • Nephroprotective role of edaravone against polystyrene nanoplastic-induced endoplasmic reticulum stress in Wistar rats
    Rachna Yadav, Ashok Jangra, Dinesh Dhingra, Sapana Kushwaha, Itishree Dubey, Dinesh Kumar
    Toxicology Mechanisms and Methods.2026; 36(7): 1130.     CrossRef
  • sEH inhibition attenuates mtROS-mediated NLRP3 inflammasome activation by promoting mitophagy in tubular epithelial cells in diabetic kidney disease
    Xushun Jiang, Wenge Huang, Wen Wen, Ting Liu, Wei Ren, Jia Shi, Junling He, Xiaogang Du
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • Apocynum venetum L. leaves extract inhibits ferroptosis and improves renal fibrosis in diabetic kidney disease by regulating the Nrf2/HO-1 pathway
    Guohua Shi, Subinuer Abuduaini, Li Chen, Subinuer Erreken, Mei Long, Xiaoqian Tang, Jinsen Kang
    Frontiers in Pharmacology.2026;[Epub]     CrossRef
  • A stabilized enrichment method for rosemary diterpenoids and their therapeutic potential in diabetic kidney disease
    Jiali Wei, Qian Xiao, Hua Yang, Fei Li, Ping Li
    Chinese Medicine.2026;[Epub]     CrossRef
  • Comment on “Predictive value of the C-reactive protein-albumin-lymphocyte (CALLY) index for all-cause mortality in peritoneal dialysis patients”
    Wendi Huang, Yuebo Shi, Yuanyi Yang
    International Urology and Nephrology.2026; 58(11): 5119.     CrossRef
  • FOS drives podocyte injury and renal fibrosis in diabetic kidney disease via direct Smad3 binding
    Man Sun, Tianchi Yan, Wenjing Zhao, Zhifeng Cheng
    Cellular and Molecular Life Sciences.2026;[Epub]     CrossRef
  • TangShenKang decoction plays an anti-inflammatory and anti-fibrotic role in diabetic nephropathy by activating AT2R/ATIP1/SHP1 axis and antagonizing angiotensin II
    Ran Wei, Jian Ma, Zeyu Yu, Wei Zou, Na Zhao
    Molecular and Cellular Biochemistry.2026; 481(6): 2691.     CrossRef
  • Urinary exosomes in diabetic kidney disease: Pathophysiological insights and diagnostic potential
    V. Haripriya, Urmila Anandh, Amit Kumar Dinda, Bhargab Kalita
    Life Sciences.2026; 399: 124477.     CrossRef
  • Regulatory Effects and Mechanisms of Electromagnetic Low-Energy Shock Wave Therapy on Blood Glucose in Type 2 Diabetic Rats
    Yinghui He, Shuying Huo, Linyao Hao, Zipeng Yue, Ying Jiang, Jianhua Zhu, Zhidong Zhou
    Biology.2026; 15(10): 810.     CrossRef
  • Bufalin post-transcriptionally suppresses STAT3 to alleviate renal ferroptosis and tubulointerstitial fibrosis in diabetic kidney disease
    Yunyang Qiao, Chen Gao, Jialing Ji, Zuolin Li, Huimin Shi, Ruilian Yan, Jiayue Sun, Yueyi Wang, Qiang Lin, Aiqing Zhang
    Renal Failure.2026;[Epub]     CrossRef
  • Metabolic Memory-Mediated Epigenetic Regulation of EMT in Diabetic Kidney Disease: Mechanisms and Therapeutic Implications
    Xinning Ran, Yidan Xu, Ruonan Liang, Yuqi Duan, Wanying Jia, Yuhong Bian, Chenduo Li, Mingxing Zhang
    International Journal of Molecular Sciences.2026; 27(11): 4801.     CrossRef
  • Identification of diagnostic markers for diabetic kidney disease by weighted gene co‑expression network analysis and machine learning
    Qiming Xu, Chunjing Xu, Ziyang Liu, Jianrao Lu, Jing Hu, Lin Liao
    International Journal of Molecular Medicine.2026; 58(1): 1.     CrossRef
  • Comparative efficacy of lipid-lowering therapies on the cardio-renal-metabolic axis in diabetic kidney disease: a Bayesian network meta-analysis addressing residual CRM risk
    Jun Luo, Yinzhong Dai, Chenguang Wu, Chengying Lan, Junwei Shi, Jinfeng Qi, Shimei Hua, Yan An, Lifan Wang, Ping Li, Peng Liu
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • A plasma N-acetyl amino acid panel for type 2 diabetes discrimination built by targeted LC–MS/MS: A case–control study
    Shusi Ding, Zhanxiong Xie, Daqiu Chen, Xiaomai Huang, Qiutong Wu, Lemin Zheng, Shanghua Xu, Shunxiang Luo
    Frontiers in Medicine.2026;[Epub]     CrossRef
  • Cardiorespiratory Fitness and Risk of Microvascular Complications in Patients with Type 2 Diabetes Mellitus
    Anning Xu, Haofeng Zhou, Chaofan Wang, Qian He, Ping Wu, Wenjing Wu, Hongjiang Wu, Alice P.S. Kong, Huanyi Cao, Haixia Guan, Yunjiu Cheng
    Diabetes & Metabolism Journal.2026;[Epub]     CrossRef
  • Biochemical Markers of Diabetic Kidney Injury: A Pharmacological Perspective on Early Intervention
    Dr. Abha Sinha, Dr. B. SENTHIL KUMAR, Dr. Pallavi Kadwe, Dr. Niraj Lodha, Radha M, Dr. Souvik Sur
    KIDNEYS.2026; 15(1): 257.     CrossRef
  • Renal Biomarkers as Predictors of Renal Damage in Patients With Type 2 Diabetes
    Mohamed Osman Ali, DafaAllah Hassan Billal, GadAllah Modawe, Abdelhakam G. Tamomh, Ahmed Ibn Edriss, Yoel A. Klug
    BioMed Research International.2026;[Epub]     CrossRef
  • Sex-specific modulation of gut microbiota by empagliflozin contributes to renoprotection in diabetic kidney disease mice
    Jundong He, Jiaxin Liu, Heming Zhang, Yiting Wang
    Frontiers in Microbiology.2026;[Epub]     CrossRef
  • Biomarkers for Early Detection of Diabetic Kidney Disease in Pediatric and Adolescent Populations: A Narrative Review
    Iran Malekzadeh, Narges Falsafi, Mohammad Nazemi, Hanie Taherkhani, Mahboube Bahroudi, Asim Abbas, Mastaneh Moghtaderi
    Health Science Reports.2026;[Epub]     CrossRef
  • NAA10 and BTRC drive CREBRF degradation in endoplasmic reticulum stress and renal tubular injury
    Sitian Fang, Jing Ning, Jinjing Huang, Yanxia Chen
    Journal of Diabetes Investigation.2026; 17(8): 1268.     CrossRef
  • Silencing of USP22 promotes FGF11 degradation to attenuates renal fibrosis in diabetic kidney disease
    Zhigang Wang, Chao Liu, Jing Lv, Jiping Sun, Xiaoyang Yu, Huixian Li
    Renal Failure.2026;[Epub]     CrossRef
  • Identifying Diabetic Kidney Disease in Type 2 Diabetes Patients Using Explainable Machine Learning: A Case‐Control Study
    Tongtong Qiu, Yi Bai, Hai Zhao, Mengyao Huang, Ping Zhang, Yu Zhang, Ruoyu Wang, Liqin An, Hannah Wesley
    Journal of Diabetes Research.2026;[Epub]     CrossRef
  • Key module genes in proximal tubular cells drive microenvironmental chronic inflammation and fibrosis in diabetic kidney disease: A single-cell transcriptomic study
    Wenjing Zhou, Zhaogui Chen, Guanghui Ying, Li Liu, Wei Xiao, Jian Liu, Min Xia, Qiao Zhang, Xuelin He
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2026; 1872(7): 168326.     CrossRef
  • Baseline and Longitudinal Metabolic Vulnerability Index and Risk of Incident Chronic Kidney Disease Among Adults With Dysglycemia
    Dan Chen, Jinsheng Mai, Ziliang Ye, Yanjun Zhang, Sisi Yang, Xiaoqin Gan, Yu Huang, Yiting Wu, Yiwei Zhang, Xianglian Cai, Xiaolong Liang, Xianhui Qin, Yuanyuan Zhang
    Journal of Renal Nutrition.2026; 36(5): 739.     CrossRef
  • From cytokine storm to renal scarring in diabetic kidney disease: Biomarkers, risk stratification, and precision therapeutics
    Emmanuel Ifeanyi Obeagu
    Precision Medical Sciences.2026;[Epub]     CrossRef
  • The dysregulated unfolded protein response in diabetic kidney disease: mechanisms and crosstalk with cell death pathways
    Hao Zhang, Kaixiang Li, Jia Ma, Ling Ma, Muhammad Asad Farooq, Jing E
    Frontiers in Pharmacology.2026;[Epub]     CrossRef
  • Hsa-miR-5585-3p regulates the NLRP3 activation and the expression of cytokines through CHUK in a cellular model of diabetic kidney disease
    Jing Zeng, Xuexiang Qin, Jielian Wang, Cunyou Xiong, Xiaoyun Feng
    BMC Endocrine Disorders.2026;[Epub]     CrossRef
  • Ubiquitination‐Related Diagnostic Biomarkers for Diabetic Nephropathy: Insights From Multiomic Analysis, Drug Docking, and Experimental Validation
    Ting Dong, Miao Hu, Haibo Yu, Ling Zhou, Qing Qiao
    The FASEB Journal.2026;[Epub]     CrossRef
  • Association between 24-h proteinuria and phenotypic age acceleration in adults with preserved kidney function: a cross-sectional study
    Yiqi Su, Fangfang Xiang, Yi Fang, Xiaoqiang Ding, Wuhua Jiang
    International Urology and Nephrology.2026;[Epub]     CrossRef
  • Exosomes from diabetic perirenal adipose-derived MSCs promote inflammation and fibrosis in diabetic nephropathy via the miR-331-3p/TSC1/mTORC1 Axis
    Yumei Zhao, Hejia Yin, Hong Tan, Yan Zhao, Rou Shi, Ye Xing, Yang Li
    International Immunopharmacology.2026; 186: 117107.     CrossRef
  • Thai Probiotic Strains Protect Against Diabetic Kidney Injury in HFD/STZ-induced Type 2 Diabetic Rats via Gut Microbiota Modulation
    Chattramat Jaiyim, Jirakit Suppamanta, Sasikarn In-um, Kattika Tongdee, Marut Tangwattanachuleeporn, Anongnard Kasorn, Malai Taweechotipatr
    Journal of Applied Pharmaceutical Science.2026; 16(6): 176.     CrossRef
  • Gardenin A Alleviates Diabetic Nephropathy by Modulating Oxidative Stress and Inflammation in Experimental Rats
    Juan Ji, Longhai Song, Chong Yang, Yan Gao, Song Li, Qiaoying Wu
    Pharmacognosy Magazine.2026; 22(4): 1651.     CrossRef
  • Tubular PFKFB3 drives diabetic kidney fibrosis via lactate‑dependent H4K12 lactylation and HIPK2 transactivation
    Mingkun Xu, Linhang Fu, Yulong Zhang, Xiuli Guo, Han Wu, Sijing Gao, Fei Xiao, Li Xu
    International Journal of Molecular Medicine.2026; 58(3): 1.     CrossRef
  • The translational potential of m6A RNA methylation in DKD: emerging biomarkers for early detection and targeted therapies
    Huihui Liu, Jun Luo, Yinzhong Dai, Chenguang Wu, Yan An, Wei Jiang
    Frontiers in Medicine.2026;[Epub]     CrossRef
  • Roles of Biomarkers in Chronic Kidney Disease and Related Conditions
    Takayasu Ohtake, Shuzo Kobayashi
    Journal of Clinical Medicine.2026; 15(15): 5920.     CrossRef
  • Pathology-Anchored Biomarker Research Progress for the Early Diagnosis of Diabetic Kidney Disease: From Pathological Association to Early Validation
    Qiu Li, Mei Yang, Yingyu Luo, Nannan Zhang
    Biomedicines.2026; 14(7): 1643.     CrossRef
  • Defective autophagy in diabetic nephropathy sensitizes podocytes to hyperuricemia induced injury by amplifying inflammasome activation
    Chengyu Cao, Yan Fang, Yingxiao Ding, Anyan Li, Fei Jiang, Li Fang
    Clinical and Experimental Nephrology.2026; 30(10): 1415.     CrossRef
  • Prognostic Nutritional Index as a Marker Associated With Disease Severity in Diabetic Kidney Disease: A Real-World North African Experience
    Khawla Salhi, Salma Berghazi, Mohammed Amine Essafi, Zineb Elazime, Hayat Aynaou, Houda Salhi
    Cureus.2026;[Epub]     CrossRef
  • Integrated UHPLC-MS-based metabolomics and transcriptomic profiling reveal the potential role of Phytolacca latbenia in diabetic kidney disease
    Fengpu Xie, Nan Wang, Run Qian, Zhao Hu
    Chinese Journal of Analytical Chemistry.2026; 54(8): 100737.     CrossRef
  • Mechanism of FABP4-driven macrophage pyroptosis in promoting renal tubular epithelial-mesenchymal transition of diabetic kidney disease in mice
    Wenkai Zhang, Songbo Zhao, Li Huang, Rongrong Deng, Xuezhen Ma, Tingting Xing, Ziyi Li, Yingying Wang, Shujun Shi, Xiaochun Zhou, Jianqin Wang
    Biochemical Pharmacology.2026; 253: 118378.     CrossRef
  • Multi‐omics–driven precision medicine
    Huibo Li, Zhe Zhao, Yifan Zhang, Yao Ma, Gaofei Hu, Min Zeng, Zhanqun Yang, Zixuan Zhao, Xin Zhou, Wei Hu, Yuxuan Sun, Meng Su, Jun Li, Matthew Whiteman, Wei Fu, Chao Zhong, Lemin Zheng, Long Chen, Hairong Lv, Rongsheng Zhao, Yi Zhun Zhu
    iMeta.2026;[Epub]     CrossRef
  • LncRNA RAD51-AS1 Alleviates Oxidative Stress and Inflammation in Diabetic Nephropathy by Adsorbing miR-154-5p
    Mengmeng Pu, Yijun Chen, Dewei Ouyang
    Kidney and Blood Pressure Research.2026; 51(1): 737.     CrossRef
  • Human biomarker navigator
    Meng‐Yao Li, Qian Zhang, Zijie Wang, Zeping Gui, Jing Liu, Jingda Li, Maojun Jiang, Zukang Chang, Qingqing Han, Bendong Yang, Tariq Saeed, Jun Li, Jinghan Jia, Chenghu Song, Tong Shao, Tianhuan Peng, Xueying Zhang, Pingping Guo, Jun Luo, Gangao Yang, Yuan
    iMeta.2026;[Epub]     CrossRef
  • Emerging therapies for diabetic kidney disease: beyond SGLT2 inhibitors
    Huajing Ni, Simon Piggott, Maria Carolina Festa, Labib Faruque, David Z. I. Cherney
    Expert Opinion on Pharmacotherapy.2026; 27(13): 1485.     CrossRef
  • Determinants of biochemical factors and microalbuminuria among type 2 diabetes mellitus patients
    Ruqaya M. Hassan, Mawj N. Modher, Shahad M. Hussain, Baneen S. Rasool, Yousif Sh. Raheem, Ahmed Flayyih Hasan
    Polski Merkuriusz Lekarski.2026; 54(4): 404.     CrossRef
  • The association between pan-immune-inflammation value and diabetic kidney disease: a combined cross-sectional and prospective cohort study
    Jian Jin, Shuwu Wei, Jiale Zhang, Jie Yang, Weishuai Sun, Weiwei Sun, Junping Wei, Juan Miao
    BMC Endocrine Disorders.2026;[Epub]     CrossRef
  • Clinical value of probiotics as adjunctive therapy for diabetic nephropathy: a meta-analysis and trial sequential analysis
    Xiangning Huang, Xinyu Yang, Yunfeng Yu, Jiawang Huang, Wang Tao, Rong Yu, Xiu Liu
    Frontiers in Nutrition.2026;[Epub]     CrossRef
  • Diosmetin Restores Endoplasmic Reticulum Homeostasis to Ameliorate Podocyte Injury in Diabetic Kidney Disease by Targeting DNAJC3
    Tianyu Zhang, Na Zhao, Tongjin Liu, Yamei Gao, Zhiyue Di, Yue Gao, Yanan Ji, Shuquan Lv, Qingying Xie, Jian Ma, Huantian Cui
    Journal of Diabetes Research.2026;[Epub]     CrossRef
  • Association between the cholesterol-high-density lipoprotein-glucose (CHG) index and albuminuria risk in diabetic patients
    Yuren Zhang, Jinting Xu, Yiping Zhang, Yinan Chen, Qiaolan Liu
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Integrative bioinformatics analysis of Lianmei granules in diabetic nephropathy
    Pengyan Dong, Hongying Zhang, Zeyou Wei, Weiran He, Jiwei Liu, Shaoxia Li, Yu Yang, Nan Wang, Ning Su, Yuan Yuan, Min Wang, Jiming Wan, Jizhen Liang, Duohua Su, Jinxing Hu, Hua Li, Qi Wang
    Medicine.2026; 105(41): e51011.     CrossRef
  • Effectiveness of a self-management intervention on clinical outcomes among patients with type 2 diabetes at high risk for Diabetic Kidney Disease: A Randomised Controlled Trial
    Dongmei Chu, Bingyang Liu, Kim Lam Soh, Hasni Idayu Saidi, Salimah Japar, Diego Moriconi
    PLOS One.2026; 21(10): e0360475.     CrossRef
  • Lipid metabolism-related inflammatory indices and diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study
    Jing Liu, Xiaochan Tian, Mingjun Xu, Yao Xiao, Shuwu Wei, Xinyu Pan, Yue Shi, Hangyu Duan, Yu Zhang, Junping Wei
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Retinal and choroidal features in patients with diabetic peripheral neuropathy: a stratified analysis by retinopathy status
    Qing Zhao, Linxin Wei, Xinyu Zhao, Xingwang Gu, Shiyu Cheng, Zhixuan Xie, Meiqian He, Youxin Chen
    Advances in Ophthalmology Practice and Research.2026;[Epub]     CrossRef
  • Biomarkers for the diagnosis and management of cardiovascular-kidney-metabolic syndrome: recent advances and prospects for clinical application
    Liuqi Hu, Min Yang
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Mechanistic insights into lactate-driven pathogenesis in diabetic kidney disease
    Shihao He, Longyan Yang, Ruili Yin
    Frontiers in Pharmacology.2026;[Epub]     CrossRef
  • Programmed cell death in primary Sjögren’s disease: regulatory network analysis and therapeutic prospects evaluation
    Wang Chengzhi, Liu Yifan, Li Songwei, Du Mengmeng, Zhu Keying, Li Huan
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • Development and internal validation of an interpretable machine learning-based risk stratification model for sarcopenic obesity in patients with type 2 diabetes mellitus
    Ting Shi, Xiaohong Liu, Meiling Fu, Yuxuan Lu, Qi Li, Jie Zou, Yinqin Zhong, Yun Chen
    Frontiers in Medicine.2026;[Epub]     CrossRef
  • N6-methyladenosine in inflammatory diseases: Important actors and regulatory targets
    Zewen Li, Yongfeng Lao, Rui Yan, Fuhan Li, Xin Guan, Zhilong Dong
    Gene.2025; 936: 149125.     CrossRef
  • Proteomics exploration of metformin hydrochloride for diabetic kidney disease treatment via the butanoate metabolism pathway
    Jinxuan Chai, Yan Wang, Sifan Guo, Zhibo Wang, Hongwei Chen, Xian Wang, Dandan Xie, Ying Cai, Shiwei Wang, Zhencai Hu, Aihua Zhang, Shi Qiu
    Journal of Pharmaceutical and Biomedical Analysis.2025; 254: 116584.     CrossRef
  • Global research hotspots and trends in oxidative stress-related diabetic nephropathy: a bibliometric study
    Xiao-rong Wang, Zeng Wu, Tong-tong He, Xiao-han Chen, Xiao-fei Jin, Chun-yue Zuo, Shao-ze Yang, Yu Gao, Xiao-hong Zhou, Wei-juan Gao
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Implementing novel complete blood count-derived inflammatory indices in the diabetic kidney diseases diagnostic models
    Ali Hassanzadeh, Mehdi Allahdadi, Sepehr Nayebirad, Nazli Namazi, Ensieh Nasli-Esfahani
    Journal of Diabetes & Metabolic Disorders.2025;[Epub]     CrossRef
  • NR4A1 silencing alleviates high-glucose-stimulated HK-2 cells pyroptosis and fibrosis via hindering NLRP3 activation and PI3K/AKT pathway
    Jin-Meng Li, Zi-Hua Song, Yuan Li, Han-Wen Chen, Han Li, Lu Yuan, Jing Li, Wen-Yue Lv, Lei Liu, Na Wang
    World Journal of Diabetes.2025;[Epub]     CrossRef
  • Association between drinking patterns and diabetic kidney disease in United States adults: a cross-sectional study based on data from NHANES 1999–2016
    Xusheng Yang
    Renal Failure.2025;[Epub]     CrossRef
  • Mechanisms, Biomarkers, and Treatment Approaches for Diabetic Kidney Disease: Current Insights and Future Perspectives
    Jean Paule Joumaa, Angela Raffoul, Charbel Sarkis, Elizabeth Chatrieh, Sally Zaidan, Philippe Attieh, Frederic Harb, Sami Azar, Hilda E. Ghadieh
    Journal of Clinical Medicine.2025; 14(3): 727.     CrossRef
  • Investigation of the role and mechanism of dapagliflozin in mitigating renal injury in rats afflicted with diabetic kidney disease
    Hao Wang, Xiuli Zhao, Xiao Wang, Yi Gong, Songping Li, Yanting Gu, Bosai He, Jiahong Wang
    Biochemical Pharmacology.2025; 233: 116795.     CrossRef
  • Progress in the application of novel inflammatory indicators in chronic kidney disease
    Wenrui Gao, Xiangyu Wang, Yulin Zou, Sheng Wang, Jun Dou, Senlin Qian
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Serum advanced glycation end products as a putative biomarker in Type2 DKD patients’ prognosis
    Ze-Hou Wang, Zong-Jin Zhang, Yue-Fen Wang, Jin Xie, Yi-Min Li, Cun Shen, Yuan Meng, Wen-Jing Zhao, Lu-Ying Sun, Wei Jing Liu
    Frontiers in Physiology.2025;[Epub]     CrossRef
  • The Potential of Blood KIM‐1 as a Biomarker in Early Diagnosis of Diabetic Kidney Disease
    Ningjie Gong, Qian Wang, Zhaoqing Cong, Lezhi Xu, Wenqian Yang, Yang Du
    iLABMED.2025; 3(1): 29.     CrossRef
  • Detection of Fast Decliner of Diabetic Kidney Disease Using Chiral Amino Acid Profiling: A Pilot Study
    Yosuke Hirakawa, Tomonori Kimura, Shinsuke Sakai, Masayuki Mizui, Masashi Mita, Yoshitaka Isaka, Masaomi Nangaku, Reiko Inagi
    Chemistry & Biodiversity.2025;[Epub]     CrossRef
  • Biomarkers: New Advances in Diabetic Nephropathy
    Yujia Chen, Xinan Liu, Meniga Shengbu, Qian Shi, Suolang Jiaqiu, Xianrong Lai
    Natural Product Communications.2025;[Epub]     CrossRef
  • Uncovering the mechanism of Huangkui capsule in the treatment of diabetic kidney disease based on network pharmacology and experimental validation
    Junhong Liu, Ziwei Li, ZongYao Zhang, Zhongyuan Shen
    Scientific Reports.2025;[Epub]     CrossRef
  • Melatonin attenuates kidney injury by alleviating lysosomal damage in diabetic kidney disease
    Jiaqi Chen, Shuting Zhang, Xiaoquan Xue, Xiaoqin Ma, Aomiao Chen, Yichuan Wu, Geningyue Wang, Qian Zhang, Yaoming Xue, Yijie Jia, Zongji Zheng
    Acta Biochimica et Biophysica Sinica.2025; 57(10): 1589.     CrossRef
  • Association of normal range of urinary albumin‐to‐creatinine ratio with all‐cause mortality among diabetic adults with preserved kidney function: National Health and Nutrition Examination Survey (NHANES) 2003–2018
    Xiaoxia Pang, Wenchao Dan, Lan Lin, Huimei Li, Xiangrong Rao, Shen Li
    Diabetes, Obesity and Metabolism.2025; 27(5): 2670.     CrossRef
  • Oxidative protein destruction products as markers of chronic kidney disease progression in diabetes mellitus
    MV Osikov, LA Efros, LYu Zhuravleva, AA Fedosov
    Bulletin of Russian State Medical University.2025;[Epub]     CrossRef
  • Research Progress of Factors Influencing Bleeding of Percutaneous Nephrolithotomy
    丽梅 王
    Advances in Clinical Medicine.2025; 15(03): 1580.     CrossRef
  • Serum metabolic profiling of patients with diabetic kidney disease based on gas chromatography-mass spectrometry
    Xueyan Bian, Chenwen Wang, Majie Wang, Ailing Yin, Jiayan Xu, Mijia Liu, Hui Wang, Yating Cao, Xin Huang, Chenxue Qin, Ye Zhang, Heming Yu
    Frontiers in Molecular Biosciences.2025;[Epub]     CrossRef
  • A Machine Learning-Based Prediction Model for Diabetic Kidney Disease in Korean Patients with Type 2 Diabetes Mellitus
    Kyung Ae Lee, Jong Seung Kim, Yu Ji Kim, In Sun Goak, Heung Yong Jin, Seungyong Park, Hyejin Kang, Tae Sun Park
    Journal of Clinical Medicine.2025; 14(6): 2065.     CrossRef
  • Association of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in population with cardiovascular-kidney-metabolic syndrome stages 0–4: evidence from a large cohort study
    Fan-Shun Guo, Jia-Hao Dou, Jun-Xiang Wang, Chen Guo, Rui-Yun Wu, Xue-Lu Sun, Yi-Wei Hu, Jin Wei
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Progress and perspectives of metabolic biomarkers in blood sample for diabetic microvascular complications
    Li Yan, Xu Wang, Yujie Xiang, Shuyi Ru, Cheng Fang, Xiuhong Wu
    Metabolomics.2025;[Epub]     CrossRef
  • Predicting diabetic kidney disease with serum metabolomics and gut microbiota
    Yuyun Hu, Xue Ni, Qinghuo Chen, Yihui Qu, Kanan Chen, Gaohui Zhu, Minqiao Zhang, Ningjie Xu, Xu Bai, Jing Wang, Yanhong Ma, Qun Luo, Kedan Cai
    Scientific Reports.2025;[Epub]     CrossRef
  • Loureirin B analogs mitigate oxidative stress and confer renal protection
    Haowen Fang, Xiaodong Sun, Yanting Ding, Bing Niu, Qin Chen
    Cellular Signalling.2025; 132: 111787.     CrossRef
  • Circulating Neutrophil and Monocyte Ratios to High Density Lipoprotein-Cholesterol Are Elevated with Increased Triglyceride-Glucose Index
    Ishwarlal Jialal, Beverley Adams-Huet
    International Journal of Clinical and Translational Medicine.2025;[Epub]     CrossRef
  • Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: What Does the Cardiologist Need to Know?
    Martin Berger, Nikolaus Marx, Katharina Marx-Schütt
    European Cardiology Review.2025;[Epub]     CrossRef
  • Contemporary Perspectives on Chronic Renal Disorders
    Deenadhayalan Ashok, Poornima Ajay Manjrekar, Bhushan C. Shetty, Sujina S. S, Rukmini Mysore Srikantiah, Sowndarya Kollampare
    Chronic Diseases and Translational Medicine.2025; 11(2): 89.     CrossRef
  • Baseline comorbidity of cardiovascular-kidney-metabolic syndrome increases the risk of adverse clinical outcomes in patients with chronic kidney disease
    Jiali Meng, Wen Li, Wenjing Fu, Aihua Zhang
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Yangonin Attenuates Streptozotocin-induced Diabetic Nephropathy in Rats via Downregulating Oxidative Stress and Inflammatory Responses
    Zhenzhen Hao, Lin Li, Youlan Gong, Yang Xu
    Pharmacognosy Magazine.2025; 21(4): 1562.     CrossRef
  • The association between the cardiac metabolic index and rapid kidney function decline and CKD in individuals with different glucose metabolism statuses: results from the China health and retirement longitudinal study
    Wei-Zhen Tang, Qin-Yu Cai, Tai-Hang Liu, Tao-Ting Li, Gao-hui Zhu, Jia-cheng Li, Kang-Jin Huang, Hong-Yu Xu, He-Zhe Hua, Rong Li
    Lipids in Health and Disease.2025;[Epub]     CrossRef
  • Systemic immune indicators for predicting renal damage in newly diagnosed type 1 diabetic children
    Lan-Fang Cao, Qing-Bo Xu, Li Yang
    World Journal of Diabetes.2025;[Epub]     CrossRef
  • Shenzhuo formulation ameliorates diabetic nephropathy by regulating cytochrome P450-mediated arachidonic acid metabolism
    Zhong-Yong Zhang, Yu-Ming Wang, Ning Wang, Yuan-Song Wang, Hui Zhang, Duo Wang, Li-Xin Wang, Huan-Tian Cui, Wei-Bo Wen, Shu-Quan Lv, Yong-Jun Cao
    World Journal of Diabetes.2025;[Epub]     CrossRef
  • An update on renal tubular injury as related to glycolipid metabolism in diabetic kidney disease
    Anqi Feng, Ruili Yin, Rong Xu, Baoyu Zhang, Longyan Yang
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Revealing VCAN as a Potential Common Diagnostic Biomarker of Renal Tubules and Glomerulus in Diabetic Kidney Disease Based on Machine Learning, Single-Cell Transcriptome Analysis and Mendelian Randomization
    Li Jiang, Jie Jian, Xulin Sai, Xiai Wu
    Diabetes & Metabolism Journal.2025; 49(3): 407.     CrossRef
  • Dynamic DNA methylation of EPHX2 in diabetic kidney disease progression: A potential biomarker
    Guoxiong Deng, Ziyi Feng, Xiaomu Kong, Peng Gao, Yongwei Jiang, Yi Liu, Meimei Zhao, LiangMa
    Gene Reports.2025; 40: 102245.     CrossRef
  • Histone deacetylases and their inhibitors in kidney diseases
    Yue Zheng, Tie-Ning Zhang, Peng-Hui Hao, Ni Yang, Yue Du
    Molecular Therapy.2025; 33(8): 3485.     CrossRef
  • Spinach Extract Reduces Kidney Damage in Diabetic Rats by Impairing the AGEs/RAGE Axis
    Javier Flores-Estrada, Agustina Cano-Martínez, Luz Ibarra-Lara, Adriana Jiménez, Carmen Palacios-Reyes, Luis J. Pinto García, María G. Ortiz-López, Olga Nelly Rodríguez-Peña, Luis Barbo Hernández-Portilla
    International Journal of Molecular Sciences.2025; 26(10): 4730.     CrossRef
  • KIM-1 como biomarcador de lesão tubular renal em pacientes com diabetes mellitus tipo 2 normoalbuminúricos e com resistência à insulina
    Laura Eduarda de Oliveira, Clóvis Paniz, Rafael Noal Moresco, José Antonio Mainardi de Carvalho
    Brazilian Journal of Nephrology.2025;[Epub]     CrossRef
  • KIM-1 as a biomarker of kidney tubular damage in normoalbuminuric patients with type 2 diabetes mellitus and insulin resistance
    Laura Eduarda de Oliveira, Clóvis Paniz, Rafael Noal Moresco, José Antonio Mainardi de Carvalho
    Brazilian Journal of Nephrology.2025;[Epub]     CrossRef
  • Role of Physical Activity in Reducing Diabetic Kidney Disease Risk in Adults: Data From the National Health and Nutrition Examination Survey, 2017–2018
    Wirampa Tanglai, Apichai Wattanapisit, Osamu Watanabe, Thanakrit Jeamjitvibool, Mark Lockwood, Mia Cajita
    Diabetes/Metabolism Research and Reviews.2025;[Epub]     CrossRef
  • Genetics of diabetes and its complications: a comprehensive review
    Abdul Sami, Ahsan Javed, Dilber Uzun Ozsahin, Ilker Ozsahin, Khalid Muhammad, Yasir Waheed
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Serum metabolic profiling in diabetic kidney disease patients using ultra-high performance liquid chromatography-tandem mass spectrometry
    Bin Zhang, Chunmei Dai, Jiuyi Jiang, Jun Wang, Yuwei Yang, Jiafu Feng
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Urine Biomarkers for Diabetic Kidney Disease Progression in Participants of the Chronic Renal Insufficiency Cohort Study
    Sarah J. Schrauben, Xiaoming Zhang, Dawei Xie, Steven Coca, Jason H. Greenberg, Joachim H. Ix, Michael G. Shlipak, Chi-yuan Hsu, Jonathan J. Taliercio, Chirag R. Parikh, Orlando Gutierrez, Mark J. Sarnak, Mirela A. Dobre, Debbie Cohen, Jeffrey R. Schellin
    Clinical Journal of the American Society of Nephrology.2025; 20(7): 958.     CrossRef
  • Melatonin Protects Against Diabetic Kidney Disease via the SIRT1/NLRP3 Signalling Pathway
    Yaping Zhang, Yinghui Wang, Jingyan Yang, Gang Liu
    Nephrology.2025;[Epub]     CrossRef
  • Apelin Alleviated Endothelial‐To‐Mesenchymal Transition via Increasing BKCa in Diabetic Nephropathy
    Chunmeng Fan, Yu Liu, Jing Chang, Mingcong Huang, Zihao Gao, Huade Wang, Xiang Zheng, Menghe Li, Jialiang Xu, Jiming Yin, Xiangjun Zeng
    The FASEB Journal.2025;[Epub]     CrossRef
  • Association Between DNA Methylation of MTHFR and Diabetic Kidney Disease
    Guoxiong Deng, Ziyi Feng, Xiaomu Kong, Peng Gao, Yongwei Jiang, Yi Liu, Meimei Zhao, Liang Ma, Kalyani Sen
    Journal of Diabetes Research.2025;[Epub]     CrossRef
  • PHGDH alleviates DKD by regulating YB1/SLC7A11-mediated ferroptosis in podocytes
    Yinghui Wang, Qingqing Zhang, Shasha Lv, Xueling Wang, Qingzhen Liu, Xiangchun Liu, Yaping Zhang, Gang Liu
    Translational Research.2025; 282: 1.     CrossRef
  • Comparative effectiveness of traditional Chinese medicine injections combined with ACEI/ARB for diabetic nephropathy: A systematic review and network meta-analysis
    Aijing Li, Maoying Wei, Chan Wu, Dan Yin, Yiting Tang, Yijia Jiang, Churan Wang, Jingyi Guo, Anning Sun, Xin Gu, Yanbing Gong
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Fecal microbiota transplantation is a promising therapy for kidney diseases
    Jiawei Zhang, Xiangge Ren, Bing Li, Zhifen Zhao, Shoudao Li, Wensheng Zhai
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Kaempferol improves mitochondrial homeostasis via mitochondrial dynamics and mitophagy in diabetic kidney disease
    Chenhui Xia, Jiale Zhang, Huixi Chen, Weimin Jiang, Shaofeng Zhou, Huijuan Zheng, Weiwei Sun
    International Immunopharmacology.2025; 162: 115121.     CrossRef
  • Polygonati Rhizoma Polysaccharides Ameliorated Diabetic Kidney Disease in db/db Mice via Inhibiting TGFβ/Smad2 Signaling Pathway
    Xiyu Mei, Zeming Ren, Ziyun Gao, Sisi Chen, Xuan Chen, Qingyun Zhou, Yeling Tong, Guanhai Dai
    Food Science & Nutrition.2025;[Epub]     CrossRef
  • Therapeutic Potential of Cinnamic Acid as an SGLT2 Inhibitor in Mitigating Diabetic Nephropathy in a Rat Model of Type 2 Diabetes
    Setah Naif Alotaibi, Ghedeir M. Alshammari, Nawal A. Albadr, Mohammed Abdo Yahya
    Molecular Nutrition & Food Research.2025;[Epub]     CrossRef
  • Asprosin Levels in Adults with Type 2 Diabetes Mellitus and Diabetic Kidney Disease: A Systematic Review and Meta-Analysis
    Jovana Ristic, Sena Kodalak, Gonzalo Peralta-Jiménez, Maria Moura de Lima, Marijana Kovacevic, Srdjan Masic, Tatjana Nikolic
    Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 2493.     CrossRef
  • Notch signaling in diabetic kidney disease: recent progress
    Zhi-Hui Wang, Wei Tu, Ya-Ni Long, Peng-Fei Li, Kai-Ying He, Jing Wu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Sirtuin 3 in diabetic kidney disease: mechanisms and pharmacotherapy
    Yinfeng Chen, Ying Wang, Dongrong Yu, Hailing Zhao, Ping Li
    Renal Failure.2025;[Epub]     CrossRef
  • Mechanism of Rhizoma Chuanxiong for the treatment of diabetic kidney disease based on network pharmacology
    Yuhe Yan, Honghong Shi, Yue Li, Xing Wan, Jinxin Li, Lihua Wang
    Renal Failure.2025;[Epub]     CrossRef
  • The potential adding therapeutic effect of pentoxifylline and/or folic acid for chronic kidney disease patients: randomized controlled trial
    Amira Reda Muhammad Galal, Nahla Mohamed Teama, Karema Abu–Elfotuha, Ahmed D. Alatawi, Hanan Alshareef, Ahmed M. E. Hamdan, Ahmed Aljabri, Mohannad Alshibani, Zeinab AlKasaby Mahmoud Zalat
    BMC Nephrology.2025;[Epub]     CrossRef
  • Association between a diabetes-predictive index and diabetes-related kidney disease in U.S. adults: A cross-sectional study
    Haonan Wu, Zheng Nan
    Preventive Medicine Reports.2025; 58: 103225.     CrossRef
  • Asprosin Aggravates Tubular Epithelial Cell Injury and Phenotypic Transformation via Mitochondrial Dynamics Disorder Mediated by Excessive Drp1 SUMOylation in Diabetic Nephropathy Mice
    Qianqian Huang, Xiaowei Xiong, Sheng Chen, Yuan Wang, Li Wang, Wentao Liu, Chen Liu, Guohua Zeng, Qiren Huang
    Advanced Science.2025;[Epub]     CrossRef
  • C3AR1 may aggravate diabetic nephropathy by mediating oxidative stress via ITGB2 regulation in renal tubular epithelial cells
    Alex Abura, Shan Gao, Shinsuke Yuasa
    PLOS One.2025; 20(9): e0331900.     CrossRef
  • Exploration of the renoprotective effect of Yi-Shen-Hua-Shi granules on db/db mice and the mechanism of podocyte apoptosis based on the GRP78/CHOP signaling pathway
    Yanmo Cai, Yunhua Liu, Sitong Wang, Ge Jin, Kaidong Zhou, Xin Zhou, Xinxue Zhang, Min Zhang, Zongjiang Zhao
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Protective effects of Shenkang injection against diabetic kidney disease via p38 MAPK/NFκB/MCP-1/CCR2 pathway inhibition
    Xin Zhou, Sitong Wang, Ge Jin, Kaidong Zhou, Yanmo Cai, Zongjiang Zhao
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Prevalence of diabetes and prediabetes among working-age adults and influencing factors of new-onset diabetes: a five-year cohort study (2018–2023)
    Jing Tan, Mingzhu Chen, Yang Lei, Xiaofen Shi, Cuiping Cao, Naili Du, Yuyou Yao, Xiaojuan Yao
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Celastrol, a bioactive compound from Tripterygium wilfordii, exerts renoprotective effects by modulating the gut-kidney axis and PPAR signaling in a mouse model of diabetic kidney disease
    Yue-Wen Tang, Jia-Wei Cao, Meng-Dan Lu, Ru-Chun Yang, Feng Wan
    Asian Pacific Journal of Tropical Biomedicine.2025; 15(9): 353.     CrossRef
  • Expression Profile of Urinary Exosomal miRNAs in Patients With Diabetic Kidney Disease and Their Association With Kidney Damage
    Juan Li, Lulu Han, Ting Wang, Lin Yang, Hong Zhou, Pawel Grzmil
    International Journal of Endocrinology.2025;[Epub]     CrossRef
  • Commentary on: Inhibition of LINC00707/miR‐223‐3p/FKBP5 axis has a protective effect on diabetic kidney disease
    Yirui Zhao, Fengyue Zhang
    Journal of Diabetes Investigation.2025; 16(12): 2251.     CrossRef
  • Research on Glycemic Variability Characteristics in Diabetic Patients Undergoing Hemodialysis
    俊杰 苏
    Journal of Clinical Personalized Medicine.2025; 04(05): 100.     CrossRef
  • Short-Term: Cellular Metabolism and Gene Expression During the Onset of Diabetic Kidney Disease: A Diabetes Mellitus Experimental Model
    Jéssica Encinas, Glaucia Veiga, Joyce Raimundo, Matheus Perez, Giuliana Petri, Renan Cavalheiro, Pedro Reis, Laura Maifrino, Beatriz Alves, Fernando Fonseca
    International Journal of Molecular Sciences.2025; 26(19): 9676.     CrossRef
  • Construction of a diagnostic model and identification of effect genes for diabetic kidney disease with concurrent vascular calcification based on bioinformatics and multiple machine learning approaches
    Lili Huang, Wenjing Wu, Shenhui Lv, Danfang Deng, Xiaoqin Wang
    Frontiers in Molecular Biosciences.2025;[Epub]     CrossRef
  • Selected miRNAs in Urinary Extracellular Vesicles Show Promise for Early and Specific Diagnostics of Diabetic Kidney Disease
    Karina Barreiro, Jenni Karttunen, Erkka Valo, Essi Viippola, Ileana Quintero, Annemari Käräjämäki, Antti Rannikko, Harry Holthöfer, Andrea Ganna, Niina Sandholm, Lena M. Thorn, Per‐Henrik Groop, Tiinamaija Tuomi, Om Prakash Dwivedi, Maija Puhka
    Journal of Extracellular Biology.2025;[Epub]     CrossRef
  • Multi-omics and machine learning identify FN1 and ALDH2 as diagnostic biomarkers and therapeutic targets in early and late diabetic kidney disease
    Jingwei Lin, Yingying Zheng, Diman Mai, Fuxiang Fang, Zhuokun Wei, Mengyu Liu, Trung Hieu Pham, Ming Li, Jiawen Zhao
    Renal Failure.2025;[Epub]     CrossRef
  • Yiqi Wenyang Formula ameliorates diabetic kidney disease via inhibiting inflammation and regulating the gut microbiota-bile acid axis in mice by FXR signaling pathway
    Tongyi Yuan, Xiang Gao, Xinxin Wang, Xiaolei Tang, Zuguo Liang, Yifei Yin, Songyan Liu, Jianze Ou, Wenjie Su, Zepeng Zhang, Xiangyan Li, Qingxia Huang, Daqing Zhao, He Zhang
    Chinese Medicine.2025;[Epub]     CrossRef
  • Qing-Re-Xiao-Zheng-yi-qi formula protects renal function by stabilizing lysosomal membranes and inhibiting NLRP3-inflammasome-mediated pyroptosis in diabetic kidney disease
    Lei Tian, Lin Wang, Yutong Wang, Weijing Liu, Wenjing Zhao, Yaoxian Wang
    Annals of Medicine.2025;[Epub]     CrossRef
  • The Inflammatory Cell Death in Diabetic Kidney Disease: Integrating Multifactorial Mechanisms into Novel Therapeutics
    Bin Fang, Wei Huang, Sijia Du, Yu Hao, Fangfang He, Chun Zhang
    International Journal of Molecular Sciences.2025; 26(22): 11033.     CrossRef
  • Rhein Inhibits Podocyte Ferroptosis and Epithelial-Mesenchymal Transition in Diabetic Nephropathy by Activating the SIRT1/p53/SLC7A11 Pathway
    Wei Hu, Dan Xiong
    BIOCELL.2025; 49(9): 1711.     CrossRef
  • Diagnostic Roles of circXPNPEP3 as Biomarker for Diabetic Nephropathy
    Miao Liu, Qiunan Zhan, Junjun Zhu, Junli Zhao, Danyan Min
    Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 4287.     CrossRef
  • Protective Effects of Hydrogen Treatment Against High Glucose-Induced Oxidative Stress and Apoptosis via Inhibition of the AGEs/RAGE/NF-κB Signaling Pathway in Skin Cells
    Pan Yu, Nan Hong, Qiong Wu, Zhipeng Zhao
    Endocrine, Metabolic & Immune Disorders - Drug Targets.2025;[Epub]     CrossRef
  • The Clinical Significance of Serum Sirtuin 2 in Diabetic Nephropathy: Evidence for a Potential Biomarker of Renal Injury
    Ozgur Yilmaz, Osman Erinc, Murvet Algemi, Recep Demirci, Sengul Aydin Yoldemir, Murat Akarsu
    Journal of Clinical Medicine.2025; 14(22): 8095.     CrossRef
  • The “Picasso faces” of diabetic kidney disease – how the art of phenotyping and molecular biomarkers is transforming clinical nephrology: an observational study in patients with type 2 diabetes
    Małgorzata Rodzoń-Norwicz, Natalia Potocka, Marzena Skrzypa, Izabela Zawlik, Katarzyna Milian–Ciesielska, Patryk Kogut, Krzysztof Gargasz, Michael Maes, Magdalena Sowa-Kućma, Agnieszka Gala-Błądzińska
    BMC Nephrology.2025;[Epub]     CrossRef
  • The Association of Lipoic Acid Synthase (LIAS) Gene Methylation With Diabetic Kidney Disease
    Ziyi Feng, Ting Liu, Peng Gao, Yongwei Jiang, Meimei Zhao, Yi Liu, Haoyan Zhu, Mo Li, Nan Li, Xiaomu Kong, Liang Ma, Zhipeng Tao
    Journal of Diabetes Research.2025;[Epub]     CrossRef
  • Association between triglyceride–glucose index and its derivatives and lung adenocarcinoma risk: a case–control study in Chinese adults
    Pengcheng Qiu, Jinshi Xie, Yayuan He, Rizheng Cong, Keyue Huang, Bo Huang
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Klotho in diabetes mellitus: research progress and clinical implications
    Tingyuan Zhu, Songfeng Zhao, Ning Lu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • The mediating role of inflammation in the association between coagulation parameters and diabetic kidney diseases in patients with type 2 diabetes mellitus: a muti-center cross-sectional retrospective study in Southwest China from 2013 to 2022
    Bei-Hui Ren, Ling-Zhi Xing, Bai-Yu-Lu Chen, Guo-Jia Liao, Li-Yuan Chen, Ying-Dan Zhang, Jie Fan, Ling Chen
    BMC Nephrology.2025;[Epub]     CrossRef
  • Syndecan-1 as a Prognostic Biomarker for Early Diabetic Kidney Disease Progression: A Cohort Study
    Yiqun Peng, Dongguang Wang, Kaifa Guo, Liang Peng
    Journal of Medicine and Physical Education.2025; 2(5): 40.     CrossRef
  • Role of polyphenols in the management of diabetic complications
    Jeevika Raina, Atika Firdous, Gurvinder Singh, Rajesh Kumar, Charanjit Kaur
    Phytomedicine.2024; 122: 155155.     CrossRef
  • Single-Cell RNA Sequencing Reveals RAC1 Involvement in Macrophages Efferocytosis in Diabetic Kidney Disease
    Yi Song, Yifan Liu, Feng Guo, Lin Zhao, Guijun Qin
    Inflammation.2024; 47(2): 753.     CrossRef
  • Role of MCP-1 as an inflammatory biomarker in nephropathy
    Yanlong Liu, Ke Xu, Yuhua Xiang, Boyan Ma, Hailong Li, Yuan Li, Yue Shi, Shuju Li, Yan Bai
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Urinary podocyte stress marker as a prognostic indicator for diabetic kidney disease
    Lingfeng Zeng, Jack Kit-Chung Ng, Winston Wing-Shing Fung, Gordon Chun-Kau Chan, Kai-Ming Chow, Cheuk-Chun Szeto
    BMC Nephrology.2024;[Epub]     CrossRef
  • Identification and validation of immune and cuproptosis - related genes for diabetic nephropathy by WGCNA and machine learning
    Yubing Chen, Lijuan Liao, Baoju Wang, Zhan Wu
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Specific Alternation of Gut Microbiota and the Role of Ruminococcus gnavus in the Development of Diabetic Nephropathy
    Jinni Hong, Tingting Fu, Weizhen Liu, Yu Du, Junmin Bu, Guojian Wei, Miao Yu, Yanshan Lin, Cunyun Min, Datao Lin
    Journal of Microbiology and Biotechnology.2024; 34(3): 547.     CrossRef
  • The triglyceride-glucose index is superior to homeostasis model assessment of insulin resistance in predicting metabolic syndrome in an adult population in the United States
    Beverley Adams-Huet, Rafael Zubirán, Alan T. Remaley, Ishwarlal Jialal
    Journal of Clinical Lipidology.2024; 18(4): e518.     CrossRef
  • Association of the dietary inflammatory index with complicated diabetic kidney disease in people with diabetes mellitus: evidence from NHANES 2009–2018
    Yixin Rui, Xiumeng Zhang, Hongxiao Xie, Hu Qi, Rong Liu, Nan Zeng
    Acta Diabetologica.2024; 61(11): 1375.     CrossRef
  • Multiomics Analyses Identify AKR1A1 as a Biomarker for Diabetic Kidney Disease
    DengFeng Li, Fang-Chi Hsu, Nicholette D. Palmer, Liang Liu, Young A. Choi, Mariana Murea, John S. Parks, Donald W. Bowden, Barry I. Freedman, Lijun Ma
    Diabetes.2024; 73(7): 1188.     CrossRef
  • Serum L C3-II levels in type 2 diabetic patients with impaired renal functions
    Shahab Ahmed Salıh Gezh, Koksal Deveci, Hakan Sivgin, Figen Guzelgul
    Cytokine.2024; 181: 156683.     CrossRef
  • Diabetic Nephropathy as a Result of Uncontrolled Hyperglycemia
    Camila Silva de Aquino, Estênio Gabriel Miranda, Francisco José Pascoal Ribeiro Júnior, Hérika Juliana de Araújo Lucena, Jéssica Pará Amaral de Oliveira, João Ferreira Lima Neto, Lênio Airam de Pinho, Miguel Valentim Rodrigues, Pedro Henrique Borges Silve
    Revista de Gestão Social e Ambiental.2024; 18(1): e07716.     CrossRef
  • Pharmacological effects of bioactive agents in earthworm extract: A comprehensive review
    Zihan Zhu, Xinyi Deng, Wenqing Xie, Hengzhen Li, Yusheng Li, Zhenhan Deng
    Animal Models and Experimental Medicine.2024; 7(5): 653.     CrossRef
  • Efficacy and safety of polyethylene glycol loxenatide in treating mild-to-moderate diabetic kidney disease in type 2 diabetes patients: a randomized, open-label, clinical trial
    YongSheng Cao, Shujie Cao, Jiangang Zhao, Jianqin Zhao, Yanan Zhao, Ying Liu
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Fish oil supplementation in relation to the risk of chronic kidney disease among patients with diabetes
    Yang Ao, Hao Ye, Xiaohui Liu, Yin Li, Haoyin Liu, Shu Ye, Yepeng Hu, Pan Zhuang, Yu Zhang, Chao Zheng, Jingjing Jiao
    Diabetes, Obesity and Metabolism.2024; 26(11): 5283.     CrossRef
  • CYSTATIN C—A Monitoring Perspective of Chronic Kidney Disease in Patients with Diabetes
    Alexandra-Mihaela Visinescu, Emilia Rusu, Andrada Cosoreanu, Gabriela Radulian
    International Journal of Molecular Sciences.2024; 25(15): 8135.     CrossRef
  • Role of proadrenomedullin in the progression of diabetic kidney disease in patients with type 2 diabetes mellitus
    A.M. Urbanovych, A.P. Vereshchynska
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2024; 20(4): 266.     CrossRef
  • Sirt6 overexpression relieves ferroptosis and delays the progression of diabetic nephropathy via Nrf2/GPX4 pathway
    Lingyu Du, Canghui Guo, Shengnan Zeng, Ke Yu, Maodong Liu, Ying Li
    Renal Failure.2024;[Epub]     CrossRef
  • Single-cell RNA sequencing in diabetic kidney disease: a literature review
    Wei Tan, Jiaoyan Chen, Yunyan Wang, Kui Xiang, Xianqiong Lu, Qiuyu Han, Mingyue Hou, Jurong Yang
    Renal Failure.2024;[Epub]     CrossRef
  • Podocyte Death in Diabetic Kidney Disease: Potential Molecular Mechanisms and Therapeutic Targets
    Suye Zhong, Na Wang, Chun Zhang
    International Journal of Molecular Sciences.2024; 25(16): 9035.     CrossRef
  • Serum biomarkers for predicting microvascular complications of diabetes mellitus
    Jiajia Wang, Xiaoyi Song, Ziqiao Xia, Shu Feng, Hangfeng Zhang, Chengjie Xu, Hui Zhang
    Expert Review of Molecular Diagnostics.2024; 24(8): 703.     CrossRef
  • Association of Serum Tsukushi Levels with Urinary Albumin-Creatinine Ratio in Type 2 Diabetes Patients
    Yanyan Li, Xia Deng, Xunan Wu, Ligang Zhou, Guoyue Yuan
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 3295.     CrossRef
  • Liraglutide ameliorates inflammation and fibrosis by downregulating the TLR4/MyD88/NF-κB pathway in diabetic kidney disease
    Linjing Huang, Tingting Lin, Meizhen Shi, Peiwen Wu
    American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.2024; 327(4): R410.     CrossRef
  • Molecular Therapeutics for Diabetic Kidney Disease: An Update
    Man Guo, Fangfang He, Chun Zhang
    International Journal of Molecular Sciences.2024; 25(18): 10051.     CrossRef
  • Angiopoietin‐like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients
    Yan Wang, Kun Li, Shasha Yuan, Caiguo Yu, Ruili Yin, Di Wang, Yongsong Xu, Lijie Zhang, Lingling Wei, Yanan Cheng, Lin Mao, Dong Zhao, Longyan Yang
    Journal of Diabetes Investigation.2024; 15(12): 1763.     CrossRef
  • Integrating network pharmacology and experimental validation to decipher the pharmacological mechanism of DXXK in treating diabetic kidney injury
    Chenxu Zhang, Zhangxin Ji, Na Xu, Jingjing Yuan, Wen Zeng, Yadong Wang, Qing He, Jiaxing Dong, Xinyu Zhang, Dongmei Yang, Wei Jiang, Yibo Yan, Wencui Shang, Jun Chu, Quangen Chu
    Scientific Reports.2024;[Epub]     CrossRef
  • Proteome-wide mendelian randomization identifies novel therapeutic targets for chronic kidney disease
    Pin Zhao, Zhenhao Li, Shilong Xue, Jinshan Cui, Yonghao Zhan, Zhaowei Zhu, Xuepei Zhang
    Scientific Reports.2024;[Epub]     CrossRef
  • Update on the Pathogenesis, Diagnosis, and Treatment of Diabetic Tubulopathy
    Danfeng Liu, Xiaojie Chen, Weiting He, Min Lu, Qiuling Li, Shaogui Zhang, Jianteng Xie, Yifan Zhang, Wenjian Wang
    Integrative Medicine in Nephrology and Andrology.2024;[Epub]     CrossRef
  • Identification of circulating microbial DNA and its association with kidney function in patients with diabetic kidney disease
    Hoang Thuy Linh, Megumi Oshima, Keisuke Sako, Masahiro Konishi, Daiki Hayashi, Hajime Sanada, Takahiro Yuasa, Akihiko Koshino, Keisuke Horikoshi, Taichiro Minami, Shunsuke Tsuge, Akira Tamai, Shiori Nakagawa, Ryo Nishioka, Takeshi Zoshima, Kiyoaki Ito, Ic
    Nephrology.2024; 29(12): 909.     CrossRef
  • Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
    Inha Jung, Seungyoon Nam, Da Young Lee, So Young Park, Ji Hee Yu, Ji A Seo, Dae Ho Lee, Nan Hee Kim
    Diabetes & Metabolism Journal.2024; 48(6): 1126.     CrossRef
  • Role of Epigenetic Changes in the Pathophysiology of Diabetic Kidney Disease
    Marita Liebisch, Gunter Wolf
    Glomerular Diseases.2024; 4(1): 211.     CrossRef
  • Characteristics and Risk of Incident Diabetic Nephropathy between Early-onset versus Late-onset Type 2 Diabetics of Nigerian Origin
    Collins Amadi, Johnbosco Chidozie Okafor, Ochuko Otokunefor, Ezra Agbo
    European Journal of Medical and Health Sciences.2024; 6(6): 60.     CrossRef
  • Research progress of gut microbiome and diabetic nephropathy
    Chenling Chu, Tapas Ranjan Behera, Ying Huang, Wenhui Qiu, Jiayi Chen, Quanquan Shen
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy
    Fengzhao Liu, Zhenyu Yang, Jixin Li, Tao Wu, Xiangyu Li, Lijuan Zhao, Wenru Wang, Wenfei Yu, Guangheng Zhang, Yunsheng Xu
    Molecular Medicine.2024;[Epub]     CrossRef
  • Dynamic changes of inflammatory markers in the early stages of chronic kidney disease in patients with type 1 diabetes mellitus
    MV Osikov, LA Efros, LYu Zhuravleva, AA Fedosov
    Bulletin of Russian State Medical University.2024;[Epub]     CrossRef
  • Ранние биомаркеры диабетической болезни почек
    Барно Шагазатова, Ziyoda Rakhimberdiyeva
    Eurasian Journal of Medical and Natural Sciences.2024; 4(9): 34.     CrossRef
  • A Narrative Review of New Treatment Options for Diabetic Nephropathy
    Aadhira Pillai, Darshna Fulmali
    Cureus.2023;[Epub]     CrossRef
  • Bamboo leaf: A review of traditional medicinal property, phytochemistry, pharmacology, and purification technology
    Yaqian Cheng, Siqi Wan, Linna Yao, Ding Lin, Tong Wu, Yongjian Chen, Ailian Zhang, Chenfei Lu
    Journal of Ethnopharmacology.2023; 306: 116166.     CrossRef
  • Molecular Pathways of Diabetic Kidney Disease Inferred from Proteomics
    Lan Wei, Yuanyuan Han, Chao Tu
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 117.     CrossRef
  • Omics and Artificial Intelligence in Kidney Diseases
    Nadja Grobe, Josef Scheiber, Hanjie Zhang, Christian Garbe, Xiaoling Wang
    Advances in Kidney Disease and Health.2023; 30(1): 47.     CrossRef
  • Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective
    Soumik Das, Ramanathan Gnanasambandan
    Life Sciences.2023; 316: 121414.     CrossRef
  • Pediatric Diabetic Nephropathy: Novel Insights from microRNAs
    Francesca Lanzaro, Annalisa Barlabà, Angelica De Nigris, Federica Di Domenico, Valentina Verde, Emanuele Miraglia del Giudice, Anna Di Sessa
    Journal of Clinical Medicine.2023; 12(4): 1447.     CrossRef
  • Novel Biomarkers of Diabetic Kidney Disease
    Jorge Rico-Fontalvo, Gustavo Aroca-Martínez, Rodrigo Daza-Arnedo, José Cabrales, Tomás Rodríguez-Yanez, María Cardona-Blanco, Juan Montejo-Hernández, Dairo Rodelo Barrios, Jhonny Patiño-Patiño, Elber Osorio Rodríguez
    Biomolecules.2023; 13(4): 633.     CrossRef
  • Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
    Yiwen Li, Yanfei Liu, Shiwei Liu, Mengqi Gao, Wenting Wang, Keji Chen, Luqi Huang, Yue Liu
    Signal Transduction and Targeted Therapy.2023;[Epub]     CrossRef
  • Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes
    Lijun Zhao, Yutong Zou, Yucheng Wu, Linli Cai, Yuancheng Zhao, Yiting Wang, Xiang Xiao, Qing Yang, Jia Yang, Honghong Ren, Nanwei Tong, Fang Liu
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Identification of a New RNA and Protein Integrated Biomarker Panel Associated with Kidney Function Impairment in DKD: Translational Implications
    Alessandra Scamporrino, Stefania Di Mauro, Agnese Filippello, Grazia Di Marco, Antonino Di Pino, Roberto Scicali, Maurizio Di Marco, Emanuele Martorana, Roberta Malaguarnera, Francesco Purrello, Salvatore Piro
    International Journal of Molecular Sciences.2023; 24(11): 9412.     CrossRef
  • Increased serum PCSK9 levels are associated with renal function impairment in patients with type 2 diabetes mellitus
    Zhicai Feng, Xiangyu Liao, Hao Zhang, Juan Peng, Zhijun Huang, Bin Yi
    Renal Failure.2023;[Epub]     CrossRef
  • Analysis of Serum Pyrodeath Re-lated Proteins and Renal Injury in Patients with Type 2 DKD
    茹洁 马
    Asian Case Reports in Emergency Medicine.2023; 11(02): 53.     CrossRef
  • Loganin reduces diabetic kidney injury by inhibiting the activation of NLRP3 inflammasome-mediated pyroptosis
    Xiangri Kong, Yunyun Zhao, Xingye Wang, Yongjiang Yu, Ying Meng, Guanchi Yan, Miao Yu, Lihong Jiang, Wu Song, Bingmei Wang, Xiuge Wang
    Chemico-Biological Interactions.2023; 382: 110640.     CrossRef
  • Machine-learning algorithm-based prediction of a diagnostic model based on oxidative stress-related genes involved in immune infiltration in diabetic nephropathy patients
    Heng-Mei Zhu, Na Liu, Dong-Xuan Sun, Liang Luo
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • The roles of gut microbiota and its metabolites in diabetic nephropathy
    Hui Zhao, Cheng-E Yang, Tian Liu, Ming-Xia Zhang, Yan Niu, Ming Wang, Jun Yu
    Frontiers in Microbiology.2023;[Epub]     CrossRef
  • High triglyceride levels increase the risk of diabetic microvascular complications: a cross-sectional study
    Jiahang Li, Lei Shi, Guohong Zhao, Fei Sun, Zhenxing Nie, Zhongli Ge, Bin Gao, Yan Yang
    Lipids in Health and Disease.2023;[Epub]     CrossRef
  • Correlation of Kidney Injury Molecule-1 and Nephrin Levels in Iraqi Patients with Diabetic Nephropathy
    Raghda Hisham Aljorani, Eman Saadi Saleh , Khalaf Gata Hussein Al Mohammadawi
    Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ).2023; 5: 99.     CrossRef
  • Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies
    Marina Darenskaya, Sergey Kolesnikov, Natalya Semenova, Lyubov Kolesnikova
    International Journal of Molecular Sciences.2023; 24(15): 12378.     CrossRef
  • Evaluation of Neutrophil/Lymphocyte Ratio, Low-Density Lipoprotein/Albumin Ratio, and Red Cell Distribution Width/Albumin Ratio in the Estimation of Proteinuria in Uncontrolled Diabetic Patients
    Duygu Tutan, Murat Doğan
    Cureus.2023;[Epub]     CrossRef
  • Hedysarum polybotrys polysaccharide attenuates renal inflammatory infiltration and fibrosis in diabetic mice by inhibiting the HMGB1/RAGE/TLR4 pathway
    Changqing Xu, Yanxu Cheng, Zongmei Liu, Xiaoyan Fu
    Experimental and Therapeutic Medicine.2023;[Epub]     CrossRef
  • Abdominal adipose tissue and type 2 diabetic kidney disease: adipose radiology assessment, impact, and mechanisms
    Fei Lu, Jinlei Fan, Fangxuan Li, Lijing Liu, Zhiyu Chen, Ziyu Tian, Liping Zuo, Dexin Yu
    Abdominal Radiology.2023; 49(2): 560.     CrossRef
  • Inhibition of MD2 by natural product-drived JM-9 attenuates renal inflammation and diabetic nephropathy in mice
    Minxiu Wang, Qianhui Zhang, Shuaijie Lou, Leiming Jin, Gaojun Wu, Wenqi Wu, Qidong Tang, Yi Wang, Xiaohong Long, Ping Huang, Wu Luo, Guang Liang
    Biomedicine & Pharmacotherapy.2023; 168: 115660.     CrossRef
  • Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes
    Pasquale Esposito, Daniela Picciotto, Francesca Cappadona, Francesca Costigliolo, Elisa Russo, Lucia Macciò, Francesca Viazzi
    World Journal of Diabetes.2023; 14(10): 1450.     CrossRef
  • Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease
    Meng Wu, Zhiyin Pei, Guangfeng Long, Hongbing Chen, Zhanjun Jia, Weiwei Xia
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Research progress on multiple cell death pathways of podocytes in diabetic kidney disease
    Can Yang, Zhen Zhang, Jieting Liu, Peijian Chen, Jialing Li, Haiying Shu, Yanhui Chu, Luxin Li
    Molecular Medicine.2023;[Epub]     CrossRef
  • Quantitative profiling of carboxylic compounds by gas chromatography-mass spectrometry for revealing biomarkers of diabetic kidney disease
    Rongrong Zhu, Yan Yuan, Rourou Qi, Jianying Liang, Yan Shi, Hongbo Weng
    Journal of Chromatography B.2023; 1231: 123930.     CrossRef
  • Jiangtang Decoction Ameliorates Diabetic Kidney Disease Through the Modulation of the Gut Microbiota
    Jinni Hong, Tingting Fu, Weizhen Liu, Yu Du, Junmin Bu, Guojian Wei, Miao Yu, Yanshan Lin, Cunyun Min, Datao Lin
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 3707.     CrossRef
  • GLP-1RA Combined with SGLT2 Inhibitors for the Treatment of Diabetic Kidney Disease: A Meta Analysis
    莹 郭
    Advances in Clinical Medicine.2023; 13(11): 18117.     CrossRef
  • Potential application of Klotho as a prognostic biomarker for patients with diabetic kidney disease: a meta-analysis of clinical studies
    Li Xia Yu, Min Yue Sha, Yue Chen, Fang Tan, Xi Liu, Shasha Li, Qi-Feng Liu
    Therapeutic Advances in Chronic Disease.2023;[Epub]     CrossRef
  • Research progress of natural active compounds on improving podocyte function to reduce proteinuria in diabetic kidney disease
    Le Gong, Rui Wang, Xinyu Wang, Jing Liu, Zhaodi Han, Qian Li, Yi Jin, Hui Liao
    Renal Failure.2023;[Epub]     CrossRef
  • Identification of potential crosstalk genes and mechanisms between periodontitis and diabetic nephropathy through bioinformatic analysis
    Huijuan Lu, Jia Sun, Jieqiong Sun
    Medicine.2023; 102(52): e36802.     CrossRef
  • Identifying Biomarkers for Diabetic Kidney Disease Using GraphSAGE Neural Network
    Sesugh Gabriel Abenga, Kehinde Seyi Olalekan, Francis Akogwu Alu, Stephen Yavenga Uyoo
    Journal of Computer and Communications.2023; 11(10): 51.     CrossRef
  • Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease
    Stefania Di Mauro, Alessandra Scamporrino, Agnese Filippello, Maurizio Di Marco, Maria Teresa Di Martino, Francesca Scionti, Antonino Di Pino, Roberto Scicali, Roberta Malaguarnera, Francesco Purrello, Salvatore Piro
    International Journal of Molecular Sciences.2022; 23(15): 8198.     CrossRef
  • Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
    Nam Hoon Kim, Nan Hee Kim
    Diabetes & Metabolism Journal.2022; 46(4): 543.     CrossRef
  • Partial Synthetic PPARƳ Derivative Ameliorates Aorta Injury in Experimental Diabetic Rats Mediated by Activation of miR-126-5p Pi3k/AKT/PDK 1/mTOR Expression
    Yasmin M. Ahmed, Raha Orfali, Nada S. Abdelwahab, Hossam M. Hassan, Mostafa E. Rateb, Asmaa M. AboulMagd
    Pharmaceuticals.2022; 15(10): 1175.     CrossRef
  • Polydatin attenuates tubulointerstitial fibrosis in diabetic kidney disease by inhibiting YAP expression and nuclear translocation
    Manlin He, Lan Feng, Yang Chen, Bin Gao, Yiwei Du, Lu Zhou, Fei Li, Hongbao Liu
    Frontiers in Physiology.2022;[Epub]     CrossRef
  • Prevalence of diabetic nephropathy in the diabetes mellitus population: A protocol for systematic review and meta-analysis
    Sicheng Li, Huidi Xie, Yang Shi, Hongfang Liu
    Medicine.2022; 101(42): e31232.     CrossRef
  • Stratification of diabetic kidney diseases via data-independent acquisition proteomics–based analysis of human kidney tissue specimens
    Qinghua Huang, Xianming Fei, Zhaoxian Zhong, Jieru Zhou, Jianguang Gong, Yuan Chen, Yiwen Li, Xiaohong Wu
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives
    Ziyan Xie, Xinhua Xiao
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Diabetic Kidney Disease
    Susanne B. Nicholas, Amy K. Mottl
    Nephrology Self-Assessment Program.2022; 21(5): 394.     CrossRef
Original Articles
Type 1 Diabetes
Article image
Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus
Qianwen Huang, Daizhi Yang, Hongrong Deng, Hua Liang, Xueying Zheng, Jinhua Yan, Wen Xu, Xiangwen Liu, Bin Yao, Sihui Luo, Jianping Weng
Diabetes Metab J. 2022;46(1):93-103.   Published online August 31, 2021
DOI: https://doi.org/10.4093/dmj.2020.0240
  • 16,730 View
  • 259 Download
  • 16 Web of Science
  • 20 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Both type 1 diabetes mellitus (T1DM) and metabolic syndrome (MetS) are associated with an elevated risk of morbidity and mortality yet with increasing heterogeneity. This study primarily aimed to evaluate the prevalence of MetS among adult patients with T1DM in China and investigate its associated risk factors, and relationship with microvascular complications.
Methods
We included adult patients who had been enrolled in the Guangdong T1DM Translational Medicine Study conducted from June 2010 to June 2015. MetS was defined according to the updated National Cholesterol Education Program criterion. Logistic regression models were used to estimate the odds ratio (OR) for the association between MetS and the risk of diabetic kidney disease (DKD) and diabetic retinopathy (DR).
Results
Among the 569 eligible patients enrolled, the prevalence of MetS was 15.1%. While female gender, longer diabetes duration, higher body mass index, and glycosylated hemoglobin A1c (HbA1c) were risk factors associated with MetS (OR, 2.86, 1.04, 1.14, and 1.23, respectively), received nutrition therapy education was a protective factor (OR, 0.46). After adjustment for gender, age, diabetes duration, HbA1c, socioeconomic and lifestyle variables, MetS status was associated with an increased risk of DKD and DR (OR, 2.14 and 3.72, respectively; both P<0.05).
Conclusion
Although the prevalence of MetS in adult patients with T1DM in China was relatively low, patients with MetS were more likely to have DKD and DR. A comprehensive management including lifestyle modification might reduce their risk of microvascular complications in adults with T1DM.

Citations

Citations to this article as recorded by  
  • Optimizing Semaglutide Therapy in Type 2 Diabetes: Pharmacokinetic Limitations, Nanoemulsion-Based Delivery Strategies and Translational Potential
    Satya Prakash, Nidhi Dhama, Aadesh Kumar
    Journal of Pharmaceutical Innovation.2027;[Epub]     CrossRef
  • How Emerging Digital Health Technologies Based on Dietary and Physical Activity Regulation Improve Metabolic Syndrome-Related Outcomes in Adolescents: A Systematic Review
    Ruida Yu, Angkun Li, Yufei Qi, Jianhong Hu, Fei Peng, Shengrui Cao, Siyu Rong, Hao Zhang
    Metabolites.2026; 16(2): 106.     CrossRef
  • Systemic Inflammatory Markers in Patients with Metabolic Syndrome with and Without Dry Eye Disease: An Observational Comparative Study
    Ayse Karakullukcu, Cuneyt Ardic, Huseyin Findik, Mehmet Gokhan Aslan
    Diagnostics.2026; 16(14): 2236.     CrossRef
  • Link Between Metabolic Syndrome, Inflammation, and Eye Diseases
    Kamila Pieńczykowska, Anna Bryl, Małgorzata Mrugacz
    International Journal of Molecular Sciences.2025; 26(5): 2174.     CrossRef
  • Metabolic syndrome in type 1 diabetes: higher time above range and glycemic variability revealed by continuous glucose monitoring (CGM)
    Yayu Fang, Wei Liu, Xiaoling Cai, Yu Zhu, Mingxia Zhang, Siqian Gong, Xiangqing Wang, Chu Lin, Rui Zhang, Sai Yin, Juan Li, Yongran Huo, Xiaodan Hu, Xiaoqi Xie, Linong Ji
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Current status, trend changes, and future predictions of the disease burden of type 1 diabetes kidney disease in global and China
    Qinghua Yang, Li Jin, Mingwei Luo, Shiwei Xie
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Metabolic syndrome in type 1 diabetes mellitus in adults
    R. I. Malievskaya, D. S. Avzaletdinova, I. G. Nasretdinova, I. Z. Urmanova, D. F. Iksanova
    FOCUS. Endocrinology.2025; 6(1): 6.     CrossRef
  • Association between metabolic phenotype and diabetic kidney disease in adult-onset type 1 diabetes patients from China: A multi-center cross-sectional study
    Jun Jiang, Peng Wang, Jielong Jiang, Tingmin Zhang, Yu Ding, Xueying Zheng, Sihui Luo, Jinhua Yan, Kuanxiao Tang, Daizhi Yang
    Diabetes Research and Clinical Practice.2025; 226: 112347.     CrossRef
  • Imbalance of endotoxin-binding systems in patients with type 1 diabetes
    I. A. Yatskov, V. A. Beloglazov, E. S. Ageeva, I. N. Repinskaya, R. Kh. Useinova, Yu. S. Saenko
    Acta Biomedica Scientifica.2025; 10(3): 91.     CrossRef
  • Prospects for the use of grape polyphenols in patients with type 1 diabetes mellitus
    I. A. Yatskov, V. A. Beloglazov, S. Roy
    Obesity and metabolism.2025; 22(2): 123.     CrossRef
  • Lipopolysaccharide-binding systems in the pathogenesis of vascular complications in patients with type 1 diabetes mellitus
    I. A. Yatskov, V. A. Beloglazov, E. S. Ageeva, R. Kh. Useinova, I. N. Repinskaya, Yu. V. Usachenko
    Acta Biomedica Scientifica.2025; 10(5): 107.     CrossRef
  • Dynamic Changes in Metabolic Status Are Associated With Risk of Ocular Motor Cranial Nerve Palsies
    Daye Diana Choi, Kyung-Ah Park, Kyungdo Han, Sei Yeul Oh
    Journal of Neuro-Ophthalmology.2024; 44(3): 386.     CrossRef
  • Prevalence of Metabolic Syndrome and Its Risk Factors Influence on Microvascular Complications in Patients With Type 1 and Type 2 Diabetes Mellitus
    Asad Riaz, Shoaib Asghar, Salman Shahid, Haider Tanvir, Muhammad Hamza Ejaz, Mamuna Akram
    Cureus.2024;[Epub]     CrossRef
  • Simplified integration of optimal self-management behaviors is associated with improved HbA1c in patients with type 1 diabetes
    C. Deng, Y. Xie, F. Liu, X. Tang, L. Fan, X. Yang, Y. Chen, Z. Zhou, X. Li
    Journal of Endocrinological Investigation.2024; 47(11): 2691.     CrossRef
  • Correlation between triglyceride-glucose index and diabetic kidney disease risk in adults with type 1 diabetes mellitus
    Mengyun Lei, Ping Ling, Yongwen Zhou, Jing Lv, Ying Ni, Hongrong Deng, Chaofan Wang, Daizhi Yang, Xubin Yang, Wen Xu, Jinhua Yan
    Diabetology & Metabolic Syndrome.2024;[Epub]     CrossRef
  • Development and validation of an age-sex-ethnicity-specific metabolic syndrome score in the Chinese adults
    Shujuan Yang, Bin Yu, Wanqi Yu, Shaoqing Dai, Chuanteng Feng, Ying Shao, Xing Zhao, Xiaoqing Li, Tianjing He, Peng Jia
    Nature Communications.2023;[Epub]     CrossRef
  • Association of Endotoxemia with Low-Grade Inflammation, Metabolic Syndrome and Distinct Response to Lipopolysaccharide in Type 1 Diabetes
    Aleksejs Fedulovs, Leonora Pahirko, Kaspars Jekabsons, Liga Kunrade, Jānis Valeinis, Una Riekstina, Valdis Pīrāgs, Jelizaveta Sokolovska
    Biomedicines.2023; 11(12): 3269.     CrossRef
  • Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus (Diabetes Metab J 2022;46:93-103)
    Qianwen Huang, Sihui Luo
    Diabetes & Metabolism Journal.2022; 46(3): 515.     CrossRef
  • Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus (Diabetes Metab J 2022;46:93-103)
    Gyuri Kim
    Diabetes & Metabolism Journal.2022; 46(3): 512.     CrossRef
  • Metabolic syndrome associated with higher glycemic variability in type 1 diabetes: A multicenter cross-sectional study in china
    Keyu Guo, Liyin Zhang, Jianan Ye, Xiaohong Niu, Hongwei Jiang, Shenglian Gan, Jian Zhou, Lin Yang, Zhiguang Zhou
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
Basic Research
Article image
Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
Lili Kong, Hongyue Wang, Chenhao Li, Huiyan Cheng, Yan Cui, Li Liu, Ying Zhao
Diabetes Metab J. 2021;45(6):909-920.   Published online June 4, 2021
DOI: https://doi.org/10.4093/dmj.2020.0168
  • 13,988 View
  • 179 Download
  • 38 Web of Science
  • 43 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFPubReader   ePub   
Background
The dietary agent sulforaphane (SFN) has been reported to reduce diabetes-induced renal fibrosis, as well as inhibit histone deacetylase (HDAC) activity. Bone morphologic protein 7 (BMP-7) has been shown to reduce renal fibrosis induced by transforming growth factor-beta1. The aim of this study was to investigate the epigenetic effect of SFN on BMP-7 expression in diabetes-induced renal fibrosis.
Methods
Streptozotocin (STZ)-induced diabetic mice and age-matched controls were subcutaneously injected with SFN or vehicle for 4 months to measure the in vivo effects of SFN on the kidneys. The human renal proximal tubular (HK11) cell line was used to mimic diabetic conditions in vitro. HK11 cells were transfected to over-express HDAC2 and treated with high glucose/palmitate (HG/Pal) to explore the epigenetic modulation of BMP-7 in SFN-mediated protection against HG/Pal-induced renal fibrosis.
Results
SFN significantly attenuated diabetes-induced renal fibrosis in vivo. Among all of the HDACs we detected, HDAC2 activity was markedly elevated in the STZ-induced diabetic kidneys and HG/Pal-treated HK11 cells. SFN inhibited the diabetes-induced increase in HDAC2 activity which was associated with histone acetylation and transcriptional activation of the BMP-7 promoter. HDAC2 over-expression reduced BMP-7 expression and abolished the SFN-mediated protection against HG/Pal-induced fibrosis in vitro.
Conclusion
Our study demonstrates that the HDAC inhibitor SFN protects against diabetes-induced renal fibrosis through epigenetic up-regulation of BMP-7.

Citations

Citations to this article as recorded by  
  • Hydroalcoholic extract of Benincasa hispida (Thunb.) Cogn. reinstates renal structural and functional dynamics compromised in diabetic mice: molecular insights through integration of transcriptomics and proteomics
    Nivedita Singh, Anuradha Kesharwani, Rahul Laxman Gajbhiye, Harsha Sankar Sreenikethanam Hari, Ruthrotha Selvi Bharathavikru, Velayutham Ravichandiran, Vipan Kumar Parihar
    Journal of Ethnopharmacology.2026; 362: 121132.     CrossRef
  • Beyond hyperglycemia: histone modification-mediated epigenetic dysregulation in diabetic retinopathy and nephropathy
    Minxuan Tang, Hongyu Zhu, Suyan Li, Lei Qiao
    Diabetology & Metabolic Syndrome.2026;[Epub]     CrossRef
  • The Role of Protein Post-Translational Modifications in the Pathogenesis of Nephrolithiasis: Mechanistic Insights and Translational Potential
    Wenlong Wan, Baokang Wang, Junyi Yang, Yang Xun, Xiao Yu
    Cells.2026; 15(6): 554.     CrossRef
  • Metabolic Memory-Mediated Epigenetic Regulation of EMT in Diabetic Kidney Disease: Mechanisms and Therapeutic Implications
    Xinning Ran, Yidan Xu, Ruonan Liang, Yuqi Duan, Wanying Jia, Yuhong Bian, Chenduo Li, Mingxing Zhang
    International Journal of Molecular Sciences.2026; 27(11): 4801.     CrossRef
  • BMP7 in kidney development and disease: a multilayer regulatory network integrating inflammation, fibrosis, and regeneration
    Heng Wang, Yaling Li, Guoping Zheng
    Cell Signaling, Inflammation & Disease.2026;[Epub]     CrossRef
  • Epigenetic strategies for mitigating kidney fibrosis
    Cong Wang, Yuntong Wu, Lijuan Yu
    PeerJ.2026; 14: e21709.     CrossRef
  • Dietary and nutritional interventions for human diseases: their modulatory effects on ferroptosis
    Shiqiong Huang, Ji Sun, Chaozan Shen, Gefei He
    Food & Function.2025; 16(4): 1186.     CrossRef
  • Epigenetic alterations and memory: key players in the development/progression of chronic kidney disease promoted by acute kidney injury and diabetes
    Imari Mimura, Zhuo Chen, Rama Natarajan
    Kidney International.2025; 107(3): 434.     CrossRef
  • Protective role of sulforaphane in lipid metabolism-related diseases
    Lingfeng Zhao, Jiahuan Li, Yiping Dang, David Fisher, Nguyen Thi Thu Hien, Erkin Musabaev, Khrystyna Pronyuk, Lei Zhao
    Molecular Biology Reports.2025;[Epub]     CrossRef
  • Histone deacetylases and their inhibitors in kidney diseases
    Yue Zheng, Tie-Ning Zhang, Peng-Hui Hao, Ni Yang, Yue Du
    Molecular Therapy.2025; 33(8): 3485.     CrossRef
  • Investigating potential targets of Wulingsan in diabetic nephropathy through network pharmacology and experimental validation
    Xicheng Hu, Zhen Wang, Liyan Zhang
    Frontiers in Molecular Biosciences.2025;[Epub]     CrossRef
  • Chidamide, a novel histone deacetylase inhibitor, alleviates renal fibrosis by suppressing the PI3K/AKT signaling pathway
    Yumei Liu, Liwen Mao, Yanbing Tang, Xiaowen Huang, Cunjin Su, Ye Zhu, Qianqian Duan, Kai Song, Jie Pan, Zhanhong Hu
    Biochemical Pharmacology.2025; 240: 117098.     CrossRef
  • Contribution of histone deacetylases (HDACs) to the regulation of histone and non-histone proteins: implications for fibrotic diseases
    Sunyoung Jang, Nayun Choi, Jong Hoon Park, Kyung Hyun Yoo
    BMB Reports.2025; 58(8): 313.     CrossRef
  • Acetylation in renal physiology and pathophysiology
    Jian-Yu Zhang, Jun Wu, Zi-Han Chen, Shi-Yue Liu, Ping Li, Dan-Qian Chen
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Sulforaphane from broccoli, an epigenetic modulator in cancer cells
    Soayébo Dabre, Abdou Azaque Zoure, Lassina Barro, Jeanne d’Arc Wendmintiri Kabre, Mousso Savadogo, Aida Dje Traore, Florencia Djigma, Jacques Simpore
    Discover Oncology.2025;[Epub]     CrossRef
  • Enzymatic post-translational modifications of proteins in chronic kidney disease: mechanisms, regulation, and clinical significance
    Minlong Wei, Jinyun Lin, Yi Zeng, Xiaojuan Wang, Jialu Wen, Jing Wang, Wei Zou, Kang Tu, Menghua Liu, Juan Li
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Epigenetic repurposing of carbohydrate metabolic inhibitors for insulin resistance: targeting DNMT1 and HDAC3 for β-cell restoration
    Muhammad Javid Iqbal, Luis A. Salazar
    Frontiers in Epigenetics and Epigenomics.2025;[Epub]     CrossRef
  • Glucosinolates Hydrolysis Products: Promising Bioactives for the Prevention of Diabetes
    Rohini Bhat, Sugandh Saxena, Manu Khajuria, Dhiraj Vyas
    Molecular Nutrition & Food Research.2025;[Epub]     CrossRef
  • Pharmacological Modulation of the Nrf2–Keap1 Pathway in Diabetes: Mechanisms, Therapeutic Advances, and Future Directions
    Amar Saxena, Shrestha Saxena, Yash Saxena, Ashita Jain, Rama Chaudhary, Pooja Bharti, Shivdeep Mishra, Chandrabhan Singh, Abhishek Kumar, Ankit Kumar, Sanjeev Kumar
    Journal for Research in Applied Sciences and Biotechnology.2025; 4(5): 38.     CrossRef
  • Underlying mechanisms and molecular targets of genistein in the management of type 2 diabetes mellitus and related complications
    Tao Jiang, Yuhe Dong, Wanying Zhu, Tong Wu, Linyan Chen, Yuantong Cao, Xi Yu, Ye Peng, Ling Wang, Ying Xiao, Tian Zhong
    Critical Reviews in Food Science and Nutrition.2024; 64(31): 11543.     CrossRef
  • Sulforaphane reduces adipose tissue fibrosis via promoting M2 macrophages polarization in HFD fed-mice
    Zhenzhen Zhang, Huali Chen, Cheng Pan, Rui Li, Wangsheng Zhao, Tianzeng Song
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2024; 1871(2): 119626.     CrossRef
  • Potential of Plant-Derived Compounds in Preventing and Reversing Organ Fibrosis and the Underlying Mechanisms
    Patrícia dos Santos Azeredo, Daping Fan, E. Angela Murphy, Wayne E. Carver
    Cells.2024; 13(5): 421.     CrossRef
  • Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes
    Katarina Zeder, Edward D. Siew, Gabor Kovacs, Evan L. Brittain, Bradley A. Maron
    Nature Reviews Nephrology.2024; 20(11): 742.     CrossRef
  • Role of Histone Modifications in Kidney Fibrosis
    Shengyu Pan, Tianhui Yuan, Yuqi Xia, Weimin Yu, Xiangjun Zhou, Fan Cheng
    Medicina.2024; 60(6): 888.     CrossRef
  • Unveiling the Nutritional Veil of Sulforaphane: With a Major Focus on Glucose Homeostasis Modulation
    Yanan Wang, Xiaoyun He, Nan Cheng, Kunlun Huang
    Nutrients.2024; 16(12): 1877.     CrossRef
  • Nonsurgical therapy for lumbar spinal stenosis caused by ligamentum flavum hypertrophy: A review
    Nan Fang, Zhigang Wang, Jiecheng Jiang, Aofei Yang, Tian Mao, Zitong Wang, Qian Chen
    Medicine.2024; 103(27): e38782.     CrossRef
  • Sulforaphane alleviates renal fibrosis through dual regulation on mTOR-mediated autophagy pathway
    Di Zhang, Han Zhang, Shiqi Lv, Cheng Zhu, Shaomin Gong, Xixi Yu, Yulin Wang, Xinhui Huang, ShuangXin Yuan, Xiaoqiang Ding, Xiaoyan Zhang
    International Urology and Nephrology.2024; 57(4): 1277.     CrossRef
  • Beneficial role of broccoli and its active ingredient, sulforaphane in the treatment of diabetes
    Aminu Mohammed, Hafsat Abdullahi Mohammed
    Phytomedicine Plus.2023; 3(2): 100431.     CrossRef
  • The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease
    Christodoula Kourtidou, Konstantinos Tziomalos
    International Journal of Molecular Sciences.2023; 24(6): 6007.     CrossRef
  • Insights into the Molecular Mechanisms of NRF2 in Kidney Injury and Diseases
    Da-Wei Lin, Yung-Chien Hsu, Cheng-Chih Chang, Ching-Chuan Hsieh, Chun-Liang Lin
    International Journal of Molecular Sciences.2023; 24(7): 6053.     CrossRef
  • Beneficial Effects of Sulforaphane on Diabetes and Its Complications via Both Nrf2-Dependent and Independent Mechanisms
    Minhyuk Kim, Joo Young Lee
    Food Supplements and Biomaterials for Health.2023;[Epub]     CrossRef
  • Sulforaphane exhibits potent renoprotective effects in preclinical models of kidney diseases: A systematic review and meta-analysis
    Elisa B. Monteiro, Matheus Ajackson, Milena B. Stockler-Pinto, Fitsum Guebre-Egziabher, Julio B. Daleprane, Christophe O. Soulage
    Life Sciences.2023; 322: 121664.     CrossRef
  • Integrated single-cell RNA-seq analysis revealed podocyte injury through activation of the BMP7/AMPK/mTOR mediated autophagy pathway
    Hongzhou Lin, Huihui Chen, Rengcheng Qian, Guoqi Tang, Yinjuan Ding, Yalan Jiang, Congde Chen, Dexuan Wang, Maoping Chu, Xiaoling Guo
    Chemico-Biological Interactions.2023; 382: 110559.     CrossRef
  • Sulforaphane: A nutraceutical against diabetes-related complications
    Sinenhlanhla X.H. Mthembu, Sithandiwe E. Mazibuko-Mbeje, Marakiya T. Moetlediwa, Ndivhuwo Muvhulawa, Sonia Silvestri, Patrick Orlando, Bongani B. Nkambule, Christo J.F. Muller, Duduzile Ndwandwe, Albertus K. Basson, Luca Tiano, Phiwayinkosi V. Dludla
    Pharmacological Research.2023; 196: 106918.     CrossRef
  • Nrf2/HO-1 as a therapeutic target in renal fibrosis
    Emad H.M. Hassanein, Islam M. Ibrahim, Esraa K. Abd-alhameed, Zeina W. Sharawi, Fatima A. Jaber, Hanan S. Althagafy
    Life Sciences.2023; 334: 122209.     CrossRef
  • A mechanistic overview of sulforaphane and its derivatives application in diabetes and its complications
    Neda Mohamadi, Vafa Baradaran Rahimi, Mohammad Reza Fadaei, Fatemeh Sharifi, Vahid Reza Askari
    Inflammopharmacology.2023; 31(6): 2885.     CrossRef
  • The HDAC2/SP1/miR-205 feedback loop contributes to tubular epithelial cell extracellular matrix production in diabetic kidney disease
    Zongji Zheng, Shuting Zhang, Jiaqi Chen, Meina Zou, Yanlin Yang, Wen Lu, Shijing Ren, Xiangyu Wang, Wenhui Dong, Zikun Zhang, Ling Wang, Meiping Guan, Gladys L.Y. Cheing, Yaoming Xue, Yijie Jia
    Clinical Science.2022; 136(3): 223.     CrossRef
  • BMP-7 Upregulates Id2 Through the MAPK Signaling Pathway to Improve Diabetic Tubulointerstitial Fibrosis and the Intervention of Oxymatrine
    Yawen Xiao, Dan Liang, Zhiyang Li, Zhaowei Feng, Zhiping Yuan, Fan Zhang, Yuanyuan Wang, Yuxia Zhou, Mingjun Shi, Lingling Liu, Ying Xiao, Bing Guo
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • HDAC1 Promotes Myocardial Fibrosis in Diabetic Cardiomyopathy by Inhibiting BMP-7 Transcription Through Histone Deacetylation
    Chun Ouyang, Lei Huang, Xiaoqiang Ye, Mingming Ren, Zhen Han
    Experimental and Clinical Endocrinology & Diabetes.2022; 130(10): 660.     CrossRef
  • Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation
    Jialu Li, Chao Yu, Fengchen Shen, Binbin Cui, Na Liu, Shougang Zhuang
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression
    Jiayu Wang, Jiaxing Li, Xin Zhang, Min Zhang, Xiaopeng Hu, Hang Yin
    Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
  • The improvement of sulforaphane in type 2 diabetes mellitus (T2DM) and related complications: A review
    Mengjiao Wang, Min Chen, Rui Guo, Yangyang Ding, Haihui Zhang, Yuanqing He
    Trends in Food Science & Technology.2022; 129: 397.     CrossRef
  • Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis
    Hao Yan, Jiangxin Xu, Zhifei Xu, Bo Yang, Peihua Luo, Qiaojun He
    Biomedicine & Pharmacotherapy.2021; 143: 112115.     CrossRef
Complications
Article image
Screening Tools Based on Nomogram for Diabetic Kidney Diseases in Chinese Type 2 Diabetes Mellitus Patients
Ganyi Wang, Biyao Wang, Gaoxing Qiao, Hao Lou, Fei Xu, Zhan Chen, Shiwei Chen
Diabetes Metab J. 2021;45(5):708-718.   Published online April 13, 2021
DOI: https://doi.org/10.4093/dmj.2020.0117
  • 13,854 View
  • 167 Download
  • 15 Web of Science
  • 15 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
The influencing factors of diabetic kidney disease (DKD) in Chinese patients with type 2 diabetes mellitus (T2DM) were explored to develop and validate a DKD diagnostic tool based on nomogram approach for patients with T2DM.
Methods
A total of 2,163 in-hospital patients with diabetes diagnosed from March 2015 to March 2017 were enrolled. Specified logistic regression models were used to screen the factors and establish four different diagnostic tools based on nomogram according to the final included variables. Discrimination and calibration were used to assess the performance of screening tools.
Results
Among the 2,163 participants with diabetes (1,227 men and 949 women), 313 patients (194 men and 120 women) were diagnosed with DKD. Four different screening equations (full model, laboratory-based model 1 [LBM1], laboratory-based model 2 [LBM2], and simplified model) showed good discriminations and calibrations. The C-indexes were 0.8450 (95% confidence interval [CI], 0.8202 to 0.8690) for full model, 0.8149 (95% CI, 0.7892 to 0.8405) for LBM1, 0.8171 (95% CI, 0.7912 to 0.8430) for LBM2, and 0.8083 (95% CI, 0.7824 to 0.8342) for simplified model. According to Hosmer-Lemeshow goodness-of-fit test, good agreement between the predicted and observed DKD events in patients with diabetes was observed for full model (χ2=3.2756, P=0.9159), LBM1 (χ2=7.749, P=0.4584), LBM2 (χ2=10.023, P=0.2634), and simplified model (χ2=12.294, P=0.1387).
Conclusion
LBM1, LBM2, and simplified model exhibited excellent predictive performance and availability and could be recommended for screening DKD cases among Chinese patients with diabetes.

Citations

Citations to this article as recorded by  
  • Multi-feature integrated machine learning prediction model for early nephropathy in elderly living with type 2 diabetes mellitus
    Tingting Fang, Yuanyuan Yang, Feng Zhuo, Xinran Xie, Jialun Song, Linghua Kong
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Association of glucose metabolism with advanced cardiovascular-kidney-metabolic syndrome and prediction model development in type 2 diabetes mellitus
    Qi Sun, Xinyi Yan, Xiaofeng Li, Yilun Lu, Dongqin Wei, Hai Zhang, Caoxu Zhang, Yu Shi, Yunjuan Gu
    BMC Endocrine Disorders.2026;[Epub]     CrossRef
  • Ultrasound radiomics-based machine learning models for differentiating diabetic kidney disease from non-diabetic kidney disease in type 2 diabetes
    Wenye Chen, Dan Zhao, Lehao Wu, Wenkun Bai, Xintong Wang, Ying Ying Zhang, Jian-Ying Niu, Chen Yu
    BMC Nephrology.2026;[Epub]     CrossRef
  • Machine learning-based risk predictive models for diabetic kidney disease in type 2 diabetes mellitus patients: a systematic review and meta-analysis
    Yihan Li, Nan Jin, Qiuzhong Zhan, Yue Huang, Aochuan Sun, Fen Yin, Zhuangzhuang Li, Jiayu Hu, Zhengtang Liu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Deep learning for early detection of chronic kidney disease stages in diabetes patients: A TabNet approach
    Md Nakib Hayat Chowdhury, Mamun Bin Ibne Reaz, Sawal Hamid Md Ali, María Liz Crespo, Shamim Ahmad, Ghassan Maan Salim, Fahmida Haque, Luis Guillermo García Ordóñez, Md. Johirul Islam, Taher Muhammad Mahdee, Kh Shahriya Zaman, Md Shahriar Khan Hemel, Moham
    Artificial Intelligence in Medicine.2025; 166: 103153.     CrossRef
  • The accuracy of Machine learning in the prediction and diagnosis of diabetic kidney Disease: A systematic review and Meta-Analysis
    Changmao Dai, Xiaolan Sun, Jia Xu, Maojun Chen, Wei Chen, Xueping Li
    International Journal of Medical Informatics.2025; 202: 105975.     CrossRef
  • Predictive model combining blood pressure, glycemic and renal markers for diabetic nephropathy in elderly hypertensive patients with type 2 diabetes
    Fengnian Guo, Li Qin, Baoguang Chen, Hongliang Xu, Jinxia Wang, Ran An, Qiuju Zhang
    Clinical and Experimental Hypertension.2025;[Epub]     CrossRef
  • Developing screening tools to estimate the risk of diabetic kidney disease in patients with type 2 diabetes mellitus
    Xu Cao, Xiaomei Pei
    Technology and Health Care.2024; 32(3): 1807.     CrossRef
  • Development of Serum Lactate Level-Based Nomograms for Predicting Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients
    Chunxia Jiang, Xiumei Ma, Jiao Chen, Yan Zeng, Man Guo, Xiaozhen Tan, Yuping Wang, Peng Wang, Pijun Yan, Yi Lei, Yang Long, Betty Yuen Kwan Law, Yong Xu
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 1051.     CrossRef
  • Two-Dimensional Ultrasound-Based Radiomics Nomogram for Diabetic Kidney Disease: A Pilot Study
    Xingyue Huang, Yugang Hu, Yao Zhang, Qing Zhou
    International Journal of General Medicine.2024; Volume 17: 1877.     CrossRef
  • Risk prediction models for diabetic nephropathy among type 2 diabetes patients in China: a systematic review and meta-analysis
    Wenbin Xu, Yanfei Zhou, Qian Jiang, Yiqian Fang, Qian Yang
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Changes in urinary exosomal protein CALM1 may serve as an early noninvasive biomarker for diagnosing diabetic kidney disease
    Tao Li, Tian ci Liu, Na Liu, Man Zhang
    Clinica Chimica Acta.2023; 547: 117466.     CrossRef
  • Development and validation of a novel nomogram to predict diabetic kidney disease in patients with type 2 diabetic mellitus and proteinuric kidney disease
    Hui Zhuan Tan, Jason Chon Jun Choo, Stephanie Fook-Chong, Yok Mooi Chin, Choong Meng Chan, Chieh Suai Tan, Keng Thye Woo, Jia Liang Kwek
    International Urology and Nephrology.2022; 55(1): 191.     CrossRef
  • Nomogram-Based Chronic Kidney Disease Prediction Model for Type 1 Diabetes Mellitus Patients Using Routine Pathological Data
    Nakib Hayat Chowdhury, Mamun Bin Ibne Reaz, Sawal Hamid Md Ali, Shamim Ahmad, María Liz Crespo, Andrés Cicuttin, Fahmida Haque, Ahmad Ashrif A. Bakar, Mohammad Arif Sobhan Bhuiyan
    Journal of Personalized Medicine.2022; 12(9): 1507.     CrossRef
  • Development and assessment of diabetic nephropathy prediction model using hub genes identified by weighted correlation network analysis
    Xuelian Zhang, Yao Wang, Zhaojun Yang, Xiaoping Chen, Jinping Zhang, Xin Wang, Xian Jin, Lili Wu, Xiaoyan Xing, Wenying Yang, Bo Zhang
    Aging.2022; 14(19): 8095.     CrossRef
Complications
Article image
Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
Hua-Xing Huang, Liang-Lan Shen, Hai-Yan Huang, Li-Hua Zhao, Feng Xu, Dong-Mei Zhang, Xiu-Lin Zhang, Tong Chen, Xue-Qin Wang, Yan Xie, Jian-Bin Su
Diabetes Metab J. 2021;45(6):868-879.   Published online March 23, 2021
DOI: https://doi.org/10.4093/dmj.2020.0149
  • 12,265 View
  • 198 Download
  • 10 Web of Science
  • 9 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Type 2 diabetes mellitus (T2DM) is characterized by elevated fasting glucagon and impaired suppression of postprandial glucagon secretion, which may participate in diabetic complications. Therefore, we investigated the associations of plasma glucagon with estimated glomerular filtration rate (eGFR), albuminuria and diabetic kidney disease (DKD) in T2DM patients.
Methods
Fasting glucagon and postchallenge glucagon (assessed by area under the glucagon curve [AUCgla]) levels were determined during oral glucose tolerance tests. Patients with an eGFR <60 mL/min/1.73 m2 and/or a urinary albumin-to-creatinine ratio (UACR) ≥30 mg/g who presented with diabetic retinopathy were identified as having DKD.
Results
Of the 2,436 recruited patients, fasting glucagon was correlated with eGFR and UACR (r=–0.112 and r=0.157, respectively; P<0.001), and AUCgla was also correlated with eGFR and UACR (r=–0.267 and r=0.234, respectively; P<0.001). Moreover, 31.7% (n=771) presented with DKD; the prevalence of DKD was 27.3%, 27.6%, 32.5%, and 39.2% in the first (Q1), second (Q2), third (Q3), and fourth quartile (Q4) of fasting glucagon, respectively; and the corresponding prevalence for AUCgla was 25.9%, 22.7%, 33.7%, and 44.4%, respectively. Furthermore, after adjusting for other clinical covariates, the adjusted odds ratios (ORs; 95% confidence intervals) for DKD in Q2, Q3, and Q4 versus Q1 of fasting glucagon were 0.946 (0.697 to 1.284), 1.209 (0.895 to 1.634), and 1.521 (1.129 to 2.049), respectively; the corresponding ORs of AUCgla were 0.825 (0.611 to 1.114), 1.323 (0.989 to 1.769), and 2.066 (1.546 to 2.760), respectively. Additionally, when we restricted our analysis in patients with glycosylated hemoglobin <7.0% (n=471), we found fasting glucagon and AUCgla were still independently associated with DKD.
Conclusion
Both increased fasting and postchallenge glucagon levels were independently associated with DKD in T2DM patients.

Citations

Citations to this article as recorded by  
  • Acetylation of CPT1A reduces fatty acid oxidation and leads to dysfunctional renal tubular mitochondria in diabetic kidney disease
    Siyao Sun, Sen Liu, Shiyan Ruan, Hongli Zhou, Xiangfei Cui, Ning Lu, Liu Hong, Miaomiao Lu
    Biochemical Pharmacology.2026; 243: 117465.     CrossRef
  • The novel antidiabetic medications on diabetic retinopathy: relevant molecular mechanisms, advancing diagnostic innovations, and therapeutic implications
    Song Wen, Chenglin Xu, Yue Yuan, Lijiao Chen, Yishu Ren, Zhimin Xu, Jianlan Jin, Jiyu Li, Ligang Zhou
    Frontiers in Medicine.2026;[Epub]     CrossRef
  • Association of serum fibroblast growth factor 19 with DKD as assessed by the UACR and eGFR in patients with type 2 diabetes
    Yinan Jia, Siyu Liu, Tianli Xu, Xiaojun Cao, Limin Shen, Mengjie Tang
    Endocrine Research.2026; 51(4): 225.     CrossRef
  • Glucagon in metabolic disease: a mini-review of emerging multi-organ roles beyond glycemic control
    Seung Hee Lee, Hyeon Young Park, Ji Ho Yun, Eun Kyoung Do
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Prolonged glucagon exposure rewires lipid oxidation and drives diabetic kidney disease progression
    Xingfeng Liu, Jingwen Chen, Shengying Gu, Yibing Chen, Ruiping Zhang, Qingce Zang, Ting Li, Hanwen Li, Dejin Lu, Shaocong Hou, Lijuan Kong, Qian Jiang, Caiyi Xing, Wenjia Fan, Yanjun Wan, Jiaqi Zhang, Linyuan Zhu, Chunxiao Ma, Qijin Zhao, Hai Yan, Zeper A
    Nature Communications.2025;[Epub]     CrossRef
  • Fasting glucagon as an independent risk indicator for CAD in patient with type 2 diabetes
    Linlin Kong, Lina Chang, Jiamin Nie, Yian Gu, Xin Wang, Siyu Yan, Wantong Han, Hequn Sang, Shaofang Tang, Ming Liu, Qing He
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Random survival forest for predicting the combined effects of multiple physiological risk factors on all-cause mortality
    Bu Zhao, Vy Kim Nguyen, Ming Xu, Justin A. Colacino, Olivier Jolliet
    Scientific Reports.2024;[Epub]     CrossRef
  • Endocrine Disorders in Nephrotic Syndrome—A Comprehensive Review
    Maja Mizdrak, Bozo Smajic, Ivan Mizdrak, Tina Ticinovic Kurir, Marko Kumric, Ivan Paladin, Darko Batistic, Josko Bozic
    Biomedicines.2024; 12(8): 1860.     CrossRef
  • Glucagon in type 2 diabetes: Friend or foe?
    Irene Caruso, Nicola Marrano, Giuseppina Biondi, Valentina Annamaria Genchi, Rossella D'Oria, Gian Pio Sorice, Sebastio Perrini, Angelo Cignarelli, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino
    Diabetes/Metabolism Research and Reviews.2023;[Epub]     CrossRef
Complications
Article image
Association of Urinary N-Acetyl-β-D-Glucosaminidase with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Mellitus without Nephropathy
Min Sun Choi, Ji Eun Jun, Sung Woon Park, Jee Hee Yoo, Jiyeon Ahn, Gyuri Kim, Sang-Man Jin, Kyu Yeon Hur, Moon-Kyu Lee, Jae Hyeon Kim
Diabetes Metab J. 2021;45(3):349-357.   Published online February 2, 2021
DOI: https://doi.org/10.4093/dmj.2019.0211
  • 12,579 View
  • 159 Download
  • 1 Web of Science
  • 2 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFPubReader   ePub   
Background
Cardiovascular autonomic neuropathy (CAN) is a common microvascular complication of diabetes and related to albuminuria in diabetic nephropathy (DN). Urinary N-acetyl-β-D-glucosaminidase (uNAG) is a renal tubular injury marker which has been reported as an early marker of DN even in patients with normoalbuminuria. This study evaluated whether uNAG is associated with the presence and severity of CAN in patients with type 1 diabetes mellitus (T1DM) without nephropathy.
Methods
This cross-sectional study comprised 247 subjects with T1DM without chronic kidney disease and albuminuria who had results for both uNAG and autonomic function tests within 3 months. The presence of CAN was assessed by age-dependent reference values for four autonomic function tests. Total CAN score was assessed as the sum of the partial points of five cardiovascular reflex tests and was used to estimatethe severity of CAN. The correlations between uNAG and heart rate variability (HRV) parameters were analyzed.
Results
The association between log-uNAG and presence of CAN was significant in a multivariate logistic regression model (adjusted odds ratio, 2.39; 95% confidence interval [CI], 1.08 to 5.28; P=0.031). Total CAN score was positively associated with loguNAG (β=0.261, P=0.026) in the multivariate linear regression model. Log-uNAG was inversely correlated with frequency-domain and time-domain indices of HRV.
Conclusion
This study verified the association of uNAG with presence and severity of CAN and changes in HRV in T1DM patients without nephropathy. The potential role of uNAG should be further assessed for high-risk patients for CAN in T1DM patients without nephropathy.

Citations

Citations to this article as recorded by  
  • Determination of Diabetes-associated Cardiovascular Autonomic Neuropathy Risk Factors among Insulin and Non-insulin Dependent Diabetics
    Ibrahim Abdulsada, Zain Alabdeen Obaid, Farah Almerza, Mays Alwaeli, Anmar Al-Elayawi, Taha Al-Dayyeni, Harir Al-Tuhafy
    The Journal of Medical Research.2023; 9(6): 141.     CrossRef
  • Association between carotid atherosclerosis and presence of intracranial atherosclerosis using three-dimensional high-resolution vessel wall magnetic resonance imaging in asymptomatic patients with type 2 diabetes
    Ji Eun Jun, You-Cheol Hwang, Kyu Jeong Ahn, Ho Yeon Chung, Geon-Ho Jahng, Soonchan Park, In-Kyung Jeong, Chang-Woo Ryu
    Diabetes Research and Clinical Practice.2022; 191: 110067.     CrossRef
Review
Complications
Article image
Treatment of Diabetic Kidney Disease: Current and Future
Tomotaka Yamazaki, Imari Mimura, Tetsuhiro Tanaka, Masaomi Nangaku
Diabetes Metab J. 2021;45(1):11-26.   Published online January 22, 2021
DOI: https://doi.org/10.4093/dmj.2020.0217
  • 47,871 View
  • 1,779 Download
  • 207 Web of Science
  • 208 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFPubReader   ePub   
Diabetic kidney disease (DKD) is the major cause of end-stage kidney disease. However, only renin-angiotensin system inhibitor with multidisciplinary treatments is effective for DKD. In 2019, sodium-glucose cotransporter 2 (SGLT2) inhibitor showed efficacy against DKD in Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) trial, adding a new treatment option. However, the progression of DKD has not been completely controlled. The patients with transient exposure to hyperglycemia develop diabetic complications, including DKD, even after normalization of their blood glucose. Temporary hyperglycemia causes advanced glycation end product (AGE) accumulations and epigenetic changes as metabolic memory. The drugs that improve metabolic memory are awaited, and AGE inhibitors and histone modification inhibitors are the focus of clinical and basic research. In addition, incretin-related drugs showed a renoprotective ability in many clinical trials, and these trials with renal outcome as their primary endpoint are currently ongoing. Hypoxia-inducible factor prolyl hydroxylase inhibitors recently approved for renal anemia may be renoprotective since they improve tubulointerstitial hypoxia. Furthermore, NF-E2–related factor 2 activators improved the glomerular filtration rate of DKD patients in Bardoxolone Methyl Treatment: Renal Function in chronic kidney disease/Type 2 Diabetes (BEAM) trial and Phase II Study of Bardoxolone Methyl in Patients with Chronic Kidney Disease and Type 2 Diabetes (TSUBAKI) trial. Thus, following SGLT2 inhibitor, numerous novel drugs could be utilized in treating DKD. Future studies are expected to provide new insights.

Citations

Citations to this article as recorded by  
  • Mechanisms of diabetic kidney disease and established and emerging treatments
    Victor Martinez Leon, Rachel Hilburg, Katalin Susztak
    Nature Reviews Endocrinology.2026; 22(1): 21.     CrossRef
  • Formononetin in Jiawei Qihuangyin inhibits podocyte epithelial–mesenchymal transition and ameliorates diabetic nephropathy via SIRT1/NF-κB axis
    Huiyuan Li, Jiaer Ke, Yanli Zhou, Huanhuan Chen, Xufang Wu, Huoliang Liu, Juan Li
    Molecular Immunology.2026; 190: 1.     CrossRef
  • The Incidence and Correlation of Renal Pathologies Based on 14-Year Kidney Biopsy Material: A Retrospective Single-Centre Study in Poland
    Krzysztof Benc, Ewa Tabaka, Wiktoria Pabian, Dominika Pisarek, Krzysztof Letachowicz, Tomasz Gołębiowski, Magdalena Kuriata-Kordek, Maciej Kanafa, Patryk Jerzak, Karolina Skalec, Piotr Donizy, Agnieszka Hałoń, Andrzej Konieczny, Mirosław Banasik
    Journal of Clinical Medicine.2026; 15(2): 495.     CrossRef
  • SMTP-44D Exerts Renoprotective Effects against Diabetic Nephropathy via Its Anti-inflammatory and Antioxidant Action
    Taiki Awane, Hayato Sasaki, Keita Shibata, Keiji Hasumi, Koji Nobe
    Biological and Pharmaceutical Bulletin.2026; 49(1): 57.     CrossRef
  • Therapeutic effect and underlying mechanism of emodin on renal injury
    Palash Mitra, Sahadeb Jana, Barnali Singha Modak, Suchismita Roy
    Pharmacological Research - Modern Chinese Medicine.2026; 18: 100757.     CrossRef
  • Associations of perfluoroalkyl and polyfluoroalkyl substances with markers of glycaemic control, insulin secretion and sensitivity, and diabetes risk: a systematic review and meta-analyses
    Sandra India Aldana, Xin Yu, Meizhen Yao, Nathan Cohen, Eftychia Markopoulou, Maanal Chowdhury, Vishal Midya, Stephanie M. Eick, Jessica Trowbridge, Anne P. Starling, Dinesh Barupal, Douglas I. Walker, Leda Chatzi, Veronica Wendy Setiawan, Ryan W. Walker,
    eClinicalMedicine.2026; 92: 103747.     CrossRef
  • Diabetic kidney disease: integrating multi-omics insights, artificial intelligence, and novel therapeutics for precision medicine
    Tao Li, Kaili Chen, Yiting Sun, Linqi Zhang
    Frontiers in Genetics.2026;[Epub]     CrossRef
  • Targeting cellular senescence in diabetic kidney disease: potential of regenerative, cell-based therapies and other senotherapeutic approaches
    Helly A. Patel, Jiaxuan Wang, Caroline J. Zinn, Maya Learmonth, Xiaohui Bian, Diana Jurk, Lilach O. Lerman, Joy Wolfram, LaTonya J. Hickson
    Kidney International.2026; 109(4): 684.     CrossRef
  • The diagnostic value of immune-inflammatory markers for diabetic kidney disease in type 2 diabetic patients: a meta-analysis
    Yan Wang, Xiaohua Liu, Zhenwen Xiao
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Prevalence and Determinants of Anemia in Patients with Chronic Kidney Disease on Maintenance Hemodialysis
    Md Siddiqur Rahman, Md Mahidul Alam, Md Safayet Hossain Pramanik, Nasir Uddin, Anwarul Haque, Marufa Sobnom, Hasibul Hasan
    TAJ: Journal of Teachers Association.2026; 39(1): 71.     CrossRef
  • Epigenetic regulation in a high-sugar environment (Review)
    Huili Zhou, Xinhe Lv, Yu Liang, Dehai Yu, Wanning Wang
    International Journal of Molecular Medicine.2026; 57(5): 1.     CrossRef
  • Unveiling lactylation: A novel frontier in the pathogenesis of diabetic nephropathy (Review)
    Yuanyuan Xiao, Niansong Wang, Dingkun Gui, Youhua Xu
    International Journal of Molecular Medicine.2026; 57(6): 1.     CrossRef
  • White Blood Cell-to-Hemoglobin Ratio, a Promising Indicator for Diabetic Kidney Disease: An Observational Cross-Sectional Study
    Meng Zhang, Ling Wang, Yuxuan Lin, Mengzhi Wu, Jing Tan, Yu Chen, Jiarui Zhao, Huayang Xu, Wei Qiang, Hui Guo, Yue Wang, Bingyin Shi, Mingqian He
    Journal of Inflammation Research.2026; Volume 19: 1.     CrossRef
  • Targeting GHSR-1α with silibinin to enhance mitophagy and prevent tubular injury in diabetic kidney disease
    Nannan Zhang, Chao Chen, Lin Chen, Yuqiong Chen, Peiran Yu, Hao Yu, Bimin Shi, Bin Feng
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2026; 1872(6): 168255.     CrossRef
  • A biomimetic in vitro glomerular filtration barrier model for investigating renal barrier dysfunction in hyperglycemia
    Gaddam Kiranmai, Samuel Kaki, Shibu Chameettachal, Amit Ghosh, Meenu TS, Mudrika Khandelwal, Falguni Pati
    Biomaterials Advances.2026; 185: 214885.     CrossRef
  • TangShenKang decoction plays an anti-inflammatory and anti-fibrotic role in diabetic nephropathy by activating AT2R/ATIP1/SHP1 axis and antagonizing angiotensin II
    Ran Wei, Jian Ma, Zeyu Yu, Wei Zou, Na Zhao
    Molecular and Cellular Biochemistry.2026; 481(6): 2691.     CrossRef
  • FOS drives podocyte injury and renal fibrosis in diabetic kidney disease via direct Smad3 binding
    Man Sun, Tianchi Yan, Wenjing Zhao, Zhifeng Cheng
    Cellular and Molecular Life Sciences.2026;[Epub]     CrossRef
  • Silencing of USP22 promotes FGF11 degradation to attenuates renal fibrosis in diabetic kidney disease
    Zhigang Wang, Chao Liu, Jing Lv, Jiping Sun, Xiaoyang Yu, Huixian Li
    Renal Failure.2026;[Epub]     CrossRef
  • Key module genes in proximal tubular cells drive microenvironmental chronic inflammation and fibrosis in diabetic kidney disease: A single-cell transcriptomic study
    Wenjing Zhou, Zhaogui Chen, Guanghui Ying, Li Liu, Wei Xiao, Jian Liu, Min Xia, Qiao Zhang, Xuelin He
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2026; 1872(7): 168326.     CrossRef
  • Evaluation of betanin as a multi-target therapeutic agent against diabetic kidney disease, peripheral neuropathy, and dyslipidaemia in a rodent model of type 2 diabetes
    Rathi Bishakha Jayprakash, Amrita Parida, Ramya Kateel, Jagnoor Singh Sandhu
    Journal of Complementary and Integrative Medicine.2026; 23(3): 413.     CrossRef
  • Gardenin A Alleviates Diabetic Nephropathy by Modulating Oxidative Stress and Inflammation in Experimental Rats
    Juan Ji, Longhai Song, Chong Yang, Yan Gao, Song Li, Qiaoying Wu
    Pharmacognosy Magazine.2026; 22(4): 1651.     CrossRef
  • A study on risk factors for the progression from T2DM to end-stage renal disease based on Mendelian randomization and logistic regression analysis
    Yakun Wang, Xinjia Guo, Yanhong Li, Qiyu Fu, Chong Zhang, Shoujun Bai
    Renal Failure.2026;[Epub]     CrossRef
  • Hypoxia-inducible factor-1α promotes epithelial-to-mesenchymal transition through upregulating cathepsin S expression in diabetic kidney disease
    Haidong Zhang, Qi Li, Yue Wang, Bai Qiong
    Renal Failure.2026;[Epub]     CrossRef
  • The Effects of Self-management Interventions on Diabetic Kidney Disease Progression and Related Health Behaviors in Type 2 Diabetes Mellitus: A Systematic Review
    Dongmei CHU, Bingyang Liu, Kim Lam Soh, Hasni Idayu Saidi, Salimah Japar
    Journal of Nursing and Midwifery Sciences.2026;[Epub]     CrossRef
  • Protein mediators of chronic kidney disease in Type 2 diabetes: A mendelian randomization study
    Kevin Y. H. Liang, Thomas M. Zheng, Dandan Tan, Takayoshi Sasako, Yann Ilboudo, Yiheng Chen, Guillaume Butler-Laporte, Satoshi Yoshiji, J. Brent Richards, Weiping Jia
    PLOS Medicine.2026; 23(9): e1004802.     CrossRef
  • Gegen Flavonoids and Huangqi Saponins Combination Ameliorates Diabetic Nephropathy By Modulating the Gut–Kidney Axis and Regulating Macrophage Polarization
    Yue Liu, Fangfang Fan, Hongyan Zhai, Xiaoliang Li, Xiaoqin Chu
    Applied Biochemistry and Biotechnology.2026; 198(11): 8391.     CrossRef
  • Hyperglycaemia-induced molecular reprogramming of proximal tubular epithelial cells and its contribution to diabetic kidney disease progression—a narrative review
    Terry Gbaa
    Frontiers in Cell and Developmental Biology.2026;[Epub]     CrossRef
  • Micro-energy acoustic pulse therapy attenuates diabetic nephropathy by restoring renal proliferative capacity and progenitor cell homeostasis independent of glycemic control
    Wei-Ting Kuo, Ying-Chun Lo, Tian Bai, Emily Xing, Thomas Cao, Lia Banie, Guifang Wang, Guiting Lin, Tom F. Lue
    Life Sciences.2026; 405: 124683.     CrossRef
  • A bibliometric analysis of trace elements and diabetic kidney disease: scientific hotspots and research evolution
    Xi Sun, Yuchen Jiang, Huanjing Wang, Zhanzheng Wang, Wansen Sun, Yan Liu
    Renal Failure.2026;[Epub]     CrossRef
  • Effect of Kunxian capsule, a novel Tripterygium wilfordii preparation, on reducing proteinuria and slowing renal function decline in diabetic kidney disease: a 48–week randomized controlled trial
    Shengnan Chen, Yajuan Gao, Zishen Liang, Yixue Zhang, Cui Wang, Yali Tang, Jun Zhao, Ani Wang, Yan Shen
    Renal Failure.2026;[Epub]     CrossRef
  • FOSL2 activates TGF‐β1‐mediated GLUT1/mTOR signaling to promote diabetic kidney disease
    Xuelin He, Min Xia, Guanghui Ying, Qien He, Zhaogui Chen, Li Liu, Qiao Zhang, Jianxin Cai
    Journal of Diabetes Investigation.2025; 16(2): 187.     CrossRef
  • Hyperbaric oxygen therapy prevents epithelial atrophy in distal tubules and TGF-β1 overexpression in diabetic rat kidneys
    Judielson Ribeiro Gomes, Marcus Vinícius de Moraes, Flávio Santos da Silva, Isadora Luísa Gomes da Silva, Raimundo Fernandes de Araújo Júnior, Karina Paula de Paula Medeiros, Bento João Abreu, Naisandra Silva da Silva Farias
    Journal of Molecular Histology.2025;[Epub]     CrossRef
  • The efficacy and safety of Ginkgo biloba L. leaves extract combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta-analysis of 41 randomized controlled trials
    Zehua Zhang, Shiyun Tang, Shiyu Liu, Yulin Leng, Xiaoxu Fu, Hongyan Xie, Hong Gao, Chunguang Xie
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Serum advanced glycation end products as a putative biomarker in Type2 DKD patients’ prognosis
    Ze-Hou Wang, Zong-Jin Zhang, Yue-Fen Wang, Jin Xie, Yi-Min Li, Cun Shen, Yuan Meng, Wen-Jing Zhao, Lu-Ying Sun, Wei Jing Liu
    Frontiers in Physiology.2025;[Epub]     CrossRef
  • New insights in the treatment of DKD: recent advances and future prospects
    Meimei Zhao, Yongtong Cao, Liang Ma
    BMC Nephrology.2025;[Epub]     CrossRef
  • Proteomic and metabolomic profiling reveals the underlying molecular mechanisms in modified alternate-day fasting-mediated protection against Diabetic kidney disease
    Xin Zeng, Yi-hang Xing, Xiu-mei Ma, Yang Long, Zong-zhe Jiang, Yong Xu, Milad Khorasani
    PLOS ONE.2025; 20(2): e0319053.     CrossRef
  • New insights into the mechanism of triphenyl phosphate and its metabolite diphenyl phosphate in diabetic kidney disease
    Ting Fang, Qiaoyan Liu, Xinxin Huangfu, Hongkai Zhu, Hongwen Sun, Liming Chen
    Ecotoxicology and Environmental Safety.2025; 291: 117877.     CrossRef
  • Development of Predictive Models for Progression from Diabetic Kidney Disease to End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Retrospective Cohort Study
    Huiyue Hu, Xiaodie Mu, Shuya Zhao, Min Yang, Hua Zhou
    Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 383.     CrossRef
  • Causal insights into major risk factors for diabetic kidney disease: a comprehensive meta-analysis and Mendelian randomization study
    Yucong Zhou, Yahong Liu, Liang Wu, Yucai Zhang, Huixin Wen, Jiangwei Hu, Zhenxia Huo, Shuyuan Ju, Ruizheng Sheng
    Renal Failure.2025;[Epub]     CrossRef
  • The role of advanced glycation end products between thyroid function and diabetic nephropathy and metabolic disorders
    Yi Zhang, Yanlei Wang, Qingqing Kang, Yijing Chen, Liya Ai, Keyan Hu, Li Gong, Li Zhu, Zixiang Yu, Ran Chen, Jin Cui, Tian Jiang, Qiu Zhang
    Scientific Reports.2025;[Epub]     CrossRef
  • Research progress on small extracellular vesicles in diabetic nephropathy
    Bingqing Yu, Lanfeng Wang, Yiping Mao, Xinyi Hu, Yukang Lu, Jiahui He, Xiaoying Yuan, Man Zhang, Zhiping Chen
    Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
  • PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes
    Kirsten E. Peters, Isabella A. Joubert, Scott D. Bringans, Wendy A. Davis, Richard J. Lipscombe, Timothy M. E. Davis
    Diagnostics.2025; 15(6): 662.     CrossRef
  • Caminos fisiopatológicos y blancos terapéuticos actuales para nefropatía diabética en diabetes tipo 1 y 2
    Enrique Juan Díaz Greene, Roxana Sánchez Arreguín, Brenda Bautista Martínez
    Acta Médica Grupo Ángeles.2025; 23(1): 41.     CrossRef
  • Neutrophils and NETs in kidney disease
    Daigo Nakazawa, Sakiko Masuda, Yuka Nishibata, Kanako Watanabe-Kusunoki, Utano Tomaru, Akihiro Ishizu
    Nature Reviews Nephrology.2025; 21(6): 383.     CrossRef
  • Analysis of correlation between dietary fiber intake and risk of diabetic kidney disease in adults with type 2 diabetes mellitus: results from the United States National Health and Nutrition Examination Surveys 2009–2018
    Yuanyuan Luo, Ruojing Bai
    Renal Failure.2025;[Epub]     CrossRef
  • Klotho antiaging protein: molecular mechanisms and therapeutic potential in diseases
    Aditya Dipakrao Hajare, Neha Dagar, Anil Bhanudas Gaikwad
    Molecular Biomedicine.2025;[Epub]     CrossRef
  • Nutritional considerations in diabetic kidney disease
    Vigil Moyo, Graca Pang, Oscar Walton, Bruno Mafrici
    Journal of Kidney Care.2025; 10(2): 70.     CrossRef
  • SETD7 drives diabetic endothelial dysfunction through FBXO45-mediated GPX4 ubiquitylation
    Wen Zhong, Ruoxue Chen, Jialin Zhao, Yuyu Zhang, Jintao He, Huibin Wang, Feng Zhu, Chunxiang Fan, Xinhua Liu
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • Diagnostic Value and Mechanism of Action of Serum miR‐1281 Involved in T2DM and Complications of DKD
    Cuicui Hao, Cui Li, Junhong Wang, Shan Yu
    Nephrology.2025;[Epub]     CrossRef
  • Urinary exosomes exacerbate diabetic kidney disease by promoting NLRP3 inflammasome activation via the microRNA-516b-5p/SIRT3/AMPK pathway
    Haiying Zhang, Yubo Jiang, Jun Song, Shaoqing Wang, Jianhong Lu, Fuxin Wei, Xiu Li
    American Journal of Physiology-Endocrinology and Metabolism.2025; 328(6): E911.     CrossRef
  • Flavonoids Derived from Opuntia ficus-indica Fruit Alleviate Renal Injury in Diabetic Nephropathy Mice by Altering Gut Microbiota and Promoting the Production of SCFAs
    Haiping Liao, Yunyi Zhao, Yongheng Liang, Kang Zou
    Nutrients.2025; 17(11): 1800.     CrossRef
  • The Predictive Value of Insulin Resistance Surrogates for Diabetic Kidney Disease in Type 2 Diabetes Mellitus
    Qiuying Sun, Meiru Zhao, Xiaonan Wang, Jiangteng Wang, Yaxi Yang, Lin Liu, Di Zhu, Xu Li, Qingbo Guan, Xu Zhang
    Diabetes Therapy.2025; 16(8): 1649.     CrossRef
  • Mesenchymal Stem Cells Mediated Suppression of GREM2 Inhibits Renal Epithelial-Mesenchymal Transition and Attenuates the Progression of Diabetic Kidney Disease
    Myoung Seok Ko, Ji-Young Yun, Serin Kim, Mi-Ok Kim, Sang-hyeok Go, Hye Jin Jin, Eun Hee Koh
    International Journal of Stem Cells.2025; 18(2): 158.     CrossRef
  • The role of the Nrf2 pathway in inhibiting ferroptosis in kidney disease and its future prospects
    Jia-Yuan Huang, Hai-ning Yu
    Pathology - Research and Practice.2025; 272: 156084.     CrossRef
  • Efficacy and Safety of Low‐Dose Spironolactone in Management of Diabetic Kidney Disease in a Real‐World Setting
    Manochehr Amini, Davood Dalil, Fatemeh Yaghoubi, Zoleykha Valizadeh, Farnaz Tavakoli, Zohreh Koohpayezadeh
    Endocrinology, Diabetes & Metabolism.2025;[Epub]     CrossRef
  • Decoding diabetic kidney disease: a comprehensive review of interconnected pathways, molecular mediators, and therapeutic insights
    Esienanwan Esien Efiong, Kathrin Maedler, Emmanuel Effa, Uchechukwu Levi Osuagwu, Esther Peters, Joshua Onyeka Ikebiuro, Chisom Soremekun, Ugwunna Ihediwa, Jiefei Niu, Markéta Fuchs, Homa Bazireh, Akang Leonard Bassey, Peter Uchenna Amadi, Qiuling Dong, N
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Histidine‐Containing Dipeptides in Obesity and Cardiometabolic Health: A Systematic Scoping Review
    Saeede Saadati, Robel Hussen Kabthymer, Giancarlo Aldini, Thilini R. Thrimawithana, Julie E. Stevens, Kathy Ngyuen, Arshad Majid, Simon M. Bell, Jack Feehan, Aya Mousa, Barbora de Courten
    Obesity Reviews.2025;[Epub]     CrossRef
  • β2‐Adrenergic Receptor Agonists in Diabetic Kidney Disease: Exploring a New Frontier
    Shreya Hegde, Bharti Chogtu, Rahul Magazine, Ravindra Prabhu, Harleen Khatra
    Biochemistry Research International.2025;[Epub]     CrossRef
  • Nedd4-2 ablation in kidney improves glycaemic control in diabetic mice
    Jantina A. Manning, Shilpanjali Jesudason, Paul A. B. Moretti, Stuart M. Pitson, Angela S. Y. Chou, Meriam Shabbar, Sonia Saad, Carol Pollock, Sharad Kumar
    Cell Death & Disease.2025;[Epub]     CrossRef
  • Effects of RAS and SGLT2 inhibitors alone or in combination on end-stage kidney disease and/or all-cause death in patients with both diabetes and hypertension: a nationwide cohort study
    Sangmo Hong, Kyungdo Han, Kyung-Soo Kim, Cheol-Young Park
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • Canagliflozin ameliorates diabetic podocyte damage via enriching mitochondria-associated endoplasmic reticulum membranes
    Ting Zheng, Liman Luo, Xing Wang, Xuan Deng, Mei Xue
    Cellular Signalling.2025; 135: 112038.     CrossRef
  • Free prostate-specific antigen, total prostate-specific antigen, and their ratio associated with diabetic kidney disease: new evidence from male patients with diabetes in the United States
    Limei Zhang, Chengxia Li, Deying Niu, Shihua Zhao
    European Journal of Medical Research.2025;[Epub]     CrossRef
  • Long-term impact of PM2.5 exposure on diabetic kidney disease patients considering time-dependent medication adjustment
    Soie Kwon, Hyunman Sim, Ara Ko, Whanhee Lee, Ho Kim, Seung Hyun Han, Hyeon Seok Hwang, Dong Ki Kim, Chun Soo Lim, Yon Su Kim, Jung Pyo Lee, Woojoo Lee
    Clinical Kidney Journal.2025;[Epub]     CrossRef
  • Advances in the Epigenetic Mechanisms of Diabetic Nephropathy Pathogenesis
    Changlong Zhang, Song Xue, Peijun Ren, Shuaijie Han, Yu Zhou, Yingkui Si, Xue Han, Xiaoqian Zhang, Yanan Zhang, Na Chen, Hua He, Ran Feng, Lili Shang
    Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 2629.     CrossRef
  • Association of Life’s Essential 8 Score with All-Cause and Cardiovascular Mortality in Patients with Diabetic Nephropathy: A NHANES-Based Cohort Study
    Fan Zhang, Wenjian Li
    Journal of Multidisciplinary Healthcare.2025; Volume 18: 4795.     CrossRef
  • Research Progress on the Analysis of Wuzi Yanzong Decoction Prescription Drugs and Their Application in Diabetic Kidney Disease
    明玉 陈
    Traditional Chinese Medicine.2025; 14(08): 3310.     CrossRef
  • Integrating bioinformatics and machine learning to elucidate the role of protein glycosylation-related genes in the pathogenesis of diabetic kidney disease
    Ziyang Liu, Zengyuan Qin, Wenxin Bai, Shasha Wang, Chunling Huang, Na Li, Lei Yan, Yue Gu, Fengmin Shao, Yusuf Oloruntoyin Ayipo
    PLOS One.2025; 20(8): e0329640.     CrossRef
  • The Research Progress of Promoting Blood Circulation and Removing Blood Stasis Method in the Treatment of Diabetic Nephropathy
    欣 周
    Traditional Chinese Medicine.2025; 14(08): 3383.     CrossRef
  • Immuno-metabolic diseases and therapeutics: molecular mechanisms via inflammasome signaling
    Joo-Hui Han
    Cell Communication and Signaling.2025;[Epub]     CrossRef
  • Advancements in Pharmacotherapy for Diabetic Kidney Disease: A Systematic Review
    Hongli Zhang, Jiewen Chen, Niansong Wang, Wei Chen, Youhua Xu, Dingkun Gui
    Diabetes/Metabolism Research and Reviews.2025;[Epub]     CrossRef
  • Sodium-glucose cotransporter 2 inhibitors alleviate renal fibrosis in diabetic kidney disease by inhibiting Hmgcs2 and Btg2 in proximal tubular cells
    Shengzhe Yan, Minhui Luo, Rui Zhou, Fenfen Peng, Mingze Zhang, Yujie Feng, Liang Zhao, Li Yang, Yanzhen Cheng
    Journal of Translational Medicine.2025;[Epub]     CrossRef
  • Unraveling the Systems Biology of Curcumin: A Mini-review of its Anti-diabetic Potential through Network Pharmacology
    Miah Roney, Mohd Fadhlizil Fasihi Mohd Aluwi
    Cell Biochemistry and Biophysics.2025; 84(1): 107.     CrossRef
  • Neutrophil Percentage to Albumin Ratio is Associated With Diabetic Kidney Disease in Community Cohorts: A More In‐Depth Insight Incorporating Machine Learning
    Lu Yi, Xiaoli Wen, Yipeng Gong, Gaosi Xu
    Nephrology.2025;[Epub]     CrossRef
  • Prolonged glucagon exposure rewires lipid oxidation and drives diabetic kidney disease progression
    Xingfeng Liu, Jingwen Chen, Shengying Gu, Yibing Chen, Ruiping Zhang, Qingce Zang, Ting Li, Hanwen Li, Dejin Lu, Shaocong Hou, Lijuan Kong, Qian Jiang, Caiyi Xing, Wenjia Fan, Yanjun Wan, Jiaqi Zhang, Linyuan Zhu, Chunxiao Ma, Qijin Zhao, Hai Yan, Zeper A
    Nature Communications.2025;[Epub]     CrossRef
  • Multi‐Target Modulation of Polyphenols in Diabetic Kidney Disease Therapeutics: A Comprehensive Review
    Esienanwan E. Efiong, Emmanuel Effa, Esther Peters, Ochuko L. Erukainure, Peter U. Amadi, Joshua Onyeka Ikebuiro, Sapna Sharma, Christoph Schmaderer, Kathrin Maedler, Emmy Tuenter, Harald Grallert
    Food Science & Nutrition.2025;[Epub]     CrossRef
  • Diabetic nephropathy: Role of nitric oxide
    Sajad Jeddi, Khosrow Kashfi, Asghar Ghasemi
    Nitric Oxide.2025; 159: 89.     CrossRef
  • Analysis of the potential mechanism of stem cells in the treatment of diabetic nephropathy based on 16S, metabolome and transcriptome
    Xing-na Liao, Li-lan Huang, Ji Yang, Yue-yuan Hou, Yi-xiao Quan, Yi-hua Bai
    Genomics.2025; 117(6): 111113.     CrossRef
  • Sensitive detection of glucose enantiomers using open-ring resonator-based metamaterial sensor
    Ruichen Chao, Xujun Xu, Yujiao Li, Xinli Kuang, Jianjun Liu, Yong Du
    Journal of Applied Physics.2025;[Epub]     CrossRef
  • The relationship between copper intake and chronic kidney disease/diabetic kidney disease: insights from NHANES data (2011-2018)
    Shasha Hu, Xiao Tian, Zhenzhen Wang, Mengmeng Li
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • ROS homeostasis in cell fate, pathophysiology, and therapeutic interventions
    Yuan-Shen Chen, Hui-Xiang Tian, Ding-Chao Rong, Luozixian Wang, Shan Chen, Jun Zeng, Heng Xu, Jie Mei, Lei-Yun Wang, Yu-Ligh Liou, Hong-Hao Zhou
    Molecular Biomedicine.2025;[Epub]     CrossRef
  • Pharmacological Modulation of the Nrf2–Keap1 Pathway in Diabetes: Mechanisms, Therapeutic Advances, and Future Directions
    Amar Saxena, Shrestha Saxena, Yash Saxena, Ashita Jain, Rama Chaudhary, Pooja Bharti, Shivdeep Mishra, Chandrabhan Singh, Abhishek Kumar, Ankit Kumar, Sanjeev Kumar
    Journal for Research in Applied Sciences and Biotechnology.2025; 4(5): 38.     CrossRef
  • Effect of Combination of Finerenone with Empagliflozin on Urinary Albumin to Creatinine Ratio and Estimated Glomerular Filtration Rate in Chronic Kidney Disease and Type 2 Diabetes
    Varun Damle, Ranjit Unnikrishnan, Viswanathan Mohan
    Journal of Diabetology.2025; 16(4): 285.     CrossRef
  • Ambient particulate air pollution is associated with higher risk of microvascular complications and diabetic ketoacidosis among persons with type 1 diabetes mellitus in an observational survival study
    Trenton Honda, Trenton Henry, James VanDerslice, Christina A. Porucznik, Laura Corlin, Owais Gilani, Kipruto Kirwa, Jose M. Lazaro-Guevara, Marcus G. Pezzolesi
    Diabetes Research and Clinical Practice.2025; 230: 112983.     CrossRef
  • Comparing the efficacy and renal safety of metformin and imeglimin in diabetic rats
    Charang Ngammoiran, Thongam Ramananda Singh, Laishram Elizabeth Devi, L. Tarinita Devi, Usham Dharmaraja Meetei
    International Journal of Research in Medical Sciences.2025; 13(12): 5387.     CrossRef
  • From Classic to Contemporary, Evolving Therapies in Diabetic Kidney Disease: The Point of View of the Nephrologist and the Diabetologist
    Micaela Gentile, Marta D’Angelo, Maria Rosaria Varì, Andrea Mario Bolla, Maurizio Bianco, Roberto Scarpioni
    Diabetology.2025; 6(12): 144.     CrossRef
  • Assessing Renoprotective Effects of Empagliflozin and Telmisartan Combination Therapy in Non-albuminuric Diabetic Nephropathy: A Retrospective Cohort Study
    Anand Acharya, Chandra Mouli Krishna Kotakala, Burli Kodanda Ramu, Tanvi Padala, Palle Aditya Reddy, Prashanth Kumar Patnaik, Blessy Niharika Mede
    Cureus.2025;[Epub]     CrossRef
  • Aucubin ameliorates diabetic kidney disease by restoring hGENCs autophagy through promoting phosphorylation of ATG4B protein
    Hong Wang, Lei Yang, Dishu Ao, Kai Yang, Songzhu Zou, Zhengjun Lin, Qi Liu, Kunming Wen
    Renal Failure.2025;[Epub]     CrossRef
  • Management of Diabetic Kidney Disease
    Usha Ayyagari
    International Journal of Clinical Metabolism and Diabetes.2025; 1(3): 209.     CrossRef
  • Cyproheptadine, a SET7/9 inhibitor, reduces hyperglycaemia-induced ER stress alleviating inflammation and fibrosis in renal tubular epithelial cells
    Himanshu Sankrityayan, Ajinath Kale, Vishwadeep Shelke, Anil Bhanudas Gaikwad
    Archives of Physiology and Biochemistry.2024; 130(4): 411.     CrossRef
  • Clinical value of serum MMP-3 in chronic kidney disease
    Yulin Fu, Cheng Song, Yuan Qin, Tianyu Zheng, Xiumei Zhou, Xueqin Zhao, Jian Zou, Biao Huang
    Clinica Chimica Acta.2024; 553: 117725.     CrossRef
  • β2-Adrenergic receptor agonists as a treatment for diabetic kidney disease
    Ehtesham Arif, Danira Medunjanin, Ashish Solanki, Xiaofeng Zuo, Yanhui Su, Yujing Dang, Brennan Winkler, Kasey Lerner, Ahmed I. Kamal, Oleg Palygin, Marc-Andre Cornier, Bethany J. Wolf, Kelly J. Hunt, Joshua H. Lipschutz
    American Journal of Physiology-Renal Physiology.2024; 326(1): F20.     CrossRef
  • β2-Adrenergic receptor agonists: a new treatment for diabetic kidney disease?
    Zhiwen Liu, Zheng Dong
    American Journal of Physiology-Renal Physiology.2024; 326(1): F1.     CrossRef
  • Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease
    Lu-Lu Han, Sheng-Hai Wang, Ming-Yan Yao, Hong Zhou
    World Journal of Diabetes.2024; 15(1): 92.     CrossRef
  • Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway
    Honghong Liu, Jiao Wang, Guanru Yue, Jixiong Xu
    Renal Failure.2024;[Epub]     CrossRef
  • Association of serum Nrf2 protein levels with disease activity and renal impairment in lupus nephritis
    Jicui Li, Qiaoyan Guo, Xianping Wei, Yuexin Zhu, Manyu Luo, Ping Luo
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Effects of Qidan Tangshen Granule on diabetic kidney disease in patients with type 2 diabetes
    Hua Yang, Shisi Xia, Yilei Cong, Xinyu Yang, Jie Min, Tengfei Wu
    Diabetes Research and Clinical Practice.2024; 209: 111128.     CrossRef
  • Comparison of conventional mathematical model and machine learning model based on recent advances in mathematical models for predicting diabetic kidney disease
    Yingda Sheng, Caimei Zhang, Jing Huang, Dan Wang, Qian Xiao, Haocheng Zhang, Xiaoqin Ha
    DIGITAL HEALTH.2024;[Epub]     CrossRef
  • Network Pharmacology, Molecular Docking, and Experimental Verification to Reveal the Mitophagy-Associated Mechanism of Tangshen Formula in the Treatment of Diabetic Nephropathy
    Yinfeng Chen, Xiaying Wang, Jie Min, Jie Zheng, Xuanli Tang, Xiaoling Zhu, Dongrong Yu, De Jin
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 739.     CrossRef
  • Senolytic combination of dasatinib and quercetin protects against diabetic kidney disease by activating autophagy to alleviate podocyte dedifferentiation via the Notch pathway
    Xinwang Zhu, Congxiao Zhang, Linlin Liu, Li Xu, Li Yao
    International Journal of Molecular Medicine.2024;[Epub]     CrossRef
  • Decreased risk of renal cell carcinoma in patients with type 2 diabetes treated with sodium glucose cotransporter‐2 inhibitors
    Chun‐Huei Chiu, Wei‐Yao Wang, Hung‐Yi Chen, Pei‐Lun Liao, Gwo‐Ping Jong, Tsung‐Yuan Yang
    Cancer Science.2024; 115(6): 2059.     CrossRef
  • System biology approaches for systemic diseases: Emphasis on type II diabetes mellitus and allied metabolism
    Mohan Das, Moumita Chakraborty, Promi Das, Sayantan Santra, Abhishek Mukherjee, Sarobi Das, Krisztian Banyai, Souvik Roy, Lopamudra Choudhury, Rudrak Gupta, Tama Dey, Dibya Das, Anirbandeep Bose, Balasubramanian Ganesh, Rintu Banerjee
    Biocatalysis and Agricultural Biotechnology.2024; 58: 103176.     CrossRef
  • Two-Dimensional Ultrasound-Based Radiomics Nomogram for Diabetic Kidney Disease: A Pilot Study
    Xingyue Huang, Yugang Hu, Yao Zhang, Qing Zhou
    International Journal of General Medicine.2024; Volume 17: 1877.     CrossRef
  • Autocatalytic, Brain Tumor‐Targeting Delivery of Bardoxolone Methyl Self‐Assembled Nanoparticles for Glioblastoma Treatment
    Zhang Ye, Wendy C. Sheu, Huan Qu, Bin Peng, Jia Liu, Li Zhang, Fanen Yuan, Yuxin Wei, Jiangbing Zhou, Qianxue Chen, Xuan Xiao, Shenqi Zhang
    Small Science.2024;[Epub]     CrossRef
  • Diabetic Nephropathy as a Result of Uncontrolled Hyperglycemia
    Camila Silva de Aquino, Estênio Gabriel Miranda, Francisco José Pascoal Ribeiro Júnior, Hérika Juliana de Araújo Lucena, Jéssica Pará Amaral de Oliveira, João Ferreira Lima Neto, Lênio Airam de Pinho, Miguel Valentim Rodrigues, Pedro Henrique Borges Silve
    Revista de Gestão Social e Ambiental.2024; 18(1): e07716.     CrossRef
  • Low molecular weight heparin promotes the PPAR pathway by protecting the glycocalyx of cells to delay the progression of diabetic nephropathy
    Bin Zhang, Changkai Bu, Qingchi Wang, Qingqing Chen, Deling Shi, Hongyan Qiu, Zhangjie Wang, Jian Liu, Zhe Wang, Qunye Zhang, Lianli Chi
    Journal of Biological Chemistry.2024; 300(8): 107493.     CrossRef
  • In Silico Investigation against Inhibitors of Alpha-Amylase Using Structure-based Screening, Molecular Docking, and Molecular Simulations Studies
    Fariya Khan, Altaf Ahmad Shah, Ajay Kumar, Salman Akhtar
    Cell Biochemistry and Biophysics.2024; 82(3): 2873.     CrossRef
  • Associations between Anemia and Glomerular Filtration Rate and Albuminuria in Korean Adults by Metabolic Syndrome Status: Analysis of KNHNES V-3 Data
    Hyun YOON
    Korean Journal of Clinical Laboratory Science.2024; 56(2): 125.     CrossRef
  • Urine biomarkers in type 2 diabetes mellitus with or without microvascular complications
    Chanyuan Zhang, Tiebing Liu, Xiaoqian Wang, Jing Yang, Dongfang Qin, Yin Liang, Xuejing Wang
    Nutrition & Diabetes.2024;[Epub]     CrossRef
  • Quercetin‐4′‐O‐β‐D‐glucopyranoside inhibits podocyte injury by SIRT5‐mediated desuccinylation of NEK7
    Menghua Wu, Xiaoli Ye
    Clinical and Experimental Pharmacology and Physiology.2024;[Epub]     CrossRef
  • Mesenchymal stem cell-derived exosomes ameliorate diabetic kidney disease through NOD2 signaling pathway
    Yinghui Wang, Donglin Lu, Shasha Lv, Xiangchun Liu, Gang Liu
    Renal Failure.2024;[Epub]     CrossRef
  • Real-World Clinical Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist on Mild-to-Moderate Diabetic Kidney Disease in Patients with Type 2 Diabetes: A Retrospective, Single-Arm Clinical Trial
    Yongsheng Cao, Jianqin Zhao, Yanjuan Ma, Shujie Cao, Ying Liu
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 2913.     CrossRef
  • Single-cell RNA sequencing in diabetic kidney disease: a literature review
    Wei Tan, Jiaoyan Chen, Yunyan Wang, Kui Xiang, Xianqiong Lu, Qiuyu Han, Mingyue Hou, Jurong Yang
    Renal Failure.2024;[Epub]     CrossRef
  • Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetic kidney disease in mice via inhibiting the SGLT2/glycolysis pathway
    Ziyang Lin, Hongyan Huo, Minyi Huang, Jie Tao, Yiqi Yang, Jiao Guo
    Journal of Ethnopharmacology.2024; 335: 118698.     CrossRef
  • Podocyte Death in Diabetic Kidney Disease: Potential Molecular Mechanisms and Therapeutic Targets
    Suye Zhong, Na Wang, Chun Zhang
    International Journal of Molecular Sciences.2024; 25(16): 9035.     CrossRef
  • Astragaloside IV attenuates fatty acid-induced renal tubular injury in diabetic kidney disease by inhibiting fatty acid transport protein-2
    Jing Wang, Lingchen Wang, Xiaoxuan Feng, Yizeng Xu, Liang Zhou, Chen Wang, Meng Wang
    Phytomedicine.2024; 134: 155991.     CrossRef
  • Deciphering interleukin‐18 in diabetes and its complications: Biological features, mechanisms, and therapeutic perspectives
    Runlin Gui, Yuanyuan Ren, Zhen Wang, Yang Li, Chengsong Wu, Xiaofang Li, Man Li, Yujia Li, Lu Qian, Yuyan Xiong
    Obesity Reviews.2024;[Epub]     CrossRef
  • Cardiovascular autonomic neuropathy and the risk of diabetic kidney disease
    Injeong Cho, Seohyun Lim, Minjae Kwon, Seung Min Chung, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Molecular Therapeutics for Diabetic Kidney Disease: An Update
    Man Guo, Fangfang He, Chun Zhang
    International Journal of Molecular Sciences.2024; 25(18): 10051.     CrossRef
  • Effect of GLP-1 Receptor Agonists on Renal Functions and Diabetic Nephropathy in Type 2 Diabetes Mellitus (T2DM) Patients: A Systematic Review and Meta-Analysis
    Ali J Mohamed, Ali H AlSaffar, Ali A Mohamed , Mohamed H Khamis, Ahmed A Khalaf, Husain J AlAradi, Abdulla I Abuhamaid, Ali H Sanad, Hasan L Abbas, Abdulla M Abdulla, Osama A Alkhamis
    Cureus.2024;[Epub]     CrossRef
  • Radish red protects against early diabetic kidney disease through inhibiting inflammation, pyroptosis and insulin resistance via IRAK1 signaling suppression
    Qiang Li, Yanbin Zheng, Jianyu Zhao, Xinyi Wei, Zongxin Shi, Haonan Fan, Chenxu Ge, Minxuan Xu, Jun Tan
    Journal of Functional Foods.2024; 122: 106470.     CrossRef
  • New insights on genetic background of major diabetic vascular complications
    Zuira Tariq, Salah Abusnana, Bashair M. Mussa, Hala Zakaria
    Diabetology & Metabolic Syndrome.2024;[Epub]     CrossRef
  • Assessment of basic pharmacokinetic parameters of dapagliflozin in TTS formulations in male minipigs
    Biernat Paweł, Radosław Balwierz, Dyliński Mieszko, Kołacki Mikołaj, Ewa Micewicz, Bursy Dawid, Łukasz Pogorzelec
    Scientific Reports.2024;[Epub]     CrossRef
  • Crosstalk of Hyperglycaemia and Cellular Mechanisms in the Pathogenesis of Diabetic Kidney Disease
    Esienanwan Esien Efiong, Homa Bazireh, Markéta Fuchs, Peter Uchenna Amadi, Emmanuel Effa, Sapna Sharma, Christoph Schmaderer
    International Journal of Molecular Sciences.2024; 25(20): 10882.     CrossRef
  • A mathematical model of glomerular fibrosis in diabetic kidney disease to predict therapeutic efficacy
    Haryana Y. Thomas, Ashlee N. Ford Versypt
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Integrative Network Pharmacology, Molecular Docking, and Dynamics Simulations Reveal the Mechanisms of Cinnamomum tamala in Diabetic Nephropathy Treatment: An In Silico Study
    Rashmi Singh, Nilanchala Sahu, Rama Tyagi, Perwez Alam, Ali Akhtar, Ramanpreet Walia, Amrish Chandra, Swati Madan
    Current Issues in Molecular Biology.2024; 46(11): 11868.     CrossRef
  • Exercise as a therapeutic approach to alleviate diabetic kidney disease: mechanisms, clinical evidence and potential exercise prescriptions
    Rao Fan, Jianda Kong, Jiahao Zhang, Lei Zhu
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Sodium cromoglycate exerts anti-pulmonary fibrosis effects by targeting the Keap1 protein to activate Nrf2 signaling
    Xiaofeng Liu, Yuwei Huang, Xianchen Zhao, Yingjun Guan, Yanchun Li, Lei Yuan, Chuncheng Wang, Chao Ma, Enlong Ma
    Bioorganic Chemistry.2024; 153: 107961.     CrossRef
  • Efficacy and Safety of Jiedu Tongluo Therapy for Diabetic Kidney Disease Treatment: A Systematic Review and Meta‐Analysis
    Yuxin Liu, Xiaoling Shang, Hongliang Wu, Ze He, Huantian Cui
    Journal of Diabetes Research.2024;[Epub]     CrossRef
  • Oxidative balance score is associated with the risk of diabetic kidney disease in patients with type 2 diabetes mellitus: evidence from NHANES 2007–2018
    Yu Liang, Zhonggao Xu, Wanning Wang
    Frontiers in Nutrition.2024;[Epub]     CrossRef
  • Beneficial effects of ginsenosides on diabetic nephropathy: A systematical review and meta-analysis of preclinical evidence
    Xiao-Mei Chen, Gui-Xuan Lin, Xue Wang, Hong-Yan Ma, Ru-Shang Wang, Shu-Mei Wang, Dan Tang
    Journal of Ethnopharmacology.2023; 302: 115860.     CrossRef
  • Waist circumference and end‐stage renal disease based on glycaemic status: National Health Insurance Service data 2009–2018
    Yun Kyung Cho, Ji Hye Huh, Shinje Moon, Yoon Jung Kim, Yang‐Hyun Kim, Kyung‐do Han, Jun Goo Kang, Seong Jin Lee, Sung‐Hee Ihm
    Journal of Cachexia, Sarcopenia and Muscle.2023; 14(1): 585.     CrossRef
  • A Narrative Review of New Treatment Options for Diabetic Nephropathy
    Aadhira Pillai, Darshna Fulmali
    Cureus.2023;[Epub]     CrossRef
  • Shenkang recipe alleviates renal aging in diabetic kidney disease by interfering with the lysine-specific demethylase KDM6B to modulate the PPAR-γ signaling pathway
    Anna Zuo, Jiarun Xie, Junqiao Shao, Shuyu Li, Haoyu Lin, Shaoting Wang, Wei Sun, Jinjin Xia, Weiqiang Jiang, Jia Sun, Ming Wang
    Pharmacological Research - Modern Chinese Medicine.2023; 6: 100216.     CrossRef
  • miR-223-3p mediates the diabetic kidney disease progression by targeting IL6ST/STAT3 pathway
    Ping Tang, Yushan Xu, Jingrong Zhang, Juanli Nan, Ruxian Zhong, Jingmei Luo, Dazhi Xu, Shaoqing Shi, Lihua Zhang
    Biochemical and Biophysical Research Communications.2023; 648: 50.     CrossRef
  • miR‐124‐3p improves mitochondrial function of renal tubular epithelial cells in db/db mice
    Luqun Liang, Chunxin Wo, Yao Yuan, Hongjuan Cao, Wanlin Tan, Xingcheng Zhou, Dan Wang, Rongyu Chen, Mingjun Shi, Fan Zhang, Ying Xiao, Lingling Liu, Yuxia Zhou, Tian Zhang, Yuanyuan Wang, Bing Guo
    The FASEB Journal.2023;[Epub]     CrossRef
  • Hypoxia-Inducible Factor-Prolyl-Hydroxylase and Sodium-Glucose Cotransporter 2 Inhibitors for Low-Risk Myelodysplastic Syndrome-Related Anemia in Patients with Chronic Kidney Disease: A Report of Three Cases
    Satoshi Yamasaki, Takahiko Horiuchi
    Hematology Reports.2023; 15(1): 180.     CrossRef
  • Diagnostic significance of hsa_circ_0000146 and hsa_circ_0000072 biomarkers for Diabetic Kidney Disease in patients with type 2 diabetes mellitus
    Amul Badr, Omayma Elkholy, Mona Said, Sally Fahim, Mohamed El-Khatib, Dina Sabry, Radwa Gaber
    Journal of Medical Biochemistry.2023; 42(2): 239.     CrossRef
  • The emerging insight into E3 ligases as the potential therapeutic target for diabetic kidney disease
    Vivek Akhouri, Syamantak Majumder, Anil Bhanudas Gaikwad
    Life Sciences.2023; 321: 121643.     CrossRef
  • Klotho’s impact on diabetic nephropathy and its emerging connection to diabetic retinopathy
    Anqi Tang, Yu Zhang, Ling Wu, Yong Lin, Lizeyu Lv, Liangbin Zhao, Bojun Xu, Youqun Huang, Mingquan Li
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Differences and Clinical Significance of Serum 25-Hydroxyvitamin D3 and Vasohibin-1 (VASH-1) Levels in Patients with Diabetic Nephropathy and Different Renal Injuries
    Hui Liu, Dongyan Wang, Jingnan Tang, Linlin Yu, Shanshan Su
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 1085.     CrossRef
  • Medial Arterial Calcification and the Risk of Amputation of Diabetic Foot Ulcer in Patients With Diabetic Kidney Disease
    Joon Myeong So, Ji Ho Park, Jin Gyeong Kim, Il Rae Park, Eun Yeong Ha, Seung Min Chung, Jun Sung Moon, Chul Hyun Park, Woo-Sung Yun, Tae-Gon Kim, Woong Kim, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
  • Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy
    Baranca Buijsers, Marjolein Garsen, Mark de Graaf, Marinka Bakker-van Bebber, Chunming Guo, Xue Li, Johan van der Vlag
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Influence of non-alcoholic steatohepatitis on the renal functional status in patients with type 2 diabetes and diabetic kidney disease
    Z.Ya. Кotsiubiichuk, O.S. Khukhlina, А.А. Аntoniv, O.Ye. Mandryk
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2023; 19(2): 100.     CrossRef
  • Roles of extracellular vesicles in ageing-related chronic kidney disease: Demon or angel
    Siqi Yin, Zixuan Zhou, Peiwen Fu, Chaoying Jin, Peipei Wu, Cheng Ji, Yunjie Shan, Linru Shi, Min Xu, Hui Qian
    Pharmacological Research.2023; 193: 106795.     CrossRef
  • Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer
    Giovanni Tossetta, Sonia Fantone, Daniela Marzioni, Roberta Mazzucchelli
    Cancers.2023; 15(11): 3037.     CrossRef
  • Risk factors for heart, cerebrovascular, and kidney diseases: evaluation of potential side effects of medications to control hypertension, hyperglycemia, and hypercholesterolemia
    Kazumitsu Nawata
    Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
  • Rationale and design of a prospective, clinical study of kidney biopsies in people with type 2 diabetes and severely increased albuminuria (the PRIMETIME 2 study)
    Marie Møller, Rikke Borg, Iain Bressendorff, Lisbeth N Fink, Eva Gravesen, Karina Haar Jensen, Torben Hansen, Dorrit Krustrup, Frederik Persson, Peter Rossing, Frederikke E Sembach, Anne C B Thuesen, Ditte Hansen
    BMJ Open.2023; 13(6): e072216.     CrossRef
  • Oral Chinese patent medicines for diabetic kidney disease: An overview of systematic reviews
    Xue Xue, Ke-ying Li, Shang-zhi Liu, Jia-xuan Li, Xin-yan Jin, Xue-han Liu, La-mei Lin, Xin-rong Zou, Chun-li Lu, Fang-fang Zhao, Jian-ping Liu, Xiao-qin Wang
    European Journal of Integrative Medicine.2023; 61: 102269.     CrossRef
  • Recent Advances in Proteinuric Kidney Disease/Nephrotic Syndrome: Lessons from Knockout/Transgenic Mouse Models
    Ryosuke Saiki, Kan Katayama, Kaoru Dohi
    Biomedicines.2023; 11(7): 1803.     CrossRef
  • Epigenetic regulation of angiogenesis and ischemic response by long noncoding RNA LEENE in diabetes
    Imari Mimura, Masaomi Nangaku
    Kidney International.2023; 104(6): 1048.     CrossRef
  • Advances in the pharmacological study of Chinese herbal medicine to alleviate diabetic nephropathy by improving mitochondrial oxidative stress
    Ming Chen, Yao Chen, Wenhui Zhu, Xiaoming Yan, Jing Xiao, Peiqing Zhang, Peng Liu, Ping Li
    Biomedicine & Pharmacotherapy.2023; 165: 115088.     CrossRef
  • A Systematic Review and Meta-Analysis on the Efficacy and Safety of Finerenone Therapy in Patients with Cardiovascular and Chronic Kidney Diseases in Type 2 Diabetes Mellitus
    FNU Jyotsna, Kamran Mahfooz, Tirath Patel, FNU Parshant, Fnu Simran, Fnu Harsha, Fnu Neha, Dev Jyotishna, Dipesh Mishra, Sirjana Subedi, Mahima Khatri, Satesh Kumar, Giustino Varrassi
    Cureus.2023;[Epub]     CrossRef
  • Molecular implications of glycosaminoglycans in diabetes pharmacotherapy
    Tanya Waseem, Madiha Ahmed, Tausif Ahmed Rajput, Mustafeez Mujtaba Babar
    International Journal of Biological Macromolecules.2023; 247: 125821.     CrossRef
  • SGLT2 Inhibitors in the Treatment of Diabetic Kidney Disease: More than Just Glucose Regulation
    Jasna Klen, Vita Dolžan
    Pharmaceutics.2023; 15(7): 1995.     CrossRef
  • CUL3 induces mitochondrial dysfunction via MRPL12 ubiquitination in renal tubular epithelial cells
    Xingzhao Ji, Xiaoli Yang, Xia Gu, Lingju Chu, Shengnan Sun, Jian Sun, Peng Song, Qian Mu, Ying Wang, Xiaoming Sun, Dun Su, Tong Su, Shaoshuai Hou, Yao Lu, Chen Ma, Mingqiang Liu, Tianyi Zhang, Weiying Zhang, Yi Liu, Qiang Wan
    The FEBS Journal.2023; 290(22): 5340.     CrossRef
  • HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy
    Chuanqiang Zhou, Min Wu, Gaolun Liu, Li Zhou
    Open Life Sciences.2023;[Epub]     CrossRef
  • A Review of the Potential of Nuclear Factor [Erythroid-Derived 2]-like 2 Activation in Autoimmune Diseases
    Ilker Ates, Ayşe Didem Yılmaz, Brigitta Buttari, Marzia Arese, Luciano Saso, Sibel Suzen
    Brain Sciences.2023; 13(11): 1532.     CrossRef
  • Astragalus membranaceus and Salvia miltiorrhiza ameliorate diabetic kidney disease via the “gut-kidney axis”
    Zhen Shen, Tao Cui, Yao Liu, Shuai Wu, Cong Han, Jie Li
    Phytomedicine.2023; 121: 155129.     CrossRef
  • The relevance of the non-invasive biomarkers lncRNA GAS5/miR-21 ceRNA regulatory network in the early identification of diabetes and diabetic nephropathy
    He Sun, Tong Chen, Xin Li, Yonghong Zhu, Shuang Zhang, Ping He, Yali Peng, Qiuling Fan
    Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
  • Activation of acetyl-CoA synthetase 2 mediates kidney injury in diabetic nephropathy
    Jian Lu, Xue Qi Li, Pei Pei Chen, Jia Xiu Zhang, Liang Liu, Gui Hua Wang, Xiao Qi Liu, Ting Ting Jiang, Meng Ying Wang, Wen Tao Liu, Xiong Zhong Ruan, Kun Ling Ma
    JCI Insight.2023;[Epub]     CrossRef
  • SET7, a lysine-specific methyl transferase: An intriguing epigenetic target to combat diabetic nephropathy
    Samarth Dwivedi, Atharva Chavan, Atish T. Paul
    Drug Discovery Today.2023; 28(10): 103754.     CrossRef
  • Dznep, a histone modification inhibitor, inhibits HIF1α binding to TIMP2 gene and suppresses TIMP2 expression under hypoxia
    Tomotaka Yamazaki, Imari Mimura, Yu Kurata, Tetsuhiro Tanaka, Masaomi Nangaku
    Physiological Reports.2023;[Epub]     CrossRef
  • GLP-1RAs inhibit the activation of the NLRP3 inflammasome signaling pathway to regulate mouse renal podocyte pyroptosis
    Xiang Li, Xiao Jiang, Mei Jiang, Zhi-feng Wang, Tao Zhao, Si-ming Cao, Qiu-Mei Li
    Acta Diabetologica.2023; 61(2): 225.     CrossRef
  • Highly Sensitive, Portable Detection System for Multiplex Chemiluminescence Analysis
    Yannan Yu, Wei Nie, Kaiqin Chu, Xi Wei, Zachary J. Smith
    Analytical Chemistry.2023; 95(39): 14762.     CrossRef
  • From normal population to prediabetes and diabetes: study of influencing factors and prediction models
    Di Gong, Xiaohong Chen, Lin Yang, Yongjian Zhang, Qianqian Zhong, Jing Liu, Chen Yan, Yongjiang Cai, Weihua Yang, Jiantao Wang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Diabetes Monitoring through Urine Analysis Using ATR-FTIR Spectroscopy and Machine Learning
    Sajid Farooq, Denise Maria Zezell
    Chemosensors.2023; 11(11): 565.     CrossRef
  • Treatment and practical considerations of diabetic kidney disease
    Yara Bilen, Allaa Almoushref, Kenda Alkwatli, Omar Osman, Ali Mehdi, Hanny Sawaf
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • Application of Metabolomics and Traditional Chinese Medicine for Type 2 Diabetes Mellitus Treatment
    Jing Li, Na Zhu, Yaqiong Wang, Yanlei Bao, Feng Xu, Fengjuan Liu, Xuefeng Zhou
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 4269.     CrossRef
  • Cardiovascular autonomic neuropathy and incident diabetic kidney disease in patients with type 2 diabetes
    Ji Eun Jun, Min Sun Choi, Jae Hyeon Kim
    Diabetes Research and Clinical Practice.2022; 184: 109181.     CrossRef
  • Lipidomic Analysis Reveals the Protection Mechanism of GLP-1 Analogue Dulaglutide on High-Fat Diet-Induced Chronic Kidney Disease in Mice
    Martin Ho Yin Yeung, Ka Long Leung, Lai Yuen Choi, Jung Sun Yoo, Susan Yung, Pui-Kin So, Chi-Ming Wong
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
    Ji Hee Yu, So Young Park, Da Young Lee, Nan Hee Kim, Ji A Seo
    Kidney Research and Clinical Practice.2022; 41(2): 136.     CrossRef
  • Evolving Type 2 diabetes management focuses on clinical outcomes
    Caroline Fenton, Connie Kang
    Drugs & Therapy Perspectives.2022; 38(4): 165.     CrossRef
  • Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
    Chan-Young Jung, Tae-Hyun Yoo
    Diabetes & Metabolism Journal.2022; 46(2): 181.     CrossRef
  • Critical shear stress of red blood cells as a novel integrated biomarker for screening chronic kidney diseases in cases of type 2 diabetes
    Il Rae Park, Jimi Choi, Eun Young Ha, Seung Min Chung, Jun Sung Moon, Sehyun Shin, Sin Gon Kim, Kyu Chang Won
    Clinical Hemorheology and Microcirculation.2022; 81(4): 293.     CrossRef
  • Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells
    Donghee Kim, Ga-Young Nam, Eunhui Seo, Hee-Sook Jun
    Journal of Biomedical Science.2022;[Epub]     CrossRef
  • The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1
    Yuji Oe, Volker Vallon
    Kidney and Dialysis.2022; 2(2): 349.     CrossRef
  • Dapagliflozin for the treatment of chronic kidney disease
    Yu Kurata, Masaomi Nangaku
    Expert Review of Endocrinology & Metabolism.2022; 17(4): 275.     CrossRef
  • Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease
    Javier Donate-Correa, María Dolores Sanchez-Niño, Ainhoa González-Luis, Carla Ferri, Alberto Martín-Olivera, Ernesto Martín-Núñez, Beatriz Fernandez-Fernandez, Víctor G Tagua, Carmen Mora-Fernández, Alberto Ortiz, Juan F Navarro-González
    Clinical Kidney Journal.2022; 15(12): 2200.     CrossRef
  • Pan-Src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of Fyn kinase-mediated endoplasmic reticulum stress
    Debra Dorotea, Songling Jiang, Eun Seon Pak, Jung Beom Son, Hwan Geun Choi, Sung-Min Ahn, Hunjoo Ha
    Experimental & Molecular Medicine.2022; 54(8): 1086.     CrossRef
  • Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
    Nam Hoon Kim, Nan Hee Kim
    Diabetes & Metabolism Journal.2022; 46(4): 543.     CrossRef
  • Effect of once-weekly dulaglutide on renal function in patients with chronic kidney disease
    Sungmin Kim, Jung Nam An, Young Rim Song, Sung Gyun Kim, Hyung Seok Lee, AJin Cho, Jwa-Kyung Kim, Tomislav Bulum
    PLOS ONE.2022; 17(8): e0273004.     CrossRef
  • Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives
    Daniela Maria Tanase, Evelina Maria Gosav, Madalina Ioana Anton, Mariana Floria, Petronela Nicoleta Seritean Isac, Loredana Liliana Hurjui, Claudia Cristina Tarniceriu, Claudia Florida Costea, Manuela Ciocoiu, Ciprian Rezus
    Biomolecules.2022; 12(9): 1227.     CrossRef
  • Preventive and healing effect of high dosing grape seed flour on CKD patients of various stages and aetiologies
    Wiem Bejaoui, Mohamed Mahmoudi, Kamel Charradi, Monia Abbes-Belhadj, Habib Boukhalfa, Mossadok Ben-Attia, Ferid Limam, Ezzedine Aouani
    Biomarkers.2022; 27(8): 795.     CrossRef
  • Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics
    Miyesaier Abudureyimu, Xuanming Luo, Xiang Wang, James R Sowers, Wenshuo Wang, Junbo Ge, Jun Ren, Yingmei Zhang, Wei-Ping Jia
    Journal of Molecular Cell Biology.2022;[Epub]     CrossRef
  • Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases
    Wei Huang, Yi-Yuan Chen, Zi-Qi Li, Fang-Fang He, Chun Zhang
    International Journal of Molecular Sciences.2022; 23(18): 10882.     CrossRef
  • Serum isthmin-1 levels are positively and independently correlated with albuminuria in patients with type 2 diabetes mellitus
    Chuan Wang, Mingyue Xu, Ruiying Feng, Lei Zhang, Xiaofei Yin, Ruoqi Feng, Kai Liang, Jinbo Liu
    BMJ Open Diabetes Research & Care.2022; 10(5): e002972.     CrossRef
  • hucMSC‐sEVs‐Derived 14‐3‐3ζ Serves as a Bridge between YAP and Autophagy in Diabetic Kidney Disease
    Siqi Yin, Wanzhu Liu, Cheng Ji, Yuan Zhu, Yunjie Shan, Zixuan Zhou, Wenya Chen, Leilei Zhang, Zixuan Sun, Wenqin Zhou, Hui Qian, Chaoliang Tang
    Oxidative Medicine and Cellular Longevity.2022;[Epub]     CrossRef
  • Adenosine receptors as emerging therapeutic targets for diabetic kidney disease
    Eun Seon Pak, Jin Joo Cha, Dae Ryong Cha, Keizo Kanasaki, Hunjoo Ha
    Kidney Research and Clinical Practice.2022; 41(Suppl 2): S74.     CrossRef
  • REDD1 Ablation Attenuates the Development of Renal Complications in Diabetic Mice
    Siddharth Sunilkumar, Esma I. Yerlikaya, Allyson L. Toro, William P. Miller, Han Chen, Kebin Hu, Scot R. Kimball, Michael D. Dennis
    Diabetes.2022; 71(11): 2412.     CrossRef
  • The Role of Hypoxia-Inducible Factor-1 Alpha in Renal Disease
    Huixia Liu, Yujuan Li, Jing Xiong
    Molecules.2022; 27(21): 7318.     CrossRef
  • Resistant Starch as a Dietary Intervention to Limit the Progression of Diabetic Kidney Disease
    Anna M. Drake, Melinda T. Coughlan, Claus T. Christophersen, Matthew Snelson
    Nutrients.2022; 14(21): 4547.     CrossRef
  • Aggravated renal fibrosis is positively associated with the activation of HMGB1-TLR2/4 signaling in STZ-induced diabetic mice
    Yan Yuan, Yuanxia Liu, Mengyao Sun, Huijing Ye, Yuchen Feng, Zhenzhen Liu, Lingyu Pan, Hongbo Weng
    Open Life Sciences.2022; 17(1): 1451.     CrossRef
  • Single-cell multiomics reveals the complexity of TGFβ signalling to chromatin in iPSC-derived kidney organoids
    Jessica L. Davis, Ciaran Kennedy, Shane Clerkin, Niall J. Treacy, Thomas Dodd, Catherine Moss, Alison Murphy, Derek P. Brazil, Gerard Cagney, Dermot F. Brougham, Rabi Murad, Darren Finlay, Kristiina Vuori, John Crean
    Communications Biology.2022;[Epub]     CrossRef
  • Oxidized Albumin: Evaluation of Oxidative Stress as a Marker for the Progression of Kidney Disease
    Hiroshi Watanabe
    Biological and Pharmaceutical Bulletin.2022; 45(12): 1728.     CrossRef
  • Whether Renal Pathology Is an Independent Predictor for End-Stage Renal Disease in Diabetic Kidney Disease Patients with Nephrotic Range Proteinuria: A Biopsy-Based Study
    Tingli Wang, Junlin Zhang, Yiting Wang, Lijun Zhao, Yucheng Wu, Honghong Ren, Yutong Zou, Rui Zhang, Huan Xu, Zhonglin Chai, Mark Cooper, Jie Zhang, Fang Liu
    Journal of Clinical Medicine.2022; 12(1): 88.     CrossRef
  • What’s New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances
    Kimio Watanabe, Emiko Sato, Eikan Mishima, Mariko Miyazaki, Tetsuhiro Tanaka
    International Journal of Molecular Sciences.2022; 24(1): 570.     CrossRef
  • Clinical efficacy and safety of astragalus injection combined with ACEI/ARB in the treatment of diabetic kidney disease: Protocol for a systematic review and meta-analysis
    Zhiyue Zhu, Qi Zhang, Le Liu, Pengjie Bao, Shilin Liu, Chaoqun Song, Wenbo Yang, Zheng Nan
    Medicine.2022; 101(49): e31490.     CrossRef
  • Cudrania tricuspidata Root Extract Prevents Methylglyoxal‐Induced Inflammation and Oxidative Stress via Regulation of the PKC‐NOX4 Pathway in Human Kidney Cells
    Donghee Kim, Jayeon Cheon, Haelim Yoon, Hee-Sook Jun, Evangelia Dounousi
    Oxidative Medicine and Cellular Longevity.2021;[Epub]     CrossRef
  • Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control
    Tomoaki Takata, Hajime Isomoto
    International Journal of Molecular Sciences.2021; 22(9): 4374.     CrossRef
  • HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
    Kiichi Hirota
    Biomedicines.2021; 9(5): 468.     CrossRef
  • Nephropathie bei Diabetes
    Roland E. Schmieder
    CardioVasc.2021; 21(3): 31.     CrossRef
  • Clinical Predictors of Nondiabetic Kidney Disease in Patients with Diabetes: A Single-Center Study
    Francesco Fontana, Rossella Perrone, Francesco Giaroni, Gaetano Alfano, Silvia Giovanella, Giulia Ligabue, Riccardo Magistroni, Gianni Cappelli, Udeme Ekrikpo
    International Journal of Nephrology.2021; 2021: 1.     CrossRef
  • Activated Histone Acetyltransferase p300/CBP-Related Signalling Pathways Mediate Up-Regulation of NADPH Oxidase, Inflammation, and Fibrosis in Diabetic Kidney
    Alexandra-Gela Lazar, Mihaela-Loredana Vlad, Adrian Manea, Maya Simionescu, Simona-Adriana Manea
    Antioxidants.2021; 10(9): 1356.     CrossRef
  • Plasma and urine biomarkers in chronic kidney disease: closer to clinical application
    Azadeh Zabetian, Steven G. Coca
    Current Opinion in Nephrology & Hypertension.2021; 30(6): 531.     CrossRef
  • Therapeutic effect and mechanism of combined use of FGF21 and insulin on diabetic nephropathy
    Fanrui Meng, Yukai Cao, Mir Hassan Khoso, Kai Kang, Guiping Ren, Wei Xiao, Deshan Li
    Archives of Biochemistry and Biophysics.2021; 713: 109063.     CrossRef
  • Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
    Daiji Kawanami, Yuichi Takashi, Yoshimi Muta, Naoki Oda, Dai Nagata, Hiroyuki Takahashi, Makito Tanabe
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Transcription Factor ChREBP Mediates High Glucose-Evoked Increase in HIF-1α Content in Epithelial Cells of Renal Proximal Tubules
    Aleksandra Owczarek, Katarzyna B. Gieczewska, Robert Jarzyna, Zuzanna Frydzinska, Katarzyna Winiarska
    International Journal of Molecular Sciences.2021; 22(24): 13299.     CrossRef
  • The effect of modern hypoglycemic therapy on the course of chronic kidney disease in patients with type 2 diabetes mellitus
    V.I. Katerenchuk
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(8): 624.     CrossRef
Original Articles
Complications
Article image
Serum Levels of Adipocyte Fatty Acid-Binding Protein Are Associated with Rapid Renal Function Decline in Patients with Type 2 Diabetes Mellitus and Preserved Renal Function
Da Hea Seo, Moonsuk Nam, Mihye Jung, Young Ju Suh, Seong Hee Ahn, Seongbin Hong, So Hun Kim
Diabetes Metab J. 2020;44(6):875-886.   Published online July 10, 2020
DOI: https://doi.org/10.4093/dmj.2019.0221
  • 12,092 View
  • 166 Download
  • 18 Web of Science
  • 18 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Recent studies have demonstrated that the levels of adipocyte fatty acid-binding protein (A-FABP) are closely associated with diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus (T2DM). This study aimed to examine the association between serum A-FABP level and rapid renal function decline in patients with T2DM and preserved renal function.

Methods

This was a prospective observational study of 452 patients with T2DM and preserved renal function who had serial measurements of estimated glomerular filtration rate (eGFR). Rapid renal function decline was defined as an eGFR decline of >4% per year. The association between baseline serum A-FABP level and rapid renal function decline was investigated.

Results

Over a median follow-up of 7 years, 82 participants (18.1%) experienced rapid renal function decline. Median A-FABP levels were significantly higher in patients with rapid renal function decline, compared to non-decliners (20.2 ng/mL vs. 17.2 ng/mL, P=0.005). A higher baseline level of A-FABP was associated with a greater risk of developing rapid renal function decline, independent of age, sex, duration of diabetes, body mass index, systolic blood pressure, history of cardiovascular disease, baseline eGFR, urine albumin creatinine ratio, total cholesterol, glycosylated hemoglobin, high-sensitivity C-reactive protein and use of thiazolidinedione, insulin, angiotensin-converting-enzyme inhibitors and angiotensin II-receptor blockers and statin (odds ratio, 3.10; 95% confidence interval, 1.53 to 6.29; P=0.002).

Conclusion

A high level of serum A-FABP is associated with an increased risk of rapid renal function decline in patients with T2DM and preserved renal function. This suggests that A-FABP could play a role in the progression of DKD in the early stages.

Citations

Citations to this article as recorded by  
  • Pathway‐Specific Polygenic Risk Scores and Cardiorenal Complications in Asians With Type 2 Diabetes
    Resham L. Gurung, Huili Zheng, Jia Le Ivan Tan, Sylvia Liu, Jian‐Jun Liu, Keven Ang, Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim
    Diabetes, Obesity and Metabolism.2026; 28(6): 5330.     CrossRef
  • Diet supplementation with the macroalgae Laurencia glandulifera and Dictyopteris membranacea limits postprandial hyperglycemia and alters intestinal microbiome in mice
    Maria G. Daskalaki, Ahmed A. Al-Qahtani, Antiopi Tsoureki, Evangelia Mouchtaropoulou, Avery E. Hurst, Stefanos Kikionis, Maria Harizani, Fatimah Alhamlan, Hani Alothaid, Antonios M. Makris, Sotirios C. Kampranis, Anagnostis Argiriou, Vassilios Roussis, Ef
    Frontiers in Nutrition.2026;[Epub]     CrossRef
  • Circulating thrombospondin-2 level for identifying individuals with rapidly declining kidney function trajectory in type 2 diabetes: a prospective study of the Hong Kong West Diabetes Registry
    Chi-Ho Lee, David Tak-Wai Lui, Chloe Yu-Yan Cheung, Carol Ho-Yi Fong, Michele Mae-Ann Yuen, Wing-Sun Chow, Aimin Xu, Karen Siu-Ling Lam
    Nephrology Dialysis Transplantation.2025; 40(4): 788.     CrossRef
  • An In-Silico Approach to Identify Therapeutic Target and Markers Associated with Diabetic Nephropathy
    Bhuvnesh Rai, Pramod Kumar Maurya, Medha Srivastava, Prabhakar Mishra, Mehar Hasan Asif, Swasti Tiwari
    Current Diabetes Reviews.2025;[Epub]     CrossRef
  • Elevated Circulating Adipocyte-Fatty Acid Binding Protein Levels Predict Incident Ischemic Cardiovascular Events in a Longitudinal and Prospective AMI Aging Study
    Xiaoxiao Zhao, Hanjun Zhao, Runzhen Chen, Jinying Zhou, Nan Li, Jiannan Li, Shaodi Yan, Chen Liu, Peng Zhou, Yi Chen, Li Song, Hongbing Yan
    Journal of Inflammation Research.2025; Volume 18: 1589.     CrossRef
  • Identification of Fatty Acid-Binding Protein 4 as a Potential Biomarker and Therapeutic Target for Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis
    Lu Cheng, Qian Ren, Jing Liu, Mei-Lian Yu, Rong-Shuang Huang, Fan Guo, Liang Ma, Shen-Ju Gou, Ping Fu
    Kidney Diseases.2025; 11(1): 75.     CrossRef
  • FABP4 inhibition protects renal tubular cells and ameliorates renal inflammation in diabetic kidney disease
    Yen‐Wen Wu, Jaw‐Wen Chen, Liang-Yu Lin, Jih-Hsin Huang, Chia‐Chi Chang, Ting‐Ting Chang
    Biochemical Pharmacology.2025; 236: 116899.     CrossRef
  • The Effects of FABP4 on Cardiovascular Disease in the Aging Population
    Ellen M. van der Ark-Vonk, Mike V. Puijk, Gerard Pasterkamp, Sander W. van der Laan
    Current Atherosclerosis Reports.2024; 26(5): 163.     CrossRef
  • High-expression of FABP4 in Tubules is a Risk Factor for Poor Prognosis in DKD Patients
    Yao Huang, Xinyuan Cui, Zheng Li, Shuguang Yuan, Yachun Han, Xiangqing Xu, Xiao Fu, Kewen Shi, Zurong Zhang, Jinying Wei, Shiyu Xia, Yang Xiao, Song Xue, Lin Sun, Hong Liu, Xuejing Zhu
    Current Medicinal Chemistry.2024; 31(22): 3436.     CrossRef
  • Risk factors for rapid kidney function decline in diabetes patients
    Jixin Xing, Linxi Huang, Weifu Ren, Xiaobin Mei
    Renal Failure.2024;[Epub]     CrossRef
  • Serum fatty acid-binding protein 4 as a biomarker for early detection of diabetic nephropathy in type 2 diabetes
    Amr M. Shaker, Maggie E. Mohamed, Tarek Ramzy, Mayssa I. Ali
    The Egyptian Journal of Internal Medicine.2023;[Epub]     CrossRef
  • Analysis of Inflammatory Cytokines and Estimated Glomerular Filtration Rate Decline in Japanese Patients with Diabetic Kidney Disease: A Pilot Study
    Yuka Sugawara, Yosuke Hirakawa, Koki Mise, Kosuke Kashiwabara, Ko Hanai, Satoshi Yamaguchi, Akihiro Katayama, Yasuhiro Onishi, Yui Yoshida, Naoki Kashihara, Yutaka Matsuyama, Tetsuya Babazono, Masaomi Nangaku, Jun Wada
    Biomarkers in Medicine.2022; 16(10): 759.     CrossRef
  • The role of statins in patients with early diabetic nephropathy
    Xi Zhao, Shu Chun Zhou, Xiu Fang Wang, Hong Wu Liao
    Medicine.2022; 101(24): e29099.     CrossRef
  • Serum Adipocyte Fatty-Acid Binding Protein as an Independent Marker of Peripheral Artery Disease in Patients with Type-2 Diabetes Mellitus
    Bang-Gee Hsu, Chin-Yee Mah, Du-An Wu, Ming-Chun Chen
    International Journal of Environmental Research and Public Health.2022; 19(15): 9459.     CrossRef
  • Fatty acid-binding protein 4 in kidney diseases: From mechanisms to clinics
    Weijing Lai, Min Shi, Rongshuang Huang, Ping Fu, Liang Ma
    European Journal of Pharmacology.2022; 931: 175224.     CrossRef
  • Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes
    Hong Wang, Jie Cao, Jian-bin Su, Xue-qin Wang, Xing Wang, Dong-mei Zhang, Xiao-hua Wang
    Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
  • The Low-Expression Variant of FABP4 Is Associated With Cardiovascular Disease in Type 1 Diabetes
    Emma H. Dahlström, Jani Saksi, Carol Forsblom, Nicoline Uglebjerg, Nina Mars, Lena M. Thorn, Valma Harjutsalo, Peter Rossing, Tarunveer S. Ahluwalia, Perttu J. Lindsberg, Niina Sandholm, Per-Henrik Groop
    Diabetes.2021; 70(10): 2391.     CrossRef
  • White adipocyte-targeted dual gene silencing of FABP4/5 for anti-obesity, anti-inflammation and reversal of insulin resistance: Efficacy and comparison of administration routes
    Jee Young Chung, Juhyeong Hong, Hyung-Jin Kim, Yoonsung Song, Seok-Beom Yong, Jieun Lee, Yong-Hee Kim
    Biomaterials.2021; 279: 121209.     CrossRef
Type 1 Diabetes
Article image
Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus
Jong Ha Baek, Woo Je Lee, Byung-Wan Lee, Soo Kyoung Kim, Gyuri Kim, Sang-Man Jin, Jae Hyeon Kim
Diabetes Metab J. 2021;45(1):46-54.   Published online July 10, 2020
DOI: https://doi.org/10.4093/dmj.2019.0134
  • 15,950 View
  • 304 Download
  • 28 Web of Science
  • 27 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

The aim of this study was to evaluate characteristics and risk of diabetic complications according to age at diagnosis among young adults with type 1 diabetes mellitus (T1DM).

Methods

A total of 255 T1DM patients aged less than 40 years were included. Patients were categorized into three groups (<20, 20 to 29, and 30 to 40 years) according to age at diagnosis. Diabetic nephropathy (DN) was defined when spot urine-albumin creatinine ratio was 300 mg/g or more and/or estimated glomerular filtration ratio (eGFR) level was 60 mL/min/1.73 m2 or less.

Results

Median age at diagnosis was 25 years and disease duration was 14 years. Individuals diagnosed with T1DM at childhood/adolescent (age <20 years) had lower stimulated C-peptide levels. They received more intensive insulin treatment with higher total daily insulin doses compared to older onset groups. The prevalence of DN was higher in the childhood/adolescent-onset group than in older onset groups (25.3% vs. 15.3% vs. 9.6%, P=0.022). The eGFR was inversely associated with disease duration whilst the degree of decrease was more prominent in the childhood/adolescent-onset group than in the later onset group (aged 30 to 40 years; P<0.001). Childhood/adolescent-onset group was independently associated with the risk of DN compared to the older onset group (aged 30 to 40 years; odds ratio, 3.47; 95% confidence interval, 1.45 to 8.33; P=0.005).

Conclusion

In individuals with childhood/adolescent-onset T1DM, the reduction in renal function is more prominent with disease duration. Early age-onset T1DM is an independent risk of DN.

Citations

Citations to this article as recorded by  
  • Glycemia Risk Index is Associated With Risk of Albuminuria Among Individuals With Type 1 Diabetes
    Ji Yoon Kim, Jee Hee Yoo, Nam Hoon Kim, Jae Hyeon Kim
    Journal of Diabetes Science and Technology.2026; 20(3): 775.     CrossRef
  • Impact of sotagliflozin on glomerular hyperfiltration in people with type 1 diabetes: A post hoc analysis of the inTandem3 trial
    Amrit Pathak, M. Belinda Hardin, Manon Girard, Michael J. Davies, William B. Horton
    Diabetes, Obesity and Metabolism.2026; 28(2): 1537.     CrossRef
  • In-silico molecular docking of berberine HCl and gallic acid: A multi-targeted approach for diabetic nephropathy
    P. Roshan Ali, Gottimukkala Rakshitha, V.V. Rajesham, Kavirayani Naga Lakshmi Shivani, Rajinikanth Sagapola, S. Sravanthi
    Pharmacological Research - Natural Products.2026; 10: 100502.     CrossRef
  • Co-transplantation of pancreatic islets with adipose-derived mesenchymal stem cells in vascularized kidney ECM scaffolds to restore type 1 diabetes mellitus
    Minji Choi, Prayas Chakma Shanto, Md Abdullah Al Fahad, Sang-ho Bae, Byong-Taek Lee
    Bioactive Materials.2026; 65: 268.     CrossRef
  • Age of Type 1 Diabetes Onset and Dementia Risk: A Swedish Nationwide, Register‐Based Cohort Study
    Milena Jancev, Björn Eliasson, Geert Jan Biessels, J. Hans DeVries, Erik H. Serné, Frank L. J. Visseren, Araz Rawshani, Aidin Rawshani, Tali Cukierman‐Yaffe, Naveed Sattar, Hertzel C. Gerstein, Thomas T. van Sloten
    Diabetes, Obesity and Metabolism.2026; 28(10): 9134.     CrossRef
  • Role of Nephropathological Factors with Fibrinogen in the Progression of Human Diabetic Nephropathy in the Pakistani Population
    Maha Maqsood, Saima Sharif, Muhammad Saqib, Muhammad Maqsood, Shagufta Naz, Saira Rafaqat, Ali Hasan
    Current Diabetes Reviews.2026;[Epub]     CrossRef
  • Investigating the correlation between tumor markers and metabolic indices in type 2 diabetes mellitus patients
    Pei Chen, Yanwen Xie
    International Journal of Diabetes in Developing Countries.2025; 45(4): 988.     CrossRef
  • Epidemiological trends and risk factors of CKD-T1DM in children and adolescents across 204 countries and territories (1990–2021)
    Beiyan Liu, Fengrui Li, Huanxi Cui, Lin Li, Ying Ma, Qizhi Yang, Ying Cui
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Current status, trend changes, and future predictions of the disease burden of type 1 diabetes kidney disease in global and China
    Qinghua Yang, Li Jin, Mingwei Luo, Shiwei Xie
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • The Correlation between Glycemic Control and Microvascular Complications in Type 1 Diabetes Mellitus Patients
    Yasra Memon, Ghulam Fareed, Kamran Ali Qureshi, Mahesh Kumar, Muhammad Sohail Baig, Zaheer Hussain Memon, Imran Karim
    Pakistan Journal of Health Sciences.2025; : 18.     CrossRef
  • Associations of time in tight range, time in range, and glycated hemoglobin with albuminuria in type 1 diabetes: A cross-sectional study
    Ji Yoon Kim, Seohyun Kim, Sang Ho Park, Jin A Lee, So Hyun Cho, Rosa Oh, Myunghwa Jang, You-Bin Lee, Gyuri Kim, Kyu Yeon Hur, Jae Hyeon Kim, Sang-Man Jin
    Diabetes Research and Clinical Practice.2025; 226: 112325.     CrossRef
  • Change in Age of Diagnosis and Demographics of Type 1 Diabetes Mellitus During the COVID‐19 Era
    Katya Sracic, Naveen Uli, Ryan Heksch, Andrea Scaramuzza
    Pediatric Diabetes.2025;[Epub]     CrossRef
  • Evaluation the Levels of Pentosidine and Vitamin D3 in Diabetic Nephropathy
    Maryam Hiyder Kadum, Khawla A. Shemran, Yasameen AL Saffar
    Medical Journal of Babylon.2025; 22(4): 995.     CrossRef
  • Age at onset of type 1 diabetes between puberty and 30 years old is associated with increased diabetic nephropathy risk
    Yen-Bo Lin, Wayne Huey-Herng Sheu, Su-Huey Lo, Yen-Po Yeh, Chien-Ning Huang, Chii-Min Hwu, Chang-Hsun Hsieh, Horng-Yi Ou, Lee-Ming Chuang, Jung-Fu Chen, Yu-Cheng Chen, Yun-Hsing Peng, Szu-Tah Chen, Shang-Ren Hsu, Yi-Ling Hsieh, Chih-Hsun Chu, Chieg-Hsiang
    Scientific Reports.2024;[Epub]     CrossRef
  • Targeted mapping and utilization of the perihepatic surface for therapeutic beta cell replacement and retrieval in diabetic non-human primates
    David J. Leishman, Scott H. Oppler, Laura L. Hocum Stone, Timothy D. O’Brien, Sabarinathan Ramachandran, Bradley J. Willenberg, Andrew B. Adams, Bernhard J. Hering, Melanie L. Graham
    Frontiers in Transplantation.2024;[Epub]     CrossRef
  • Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial
    Ji Yoon Kim, Sang-Man Jin, Eun Seok Kang, Soo Heon Kwak, Yeoree Yang, Jee Hee Yoo, Jae Hyun Bae, Jun Sung Moon, Chang Hee Jung, Ji Cheol Bae, Sunghwan Suh, Sun Joon Moon, Sun Ok Song, Suk Chon, Jae Hyeon Kim
    Diabetologia.2024; 67(7): 1235.     CrossRef
  • Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial
    Ji Yoon Kim, Sang-Man Jin, Kang Hee Sim, Bo-Yeon Kim, Jae Hyoung Cho, Jun Sung Moon, Soo Lim, Eun Seok Kang, Cheol-Young Park, Sin Gon Kim, Jae Hyeon Kim
    Diabetologia.2024; 67(7): 1223.     CrossRef
  • Immunopeptidome mining reveals a novel ERS-induced target in T1D
    Lina Wang, Shushu Yang, Gaohui Zhu, Jie Li, Gang Meng, Xiaoling Chen, Mengjun Zhang, Shufeng Wang, Xiangqian Li, Yu Pan, Yi Huang, Li Wang, Yuzhang Wu
    Cellular & Molecular Immunology.2024; 21(6): 604.     CrossRef
  • Is the urinary neutrophil gelatinase-associated lipocalin concentration in children and adolescents with type 1 diabetes mellitus different from that in healthy children?
    Adriana Unić, Lavinia La Grasta Sabolić, Ivan Šamija, Bernardica Valent Morić, Marijana Miler
    Biochemia medica.2024; 34(2): 327.     CrossRef
  • Network-based identification and prioritization of key transcriptional factors of diabetic kidney disease
    Ikhlak Ahmed, Mubarak Ziab, Sahar Da’as, Waseem Hasan, Sujitha P. Jeya, Elbay Aliyev, Sabah Nisar, Ajaz A. Bhat, Khalid Adnan Fakhro, Ammira S. Alshabeeb Akil
    Computational and Structural Biotechnology Journal.2023; 21: 716.     CrossRef
  • Comparison of diabetes distress and depression screening results of emerging adults with type 1 diabetes onset at different ages: findings from the German early-onset T1D study and the German Diabetes Study (GDS)
    Anna Stahl-Pehe, Christina Bächle, Kálmán Bódis, Oana-Patricia Zaharia, Karin Lange, Reinhard W. Holl, Michael Roden, Joachim Rosenbauer, M. Roden, H. Al-Hasani, B Belgardt, GJ. Bönhof, V Burkart, A. E. Buyken, G. Geerling, C. Herder, A. Icks, K. Jandelei
    Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
  • Hemoperfusion and functional state of the macula after simultaneous pancreas and kidney transplantation
    IV Vorobyeva, EV Bulava, LK Moshetova, AV Pinchuk
    Bulletin of Russian State Medical University.2022;[Epub]     CrossRef
  • Sigesbeckia orientalis Extract Ameliorates the Experimental Diabetic Nephropathy by Downregulating the Inflammatory and Oxidative Stress Signaling Pathways
    Chung-Ming Chen, Jer-Yiing Houng, Tsui-Ling Ko, Shu-Hui Juan, Hsiu-Chu Chou, Xing Li
    Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1.     CrossRef
  • Impact of low-protein diet on cardiovascular risk factors and kidney function in diabetic nephropathy: A systematic review and meta-analysis of randomized-controlled trials
    Mohammad Hassan Sohouli, Parvin Mirmiran, Shaikh Sanjid Seraj, Emad Kutbi, Hadil Ali Mohammed Alkahmous, Faisal Almuqayyid, Omar Ahnaf Arafah, Abdul Rahman Riad Barakeh, Ahmed Abu-Zaid
    Diabetes Research and Clinical Practice.2022; 191: 110068.     CrossRef
  • Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus (Diabetes Metab J 2021;45:46-54)
    Jong Ha Baek, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2021; 45(2): 281.     CrossRef
  • Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus (Diabetes Metab J 2021;45:46-54)
    Ye Seul Yang, Tae Seo Sohn
    Diabetes & Metabolism Journal.2021; 45(2): 277.     CrossRef
  • Role of magnetic resonance diffusion weighted imaging in diagnosis of diabetic nephropathy in children living with type 1 diabetes mellitus
    Eman Nabil Wahba, Ashraf Elsharkawy, Mohammad Hosny Awad, Ashraf Abdel Rahman, Amr Sarhan
    Journal of Pediatric Endocrinology and Metabolism.2021; 34(12): 1585.     CrossRef
Complications
Article image
Therapeutic Effects of Fibroblast Growth Factor-21 on Diabetic Nephropathy and the Possible Mechanism in Type 1 Diabetes Mellitus Mice
Wenya Weng, Tingwen Ge, Yi Wang, Lulu He, Tinghao Liu, Wanning Wang, Zongyu Zheng, Lechu Yu, Chi Zhang, Xuemian Lu
Diabetes Metab J. 2020;44(4):566-580.   Published online May 15, 2020
DOI: https://doi.org/10.4093/dmj.2019.0089
  • 13,311 View
  • 142 Download
  • 19 Web of Science
  • 18 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Fibroblast growth factor 21 (FGF21) has been only reported to prevent type 1 diabetic nephropathy (DN) in the streptozotocin-induced type 1 diabetes mellitus (T1DM) mouse model. However, the FVB (Cg)-Tg (Cryaa-Tag, Ins2-CALM1) 26OVE/PneJ (OVE26) transgenic mouse is a widely recommended mouse model to recapture the most important features of T1DM nephropathy that often occurs in diabetic patients. In addition, most previous studies focused on exploring the preventive effect of FGF21 on the development of DN. However, in clinic, development of therapeutic strategy has much more realistic value compared with preventive strategy since the onset time of DN is difficult to be accurately predicted. Therefore, in the present study OVE26 mice were used to investigate the potential therapeutic effects of FGF21 on DN.

Methods

Four-month-old female OVE26 mice were intraperitoneally treated with recombinant FGF21 at a dose of 100 µg/kg/day for 3 months. The diabetic and non-diabetic control mice were treated with phosphate-buffered saline at the same volume. Renal functions, pathological changes, inflammation, apoptosis, oxidative stress and fibrosis were examined in mice of all groups.

Results

The results showed that severe renal dysfunction, morphological changes, inflammation, apoptosis, and fibrosis were observed in OVE26 mice. However, all the renal abnormalities above in OVE26 mice were significantly attenuated by 3-month FGF21 treatment associated with improvement of renal adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK) activity and sirtuin 1 (SIRT1) expression.

Conclusion

Therefore, this study demonstrated that FGF21 might exert therapeutic effects on DN through AMPK-SIRT1 pathway.

Citations

Citations to this article as recorded by  
  • Immune-metabolic interactions shape the fibrotic landscape of diabetic kidney disease: emerging mechanisms and therapeutic prospects
    Yachan Gao, Xinxin Pang, Huichao Zhang, Dongdong Li, Jiarui Han, Zhenyi Chen, Xiaoyong Chen, Dongyang Li
    Frontiers in Physiology.2026;[Epub]     CrossRef
  • Targeting the NAD + -SIRT3 axis to mitigate metabolic memory in diabetic kidney disease
    Yufei Zhang, Yudian Wang, Yuhang Qiao, Liheng Liu, Hailing Zhao, Qi Jin, Liang Peng, Ping Li
    Renal Failure.2026;[Epub]     CrossRef
  • The factors between BMI and diabetic nephropathy and protective role of the FGF21-SIRT1 axis in diabetic nephropathy
    Chao Liu, Qiu Zhang, Yi Zhang
    Molecular and Cellular Biochemistry.2026; 481(8): 3635.     CrossRef
  • FGF21 ameliorates diabetic nephropathy through CDK1-dependently regulating the cell cycle
    Yudie Zhang, Fan Wang, Chongyang Zhang, Fan Yao, Bin Zhang, Yongping Zhang, Xiaobo Sun
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • The Role of Sirtuins in Diabetic Nephropathy: A Comprehensive Review
    Pranay Wal, Tarannum Tarannum, Lalji Baldaniya, Kiranjeet Kaur, Priyanka Singh, Namra Aziz, Komal Singh, Amin Gasmi
    Current Protein & Peptide Science.2025; 26(6): 407.     CrossRef
  • Role of Liver-Derived Ketones, Hepatokines, and Metabolites in the Regulation of Renal Function
    Gertrude Arthur, Michael I. Adenawoola, Sally Wahba, Bentley S. Montgomery, David E. Stec
    Kidney360.2025; 6(9): 1609.     CrossRef
  • FGF21-engineered ADSCs promote diabetic wound healing by mitigating ferroptosis and oxidative stress via the SIRT1/NRF2/GPX4 signaling pathway
    Zhen Liang, Yanan Gu, Yutao Li, Ziyu Wu, Xianghao Xu, Guizhi Wei, Na Wang, Zhaoxiang Zhang, Qianqian Hao, Yizhi Peng, Hanli Wang, Zhou Yu, Baoqiang Song
    Stem Cell Research & Therapy.2025;[Epub]     CrossRef
  • Fibroblast growth factor 21 alleviates unilateral ureteral obstruction-induced renal fibrosis by inhibiting Wnt/β-catenin signaling pathway
    Wenhui Zhong, Yuheng Jiang, Huizhen Wang, Xiang Luo, Tao Zeng, Huimi Huang, Ling Xiao, Nan Jia, Aiqing Li
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2024; 1871(2): 119620.     CrossRef
  • Urinary Excretion of Biomolecules Related to Cell Cycle, Proliferation, and Autophagy in Subjects with Type 2 Diabetes and Chronic Kidney Disease
    Anton I. Korbut, Vyacheslav V. Romanov, Vadim V. Klimontov
    Biomedicines.2024; 12(3): 487.     CrossRef
  • New developments in the biology of fibroblast growth factors
    David M. Ornitz, Nobuyuki Itoh
    WIREs Mechanisms of Disease.2022;[Epub]     CrossRef
  • SIRT1–SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms
    Wenxiu Qi, Cheng Hu, Daqing Zhao, Xiangyan Li
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases
    Min-Qi Jia, Cha-Xiang Guan, Jia-Hao Tao, Yong Zhou, Liang-Jun Yan
    Oxidative Medicine and Cellular Longevity.2022;[Epub]     CrossRef
  • Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort study
    Yutong Zou, Lijun Zhao, Junlin Zhang, Yiting Wang, Yucheng Wu, Honghong Ren, Tingli Wang, Yuancheng Zhao, Huan Xu, Lin Li, Nanwei Tong, Fang Liu
    Acta Diabetologica.2022; 60(2): 225.     CrossRef
  • FGF21 and Chronic Kidney Disease
    João Victor Salgado, Miguel Angelo Goes, Natalino Salgado Filho
    Metabolism.2021; 118: 154738.     CrossRef
  • The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
    Junyu Deng, Ye Liu, Yiqiu Liu, Wei Li, Xuqiang Nie
    Journal of Inflammation Research.2021; Volume 14: 5273.     CrossRef
  • Therapeutic effect and mechanism of combined use of FGF21 and insulin on diabetic nephropathy
    Fanrui Meng, Yukai Cao, Mir Hassan Khoso, Kai Kang, Guiping Ren, Wei Xiao, Deshan Li
    Archives of Biochemistry and Biophysics.2021; 713: 109063.     CrossRef
  • FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
    Emma Henriksson, Birgitte Andersen
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
    Erik J. Tillman, Tim Rolph
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
Basic Research
Article image
Inhibition of Ceramide Accumulation in Podocytes by Myriocin Prevents Diabetic Nephropathy
Chang-Yun Woo, Ji Yeon Baek, Ah-Ram Kim, Chung Hwan Hong, Ji Eun Yoon, Hyoun Sik Kim, Hyun Ju Yoo, Tae-Sik Park, Ranjan Kc, Ki-Up Lee, Eun Hee Koh
Diabetes Metab J. 2020;44(4):581-591.   Published online November 4, 2019
DOI: https://doi.org/10.4093/dmj.2019.0063
  • 13,973 View
  • 203 Download
  • 54 Web of Science
  • 56 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Ceramides are associated with metabolic complications including diabetic nephropathy in patients with diabetes. Recent studies have reported that podocytes play a pivotal role in the progression of diabetic nephropathy. Also, mitochondrial dysfunction is known to be an early event in podocyte injury. Thus, we tested the hypothesis that ceramide accumulation in podocytes induces mitochondrial damage through reactive oxygen species (ROS) production in patients with diabetic nephropathy.

Methods

We used Otsuka Long Evans Tokushima Fatty (OLETF) rats and high-fat diet (HFD)-fed mice. We fed the animals either a control- or a myriocin-containing diet to evaluate the effects of the ceramide. Also, we assessed the effects of ceramide on intracellular ROS generation and on podocyte autophagy in cultured podocytes.

Results

OLETF rats and HFD-fed mice showed albuminuria, histologic features of diabetic nephropathy, and podocyte injury, whereas myriocin treatment effectively treated these abnormalities. Cultured podocytes exposed to agents predicted to be risk factors (high glucose, high free fatty acid, and angiotensin II in combination [GFA]) showed an increase in ceramide accumulation and ROS generation in podocyte mitochondria. Pretreatment with myriocin reversed GFA-induced mitochondrial ROS generation and prevented cell death. Myriocin-pretreated cells were protected from GFA-induced disruption of mitochondrial integrity.

Conclusion

We showed that mitochondrial ceramide accumulation may result in podocyte damage through ROS production. Therefore, this signaling pathway could become a pharmacological target to abate the development of diabetic kidney disease.

Citations

Citations to this article as recorded by  
  • Therapeutic remodeling of the ceramide backbone prevents kidney injury
    Rebekah J. Nicholson, Luis Cedeño-Rosario, J. Alan Maschek, Trevor Lonergan, Jonathan G. Van Vranken, Angela R.S. Kruse, Chris J. Stubben, Liping Wang, Deborah Stuart, Queren A. Alcantara, Monica P. Revelo, Kate Rutter, Mayette Pahulu, Jacob Taloa, Xuanch
    Cell Metabolism.2026; 38(1): 135.     CrossRef
  • Circulating Sphingolipids and Incident CKD
    Amanda M. Fretts, Paul N. Jensen, Benjamin Lidgard, Colleen M. Sitlani, David S. Siscovick, Irena B. King, Reya H. Mokiao, Andrew N. Hoofnagle, Jason G. Umans, Rozenn N. Lemaitre
    Kidney360.2026; 7(2): 302.     CrossRef
  • The lipid–podocyte axis: emerging clues in membranous nephropathy pathogenesis
    Sichao Ma, Mingxin Chang, Dongmei Zhang, Yinping Wang, Shoulin Zhang, Hong’an Wang, Yunfan Liu
    Frontiers in Medicine.2026;[Epub]     CrossRef
  • Mitochondrial Dynamics in Diabetic Kidney Disease: Underlying Mechanisms and Novel Therapeutics
    Nan Shao, Jinghan Wang, Jiaoying Liu, Junhua Zhang, Bin Zhang, Xiaobo Sun, Xiaoqiu Liu
    International Journal of Molecular Sciences.2026; 27(5): 2429.     CrossRef
  • Lipid metabolic dysregulation in diabetic kidney disease: mechanisms, cellular impact, and therapeutic strategies
    You Wang, Lijia Wu, Xincui Bao, Jing Yang, Miao Xu, Yuzhuo Chang, Zhe Liu, Lingling Qin, Ming Gao, Cuiyan Lv, Tonghua Liu
    Journal of Clinical & Translational Endocrinology.2026; 44: 100436.     CrossRef
  • Ectopic lipid deposition in kidney diseases: mechanisms in specific cell types and therapeutic strategies
    Qi Zhong, Yue Zhang, Di Sun, Jin Peng, Peng Zhang, Ruolin Wang, Lei Cao, Hailong Chen, Chunwei Wu, Ze He
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Lipid metabolism drives podocyte injury in diabetic kidney disease
    Jiazhen Shang, Zhitao Zeng, Shouyu Chai, Xincong Lv, Xiaotian Han, Baoze Ma, Yifan Xu, Rong Wang, Zhimei Lv
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • The Sphingolipid Balance and Endothelial Dysfunction in Lysosomal Storage Diseases: Shared Mechanisms in Gaucher, Niemann–Pick and Fabry Disease
    Anastasiia Nekrasova, Sergey Kutsev, Alexander Shestopalov
    International Journal of Molecular Sciences.2026; 27(13): 5972.     CrossRef
  • Genetic and clinical evidence implicates a potential Parasutterella–sphingomyelin pathway in diabetic nephropathy
    Chunling Huang, Jing Zhou, Hongtao Zhang, Yue Gu, Fengmin Shao
    Frontiers in Microbiology.2026;[Epub]     CrossRef
  • Sphingolipid Dysregulation in Type 2 Diabetes and Its Microvascular Complications
    Ya Wen, Yayun Lin, Yi Liu, Li Zhao
    International Journal of Molecular Sciences.2026; 27(20): 9043.     CrossRef
  • Metabolites as key signaling mediators: rethinking diabetic kidney disease from a network perspective
    Xin Li, Xu Wang, Cheng Fang, Zhonghong Yan, Lei Liu, Jinwei Han, Liangyou Zhao, Xiuhong Wu
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Macrophage IgG Recycling Couples Glomerular IgG Accumulation to Podocyte Senescence in Obesity-Related Glomerulopathy
    Zikang Liu, Binbin Dai, Yuxuan Jin, Jiwen Bao, Hanxue Zhao, Yurong Lin, Hongtu Hu, Yangbin Pan
    Journal of the American Society of Nephrology.2026;[Epub]     CrossRef
  • Sphingolipid signaling in kidney diseases
    Ningjun Li, Guangbi Li
    American Journal of Physiology-Renal Physiology.2025; 328(3): F431.     CrossRef
  • Renal Lipid Alterations From Diabetes to Early‐Stage Diabetic Kidney Disease and Mitophagy: Focus on Cardiolipin
    Zhijie Li, Hongmiao Wang, Nan Liu, Xiayuchen Lan, Ailing Xie, Ge Yuan, Bowen Li, Jiaxin Geng, Xiaodan Liu
    Journal of Cellular and Molecular Medicine.2025;[Epub]     CrossRef
  • CerS6 links ceramide metabolism to innate immune responses in diabetic kidney disease
    Zijing Zhu, Yun Cao, Yonghong Jian, Hongtu Hu, Qian Yang, Yiqun Hao, Houhui Jiang, Zilv Luo, Xueyan Yang, Weiwei Li, Jijia Hu, Hongyan Liu, Wei Liang, Guohua Ding, Zhaowei Chen
    Nature Communications.2025;[Epub]     CrossRef
  • Insights into diabetic nephropathy biomarkers with focus on existing indices and potential future developments
    Ahmed Olatunde, Kaliyaperumal Saravanan, Olalekan Bukunmi Ogunro, Mayowa Shakirdeen Obidola, Abdullahi Jakwa, Abdulazeez Lawal, Abdulhakeem Akano Shittu, Habibu Tijjani, Huzaifa Umar, Dilber Uzun Ozsahin, Ayuba Mugana, Siddhaiyan Elavarsi, Ganesan Revathi
    Discover Medicine.2025;[Epub]     CrossRef
  • Sirtuin 3 in diabetic kidney disease: mechanisms and pharmacotherapy
    Yinfeng Chen, Ying Wang, Dongrong Yu, Hailing Zhao, Ping Li
    Renal Failure.2025;[Epub]     CrossRef
  • Dendrobium officinale Kimura et Migo: traditional uses, agricultural technology, processing, chemical composition, pharmacological mechanisms, toxicology, and applications
    Xiaolian Liu, Jijiao Wu, Bolin Zhao, Lin Wen, Chuipeng Liang, Zihao Sun, Jia Luo, Xiaofang Li
    Journal of Pharmacy and Pharmacology.2025; 77(12): 1611.     CrossRef
  • Approach to Studies on Podocyte Lesions Mediated by Hyperglycemia: A Systematic Review
    Jordana Souza Silva, Camila Botelho Miguel, Alberto Gabriel Borges Felipe, Ana Luisa Monteiro dos Santos Martins, Renata Botelho Miguel, Maraiza Oliveira Carrijo, Laise Mazurek, Liliane Silvano Araújo, Crislaine Aparecida da Silva, Aristóteles Góes-Neto,
    International Journal of Molecular Sciences.2025; 26(18): 8990.     CrossRef
  • Acid ceramidase as a novel target for adiponectin receptor agonist to abrogate podocyte NLRP3 inflammasome activation and glomerular inflammation during obesity
    Guangbi Li, Dandan Huang, Jason M. Kidd, Yao Zou, Xiaoyuan Wu, Yang Zhang, Todd W.B. Gehr, Ningjun Li, Pin-Lan Li
    The Journal of Pharmacology and Experimental Therapeutics.2025; 392(12): 103757.     CrossRef
  • Key targets and mechanistic insights affecting radiotherapy effectiveness in renal carcinoma patients with concurrent renal failure
    J. Wei, P. Gao, Z. Wang, L. Fan, J. Zhao
    International Journal of Radiation Research.2025; 23(4): 839.     CrossRef
  • Interplay of lipid metabolism and inflammation in podocyte injury
    Zilv Luo, Zhaowei Chen, Jijia Hu, Guohua Ding
    Metabolism.2024; 150: 155718.     CrossRef
  • Associations of plasma sphingolipids with measures of insulin sensitivity, β-cell function, and incident diabetes in Japanese Americans
    Ji Cheol Bae, Pandora L. Wander, Rozenn N. Lemaitre, Amanda M. Fretts, Colleen M. Sitlani, Hai H. Bui, Melissa K. Thomas, Donna Leonetti, Wilfred Y. Fujimoto, Edward J. Boyko, Kristina M. Utzschneider
    Nutrition, Metabolism and Cardiovascular Diseases.2024; 34(3): 633.     CrossRef
  • A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer’s disease, and their co-morbidities
    Yun Pan, Jieying Li, Panjie Lin, Lihua Wan, Yiqian Qu, Lingyong Cao, Lei Wang
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Ceramides and mitochondrial homeostasis
    Song Ding, Guorui Li, Tinglv Fu, Tianyu Zhang, Xiao Lu, Ning Li, Qing Geng
    Cellular Signalling.2024; 117: 111099.     CrossRef
  • The Influence of Soy Isoflavones and Soy Isoflavones with Inulin on Kidney Morphology, Fatty Acids, and Associated Parameters in Rats with and without Induced Diabetes Type 2
    Kamila Misiakiewicz-Has, Dominika Maciejewska-Markiewicz, Dagmara Szypulska-Koziarska, Agnieszka Kolasa, Barbara Wiszniewska
    International Journal of Molecular Sciences.2024; 25(10): 5418.     CrossRef
  • Deletion of IRE1α in podocytes exacerbates diabetic nephropathy in mice
    Andrey V. Cybulsky, Joan Papillon, Julie Guillemette, José R. Navarro-Betancourt, Chen-Fang Chung, Takao Iwawaki, I. George Fantus
    Scientific Reports.2024;[Epub]     CrossRef
  • Roles of Mitochondrial Dysfunction in Diabetic Kidney Disease: New Perspectives from Mechanism to Therapy
    Yichen Yang, Jiahui Liu, Qiling Shi, Buyu Guo, Hanbing Jia, Yuxuan Yang, Songbo Fu
    Biomolecules.2024; 14(6): 733.     CrossRef
  • Lipidomic study of kidney in a mouse model with urine flow obstruction
    Divyavani Gowda, Md. Abdul Masum, Siddabasave Gowda B. Gowda, Chandra Shekhar, Md. Zahir Uddin Rubel, Shunnosuke Kira, Osamu Ichii, Yasuhiro Kon, Hitoshi Chiba, Shu-Ping Hui
    Scientific Reports.2024;[Epub]     CrossRef
  • Sphingolipids and Chronic Kidney Disease
    Zrinka Šakić, Armin Atić, Slavica Potočki, Nikolina Bašić-Jukić
    Journal of Clinical Medicine.2024; 13(17): 5050.     CrossRef
  • A review on the novel biomarkers of systemic lupus erythematosus discovered via metabolomic profiling
    Yinghong Liu, Xiaojuan Yang
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Reduced sphingolipid biosynthesis modulates proteostasis networks to enhance longevity
    Nathaniel L. Hepowit, Eric Blalock, Sangderk Lee, Kimberly M. Bretland, Jason A. MacGurn, Robert C. Dickson
    Aging.2023; 15(2): 472.     CrossRef
  • Protective effect of natural products in the metabolic-associated kidney diseases via regulating mitochondrial dysfunction
    Peng Liu, Yao Chen, Jing Xiao, Wenhui Zhu, Xiaoming Yan, Ming Chen
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • BCAA insufficiency leads to premature ovarian insufficiency via ceramide‐induced elevation of ROS
    Xiao Guo, Yuemeng Zhu, Lu Guo, Yiwen Qi, Xiaocheng Liu, Jinhui Wang, Jiangtao Zhang, Linlin Cui, Yueyang Shi, Qichu Wang, Cenxi Liu, Guangxing Lu, Yilian Liu, Tao Li, Shangyu Hong, Yingying Qin, Xuelian Xiong, Hao Wu, Lin Huang, He Huang, Chao Gu, Bin Li,
    EMBO Molecular Medicine.2023;[Epub]     CrossRef
  • Chinese herbal medicine and its active compounds in attenuating renal injury via regulating autophagy in diabetic kidney disease
    Peng Liu, Wenhui Zhu, Yang Wang, Guijie Ma, Hailing Zhao, Ping Li
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Integrated gas chromatography‐mass spectrometry and ultra‐high‐performance liquid chromatography‐mass spectrometry renal metabolomics and lipidomics deciphered the metabolic regulation mechanism of Gushudan on kidney‐yang‐deficiency‐syndrome rats
    Qing Lu, Jing Zhang, Ling Xin, Yanwei Lou, Feng Qin, Longshan Zhao, Zhili Xiong
    Journal of Separation Science.2023;[Epub]     CrossRef
  • Advances in the pharmacological study of Chinese herbal medicine to alleviate diabetic nephropathy by improving mitochondrial oxidative stress
    Ming Chen, Yao Chen, Wenhui Zhu, Xiaoming Yan, Jing Xiao, Peiqing Zhang, Peng Liu, Ping Li
    Biomedicine & Pharmacotherapy.2023; 165: 115088.     CrossRef
  • Rodent models to study type 1 and type 2 diabetes induced human diabetic nephropathy
    Amit Talukdar, Mandira Basumatary
    Molecular Biology Reports.2023; 50(9): 7759.     CrossRef
  • Art2 mediates selective endocytosis of methionine transporters during adaptation to sphingolipid depletion
    Nathaniel L. Hepowit, Bradley Moon, Adam C. Ebert, Robert C. Dickson, Jason A. MacGurn
    Journal of Cell Science.2023;[Epub]     CrossRef
  • Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
    Alla Mitrofanova, Sandra Merscher, Alessia Fornoni
    Nature Reviews Nephrology.2023; 19(10): 629.     CrossRef
  • Research progress of autophagy in pathogenesis of diabetes nephropathy
    Shengnan Zeng, Ying Li
    Diabetic Nephropathy.2023; 3(3): 51.     CrossRef
  • Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease
    Judy Baek, Chenchen He, Farsad Afshinnia, George Michailidis, Subramaniam Pennathur
    Nature Reviews Nephrology.2022; 18(1): 38.     CrossRef
  • Podocyte Bioenergetics in the Development of Diabetic Nephropathy: The Role of Mitochondria
    Irena Audzeyenka, Agnieszka Bierżyńska, Abigail C Lay
    Endocrinology.2022;[Epub]     CrossRef
  • Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
    Xiaodie Mu, Min Yang, Peiyao Ling, Aihua Wu, Hua Zhou, Jingting Jiang
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 247.     CrossRef
  • Research Progress on Natural Products’ Therapeutic Effects on Atrial Fibrillation by Regulating Ion Channels
    Jinshan He, Sicong Li, Yumeng Ding, Yujia Tong, Xuebin Li, Simona Saponara
    Cardiovascular Therapeutics.2022; 2022: 1.     CrossRef
  • Mechanisms of podocyte injury and implications for diabetic nephropathy
    Federica Barutta, Stefania Bellini, Gabriella Gruden
    Clinical Science.2022; 136(7): 493.     CrossRef
  • A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury
    Norishi Ueda
    International Journal of Molecular Sciences.2022; 23(7): 4010.     CrossRef
  • Implications of Sphingolipid Metabolites in Kidney Diseases
    Shamroop kumar Mallela, Sandra Merscher, Alessia Fornoni
    International Journal of Molecular Sciences.2022; 23(8): 4244.     CrossRef
  • Role of ceramides in the pathogenesis of diabetes mellitus and its complications
    Nawajes Mandal, Richard Grambergs, Koushik Mondal, Sandip K. Basu, Faiza Tahia, Sam Dagogo-Jack
    Journal of Diabetes and its Complications.2021; 35(2): 107734.     CrossRef
  • Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease
    Rebekah J. Nicholson, Marcus G. Pezzolesi, Scott A. Summers
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Enhancing lifespan of budding yeast by pharmacological lowering of amino acid pools
    Nathaniel L. Hepowit, Jessica K. A. Macedo, Lyndsay E. A. Young, Ke Liu, Ramon C. Sun, Jason A. MacGurn, Robert C. Dickson
    Aging.2021; 13(6): 7846.     CrossRef
  • New insights into renal lipid dysmetabolism in diabetic kidney disease
    Alla Mitrofanova, George Burke, Sandra Merscher, Alessia Fornoni
    World Journal of Diabetes.2021; 12(5): 524.     CrossRef
  • Excessively Enlarged Mitochondria in the Kidneys of Diabetic Nephropathy
    Kiyoung Kim, Eun-Young Lee
    Antioxidants.2021; 10(5): 741.     CrossRef
  • Mechanistic insights into the role of serum-glucocorticoid kinase 1 in diabetic nephropathy: A systematic review
    Saba Noor, Taj Mohammad, Gulam M. Ashraf, Joviana Farhat, Anwar L. Bilgrami, Mathew Suji Eapen, Sukhwinder Singh Sohal, Dharmendra Kumar Yadav, Md Imtaiyaz Hassan
    International Journal of Biological Macromolecules.2021; 193: 562.     CrossRef
  • The Updates of Podocyte Lipid Metabolism in Proteinuric Kidney Disease
    Yu Sun, Sijia Cui, Yunfeng Hou, Fan Yi
    Kidney Diseases.2021; 7(6): 438.     CrossRef
  • Saturated fatty acids induce insulin resistance in podocytes through inhibition of IRS1 via activation of both IKKβ and mTORC1
    Benoit Denhez, Marina Rousseau, Crysta Spino, David-Alexandre Dancosst, Marie-Ève Dumas, Andréanne Guay, Farah Lizotte, Pedro Geraldes
    Scientific Reports.2020;[Epub]     CrossRef
Complications
Presence of Carotid Plaque Is Associated with Rapid Renal Function Decline in Patients with Type 2 Diabetes Mellitus and Normal Renal Function
Da Hea Seo, So Hun Kim, Joon Ho Song, Seongbin Hong, Young Ju Suh, Seong Hee Ahn, Jeong-Taek Woo, Sei Hyun Baik, Yongsoo Park, Kwan Woo Lee, Young Seol Kim, Moonsuk Nam
Diabetes Metab J. 2019;43(6):840-853.   Published online March 12, 2019
DOI: https://doi.org/10.4093/dmj.2018.0186
  • 12,099 View
  • 81 Download
  • 23 Web of Science
  • 20 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Recent evidences indicate that early rapid renal function decline is closely associated with the development and progression of diabetic kidney disease. We have investigated the association between carotid atherosclerosis and rapid renal function decline in patients with type 2 diabetes mellitus and preserved renal function.

Methods

In a prospective, multicenter cohort, a total of 967 patients with type 2 diabetes mellitus and preserved renal function were followed for 6 years with serial estimated glomerular filtration rate (eGFR) measurements. Common carotid intima-media thickness (CIMT) and presence of carotid plaque were assessed at baseline. Rapid renal function decline was defined as an eGFR decline >3.3% per year.

Results

Over a median follow-up of 6 years, 158 participants (16.3%) developed rapid renal function decline. While there was no difference in CIMT, the presence of carotid plaque in rapid decliners was significantly higher than in non-decliners (23.2% vs. 12.2%, P<0.001). In multivariable logistic regression analysis, presence of carotid plaque was an independent predictor of rapid renal function decline (odds ratio, 2.33; 95% confidence interval, 1.48 to 3.68; P<0.0001) after adjustment for established risk factors. The model including the carotid plaque had better performance for discrimination of rapid renal function decline than the model without carotid plaque (area under the receiver operating characteristic curve 0.772 vs. 0.744, P=0.016).

Conclusion

Close monitoring of renal function and early intensive management may be beneficial in patients with type 2 diabetes mellitus and carotid plaques.

Citations

Citations to this article as recorded by  
  • Comparison of the prognostic value of different arterial sites atherosclerosis risk markers for development of Macro- and microvascular complications in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort study
    Claudia R.L. Cardoso, Nathalie C. Leite, Alan C. de Souza, Tales R.A. Paiva, Guilherme C. Salles, Gil F. Salles
    Diabetes Research and Clinical Practice.2025; 226: 112322.     CrossRef
  • A novel nomogram for predicting carotid atherosclerosis risks in diabetic patients
    Jing Liu, Shoukun Dou, Yuan Zhang, Xiaoyun Zeng, Yingnan Kang, Qianna Xu, Xiangchen Liu, Ping Zhao
    BMC Cardiovascular Disorders.2025;[Epub]     CrossRef
  • Impact of diabetes distress on glycemic control and diabetic complications in type 2 diabetes mellitus
    Hye-Sun Park, Yongin Cho, Da Hea Seo, Seong Hee Ahn, Seongbin Hong, Young Ju Suh, Suk Chon, Jeong-Taek Woo, Sei Hyun Baik, Kwan Woo Lee, So Hun Kim
    Scientific Reports.2024;[Epub]     CrossRef
  • The Association between the Severity of Distal Sensorimotor Polyneuropathy and Increased Carotid Atherosclerosis in Individuals with Type 2 Diabetes
    Dong-Yi Hsieh, Yun-Ru Lai, Chih-Cheng Huang, Chi-Ping Ting, Wen-Chan Chiu, Yung-Nien Chen, Chia-Yi Lien, Ben-Chung Cheng, Ting-Yin Lin, Hui Ching Chiang, Cheng-Hsien Lu
    Diagnostics.2024; 14(17): 1922.     CrossRef
  • Risk factors for rapid kidney function decline in diabetes patients
    Jixin Xing, Linxi Huang, Weifu Ren, Xiaobin Mei
    Renal Failure.2024;[Epub]     CrossRef
  • Correlation analysis of carotid plaque in young patients with newly diagnosed type 2 diabetes and platelet-to-lymphocyte ratio and neutrophil–lymphocyte ratio
    Huijun Wen, Hai Yu
    Vascular.2023; 31(1): 90.     CrossRef
  • Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
    Yiwen Li, Yanfei Liu, Shiwei Liu, Mengqi Gao, Wenting Wang, Keji Chen, Luqi Huang, Yue Liu
    Signal Transduction and Targeted Therapy.2023;[Epub]     CrossRef
  • Carotid intima-media thickness and atherosclerotic plaques are associated with renal function decline: a 14-year longitudinal population-based study
    Miriam Goepfert, Till Ittermann, Marcus Dörr, Nele Friedrich, Henry Völzke, Thomas Dabers, Stephan B Felix, Ulf Schminke, Sylvia Stracke, Sabrina von Rheinbaben
    Nephrology Dialysis Transplantation.2023; 38(11): 2598.     CrossRef
  • Blood pressure and vascular determinants of glomerular filtration rate decline in diabetic kidney disease
    Luca Truscello, Dina Nobre, Vehashini Sabaratnam, Olivier Bonny, Grégoire Wuerzner, Michel Burnier, Fadi Fakhouri, Menno Pruijm, Anne Zanchi
    Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
  • Explainable Artificial Intelligence Paves the Way in Precision Diagnostics and Biomarker Discovery for the Subclass of Diabetic Retinopathy in Type 2 Diabetics
    Fatma Hilal Yagin, Seyma Yasar, Yasin Gormez, Burak Yagin, Abdulvahap Pinar, Abedalrhman Alkhateeb, Luca Paolo Ardigò
    Metabolites.2023; 13(12): 1204.     CrossRef
  • Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population
    Christodoula Kourtidou, Vasileios Rafailidis, Garyfallia Varouktsi, Efthimios Kanakis, Vassilios Liakopoulos, Timoleon-Achilleas Vyzantiadis, Maria Stangou, Smaragdi Marinaki, Konstantinos Tziomalos
    Journal of Personalized Medicine.2022; 12(7): 1139.     CrossRef
  • Prevalence and Predictors of Renal Disease in a National Representative Sample of the Romanian Adult Population: Data from the SEPHAR IV Survey
    Călin Pop, Oana Florentina Gheorghe Fronea, Ioana Antonia Branea, Lucian Mihai Itu, Roxana Darabont, Irinel Parepa, Theodora Benedek, Maria Dorobantu
    Diagnostics.2022; 12(12): 3199.     CrossRef
  • Clinical features of and risk factors for normoalbuminuric diabetic kidney disease in hospitalized patients with type 2 diabetes mellitus: a retrospective cross-sectional study
    Qi Dai, Nan Chen, Ling Zeng, Xin-Jie Lin, Feng-Xiu Jiang, Xiong-Jie Zhuang, Ze-Yuan Lu
    BMC Endocrine Disorders.2021;[Epub]     CrossRef
  • The Predictive Value of Carotid Ultrasonography With Cardiovascular Risk Factors—A “SPIDER” Promoting Atherosclerosis
    Hongwei Li, Xiaolin Xu, Baoming Luo, Yuling Zhang
    Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
  • Update on pathogenesis and diagnosis flow of normoalbuminuric diabetes with renal insufficiency
    Le Deng, Wenjie Li, Gaosi Xu
    European Journal of Medical Research.2021;[Epub]     CrossRef
  • Association of serum fibroblast growth factor 21 with kidney function in a population-based Chinese cohort
    Rui Zhang, Yufeng Li, Xianghai Zhou, Fang Zhang, Meng Li, Simin Zhang, Xiuying Zhang, Xin Wen, Linong Ji
    Medicine.2021; 100(50): e28238.     CrossRef
  • Letter: Presence of Carotid Plaque Is Associated with Rapid Renal Function Decline in Patients with Type 2 Diabetes Mellitus and Normal Renal Function (Diabetes Metab J 2019;43:840–53)
    Min-Ji Kim, Jae-Han Jeon
    Diabetes & Metabolism Journal.2020; 44(1): 201.     CrossRef
  • Response: Presence of Carotid Plaque Is Associated with Rapid Renal Function Decline in Patients with Type 2 Diabetes Mellitus and Normal Renal Function (Diabetes Metab J 2019;43:840–53)
    Da Hea Seo, So Hun Kim, Moonsuk Nam
    Diabetes & Metabolism Journal.2020; 44(1): 205.     CrossRef
  • Serum Levels of Adipocyte Fatty Acid-Binding Protein Are Associated with Rapid Renal Function Decline in Patients with Type 2 Diabetes Mellitus and Preserved Renal Function
    Da Hea Seo, Moonsuk Nam, Mihye Jung, Young Ju Suh, Seong Hee Ahn, Seongbin Hong, So Hun Kim
    Diabetes & Metabolism Journal.2020; 44(6): 875.     CrossRef
  • Proteinuria Is Associated with Carotid Artery Atherosclerosis in Non-Albuminuric Type 2 Diabetes: A Cross-Sectional Study
    Jaehyun Bae, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee
    Journal of Clinical Medicine.2020; 9(1): 136.     CrossRef
Brief Report
Complications
Effect of Empagliflozin, a Selective Sodium-Glucose Cotransporter 2 Inhibitor, on Kidney and Peripheral Nerves in Streptozotocin-Induced Diabetic Rats
Kyung Ae Lee, Heung Yong Jin, Na Young Lee, Yu Ji Kim, Tae Sun Park
Diabetes Metab J. 2018;42(4):338-342.   Published online April 25, 2018
DOI: https://doi.org/10.4093/dmj.2017.0095
  • 10,645 View
  • 122 Download
  • 30 Web of Science
  • 32 Crossref
AbstractAbstract PDFPubReader   ePub   

The effect of sodium-glucose cotransporter 2 inhibitors on peripheral nerves and kidneys in diabetes mellitus (DM) remains unexplored. Therefore, this study aimed to explore the effect of empagliflozin in diabetic rats. DM in rats was induced by streptozotocin injection, and diabetic rats were treated with empagliflozin 3 or 10 mg/kg. Following 24-week treatment, response thresholds to four different stimuli were tested and found to be lower in diabetic rats than in normal rats. Empagliflozin significantly prevented hypersensitivity (P<0.05) and the loss of skin intraepidermal nerve fibers, and mesangial matrix expansion in diabetic rats. Results of this study demonstrate the potential therapeutic effects of empagliflozin for the treatment of diabetic peripheral neuropathy and nephropathy.

Citations

Citations to this article as recorded by  
  • Targeting Neurodegeneration with SGLT2is: From Molecular Mechanisms to Clinical Implications
    Hamideh Asadinejad, Soroush Taherkhani, Sakine Mosaei Golboos, Yaser Azizi, Ali Mohammadkhanizadeh
    Molecular Neurobiology.2026;[Epub]     CrossRef
  • Peripheral nerve complications of weight loss associated with novel antihyperglycemic agents: a cohort study
    Cullen O’Gorman
    Journal of Neurology.2026;[Epub]     CrossRef
  • Diabetes and its complications: molecular mechanisms, prevention and treatment
    Lijun Zhao, Jiamin Yuan, Qing Yang, Jing Ma, Fenghao Yang, Yutong Zou, Ke Liu, Fang Liu
    Signal Transduction and Targeted Therapy.2026;[Epub]     CrossRef
  • The vicious cycle of hyperglycemia and oxidative stress: Novel mechanistic insights into a pathogenic alliance
    Emir Enis Yurdgulu, Yusuf Anil Ay, Yasin Bayir, Zekai Halici
    The International Journal of Biochemistry & Cell Biology.2026; 199: 106990.     CrossRef
  • Retinal and optic nerve measures after initiation of empagliflozin plus metformin versus metformin alone in early type 2 diabetes: a prospective observational comparative study
    Bora Deniz Argon, Akın Çakır, Sezin Doğan Çakır, Fidan Safalı, Mustafa Nuri Elçioğlu, Mine Adaş
    Graefe's Archive for Clinical and Experimental Ophthalmology.2026;[Epub]     CrossRef
  • Therapeutic potential of GLP-1 receptor agonists and SGLT2 inhibitors in diabetic neuropathy: a critical appraisal
    Dan Ziegler, Peter Kempler, Cornelia Bala, Boris Mankovsky, Oliver Schnell, Vincenza Spallone, Alin Stirban, Solomon Tesfaye
    Diabetology & Metabolic Syndrome.2026;[Epub]     CrossRef
  • Empagliflozin alleviates STZ-induced diabetic neuropathy, anxiety and depression-like behavior in C57/BL-6 mice
    Sachin P. Borikar, Pranav S. Zore, Shirish P. Jain, Satish P. Shelke, Deepali N. Tapre
    Learning and Motivation.2026; 96: 102344.     CrossRef
  • The Impact of SGLT-2 Inhibitors on Hydroxyl Radical Markers and Diabetic Neuropathy: A Short-Term Clinical Study
    Ágnes Klabuzai, Viktória Bekő, Zsófia Sütő, Marcell Horváth, Zoltán Wágner, Katalin Vágási, Veronika Pfeil, Miklós Süle, György Grosz, István Wittmann, Szilárd Kun
    Antioxidants.2025; 14(3): 289.     CrossRef
  • Modern Methods of Pharmacological Correction of Diabetic Polyneuropathy
    V. Yu. Tsepelev, I. O. Masaleva, N. V. Boldina, O. V. Polyakova, S. V. Gunov
    Ural Medical Journal.2025; 24(1): 142.     CrossRef
  • Diabetic neuropathy: cutting-edge research and future directions
    Yang Yang, Bing Zhao, Yuanzhe Wang, Hongli Lan, Xinyu Liu, Yue Hu, Peng Cao
    Signal Transduction and Targeted Therapy.2025;[Epub]     CrossRef
  • Serum Neuron‐Specific Enolase Levels in Patients With Diabetic Peripheral Neuropathy
    Selcen Duran, Asuman Celikbilek, Aysu Yetis, Bilal Ilanbey, Burc Esra Sahin, Aydan Koysuren, Himmet Durmaz, Jui An Lin
    International Journal of Clinical Practice.2025;[Epub]     CrossRef
  • Effect of empagliflozin in peripheral diabetic neuropathy of patients with type 2 diabetes mellitus
    Sahar Mohamed El-Haggar, Yasser Mostafa Hafez, Amira Mohamed El Sharkawy, Maha Khalifa
    Medicina Clínica.2024; 163(2): 53.     CrossRef
  • Effect of empagliflozin in peripheral diabetic neuropathy of patients with type 2 diabetes mellitus
    Sahar Mohamed El-Haggar, Yasser Mostafa Hafez, Amira Mohamed El Sharkawy, Maha Khalifa
    Medicina Clínica (English Edition).2024; 163(2): 53.     CrossRef
  • Neuroprotective Effects of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors (Gliflozins) on Diabetes-Induced Neurodegeneration and Neurotoxicity: A Graphical Review
    Mina Gholami, Natalie Coleman-Fuller, Mahsa Salehirad, Sepideh Darbeheshti, Majid Motaghinejad
    International Journal of Preventive Medicine.2024;[Epub]     CrossRef
  • A Review of Recent Pharmacological Advances in the Management of Diabetes-Associated Peripheral Neuropathy
    Osman Syed, Predrag Jancic, Nebojsa Nick Knezevic
    Pharmaceuticals.2023; 16(6): 801.     CrossRef
  • Renal intrinsic cells remodeling in diabetic kidney disease and the regulatory effects of SGLT2 Inhibitors
    Wenwen Guo, Han Li, Yixuan Li, Wen Kong
    Biomedicine & Pharmacotherapy.2023; 165: 115025.     CrossRef
  • A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathy
    Aqsa Ashfaq, Myriam Meineck, Andrea Pautz, Ebru Arioglu-Inan, Julia Weinmann-Menke, Martin C. Michel
    Pharmacology & Therapeutics.2023; 249: 108503.     CrossRef
  • The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial
    Jinlan Liao, Amy Kang, Chao Xia, Tamara Young, Gian Luca Di Tanna, Clare Arnott, Carol Pollock, Arun V. Krishnan, Rajiv Agarwal, George Bakris, David M. Charytan, Dick de Zeeuw, Hiddo J.L. Heerspink, Adeera Levin, Bruce Neal, David C. Wheeler, Hong Zhang,
    Diabetes & Metabolism.2022; 48(4): 101331.     CrossRef
  • Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study
    Fukashi Ishibashi, Aiko Kosaka, Mitra Tavakoli
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Protective effect of empagliflozin on gentamicin-induced acute renal injury via regulation of SIRT1/NF-κB signaling pathway
    Sandy R. Botros, Asmaa I. Matouk, Aliaa Anter, Mohamed M.A. Khalifa, Gehan H. Heeba
    Environmental Toxicology and Pharmacology.2022; 94: 103907.     CrossRef
  • Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling
    Noha F. Abdelkader, Marawan A. Elbaset, Passant E. Moustafa, Sherehan M. Ibrahim
    Archives of Pharmacal Research.2022; 45(7): 475.     CrossRef
  • Pathogenesis and Treatment of Diabetic Peripheral Neuropathy
    Seon Mee Kang
    The Journal of Korean Diabetes.2022; 23(4): 222.     CrossRef
  • Empagliflozin and neohesperidin protect against methotrexate-induced renal toxicity via suppression of oxidative stress and inflammation in male rats
    Adel T. Osman, Souty M.Z. Sharkawi, Mohamed I.A. Hassan, Amira M. Abo-youssef, Ramadan A.M. Hemeida
    Food and Chemical Toxicology.2021; 155: 112406.     CrossRef
  • Effect of exenatide on peripheral nerve excitability in type 2 diabetes
    Tushar Issar, Natalie C.G. Kwai, Ann M. Poynten, Ria Arnold, Kerry-Lee Milner, Arun V. Krishnan
    Clinical Neurophysiology.2021; 132(10): 2532.     CrossRef
  • Effectiveness of Empagliflozin With Vitamin D Supplementation in Peripheral Neuropathy in Type 2 Diabetic Patients
    Sanjana Mehta, Parminder Nain, Bimal K Agrawal, Rajinder P Singh, Jaspreet Kaur, Sabyasachi Maity, Aniruddha Bhattarcharjee, Jagannadha Peela, Shreya Nauhria, Samal Nauhria
    Cureus.2021;[Epub]     CrossRef
  • Targeting oxidative stress, proinflammatory cytokines, apoptosis and toll like receptor 4 by empagliflozin to ameliorate bleomycin-induced lung fibrosis
    Ahmed M. Kabel, Remon S. Estfanous, Majed M. Alrobaian
    Respiratory Physiology & Neurobiology.2020; 273: 103316.     CrossRef
  • Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition
    Nitin A. Das, Andrea J. Carpenter, Anthony Belenchia, Annayya R. Aroor, Makoto Noda, Ulrich Siebenlist, Bysani Chandrasekar, Vincent G. DeMarco
    Cellular Signalling.2020; 68: 109506.     CrossRef
  • Differential Effects of Empagliflozin on Microvascular Complications in Murine Models of Type 1 and Type 2 Diabetes
    Stephanie A. Eid, Phillipe D. O’Brien, Lucy M. Hinder, John M. Hayes, Faye E. Mendelson, Hongyu Zhang, Lixia Zeng, Katharina Kretzler, Samanthi Narayanan, Steven F. Abcouwer, Frank C. Brosius, Subramaniam Pennathur, Masha G. Savelieff, Eva L. Feldman
    Biology.2020; 9(11): 347.     CrossRef
  • Pre-treatment with Empagliflozin ameliorates Cisplatin induced acute kidney injury by suppressing apoptosis
    Maaly A. Abd Elmaaboud, Ahmed M. Kabel, Mohamed Elrashidy
    Journal of Applied Biomedicine.2019; 17(1): 90.     CrossRef
  • Effects of ticagrelor, empagliflozin and tamoxifen against experimentally-induced vascular reactivity defects in rats in vivo and in vitro
    Yasmin Moustafa Ahmed, Basim Anwar Shehata Messiha, Mahmoud El-Sayed El-Daly, Ali Ahmed Abo-Saif
    Pharmacological Reports.2019; 71(6): 1034.     CrossRef
  • SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
    Chenguang Li, Jie Zhang, Mei Xue, Xiaoyu Li, Fei Han, Xiangyang Liu, Linxin Xu, Yunhong Lu, Ying Cheng, Ting Li, Xiaochen Yu, Bei Sun, Liming Chen
    Cardiovascular Diabetology.2019;[Epub]     CrossRef
  • Empagliflozin Contributes to Polyuria via Regulation of Sodium Transporters and Water Channels in Diabetic Rat Kidneys
    Sungjin Chung, Soojeong Kim, Mina Son, Minyoung Kim, Eun Sil Koh, Seok Joon Shin, Seung-Hyun Ko, Ho-Shik Kim
    Frontiers in Physiology.2019;[Epub]     CrossRef
Original Articles
Complications
Risk Factors for the Development and Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Advanced Diabetic Retinopathy
Kyung-Jin Yun, Hye Ji Kim, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Hyun Baek, Young Jung Roh, Ki-Ho Song
Diabetes Metab J. 2016;40(6):473-481.   Published online September 20, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.6.473
  • 11,300 View
  • 63 Download
  • 36 Web of Science
  • 36 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Some patients with type 2 diabetes mellitus (T2DM) do not develop diabetic kidney disease (DKD) despite the presence of advanced diabetic retinopathy (DR). We aimed to investigate the presence of DKD and its risk factors in patients with T2DM and advanced DR.

Methods

We conducted a cross-sectional study in 317 patients with T2DM and advanced DR. The phenotypes of DKD were divided into three groups according to the urine albumin/creatinine ratio (uACR, mg/g) and estimated glomerular filtration rate (eGFR, mL/min/1.73 m2): no DKD (uACR <30 and eGFR ≥60), non-severe DKD (uACR ≥30 or eGFR <60), and severe DKD (uACR ≥30 and eGFR <60). Mean systolic and diastolic blood pressure, mean glycosylated hemoglobin (HbA1c) level, and HbA1c variability (standard deviation [SD] of serial HbA1c values or HbA1c-SD) were calculated for the preceding 2 years.

Results

The prevalence of no DKD, non-severe DKD, and severe DKD was 37.2% (n=118), 37.0% (n=117), and 25.8% (n=82), respectively. HbA1c-SD and the triglyceride/high density lipoprotein cholesterol (TG/HDL-C) ratio correlated positively with uACR and negatively with eGFR. Multiple linear regression analyses showed that the HbA1c-SD and TG/HDL-C ratio were significantly related with eGFR. Multiple logistic regression analyses after adjusting for several risk factors showed that HbA1c-SD and the TG/HDL-C ratio were significant risk factors for severe DKD.

Conclusion

The prevalence of DKD was about 60% in patients with T2DM and advanced DR. HbA1c variability and TG/HDL-C ratio may affect the development and progression of DKD in these patients.

Citations

Citations to this article as recorded by  
  • Connecting glycation and lipotoxicity to mitochondrial dysfunction in diabetic kidney disease: A ‘tubulocentric’ perspective
    Mayura Apte, Girish Kumthekar, Rashmi Santosh Tupe
    Biochemical and Biophysical Research Communications.2026; 809: 153479.     CrossRef
  • Diabetic kidney disease: Radiological assessment and clinical correlations
    Salvatore Silipigni, Guido Gembillo, Lorenzo Lo Cicero, Serena Ausilia Ferrara, Maria Federica Ricca, Giuseppe Spadaro, Luca Soraci, Antonio Bottari
    World Journal of Diabetes.2026;[Epub]     CrossRef
  • Body roundness index mediates the association between high-density lipoprotein cholesterol and diabetic retinopathy: a population-based cross-sectional study
    Wuping Xu, Xuedong Xu, Min Zhang, Chiping Sun
    BMC Endocrine Disorders.2026;[Epub]     CrossRef
  • Effect of systemic fibrates on diabetic retinopathy prevention and progression: A comprehensive systematic review and meta-analysis
    Luke Yaldo, Abdelaziz Abdelaal, Joshua Ong, Lauren Kiryakoza, Jesse Sengillo, Raquel Goldhardt
    Survey of Ophthalmology.2026;[Epub]     CrossRef
  • Lipid metabolism-related inflammatory indices and diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study
    Jing Liu, Xiaochan Tian, Mingjun Xu, Yao Xiao, Shuwu Wei, Xinyu Pan, Yue Shi, Hangyu Duan, Yu Zhang, Junping Wei
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Causal associations between HbA1c and multiple diseases unveiled through a Mendelian randomization phenome-wide association study in East Asian populations
    Li Han, Shuling Xu, Rumeng Chen, Zhiwei Zheng, Yining Ding, Zhu Wu, Sen Li, Binsheng He, Meihua Bao
    Medicine.2025; 104(11): e41861.     CrossRef
  • Lipid abnormality in diabetic kidney disease and potential treatment advancements
    Qian Ming Tu, Hui Min Jin, Xiu Hong Yang
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Causal relationship between obstructive sleep apnea and diabetic nephropathy: bidirectional and multivariable Mendelian randomization study
    Li Zhao, Zerui Liu, Rundong Zhang, Yanan Li, Xi Zhang
    Renal Failure.2025;[Epub]     CrossRef
  • The effect of HbA1C variability on the development and progression of diabetic nephropathy
    Alper Coskun, Aslihan Calim, Emre Sedar Saygili, Tamer Sakaci, Feyza Yener Ozturk, Yener Koc, Fatih Borlu, Yuksel Altuntas, Taner Basturk
    Frontiers in Clinical Diabetes and Healthcare.2025;[Epub]     CrossRef
  • Ocular and Systemic Risk Factors for Disease Worsening Among Patients with NPDR
    Charles C. Wykoff, Diana V. Do, Roger A. Goldberg, Dilsher S. Dhoot, Jennifer I. Lim, Weiming Du, Fabiana Q. Silva, Rutvi Desai, Hadi Moini, Kimberly Reed, Alyson J. Berliner, Robert Vitti, W. Lloyd Clark
    Ophthalmology Retina.2024; 8(4): 399.     CrossRef
  • Developing screening tools to estimate the risk of diabetic kidney disease in patients with type 2 diabetes mellitus
    Xu Cao, Xiaomei Pei
    Technology and Health Care.2024; 32(3): 1807.     CrossRef
  • Interpretable prediction model for assessing diabetes complication risks in Chinese sufferers
    Ye Shiren, Ye Jiangnan, Ye Xinhua, Ni Xinye
    Diabetes Research and Clinical Practice.2024; 209: 111560.     CrossRef
  • Dose-response association of diabetic kidney disease with routine clinical parameters in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Jianbo Guo, Chen Liu, Yifan Wang, Baoyi Shao, Tung Leong Fong, Ngai Chung Lau, Hui Zhang, Haidi Li, Jianan Wang, Xinyu Lu, Anqi Wang, Cheuk Lung Leung, Xin Wei Chia, Fei Li, Xiaoming Meng, Qingyong He, Haiyong Chen
    eClinicalMedicine.2024; 69: 102482.     CrossRef
  • Glycated haemoglobin variability and risk of renal function decline in type 2 diabetes mellitus: An updated systematic review and meta‐analysis
    Shihan Wang, Shuoning Song, Junxiang Gao, Yanbei Duo, Yuting Gao, Yong Fu, Yingyue Dong, Tao Yuan, Weigang Zhao
    Diabetes, Obesity and Metabolism.2024; 26(11): 5167.     CrossRef
  • Sex-Specific Computed Tomography Abdominal Fat and Skeletal Muscle Characteristics in Type 2 Diabetic Retinopathy Patients With/Without Comorbid Diabetic Kidney Disease
    Jinlei Fan, Liping Zuo, Mingyuan Hou, Bowen Wang, Yueming An, Baoli Hao, Dexin Yu
    Academic Radiology.2023; 30(11): 2686.     CrossRef
  • The concordance and discordance of diabetic kidney disease and retinopathy in patients with type 2 diabetes mellitus: A cross-sectional study of 26,809 patients from 5 primary hospitals in China
    Zhaoxiang Liu, Xianglan Li, Yanlei Wang, Yanxia Song, Qiang Liu, Junxia Gong, Wenshuang Fan, Chunmei Lv, Chenxiang Cao, Wenhui Zhao, Jianzhong Xiao
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Ferroptosis: new insight into the mechanisms of diabetic nephropathy and retinopathy
    Luxin Li, Yucen Dai, Dan Ke, Jieting Liu, Peijian Chen, Dong Wei, Tongtong Wang, Yanjie Teng, Xiaohuan Yuan, Zhen Zhang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Predicting diabetic kidney disease for type 2 diabetes mellitus by machine learning in the real world: a multicenter retrospective study
    Xiao zhu Liu, Minjie Duan, Hao dong Huang, Yang Zhang, Tian yu Xiang, Wu ceng Niu, Bei Zhou, Hao lin Wang, Ting ting Zhang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Association between serum complements and kidney function in patients with diabetic kidney disease
    Meng-chao Liu, Jia-lin Li, Yue-fen Wang, Yuan Meng, Gui-min Zheng, Zhen Cai, Cun Shen, Meng-di Wang, Xiang-gang Zhu, Yang-zi Chen, Yu-lin Wang, Wen-jing Zhao, Wen-quan Niu, Yao-xian Wang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Coagulation Function and Type 2 Diabetic Kidney Disease: A Real-World Observational Study
    Meng-chao Liu, Wen-quan Niu, Yue-fen Wang, Yuan Meng, Gui-min Zheng, Zhen Cai, Cun Shen, Xiang-gang Zhu, Meng-di Wang, Jia-lin Li, Wen-jing Zhao, Yao-xian Wang, Eusebio Chiefari
    Journal of Diabetes Research.2023; 2023: 1.     CrossRef
  • Punicalagin alleviates renal injury via the gut-kidney axis in high-fat diet-induced diabetic mice
    Qinglian Hua, Yaling Han, Haifeng Zhao, Haowen Zhang, Bei Yan, Shengjie Pei, Xin He, Yue Li, Xiangyuan Meng, Lei Chen, Feng Zhong, Duo Li
    Food & Function.2022; 13(2): 867.     CrossRef
  • Status and Trends of the Association Between Diabetic Nephropathy and Diabetic Retinopathy From 2000 to 2021: Bibliometric and Visual Analysis
    Wenwen Lin, Yayong Luo, Fang Liu, Hangtian Li, Qian Wang, Zheyi Dong, Xiangmei Chen
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • The Risk Threshold for Hemoglobin A1c Associated With Albuminuria: A Population-Based Study in China
    Hong Lian, Hongshi Wu, Jie Ning, Diaozhu Lin, Chulin Huang, Feng Li, Ying Liang, Yiqin Qi, Meng Ren, Li Yan, Lili You, Mingtong Xu
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Weight change and microvascular outcomes in patients with new-onset diabetes: a nationwide cohort study
    Eun Sil Koh, Kyung Do Han, Mee Kyoung Kim, Eun Sook Kim, Min-Kyung Lee, Ga Eun Nam, Hyuk-Sang Kwon
    The Korean Journal of Internal Medicine.2021; 36(4): 932.     CrossRef
  • Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
    Eugene Han, Mi Kyung Kim, Byoung Kuk Jang, Hye Soon Kim
    Diabetes & Metabolism Journal.2021; 45(5): 698.     CrossRef
  • Effect of Calcium Dobesilate in Preventing Contrast-Induced Nephropathy in Patients with Diabetes and Chronic Kidney Disease
    Hao Zhang, Shao-Hua Guo, Zheng-Kai Xue, Ya-Ru Zhang, Jia-Rui Wang, Jing-Jin Che, Tong Liu, Hua-Yue Tao, Guang-Ping Li, Seung-Woon Rha, Swapnil-Zaman Ashraful-Haque, Kang-Yin Chen
    Clinics.2021; 76: e2942.     CrossRef
  • Elevated TG/HDL-C and non-HDL-C/HDL-C ratios predict mortality in peritoneal dialysis patients
    Wenkai Xia, Xiajuan Yao, Yan Chen, Jie Lin, Volker Vielhauer, Hong Hu
    BMC Nephrology.2020;[Epub]     CrossRef
  • Thermal Perception Abnormalities Can Predict Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients
    Wei-Ching Fang, Kuei-Mei Chou, Chiao-Yin Sun, Chin-Chan Lee, I-Wen Wu, Yung-Chang Chen, Heng-Chih Pan
    Kidney and Blood Pressure Research.2020; 45(6): 926.     CrossRef
  • Association between nonalbumin proteinuria and renal tubular damage of N-acetyl-β-d-glucosaminidase and its clinical relevance in patients with type 2 diabetes without albuminuria
    Eugene Han, Mi-Kyung Kim, Yong-ho Lee, Hye Soon Kim, Byung-Wan Lee
    Journal of Diabetes and its Complications.2019; 33(3): 255.     CrossRef
  • Detection of Lower Albuminuria Levels and Early Development of Diabetic Kidney Disease Using an Artificial Intelligence-Based Rule Extraction Approach
    Yoichi Hayashi
    Diagnostics.2019; 9(4): 133.     CrossRef
  • Therapeutic effect of liraglutide on expression of CTGF and BMP‐7 in induced diabetic nephropathy
    Maggie M. Ramzy, Ahlam M. Abdalla, Nagwa M. Zenhom, Ahmed M. Okasha, Aya E. Abdelkafy, Rabeh K. Saleh
    Journal of Cellular Biochemistry.2019; 120(10): 17512.     CrossRef
  • Are blood lipids associated with microvascular complications among type 2 diabetes mellitus patients? A cross-sectional study in Shanghai, China
    Hua Yang, Doris Young, Jian Gao, Yuanzhi Yuan, Minqian Shen, Yuan Zhang, Xueyan Duan, Shanzhu Zhu, Xiaoming Sun
    Lipids in Health and Disease.2019;[Epub]     CrossRef
  • Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus
    Ki‐Ho Song, Jee‐Sun Jeong, Mee Kyoung Kim, Hyuk‐Sang Kwon, Ki‐Hyun Baek, Seung‐Hyun Ko, Yu‐Bae Ahn
    Journal of Diabetes Investigation.2019; 10(3): 745.     CrossRef
  • Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients
    Marsida Teliti, Giulia Cogni, Lucia Sacchi, Arianna Dagliati, Simone Marini, Valentina Tibollo, Pasquale De Cata, Riccardo Bellazzi, Luca Chiovato
    Diabetes and Vascular Disease Research.2018; 15(5): 424.     CrossRef
  • Higher Prevalence and Progression Rate of Chronic Kidney Disease in Elderly Patients with Type 2 Diabetes Mellitus
    Kyung-Soo Kim, Seok Won Park, Yong-Wook Cho, Soo-Kyung Kim
    Diabetes & Metabolism Journal.2018; 42(3): 224.     CrossRef
  • Determinants of the Risk of Diabetic Kidney Disease and Diabetic Retinopathy Independent of Glucose Exposure
    Bo Kyung Koo
    Diabetes & Metabolism Journal.2016; 40(6): 444.     CrossRef
Serum Ceruloplasmin Level as a Predictor for the Progression of Diabetic Nephropathy in Korean Men with Type 2 Diabetes Mellitus
Min Jung Lee, Chang Hee Jung, Yu Mi Kang, Jung Eun Jang, Jaechan Leem, Joong-Yeol Park, Woo Je Lee
Diabetes Metab J. 2015;39(3):230-239.   Published online April 22, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.3.230
  • 11,251 View
  • 77 Download
  • 30 Web of Science
  • 30 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Oxidative stress is known to be associated with progression of diabetic kidney disease. Ceruloplasmin acts as a pro-oxidant under conditions of severe oxidative stress. Thus, we conducted a longitudinal observational study to evaluate whether the serum ceruloplasmin level is a predictive biomarker for progression of diabetic nephropathy.

Methods

A total of 643 Korean men with type 2 diabetes mellitus were enrolled. Serum ceruloplasmin was measured using a nephelometric method. Progression of diabetic nephropathy was defined as transition in albuminuria class (i.e., normoalbuminuria to microalbuminuria, microalbuminuria to macroalbuminuria, or normoalbuminuria to macroalbuminuria) and/or a greater than 2-fold increase of serum creatinine at follow-up compared with the baseline value.

Results

During the follow-up period (median, 2.7 years; range, 0.3 to 4.4 years), 49 of 643 patients (7.6%) showed the progression of diabetic nephropathy and three patients (0.5%) developed end-stage renal disease. Baseline ceruloplasmin levels were higher in the progressors than in the nonprogressors (262.6±40.9 mg/L vs. 233.3±37.8 mg/L, P<0.001). Kaplan-Meier analysis showed a significantly higher incidence of nephropathy progression according to ceruloplasmin tertile (log-rank test, P<0.001). The hazard ratio (HR) for progression of diabetic nephropathy was significantly higher in the highest ceruloplasmin tertile category compared with the lowest ceruloplasmin tertile category, even after adjusting for confounding variables (HR, 3.32; 95% confidence interval, 1.28 to 8.61; P=0.003).

Conclusion

Baseline serum ceruloplasmin is an independent predictive factor for the progression of diabetic nephropathy in patients with type 2 diabetes mellitus.

Citations

Citations to this article as recorded by  
  • Ceruloplasmin-mediated copper accumulation drives cuproptosis and NLRP3 inflammasome activation to exacerbate diabetic nephropathy
    Henglan Wu, Shujun Pan, Tingyuan Chu, Wai Wilson Cheung, Jianghua Chen
    Tissue and Cell.2027; 105: 104108.     CrossRef
  • Hyperbaric Oxygen Therapy – a Potential Therapy for Macro- and Trace Elements’ Imbalance in Patients with Chronic Kidney Disease?
    Andrija Vukovic, Danijela Karanovic, Predrag Brkic, Sasa Jankovic, Jelena Nesovic-Ostojic, Milan Ivanov, Sanjin Kovacevic, Jelena Jovanovic, Una-Jovana Vajic, Silvio R. De Luka
    Biological Trace Element Research.2026; 204(7): 4796.     CrossRef
  • Key biomarkers in type 2 diabetes patients: A systematic review
    Thien Ngoc Le, Richard Bright, Vi‐Khanh Truong, Jordan Li, Rajiv Juneja, Krasimir Vasilev
    Diabetes, Obesity and Metabolism.2025; 27(1): 7.     CrossRef
  • Augmented Intrarenal and Urinary Angiotensinogen in Diabetic Nephropathy: The Role of Isoflavones
    Masumi Kamiyama, Kotoe Iijima, Rema Okuzawa, Ruka Kawata, Airi Kimura, Yuki Shinohara, Ayana Shimada, Mika Yamanaka, Ayuka Youda, Tamami Iwamoto
    International Journal of Molecular Sciences.2025; 26(4): 1443.     CrossRef
  • Proteomic analysis of urinary exosomes reveals ferroptosis-associated proteins are involved in diabetic nephropathy
    Kaida Mu, Yanping Yang, Xiaofei An, Jie Zhu, Jing Zhang, Yanfei Jiang, Xiaorong Yang, Jinan Zhang
    Genes & Diseases.2024; 11(5): 101138.     CrossRef
  • Modulatory role of Annona squamosa extract against streptozotocin-induced diabetic nephropathy in male rats
    Ghaliah Almalki, Norah Alothman, Gamal Mohamed, Mohammed Akeel, Abd El-Fattah B.M. El-Beltagy, Eman T. Salem
    Egyptian Journal of Basic and Applied Sciences.2024; 11(1): 536.     CrossRef
  • WITHDRAWN: Research on Traditional Chinese Medicine Syndrome Animal Models and Multi-omics Biomarkers in Type II Diabetes: A Review
    Yifei Wang, Yan Gao, Bonian Zhao
    Pharmacological Research - Modern Chinese Medicine.2024; : 100471.     CrossRef
  • Dynamic changes of inflammatory markers in the early stages of chronic kidney disease in patients with type 1 diabetes mellitus
    MV Osikov, LA Efros, LYu Zhuravleva, AA Fedosov
    Bulletin of Russian State Medical University.2024;[Epub]     CrossRef
  • In-depth urinary and exosome proteome profiling analysis identifies novel biomarkers for diabetic kidney disease
    Shichun Du, Linhui Zhai, Shu Ye, Le Wang, Muyin Liu, Minjia Tan
    Science China Life Sciences.2023; 66(11): 2587.     CrossRef
  • Serum Level of Ceruloplasmin, Angiotensin-Converting Enzyme and Transferrin as Markers of Severity in SARS-CoV-2 Infection in Patients with Type 2 Diabetes
    Patricia-Andrada Reștea, Ștefan Țigan, Laura Grațiela Vicaș, Luminița Fritea, Eleonora Marian, Tunde Jurca, Annamaria Pallag, Iulius Liviu Mureșan, Corina Moisa, Otilia Micle, Mariana Eugenia Mureșan
    Microbiology Research.2023; 14(4): 1670.     CrossRef
  • The nephropathy of sickle cell trait and sickle cell disease
    Kenneth I. Ataga, Santosh L. Saraf, Vimal K. Derebail
    Nature Reviews Nephrology.2022; 18(6): 361.     CrossRef
  • Integrated Analysis of Single-Cell RNA-seq and Bulk RNA-seq in the Identification of a Novel ceRNA Network and Key Biomarkers in Diabetic Kidney Disease
    Yuejun Wang, Mingming Zhao, Yu Zhang
    International Journal of General Medicine.2022; Volume 15: 1985.     CrossRef
  • Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology
    Zhidong Liu, Miao Wang, Chunbo Zhang, Shigao Zhou, Guang Ji
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 695.     CrossRef
  • A correlative study of copper, ceruloplasmin, iron, total iron binding capacity and total antioxidant capacity in diabetic nephropathy
    Ramlingareddy, Shivashankara A Ramachandrayya, Jeena Jacob, Malathi Mala
    Biomedicine.2022; 42(3): 469.     CrossRef
  • Novel biomarkers for prognosticating diabetic kidney disease progression
    Shilna Muttickal Swaminathan, Indu Ramachandra Rao, Srinivas Vinayak Shenoy, Attur Ravindra Prabhu, Pooja Basthi Mohan, Dharshan Rangaswamy, Mohan V Bhojaraja, Shivashankara Kaniyoor Nagri, Shankar Prasad Nagaraju
    International Urology and Nephrology.2022; 55(4): 913.     CrossRef
  • Evaluation of Serum Ceruloplasmin Levels as a Biomarker for Oxidative Stress in Patients With Diabetic Retinopathy
    Gurunadh Satyanarayana, Narendra Keisham, Hitender S Batra, Subrahmanya Murti V, Mansur Khan, Sandeep Gupta, Vikram Mahindra
    Cureus.2021;[Epub]     CrossRef
  • Prospection of plasma proteins as biomarkers for diabetes mellitus monitoring
    Liliane de Paula Silva, Fabiane Gomes de Moraes Rego, Geraldo Picheth, Marcelo Müller-Santos, Dayane Alberton
    Journal of Diabetes & Metabolic Disorders.2021; 20(1): 611.     CrossRef
  • Risk assessment for foot ulcers among Tunisian subjects with diabetes: a cross sectional outpatient study
    B. Zantour, S. Bouchareb, Z. El Ati, F. Boubaker, W. Alaya, W. Kossomtini, M. H. Sfar
    BMC Endocrine Disorders.2020;[Epub]     CrossRef
  • Metalloproteins and apolipoprotein C: candidate plasma biomarkers of T2DM screened by comparative proteomics and lipidomics in ZDF rats
    Shuai Wang, Zhiyuan Lu, Yuxin Wang, Tianran Zhang, Xiaodong He
    Nutrition & Metabolism.2020;[Epub]     CrossRef
  • Emerging vistas on electrochemical detection of diabetic retinopathy biomarkers
    K.S. Shalini Devi, Madhurantakam Sasya, Uma Maheswari Krishnan
    TrAC Trends in Analytical Chemistry.2020; 125: 115838.     CrossRef
  • Oxidative stress in peritoneal dialysis patients: Association with the dialysis adequacy and technique survival
    Natalia Stepanova, Lesya Korol, Olena Burdeyna
    Indian Journal of Nephrology.2019; 29(5): 309.     CrossRef
  • Recent advancements in biopolymer and metal nanoparticle-based materials in diabetic wound healing management
    Veena Vijayakumar, Sushanta K. Samal, Smita Mohanty, Sanjay K. Nayak
    International Journal of Biological Macromolecules.2019; 122: 137.     CrossRef
  • Rat Böbrek Dokusunda Kurşunun Neden Olduğu Oksidatif Strese Karşı Kitosanın Koruyucu etkisi
    Ugur ÖZDEK, Hasan TOZ, Ahmet Ufuk KÖMÜROĞLU, Leyla MİS, Zübeyir HUYUT, Yeter DEĞER
    Van Veterinary Journal.2019; 30(3): 187.     CrossRef
  • Changes in Trace Elements During Early Stages of Chronic Kidney Disease in Type 2 Diabetic Patients
    Ching-Chiang Lin, Ching-Tang Shih, Chien-Hung Lee, Yeou-Lih Huang
    Biological Trace Element Research.2018; 186(2): 330.     CrossRef
  • The Divalent Elements Changes in Early Stages of Chronic Kidney Disease
    Wan-Ju Kung, Ching-Tang Shih, Chien-Hung Lee, Ching-Chiang Lin
    Biological Trace Element Research.2018; 185(1): 30.     CrossRef
  • Long-term expression of glomerular genes in diabetic nephropathy
    Dominik Chittka, Bernhard Banas, Laura Lennartz, Franz Josef Putz, Kathrin Eidenschink, Sebastian Beck, Thomas Stempfl, Christoph Moehle, Simone Reichelt-Wurm, Miriam C Banas
    Nephrology Dialysis Transplantation.2018; 33(9): 1533.     CrossRef
  • Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies
    D. N. Koye, J. E. Shaw, C. M. Reid, R. C. Atkins, A. T. Reutens, D. J. Magliano
    Diabetic Medicine.2017; 34(7): 887.     CrossRef
  • Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis
    Pengzi Zhang, Jing Lu, Yali Jing, Sunyinyan Tang, Dalong Zhu, Yan Bi
    Annals of Medicine.2017; 49(2): 106.     CrossRef
  • Biomarkers of diabetic nephropathy: A 2017 update
    Nektaria Papadopoulou-Marketou, Christina Kanaka-Gantenbein, Nikolaos Marketos, George P. Chrousos, Ioannis Papassotiriou
    Critical Reviews in Clinical Laboratory Sciences.2017; 54(5): 326.     CrossRef
  • Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes
    Hung-Yuan Li, Hung-An Lin, Feng-Jung Nien, Vin-Cent Wu, Yi-Der Jiang, Tien-Jyun Chang, Hsien-Li Kao, Mao-Shin Lin, Jung-Nan Wei, Cheng-Hsin Lin, Shyang-Rong Shih, Chi-Sheng Hung, Lee-Ming Chuang, Emmanuel A Burdmann
    PLOS ONE.2016; 11(2): e0147981.     CrossRef
Review
Diabetic Kidney Disease: From Epidemiology to Clinical Perspectives
Cheol Whee Park
Diabetes Metab J. 2014;38(4):252-260.   Published online August 20, 2014
DOI: https://doi.org/10.4093/dmj.2014.38.4.252
  • 15,246 View
  • 84 Download
  • 82 Web of Science
  • 77 Crossref
AbstractAbstract PDFPubReader   ePub   

With worldwide epidemic of diabetes mellitus, diabetic nephropathy which is one of the major causes of microvascular complication has become a serious concern in Korea as well as the rest of the world. In view of its significance, there is an urgent and paramount need for proper managements that could either deter or slow the progression of diabetic nephropathy. Despite advances in care, ever increasing number of patients suffering from diabetic kidney disease and from end-stage renal disease implies that the current management is not adequate in many aspects. The reasons for these inadequacies compromise lack of early diagnosis, failure to intervene with timely and aggressive manner, and lack of understanding on the kind of interventions required. Another issue equally important for the adequate care of patients with diabetic nephropathy is an understanding of past, present and future epidemiology of diabetic nephropathy which serves, especially in Korea, as a material determining standard diagnosis and treatment and a national health-policy decision.

Citations

Citations to this article as recorded by  
  • Mechanisms of diabetic kidney disease and established and emerging treatments
    Victor Martinez Leon, Rachel Hilburg, Katalin Susztak
    Nature Reviews Endocrinology.2026; 22(1): 21.     CrossRef
  • Genomic mapping of diabetic kidney disease biomarkers and identification of potential inhibitors through virtual screening
    Yi LIU, Yu WANG
    Minerva Endocrinology.2026;[Epub]     CrossRef
  • Exploring the Multi-targeted Therapeutic Mechanism of Bioactives from Glycine max in Treatment of type 2 Diabetes Mellitus and Obesity through an In-vitro and In-silico Approach
    Vasundhara Sawant, Sanjay Sawant, Prerna Tamte, Minal Ghante, Jyoti Tangde
    Biosciences Biotechnology Research Asia.2025; 22(2): 637.     CrossRef
  • N6-methyladenosine RNA methylation in diabetic kidney disease
    Jiaan Huang, Fan Yang, Yan Liu, Yuehua Wang
    Biomedicine & Pharmacotherapy.2024; 171: 116185.     CrossRef
  • Unraveling the nexus of NAD+ metabolism and diabetic kidney disease: insights from murine models and human data
    Sisi Yang, Weiyuan Gong, Yujia Wang, Chuanming Hao, Yi Guan
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • The comorbidity burden of type 2 diabetes mellitus (T2DM): sex differences and associated factors among 830 cases in North-Eastern Morocco
    Ikram Kenfaoui, Said Bouchefra, Siham Daouchi, Abderrahim Benzakour, Mohammed Ouhssine
    Diabetology International.2024; 15(4): 814.     CrossRef
  • High glucose elevates intracellular calcium level and induces ferroptosis in glomerular endothelial cells through the miR-223-3p/ITPR3 pathway
    Dekai Wang, Lihua Zhang, Juanli Nan, Shengbi Wan, Jingmei Luo, Xueqiong Li, Wei Chen
    Molecular and Cellular Endocrinology.2024; 594: 112384.     CrossRef
  • DPDCD: The Intelligent Prediction Strategy for the Course Development of Diabetic Kidney Disease
    Jianfeng Wang, Guozhi Li, Jirui Li, Liang Liu
    International Journal of Pattern Recognition and Artificial Intelligence.2024;[Epub]     CrossRef
  • Association of advanced chronic kidney disease with diabetic retinopathy severity in older patients with diabetes: a retrospective cross-sectional study
    Geun Woo Lee, Chul Ho Lee, Seong Gyu Kim
    Journal of Yeungnam Medical Science.2023; 40(2): 146.     CrossRef
  • Age at Mortality in Patients with Type 2 Diabetes Who Underwent Kidney Transplantation: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
    Sun Ok Song, Eugene Han, Kang Ju Son, Bong-Soo Cha, Byung-Wan Lee
    Journal of Clinical Medicine.2023; 12(9): 3160.     CrossRef
  • Single‐cell RNA‐seq with spatial transcriptomics to create an atlas of human diabetic kidney disease
    Duo Chen, Mingwei Shao, Yi Song, Gaofei Ren, Feng Guo, Xunjie Fan, Yanyan Wang, Wei Zhang, Guijun Qin
    The FASEB Journal.2023;[Epub]     CrossRef
  • Metabolomic profiling of amino acids study reveals a distinct diagnostic model for diabetic kidney disease
    Jiao Wang, Chunyu Zhou, Qing Zhang, Zhangsuo Liu
    Amino Acids.2023; 55(11): 1563.     CrossRef
  • New insights into the mechanisms of diabetic kidney disease: Role of circadian rhythm and Bmal1
    Zhimei Peng, Yanting Liang, Xueying Liu, Jie Shao, Nan Hu, Xinzhou Zhang
    Biomedicine & Pharmacotherapy.2023; 166: 115422.     CrossRef
  • Physical exercise as a friend not a foe in acute kidney diseases through immune system modulation
    Ana Carolina Costanti-Nascimento, Leonilia Brelaz-Abreu, Elayne Bragança-Jardim, Welbert de Oliveira Pereira, Niels Olsen Saraiva Camara, Mariane Tami Amano
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Sodium-dependent glucose transporter 2 inhibitor alleviates renal lipid deposition and improves renal oxygenation levels in newly diagnosed type 2 diabetes mellitus patients: a randomized controlled trial
    Li Zhang, Tongdan Wang, Yan Kong, Haizhen Sun, Yuling Zhang, Junmei Wang, Zhida Wang, Shan Lu, Pei Yu, Saijun Zhou
    Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
  • Neutrophil lymphocyte ratio: a reliable biomarker for diabetic nephropathy?
    Ashutosh Singh, Anshu Kumar Jha, Bipul Chandra Kalita, Dharmendra Kumar Jha, Yash Alok
    International Journal of Diabetes in Developing Countries.2022; 42(3): 523.     CrossRef
  • miR-193a as a potential mediator of WT-1/synaptopodin in the renoprotective effect of Losartan on diabetic kidney
    Dan Gao, Pei Yu, Sanhui Jing, Chengcheng Yan, Dandan Ding, Yingjin Qiao, Ge Wu
    Canadian Journal of Physiology and Pharmacology.2022; 100(1): 26.     CrossRef
  • 3-Hydroxybutyrate Ameliorates the Progression of Diabetic Nephropathy
    Jeeyoun Jung, Woo Yeong Park, Yun Jin Kim, Mikyung Kim, Misun Choe, Kyubok Jin, Ji Hae Seo, Eunyoung Ha
    Antioxidants.2022; 11(2): 381.     CrossRef
  • Emerging Role of Epitranscriptomics in Diabetes Mellitus and Its Complications
    Xinqian Geng, Zheng Li, Ying Yang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Analysis of serum circulating MicroRNAs level in Malaysian patients with gestational diabetes mellitus
    Sajad Jamalpour, Shamsul Mohd Zain, Reza Vazifehmand, Zahurin Mohamed, Yuh Fen Pung, Hesam Kamyab, Siti Zawiah Omar
    Scientific Reports.2022;[Epub]     CrossRef
  • Combined Single-Cell RNA-Seq and Spatial Transcriptomics Reveal an Atlas of Human Diabetic Kidney Disease
    Duo Chen, Mingwei Shao, Yi Song, Gaofei Ren, Feng Guo, Xunjie Fan, Yanyan Wang, Wei Zhang, Guijun Qin
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • How to inhibit transforming growth factor beta safely in diabetic kidney disease
    Yuxin Yang, Kexin Shi, Devang M. Patel, Fang Liu, Tieqiao Wu, Zhonglin Chai
    Current Opinion in Nephrology & Hypertension.2021; 30(1): 115.     CrossRef
  • Plasma miR-193a-3p can be a potential biomarker for the diagnosis of diabetic nephropathy
    Yan Hong, Jidong Wang, Lai Zhang, Wenjuan Sun, Xuefang Xu, Kaiyue Zhang
    Annals of Clinical Biochemistry: International Journal of Laboratory Medicine.2021; 58(2): 141.     CrossRef
  • Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes
    Jae-Seung Yun, Yong-Moon Park, Kyungdo Han, Hyung-Wook Kim, Seon-Ah Cha, Yu-Bae Ahn, Seung-Hyun Ko
    Scientific Reports.2021;[Epub]     CrossRef
  • Integrin β3 overexpression contributes to podocyte injury through inhibiting RhoA/YAP signaling pathway
    Zhuo Li, Zhiwen Lian, Jianchao Ma, Li Zhang, Xingji Lian, Shuangxin Liu, Jianteng Xie, Zhonglin Feng, Ting Lin, Hong Zhang, Xinling Liang
    Bioengineered.2021; 12(1): 1138.     CrossRef
  • A Nonlinear Relationship Between Serum 25-Hydroxyvitamin D and Urine Albumin to Creatinine Ratio in Type 2 Diabetes: A Cross-Sectional Study in China
    Qian Liang, Haofei Hu, Han Wu, Xuan Chen, Wei Wang, Ying Le, Shufen Yang, Lijing Jia
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 2581.     CrossRef
  • Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetes
    Young-eun Kim, Minyoung Lee, Yong-ho Lee, Eun Seok Kang, Bong-soo Cha, Byung-Wan Lee
    Diabetes Research and Clinical Practice.2021; 181: 109082.     CrossRef
  • USP9X prevents AGEs-induced upregulation of FN and TGF-β1 through activating Nrf2-ARE pathway in rat glomerular mesangial cells
    Kaipeng Huang, Xilin Zhao
    Experimental Cell Research.2020; 393(2): 112100.     CrossRef
  • D-dimer Levels in Chronic Kidney Illness: A Comprehensive and Systematic Literature Review
    Sahar Vahdat, Shahrzad Shahidi
    Proceedings of the National Academy of Sciences, India Section B: Biological Sciences.2020; 90(5): 911.     CrossRef
  • Circulating Expression Level of LncRNA Malat1 in Diabetic Kidney Disease Patients and Its Clinical Significance
    Lian-ji Zhou, Da-wei Yang, Li-Na Ou, Xing-Rong Guo, Biao-liang Wu
    Journal of Diabetes Research.2020; 2020: 1.     CrossRef
  • Impact of chronic kidney disease definition on assessment of its incidence and risk factors in patients with newly diagnosed type 1 and type 2 diabetes in the UK: A cohort study using primary care data from the United Kingdom
    Antonio González-Pérez, Maria E. Saéz, David Vizcaya, Marcus Lind, Luis A. García Rodríguez
    Primary Care Diabetes.2020; 14(4): 381.     CrossRef
  • Resveratrol Inhibits Lipopolysaccharide-Induced Extracellular Matrix Accumulation and Inflammation in Rat Glomerular Mesangial Cells by SphK1/S1P2/NF-κB Pathway


    Wenyan Gong, Jie Li, Wenying Chen, Fuzhen Feng, Yanhui Deng
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 4495.     CrossRef
  • Effects of dietary iron restriction on kidney mitochondria function and oxidative stress in streptozotocin-diabetic rats
    Donovan J. Peña-Montes, Maribel Huerta-Cervantes, Mónica Ríos-Silva, Xóchitl Trujillo, Christian Cortés-Rojo, Miguel Huerta, Alfredo Saavedra-Molina
    Mitochondrion.2020; 54: 41.     CrossRef
  • Significance of glycated LDL in different stages of diabetic nephropathy
    Khalid Siddiqui, Teena P. George, Shaik Sarfaraz Nawaz, Maram Yaslam, Ebtehal Almogbel, Khalid Al-Rubeaan
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(1): 548.     CrossRef
  • Prognostic value of visit-to-visit systolic blood pressure variability related to diabetic kidney disease among patients with type 2 diabetes
    Zhe-Bin Yu, Jian-Bing Wang, Die Li, Xue-Yu Chen, Hong-Bo Lin, Kun Chen
    Journal of Hypertension.2019; 37(7): 1411.     CrossRef
  • Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
    Mitsuo Kato, Rama Natarajan
    Nature Reviews Nephrology.2019; 15(6): 327.     CrossRef
  • Resveratrol inhibits high glucose-induced activation of AP-1 and NF-κB via SphK1/S1P2 pathway to attenuate mesangial cells proliferation and inflammation
    Yanhui Deng, Wenyan Gong, Qiang Li, Xian Wu, Liyao Wu, Xiaoxia Zheng, Wenying Chen, Heqing Huang
    Journal of Functional Foods.2019; 55: 86.     CrossRef
  • Predictive Factors for Efficacy of AST-120 Treatment in Diabetic Nephropathy: a Prospective Single-Arm, Open-Label, Multi-Center Study
    You-Cheol Hwang, Se Won Kim, Kyu Yeon Hur, Bong-Soo Cha, In Joo Kim, Tae Sun Park, Sei Hyun Baik, Kun Ho Yoon, Kwan Woo Lee, In Kyu Lee, Moon-Kyu Lee
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • Potential Diagnostic Hemorheological Indexes for Chronic Kidney Disease in Patients With Type 2 Diabetes
    Hoyoon Lee, Wonwhi Na, Sang Bae Lee, Chul Woo Ahn, Jun Sung Moon, Kyu Chang Won, Sehyun Shin
    Frontiers in Physiology.2019;[Epub]     CrossRef
  • Comparing the Effect of Dipeptidyl-Peptidase 4 Inhibitors and Sulfonylureas on Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Prospective Open-Label Study
    Po-Chung Cheng, Shang-Ren Hsu, Jeng-Fu Kuo, Yun-Chung Cheng, Yu-Hsiu Liu, Shih-Te Tu
    Journal of Clinical Medicine.2019; 8(10): 1715.     CrossRef
  • Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease
    Yaeni Kim, Cheol Whee Park
    International Journal of Molecular Sciences.2019; 20(7): 1782.     CrossRef
  • Regulatory T cells in acute and chronic kidney diseases
    Rahul Sharma, Gilbert R. Kinsey
    American Journal of Physiology-Renal Physiology.2018; 314(5): F679.     CrossRef
  • Herba Artemisiae Capillaris Extract Prevents the Development of Streptozotocin‐Induced Diabetic Nephropathy of Rat
    Jianan Geng, Xiaoyan Yu, Chunyu Liu, Chengbo Sun, Menghuan Guo, Zhen Li, Yingli Jin, Yinggang Zou, Jinghua Yu, Youn C. Kim
    Evidence-Based Complementary and Alternative Medicine.2018;[Epub]     CrossRef
  • Overview of the burden of illness and the role of once-weekly glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes
    Deborah Hinnen
    Journal of the American Association of Nurse Practitioners.2018; 30(1): S4.     CrossRef
  • Previous Exercise Training Reduces Markers of Renal Oxidative Stress and Inflammation in Streptozotocin-Induced Diabetic Female Rats
    Liliany Souza de Brito Amaral, Cláudia Silva Souza, Rildo Aparecido Volpini, Maria Heloisa Massola Shimizu, Ana Carolina de Bragança, Daniele Canale, Antonio Carlos Seguro, Terezila Machado Coimbra, Amélia Cristina Mendes de Magalhães, Telma de Jesus Soar
    Journal of Diabetes Research.2018; 2018: 1.     CrossRef
  • Critical Shear Stress is Associated with Diabetic Kidney Disease in Patients with Type 2 Diabetes
    Seung Min Chung, Jung Hyun Oh, Jun Sung Moon, Yu Kyung Kim, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
    Scientific Reports.2018;[Epub]     CrossRef
  • Losartan Alleviates Renal Fibrosis and Inhibits Endothelial-to-Mesenchymal Transition (EMT) Under High-Fat Diet-Induced Hyperglycemia
    Yufeng Yao, Yong Li, Xiaofei Zeng, Zheng Ye, Xia Li, Lu Zhang
    Frontiers in Pharmacology.2018;[Epub]     CrossRef
  • Association between poor psychosocial conditions and diabetic nephropathy in Japanese type 2 diabetes patients: A cross‐sectional study
    Hiroyo Ninomiya, Naoto Katakami, Taka‐aki Matsuoka, Mitsuyoshi Takahara, Hitoshi Nishizawa, Norikazu Maeda, Michio Otsuki, Akihisa Imagawa, Hiroyasu Iso, Tetsuya Ohira, Iichiro Shimomura
    Journal of Diabetes Investigation.2018; 9(1): 162.     CrossRef
  • Is decreased lung function associated with chronic kidney disease? A retrospective cohort study in Korea
    Soo Kyoung Kim, Ji Cheol Bae, Jong-Ha Baek, Kyu Yeon Hur, Moon-Kyu Lee, Jae Hyeon Kim
    BMJ Open.2018; 8(4): e018928.     CrossRef
  • Urinary Microvesicle-Bound Uromodulin: A Potential Molecular Biomarker in Diabetic Kidney Disease
    Neng-jun Lou, Yi-hong Ni, Hong-ying Jia, Jing-ti Deng, Lu Jiang, Feng-jie Zheng, Ai-li Sun
    Journal of Diabetes Research.2017; 2017: 1.     CrossRef
  • Renoprotective effect of fucoidan from Acaudina molpadioides in streptozotocin/high fat diet-induced type 2 diabetic mice
    Shiwei Hu, Jinhui Wang, Jingfeng Wang, Shijie Li, Wei Jiang, Yu Liu
    Journal of Functional Foods.2017; 31: 123.     CrossRef
  • Analysis and comparison of the cost-effectiveness of statins according to the baseline low-density lipoprotein cholesterol level in Korea
    Y. J. Jeong, H. Kim, S. J. Baik, T. M. Kim, S. J. Yang, S.-H. Lee, J.-H. Cho, H. Lee, H. W. Yim, I. Y. Choi, K.-H. Yoon, H.-S. Kim
    Journal of Clinical Pharmacy and Therapeutics.2017; 42(3): 292.     CrossRef
  • Visualization of kidney fibrosis in diabetic nephropathy by long diffusion tensor imaging MRI with spin-echo sequence
    Jun-Ya Kaimori, Yoshitaka Isaka, Masaki Hatanaka, Satoko Yamamoto, Naotsugu Ichimaru, Akihiko Fujikawa, Hiroshi Shibata, Akira Fujimori, Sosuke Miyoshi, Takashi Yokawa, Kagayaki Kuroda, Toshiki Moriyama, Hiromi Rakugi, Shiro Takahara
    Scientific Reports.2017;[Epub]     CrossRef
  • Rutin suppresses high glucose-induced ACTA2 and p38 protein expression in diabetic nephropathy
    Chun-Shan Han, Kai Liu, Ning Zhang, Shi-Wen Li, Hai-Cheng Gao
    Experimental and Therapeutic Medicine.2017; 14(1): 181.     CrossRef
  • Emodin self-emulsifying platform ameliorates the expression of FN, ICAM-1 and TGF-β1 in AGEs-induced glomerular mesangial cells by promoting absorption
    Jiani Huang, Wenyan Gong, Zhiquan Chen, Junying Huang, Qiuhong Chen, Heqing Huang, Chunshun Zhao
    European Journal of Pharmaceutical Sciences.2017; 99: 128.     CrossRef
  • New therapeutic agents in diabetic nephropathy
    Yaeni Kim, Cheol Whee Park
    The Korean Journal of Internal Medicine.2017; 32(1): 11.     CrossRef
  • Urine clusterin/apolipoprotein J is linked to tubular damage and renal outcomes in patients with type 2 diabetes mellitus
    Sang Soo Kim, Sang Heon Song, Jong Ho Kim, Yun Kyung Jeon, Bo Hyun Kim, Min‐Cheol Kang, Sung Wan Chun, Soo Hyun Hong, Michelle Chung, Yong Ki Kim, In Joo Kim, Young‐Bum Kim
    Clinical Endocrinology.2017; 87(2): 156.     CrossRef
  • Treatment of diabetic kidney disease: current and future targets
    Mi-Kyung Kim
    The Korean Journal of Internal Medicine.2017; 32(4): 622.     CrossRef
  • Sphingosine kinase 1 mediates AGEs-induced fibronectin upregulation in diabetic nephropathy
    Cheng Chen, Wenyan Gong, Changzheng Li, Fengxiao Xiong, Shaogui Wang, Junying Huang, Yu Wang, Zhiquan Chen, Qiuhong Chen, Peiqing Liu, Tian Lan, Heqing Huang
    Oncotarget.2017; 8(45): 78660.     CrossRef
  • Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
    Eugene Han, Gyuri Kim, Ji-Yeon Lee, Yong-ho Lee, Beom Seok Kim, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
    Endocrinology and Metabolism.2017; 32(2): 274.     CrossRef
  • Glycemic Management of Patients Undergoing Dialysis
    Mi-Kyung Kim
    The Journal of Korean Diabetes.2016; 17(3): 164.     CrossRef
  • Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin–Angiotensin System Blockade
    Sang-Man Jin, Kyung Ah Han, Jae Myung Yu, Tae Seo Sohn, Sung Hee Choi, Choon Hee Chung, Ie Byung Park, Eun Jung Rhee, Sei Hyun Baik, Tae Sun Park, In-Kyu Lee, Seung-Hyun Ko, You-Cheol Hwang, Bong Soo Cha, Hyoung Woo Lee, Moon-Suk Nam, Moon-Kyu Lee
    Arteriosclerosis, Thrombosis, and Vascular Biology.2016; 36(10): 2108.     CrossRef
  • MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy
    Xiaoyan Hou, Jianwei Tian, Jian Geng, Xiao Li, Xun Tang, Jun Zhang, Xiaoyan Bai
    Oncotarget.2016; 7(30): 47760.     CrossRef
  • Lipoprotein(a) predicts a new onset of chronic kidney disease in people with Type 2 diabetes mellitus
    J.‐S. Yun, Y.‐B. Ahn, K.‐H. Song, K.‐D. Yoo, Y.‐M. Park, H.‐W. Kim, S.‐H. Ko
    Diabetic Medicine.2016; 33(5): 639.     CrossRef
  • Metabolic biomarkers for chronic kidney disease
    Marc Breit, Klaus M. Weinberger
    Archives of Biochemistry and Biophysics.2016; 589: 62.     CrossRef
  • Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
    Seok Joon Shin, Sungjin Chung, Soo Jung Kim, Eun-Mi Lee, Young-Hye Yoo, Ji-Won Kim, Yu-Bae Ahn, Eun-Sook Kim, Sung-Dae Moon, Myung-Jun Kim, Seung-Hyun Ko, Kwang-Hyun Baek
    PLOS ONE.2016; 11(11): e0165703.     CrossRef
  • Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice
    Gwon-Soo Jung, Jae-Han Jeon, Mi Sun Choe, Sung-Woo Kim, In-Kyu Lee, Mi-Kyung Kim, Keun-Gyu Park
    Diabetes & Metabolism Journal.2016; 40(3): 211.     CrossRef
  • Beneficial effects of previous exercise training on renal changes in streptozotocin-induced diabetic female rats
    Liliany S de Brito Amaral, Fernanda A Silva, Vicente B Correia, Clara EF Andrade, Bárbara A Dutra, Márcio V Oliveira, Amélia CM de Magalhães, Rildo A Volpini, Antonio C Seguro, Terezila M Coimbra, Telma de J Soares
    Experimental Biology and Medicine.2016; 241(4): 437.     CrossRef
  • Adenosine monophosphate–activated protein kinase in diabetic nephropathy
    Yaeni Kim, Cheol Whee Park
    Kidney Research and Clinical Practice.2016; 35(2): 69.     CrossRef
  • Estimated Glucose Disposal Rate (eGDR) – A Marker for the Assessment of Insulin Resistance in Type 1 Diabetes Mellitus
    Mihaela L. Bîcu, Daniel Bîcu, Sigina Gârgavu, Magdalena Sandu, Mihaela I. Vladu, Diana Clenciu, Eugen Moţa, Maria Moţa
    Romanian Journal of Diabetes Nutrition and Metabolic Diseases.2016; 23(2): 177.     CrossRef
  • Polydatin attenuates AGEs-induced upregulation of fibronectin and ICAM-1 in rat glomerular mesangial cells and db/db diabetic mice kidneys by inhibiting the activation of the SphK1-S1P signaling pathway
    Cheng Chen, Kaipeng Huang, Jie Hao, Junying Huang, Zhiying Yang, Fengxiao Xiong, Peiqing Liu, Heqing Huang
    Molecular and Cellular Endocrinology.2016; 427: 45.     CrossRef
  • Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes
    Hye-jin Yoon, Yong-ho Lee, So Ra Kim, Tyler Hyungtaek Rim, Eun Young Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Byung-Wan Lee
    Cardiovascular Diabetology.2015;[Epub]     CrossRef
  • Tripterygium Glycosides Tablet Ameliorates Renal Tubulointerstitial Fibrosis via the Toll-Like Receptor 4/Nuclear Factor Kappa B Signaling Pathway in High-Fat Diet Fed and Streptozotocin-Induced Diabetic Rats
    Ze-jun Ma, Xiao-na Zhang, Li Li, Wei Yang, Shan-shan Wang, Xin Guo, Pei Sun, Li-ming Chen
    Journal of Diabetes Research.2015; 2015: 1.     CrossRef
  • The association between abnormal heart rate variability and new onset of chronic kidney disease in patients with type 2 diabetes: A ten-year follow-up study
    Jae-Seung Yun, Yu-Bae Ahn, Ki-Ho Song, Ki-Dong Yoo, Hyung-Wook Kim, Yong-Moon Park, Seung-Hyun Ko
    Diabetes Research and Clinical Practice.2015; 108(1): 31.     CrossRef
  • Finerenone: third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease
    Licette CY Liu, Elise Schutte, Ron T Gansevoort, Peter van der Meer, Adriaan A Voors
    Expert Opinion on Investigational Drugs.2015; 24(8): 1123.     CrossRef
  • Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study
    Seung Jin Han, Hae Jin Kim, Dae Jung Kim, Seung Soo Sheen, Choon Hee Chung, Chul Woo Ahn, Se Hwa Kim, Yong-Wook Cho, Seok Won Park, Soo-Kyung Kim, Chul Sik Kim, Kyung Wook Kim, Kwan Woo Lee
    Diabetology & Metabolic Syndrome.2015;[Epub]     CrossRef
  • Proteomic Profile in Glomeruli of Type-2 Diabetic KKAy Mice using 2-Dimensional Differential Gel Electrophoresis
    Lining Wang
    Medical Science Monitor.2014; 20: 2705.     CrossRef
Original Articles
Serum Cystatin C Reflects the Progress of Albuminuria
Jeong Seon Yoo, Young Mi Lee, Eun Hae Lee, Ji Woon Kim, Shin Young Lee, Ki-Cheon Jeong, Shin Ae Kang, Jong Suk Park, Joo Young Nam, Chul Woo Ahn, Young Duk Song, Kyung Rae Kim
Diabetes Metab J. 2011;35(6):602-609.   Published online December 26, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.6.602
  • 11,306 View
  • 49 Download
  • 8 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Research on the relationship between urinary albumin excretion and serum cystatin C in diabetes is restricted to cross-sectional studies. In this study, we investigated how well serial measurements of serum cystatin C level reflect changes in the urinary albumin excretion rate.

Methods

We enrolled and retrospectively collected data on 1,058 participants with type 2 diabetes who were older than 18 years and who had more than 3 years of follow-up with serial measurements of albuminuria and serum cystatin C at an outpatient clinic.

Results

With the use of a linear mixed model, we found that the albuminuria level for each patient over time corresponded with the annual change in serum cystatin C-based estimated glomerular filtration rate (cysC-eGFR) but did not correspond with the creatinine-based eGFR calculated by the modification of diet in renal disease formula (MDRD-eGFR). The discrepancy in the direction of the trend was smaller with cysC-eGFR than with MDRD-eGFR.

Conclusion

Serum cystatin C level reflects the trend in albuminuria level more accurately than serum creatinine level in Korean type 2 diabetes mellitus patients.

Citations

Citations to this article as recorded by  
  • Serum cystatin C as a biomarker for diabetic retinopathy and its role in diabetic retinopathy-diabetic kidney disease comorbidity
    Xiaosi Chen, Weichen Yuan, Yiyun Zeng, Hanyu Wu, Linghui Pi, Yang Yang, Xinming Gu, Xinyuan Zhang
    Journal of Translational Medicine.2026;[Epub]     CrossRef
  • Selective glomerular hypofiltration syndrome: a novel renal phenotype associated with cardiovascular disease and adverse outcomes in diabetic kidney disease
    Yuan Fang, Xiaodan Guo, Liuting Zhong, Xinyan He, Xiaohong Zhang, Jianxin Wan
    BMJ Open Diabetes Research & Care.2026; 14(5): e006417.     CrossRef
  • Assessment of Cystatin C and Microalbumin as Biomarkers for Nephropathy in Patients with Type 2 Diabetes Mellitus
    Bhuneshwar Yadav, Shashidhar K.N, Raveesha A, Muninarayana C.
    Journal of Evolution of Medical and Dental Sciences.2021; 10(25): 1866.     CrossRef
  • Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
    Eugene Han, Mi Kyung Kim, Byoung Kuk Jang, Hye Soon Kim
    Diabetes & Metabolism Journal.2021; 45(5): 698.     CrossRef
  • Increase of BACE1, Brain-Renal Risk Factor, Contributes to Kidney Damage in an Alzheimer’s Disease Mouse Model
    Yan Shi, Feng Gao, Xiaoli Yang, Dongwei Liu, Qiuxia Han, Zhangsuo Liu, Hanyu Zhu, Yong Shen
    Journal of Alzheimer's Disease.2020; 76(1): 237.     CrossRef
  • Diagnostic accuracy of cystitis C and β-2 microglobulin in detection of renal impairment in patients with type 2 diabetes
    NourhanA Heiba, ManalS Negm, MaalyM Mabrouk, MohamedH Abou-Freikha
    Tanta Medical Journal.2020; 48(2): 91.     CrossRef
  • Lower Leg Fat Depots Are Associated with Albuminuria Independently of Obesity, Insulin Resistance, and Metabolic Syndrome (Korea National Health and Nutrition Examination Surveys 2008 to 2011)
    Eugene Han, Nan Hee Cho, Mi Kyung Kim, Hye Soon Kim
    Diabetes & Metabolism Journal.2019; 43(4): 461.     CrossRef
  • Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients
    Caroline Pereira Domingueti, Rodrigo Bastos Fóscolo, Ana Cristina Simões e Silva, Luci Maria S. Dusse, Janice Sepúlveda Reis, Maria das Graças Carvalho, Ana Paula Fernandes, Karina Braga Gomes
    Archives of Endocrinology and Metabolism.2016; 60(2): 108.     CrossRef
Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients
Eun Hee Kim, Ji Hee Yu, Sang Ah Lee, Eui Young Kim, Won Gu Kim, Seung Hun Lee, Eun Hee Cho, Eun Hee Koh, Woo Je Lee, Min-Seon Kim, Joong-Yeol Park, Ki-Up Lee
Korean Diabetes J. 2010;34(2):95-100.   Published online April 30, 2010
DOI: https://doi.org/10.4093/kdj.2010.34.2.95
  • 9,466 View
  • 46 Download
  • 7 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Serum cystatin C level is a more sensitive marker of renal dysfunction than serum creatinine level. Serum cystatin C level was recently reported to predict the development of cardiovascular disease. This study was performed to evaluate whether the cystatin C level is associated with coronary artery disease (CAD), independent of diabetic nephropathy.

Methods

We conducted a case-control study to assess the relationship between serum cystatin C level and coronary artery disease in diabetic patients. Among 460 diabetic patients, 38 diabetic patients had CAD. The control group consisted of 38 diabetic patients who were matched to cases by age, sex, and presence/absence of diabetic nephropathy. Serum cystatin C level was measured in stored samples.

Results

Serum cystatin C level was significantly higher in patients with diabetic nephropathy, both in CAD and non-CAD patients. However, serum cystatin C level did not differ between CAD and non-CAD patients, regardless of diabetic nephropathy.

Conclusion

Serum cystatin C level is a marker of renal dysfunction, but not coronary artery disease, in diabetic patients.

Citations

Citations to this article as recorded by  
  • Higher Levels of Cystatin C in HIV/AIDS Patients with Metabolic Syndrome
    Gordana Dragović, Danica Srdić, Khawla Al Musalhi, Ivan Soldatović, Jovana Kušić, Djordje Jevtović, Devaki Nair
    Basic & Clinical Pharmacology & Toxicology.2018; 122(4): 396.     CrossRef
  • The association between serum cystatin C and carotid intima–media thickness in metabolic syndrome patients with normal estimated glomerular filtration rate
    Rong Huang, Jingli Gu, Qin Cao, Jiahua Ma, Weiwei Gu, Zhuping Fan
    Clinica Chimica Acta.2015; 448: 170.     CrossRef
  • Association of plasma cystatin C levels with angiographically documented coronary artery disease in patients of Indian origin
    Aditya Batra, Aditya Kapoor, R.K. Sharma, Nitin Agrawal, Archana Sinha, Sudeep Kumar, Naveen Garg, Satyendra Tewari, Pravin K. Goel
    Journal of Cardiology.2012; 59(2): 182.     CrossRef
  • Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate
    Xie Qing, Wang Furong, Liu Yunxia, Zhang Jian, Wang Xuping, Gao Ling
    Cardiovascular Diabetology.2012;[Epub]     CrossRef
  • Response: Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients (Korean Diabetes J 2010;34:95-100)
    Eun Hee Kim, Ki-Up Lee
    Korean Diabetes Journal.2010; 34(3): 209.     CrossRef
  • Serum Cystatin C as a Biomarker for Predicting Coronary Artery Disease in Diabetes
    Jee-Young Oh
    Korean Diabetes Journal.2010; 34(2): 84.     CrossRef
  • Letter: Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients (Korean Diabetes J 2010;34:95-100)
    Kyu-Chang Won
    Korean Diabetes Journal.2010; 34(3): 207.     CrossRef
Association of Spot Urine Albumin-to-Creatinine Ratio and 24 Hour-Collected Urine Albumin Excretion Rate in Patients with Type 2 Diabetes Mellitus.
Jee In Lee, Hyuk Sang Kwon, Su Jin Oh, Jung Min Lee, Sang Ah Chang, Bong Yun Cha, Hyun Shik Son, Tae Seo Sohn
Korean Diabetes J. 2009;33(4):299-305.   Published online August 1, 2009
DOI: https://doi.org/10.4093/kdj.2009.33.4.299
  • 5,980 View
  • 61 Download
AbstractAbstract PDF
BACKGROUND
Measuring urine albumin in diabetic patients is an important screening test to identify those individuals at high risk for cardiovascular disease and the progression of kidney disease. Recently, spot urine albumin-to-creatinine ratio (ACR) has replaced 24 hour-collected urine albumin excretion rate (AER) as a screening test for microalbuminuria given its comparative simplicity. The purpose of the current study was to evaluate the degree of correlation between AER and ACR in the normal, microalbuminuric and macroalbuminuric ranges, and to identify the lower limits of ACR for both genders. METHODS: A total of 310 type 2 diabetics admitted to one center were enrolled in the present study. Following the collection of a spot urine sample, urine was collected for 24 hours and albumin content was measured in both specimens. RESULTS: Mean patient age was 60.2 years. A total of 25.4% had microalbuminuria and 15.8% had macroalbuminuria. The data revealed a strongly positive correlation between AER and ACR across all ranges of albuminuria (R = 0.8). The cut-off value of ACR for 30 mg/day of AER by the regression equation was 24 microgram/mg for men, 42 microgram/mg for women and 31.2 microgram/mg for all patients. The diagnostic performance expressed as the area under the curve (AUC) was 0.938 (95% CI, 0.911-0.965) for ACR. ACR revealed a sensitivity of 84% and specificity of 84%, when a cut-off value of 31.2 microgram/mg was employed. CONCLUSION: ACR was highly correlated with AER, particularly in the range of microalbuminuria. The gender combined cut-off value of ACR in type 2 diabetic patients was determined to be 31.2 microg/mg However, additional studies of large outpatient populations, as opposed to the inpatient population used in the present study, are required to confirm the utility of this value.

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP